in a pdf format

106
List of European Pharmacopoeia Reference Standards Effective from 2018/2/12 © Council of Europe, all rights reserved 2018 1 For extra charges, please see terms and conditions. DGD : Dangerous Goods Declaration. Order Code Reference Standard Batch Quantity per vial Sale Unit Information Monograph Storage Shipping group Shipment with DGD Price New Y0002004 Arsenic solution 1 10 mL 1 20420 Room temp. +20°C A1a 79 Y0001561 Abacavir sulfate 1 20 mg 1 2589 +5°C ± 3°C A1A 79 Y0001552 Abacavir for peak identification 1 10 mg 1 2589 +5°C ± 3°C A1A 79 Y0001551 Abacavir for system suitability 1 10 mg 1 2589 +5°C ± 3°C A1A 79 Y0000055 Acamprosate calcium - reference spectrum 1 n/a 1 1585 L 79 Y0000116 Acamprosate impurity A 2 110 mg 1 3-aminopropane-1-sulfonic acid (homotaurine) 1585 +5°C ± 3°C A1A 79 Y0000500 Acarbose 3 100 mg 1 See leaflet 2089 +5°C ± 3°C A1a 79 Y0000354 Acarbose for identification 1 10 mg 1 2089 +5°C ± 3°C A1A 79 Y0000427 Acarbose for peak identification 4 20 mg 1 Batch 3 is valid until 31 May 2017 2089 +5°C ± 3°C A1A 79 A0040000 Acebutolol hydrochloride 1 50 mg 1 0871 +5°C ± 3°C A1A 79 Y0000359 Acebutolol impurity B 2 10 mg 1 N-[3-acetyl-4-[(2RS)-2-hydroxy-3-[(1-methylethyl)amino] propoxy]phenyl]acetamide (diacetolol) 0871 +5°C ± 3°C A1A 79 Y0000127 Acebutolol impurity C 1 20 mg 1 N-(3-acetyl-4-hydroxyphenyl)butanamide 0871 +5°C ± 3°C A1A 79 Y0000128 Acebutolol impurity I 2 0.004 mg 1 N-[3-acetyl-4-[(2RS)-3-(ethylamino)-2- hydroxypropoxy]phenyl]butanamide 0871 +5°C ± 3°C A1A 79 Y0000056 Aceclofenac - reference spectrum 1 n/a 1 1281 L 79 Y0000085 Aceclofenac impurity F 2 15 mg 1 benzyl[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetate (benzyl ester of aceclofenac) 1281 +5°C ± 3°C A1A 79 Y0000086 Aceclofenac impurity H 1 10 mg 1 [[[[[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetyl] oxy]acetyl]oxy]acetic acid (diacetic aceclofenac) 1281 +5°C ± 3°C A1A 79 Y0001094 Aceclofenac for peak identification 1 10 mg 1 1281 +5°C ± 3°C A1A 79 Y0001915 Aceclofenac impurity I 1 15 mg 1 1281 +5°C ± 3°C A1a 79 Y0000810 Acemetacin 1 100 mg 1 1686 +5°C ± 3°C A1A 79 Y0000811 Acemetacin impurity A 1 10 mg 1 4-chlorobenzoic acid 1686 +5°C ± 3°C A1A 79 Y0000842 Acemetacin impurity mixture 1 0.06 mg 1 1686 +5°C ± 3°C A1A 79 A0070000 Acesulfame potassium 2 50 mg 1 1282 +5°C ± 3°C A1A 79 A0070020 Acesulfame potassium impurity B 4 15 mg 1 see leaflet; 5-chloro-6-methyl-1,2,3-oxathiazin-4(3§)-one 2,2- dioxide 1282 +5°C ± 3°C A1A 79 A0100000 Acetazolamide 1 100 mg 1 0454 +5°C ± 3°C A1A 79 Y0001084 Acetazolamide for system suitability 2 0.0068 mg 1 0454 +5°C ± 3°C A1A 79 Y0000002 Acetylcholine chloride 1 50 mg 1 1485,1971 -20°C ± 5°C C1A 79 A0150000 Acetylcysteine 3 50 mg 1 0967 +5°C ± 3°C A1A 79 A0152000 Acetylcysteine impurity C 11 10 mg 1 (2R,2'R)-3,3'-disulfanediylbis[2-(acetylamino)propanoic acid] (N,N'-diacetyl-L-cystine) 0967 +5°C ± 3°C A1A 79

Transcript of in a pdf format

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 1For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

New Y0002004 Arsenic solution 1 10 mL 1 20420 Room temp. +20°C

A1a 79 €

Y0001561 Abacavir sulfate 1 20 mg 1 2589 +5°C ± 3°C A1A 79 €

Y0001552 Abacavir for peak identification 1 10 mg 1 2589 +5°C ± 3°C A1A 79 €

Y0001551 Abacavir for system suitability 1 10 mg 1 2589 +5°C ± 3°C A1A 79 €

Y0000055 Acamprosate calcium - reference spectrum 1 n/a 1 1585 L 79 €

Y0000116 Acamprosate impurity A 2 110 mg 1 3-aminopropane-1-sulfonic acid (homotaurine) 1585 +5°C ± 3°C A1A 79 €

Y0000500 Acarbose 3 100 mg 1 See leaflet 2089 +5°C ± 3°C A1a 79 €

Y0000354 Acarbose for identification 1 10 mg 1 2089 +5°C ± 3°C A1A 79 €

Y0000427 Acarbose for peak identification 4 20 mg 1 Batch 3 is valid until 31 May 2017 2089 +5°C ± 3°C A1A 79 €

A0040000 Acebutolol hydrochloride 1 50 mg 1 0871 +5°C ± 3°C A1A 79 €

Y0000359 Acebutolol impurity B 2 10 mg 1 N-[3-acetyl-4-[(2RS)-2-hydroxy-3-[(1-methylethyl)amino] propoxy]phenyl]acetamide (diacetolol)

0871 +5°C ± 3°C A1A 79 €

Y0000127 Acebutolol impurity C 1 20 mg 1 N-(3-acetyl-4-hydroxyphenyl)butanamide 0871 +5°C ± 3°C A1A 79 €

Y0000128 Acebutolol impurity I 2 0.004 mg 1 N-[3-acetyl-4-[(2RS)-3-(ethylamino)-2-hydroxypropoxy]phenyl]butanamide

0871 +5°C ± 3°C A1A 79 €

Y0000056 Aceclofenac - reference spectrum 1 n/a 1 1281 L 79 €

Y0000085 Aceclofenac impurity F 2 15 mg 1 benzyl[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetate (benzyl ester of aceclofenac)

1281 +5°C ± 3°C A1A 79 €

Y0000086 Aceclofenac impurity H 1 10 mg 1 [[[[[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetyl] oxy]acetyl]oxy]acetic acid (diacetic aceclofenac)

1281 +5°C ± 3°C A1A 79 €

Y0001094 Aceclofenac for peak identification 1 10 mg 1 1281 +5°C ± 3°C A1A 79 €

Y0001915 Aceclofenac impurity I 1 15 mg 1 1281 +5°C ± 3°C A1a 79 €

Y0000810 Acemetacin 1 100 mg 1 1686 +5°C ± 3°C A1A 79 €

Y0000811 Acemetacin impurity A 1 10 mg 1 4-chlorobenzoic acid 1686 +5°C ± 3°C A1A 79 €

Y0000842 Acemetacin impurity mixture 1 0.06 mg 1 1686 +5°C ± 3°C A1A 79 €

A0070000 Acesulfame potassium 2 50 mg 1 1282 +5°C ± 3°C A1A 79 €

A0070020 Acesulfame potassium impurity B 4 15 mg 1 see leaflet; 5-chloro-6-methyl-1,2,3-oxathiazin-4(3§)-one 2,2-dioxide

1282 +5°C ± 3°C A1A 79 €

A0100000 Acetazolamide 1 100 mg 1 0454 +5°C ± 3°C A1A 79 €

Y0001084 Acetazolamide for system suitability 2 0.0068 mg 1 0454 +5°C ± 3°C A1A 79 €

Y0000002 Acetylcholine chloride 1 50 mg 1 1485,1971 -20°C ± 5°C

C1A 79 €

A0150000 Acetylcysteine 3 50 mg 1 0967 +5°C ± 3°C A1A 79 €

A0152000 Acetylcysteine impurity C 11 10 mg 1 (2R,2'R)-3,3'-disulfanediylbis[2-(acetylamino)propanoic acid] (N,N'-diacetyl-L-cystine)

0967 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 2For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

A0153000 Acetylcysteine impurity D 7 10 mg 1 (2R)-2-(acetylamino)-3-(acetylsulfanyl)propanoic acid (N,S-diacetyl-L-cysteine) ; Batch 6 is valid until 31 May 2017

0967 +5°C ± 3°C A1A 79 €

Y0000565 ß-Acetyldigoxin 2 50 mg 1 See leaflet C÷–HÿÿOŒ— 2168 +5°C ± 3°C A1A 79 €

Y0000642 ß-Acetyldigoxin for peak identification 1 10 mg 1 2168 +5°C ± 3°C A1A 79 €

A0200000 Acetylsalicylic acid 5 10 mg 1 0309 +5°C ± 3°C A1A 79 €

Y0001460 Acetylsalicylic acid for peak identification 3 10.3 mg 1 0309 +5°C ± 3°C A1A 79 €

Y0001462 Acetylsulfadiazine 2 0.002 mg 1 Batch 1 is valid until 28 February 2018 0294 +5°C ± 3°C A1A 79 €

A0208000 N-Acetyltryptophan 2 125 mg 1 1383 +5°C ± 3°C A1A 79 €

A0202000 N-Acetyltyrosine 1 200 mg 1 1384 +5°C ± 3°C A1A 79 €

Y0000693 Acholeplasma laidlawii BRP 1 1 ml 1 20607 -80°C ± 10°C

D1A 120 €

A0220000 Aciclovir 3 75 mg 1 0968 +5°C ± 3°C A1A 79 €

Y0001271 Aciclovir for peak identification 1 4 0.3 mg 1 0968 +5°C ± 3°C A1a 79 €

Y0001269 Aciclovir for peak identification 2 4 0.004 mg 1 0968 +5°C ± 3°C A1A 79 €

Y0001264 Aciclovir for system suitability 1 10 mg 1 0968 +5°C ± 3°C A1A 79 €

A0225000 Acitretin 2 100 mg 1 See leaflet CœŒHœÿO– 1385 +5°C ± 3°C B1A 79 €

New Y0001987 Acitretin for impurity A identification 1 5 mg 1 1385 +5°C ± 3°C B1a 79 €

Y0001463 Actaea racemosa HRS 1 1200 mg 1 2069 +5°C ± 3°C A1A 79 €

Y0001543 Actaea racemosa for assay CRS 1 300 mg 1 See leaflet C÷œHÿ—NOŒÿ; Monoammonium glycyrrhizate 2069 +5°C ± 3°C A1A 79 €

Y0001464 Actaea racemosa dry extract for system suitability HRS

1 1200 mg 1 2069 -20°C ± 5°C

C1A 79 €

Y0001121 Adapalene 1 100 mg 1 See leaflet Cœ‡Hœ‡O– 2445 +5°C ± 3°C A1A 79 €

Y0001120 Adapalene impurity C 3 6 mg 1 1-(2-methoxyphenyl)tricyclo[3.3.1.1]decane 2445 +5°C ± 3°C A1A 79 €

Y0001119 Adapalene for peak identification 2 2.02 mg 1 2445 +5°C ± 3°C A1A 79 €

A0230000 Adenine 2 50 mg 1 0800 +5°C ± 3°C A1A 79 €

A0230200 Adenosine 1 50 mg 1 1486 +5°C ± 3°C A1A 79 €

Y0000110 Adipic acid 1 50 mg 1 1586 +5°C ± 3°C A1A 79 €

Y0000882 Adrenaline 1 5 mg 1 2303 +5°C ± 3°C A1A 79 €

Y0000740 Adrenaline impurity mixture 3 0.005 mg 1 0254,2303 +5°C ± 3°C A1A 79 €

Y0000883 Adrenaline with impurity F 1 10 mg 1 2303 +5°C ± 3°C A1A 79 €

A0300000 Adrenaline tartrate 6 100 mg 1 0254 +5°C ± 3°C A1A 79 €

Y0000707 Adrenaline tartrate with impurity A 1 15 mg 1 0254 +5°C ± 3°C A1A 79 €

Y0001527 Aescin for LC assay HRS 1 150 mg 1 see leaflet C—÷H‡÷Oœ– 1830,1829 +5°C ± 3°C A1A 79 €

Y0001724 Agnus castus fruit dry extract 1 350 mg 1 see leaflet 2309, 2147 -20°C ± 5°C

C1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 3For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

A0325000 Alanine 3 60 mg 1 0752 +5°C ± 3°C A1A 79 €

A0325100 Albendazole 2 50 mg 1 1386 +5°C ± 3°C A1A 79 €

New Y0001964 Albendazole for system suitability 1 10 mg 1 1386 +5°C ± 3°C A1a 79 €

New Y0001959 Albendazole impurity mixture 2 0.003 mg 1 1386 +5°C ± 3°C A1a 79 €

A0325200 Alcuronium chloride 2 50 mg 1 1285 -20°C ± 5°C

C1A 79 €

New A0325450 Alfacalcidol 10 5 mg 1 See leaflet ; Batch 9 is valid until 30 June 2018 1286 -20°C ± 5°C

C1A 300 €

Y0001601 Alfacalcidol for system suitability 1 2.5 mg 1 1286 -20°C ± 5°C

C1A 79 €

A0325451 Alfacalcidol - reference spectrum 1 n/a 1 1286 L 79 €

A1225000 Alfadex 3 150 mg 1 See leaflet [CÿHŒÐ0—]ÿ 1070,1487,2769

+5°C ± 3°C A1A 79 €

A0325500 Alfentanil hydrochloride - reference spectrum 1 n/a 1 1062 L 79 €

Y0001883 Alfuzosin for peak identification 1 10 mg 1 1287 +5°C ± 3°C A1a 79 €

Y0001906 Alfuzosin for system suitability A 1 10 mg 1 1287 +5°C ± 3°C A1a 79 €

A0325800 Alfuzosin hydrochloride 2 10 mg 1 1287 +5°C ± 3°C A1A 79 €

Y0001583 Alimemazine hemitartrate 1 15 mg 1 2650 +5°C ± 3°C A1A 79 €

Y0001581 Alimemazine for system suitability 1 5 mg 1 2650 +5°C ± 3°C A1A 79 €

A0349000 Allantoin 1 60 mg 1 1288 +5°C ± 3°C A1A 79 €

A0350000 Allopurinol 3 100 mg 1 See leaflet 0576 +5°C ± 3°C A1a 79 €

A0350010 Allopurinol impurity A 3 10 mg 1 5-amino-1H-pyrazole-4-carboxamide ; Batch 2 is valid until 31 January 2018

0576 +5°C ± 3°C A1a 79 €

A0350020 Allopurinol impurity B 4 10 mg 1 5-formylamino-1H-pyrazole-4-carboxamide ; Batch 3 is valid until 28 February 2018

0576 +5°C ± 3°C A1a 79 €

A0350030 Allopurinol impurity C 3 10 mg 1 5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4-carboxamide 0576 +5°C ± 3°C A1a 79 €

A0350040 Allopurinol impurity D 4 15 mg 1 ethyl 5-amino-1H-pyrazole-4-carboxylate 0576 +5°C ± 3°C A1a 79 €

A0350050 Allopurinol impurity E 1 20 mg 1 ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate 0576 +5°C ± 3°C A1a 79 €

A0351000 Allylstrychnine bromide 1 10 mg 1 1285 -20°C ± 5°C

C1A 79 €

Y0000235 Almagate 2 50 mg 1 See leaflet 2010 +5°C ± 3°C A1A 79 €

Y0000255 Almagate - reference spectrum 1 n/a 1 2010 L 79 €

A0357000 Alprazolam - * psy 2 100 mg 1 1065 +5°C ± 3°C A2A 79 €

A0360000 Alprenolol hydrochloride 1 100 mg 1 0628,0876 +5°C ± 3°C A1A 79 €

Y0000054 Alprostadil 3 25 mg 1 See leaflet 1488 -20°C ± 5°C

C1A 79 €

Y0000606 Altizide 2 150 mg 1 See leaflet CŒŒHŒ÷ClN–O÷S– 0370,2185 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 4For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000843 Altizide impurity B 1 15 mg 1 3-[(2,2-dimethoxyethyl)sulphanyl]prop-1-ene 2185 +5°C ± 3°C A1A 79 €

Y0000687 Alverine citrate 1 5 mg 1 2156 +5°C ± 3°C A1A 79 €

Y0001819 Alverine impurity C 2 40 mg 1 N-ethyl-3-phenylpropan-1-amine 2156 -20°C ± 5°C

C1A 79 €

Y0000607 Alverine impurity D 1 10 mg 1 N-(3-cyclohexylpropyl)-N-ethyl-3-phenylpropan-1-amine 2156 +5°C ± 3°C A1A 79 €

A0363000 Amantadine hydrochloride 1 100 mg 1 0463 +5°C ± 3°C A1A 79 €

A0363700 Ambroxol hydrochloride 4 125 mg 1 Batch 3 is valid until 30 April 2018 1489 +5°C ± 3°C A1A 79 €

A0900000 Amfetamine sulfate - reference spectrum 1 n/a 1 0368 L 79 €

A0365000 Amidotrizoic acid dihydrate 1 100 mg 1 0873 +5°C ± 3°C A1A 79 €

Y0001461 Amidotrizoic acid for system suitability 1 0.08 mg 1 0873 +5°C ± 3°C A1A 79 €

A0368000 Amikacin 3 200 mg 1 See leaflet 1289,1290 +5°C ± 3°C A1a 79 €

Y0001467 Amikacin impurity I 1 20 mg 1 (2S)-4-amino-2-hydroxybutanoic acid 1289, 1290 +5°C ± 3°C A1A 79 €

Y0001117 Amikacin for system suitability 3 10 mg 1 1289,1290 +5°C ± 3°C A1A 79 €

A0365900 Amikacin sulfate 3 200 mg 1 The batch 3 is not suitable for use in the assay in monograph 1290:07/2014. Amikacin CRS A0368000 is also needed. See leaflet.

1290 +5°C ± 3°C A1a 79 €

Y0001902 Amiloride for peak identification 1 10 mg 1 0651 +5°C ± 3°C A1a 79 €

A0370000 Amiloride hydrochloride 2 100 mg 1 0651 +5°C ± 3°C A1A 79 €

Y0000020 Amiloride impurity A 3 20 mg 1 methyl-3,5-diamino-6-chloropyrazine-2-carboxylate 0651 +5°C ± 3°C A1A 79 €

Y0000173 4-Aminobenzoic acid 2 60 mg 1 1687 +5°C ± 3°C A1A 79 €

A0420000 Aminocaproic acid 1 50 mg 1 0874 +5°C ± 3°C A1A 79 €

A0460000 7-Aminodesacetoxycephalosporanic acid 2 20 mg 1 Cefadroxyl impurity B 0708,0813 +5°C ± 3°C A1A 79 €

A0496000 Aminoglutethimide 1 125 mg 1 1291 +5°C ± 3°C A1A 79 €

A0496005 Aminoglutethimide impurity A 1 20 mg 1 (3¢£)-3-(3-aminophenyl)-3-ethylpiperidine-2,6-dione (3-aminoglutethimide)

1291 +5°C ± 3°C A1A 79 €

A0496020 Aminoglutethimide impurity D 1 10 mg 1 3,3'-[diazenediylbis(4,1-phenylene)]bis(3-ethylpiperidine-2,6-dione) (azoglutethimide)

1291 +5°C ± 3°C A1A 79 €

A0575000 Amiodarone hydrochloride 3 100 mg 1 0803 +5°C ± 3°C B1A 79 €

Y0000129 Amiodarone impurity D 3 20 mg 1 (2-butylbenzofuran-3-yl)(4-hydroxy-3,5-diiodophenyl)methanone 0803 +5°C ± 3°C A1A 79 €

Y0000130 Amiodarone impurity E 3 20 mg 1 (2-butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone 0803 +5°C ± 3°C A1A 79 €

A0590000 Amisulpride 2 10 mg 1 1490 +5°C ± 3°C A1A 79 €

Y0001534 Amisulpride for system suitability 2 1.0015 mg 1 Batch 1 is valid until 30 April 2018 1490 +5°C ± 3°C A1A 79 €

Y0000563 Amitriptyline hydrochloride 1 10 mg 1 0464 +5°C ± 3°C A1A 79 €

Y0000049 Amlodipine besilate 4 150 mg 1 See leaflet 1491 +5°C ± 3°C A1A 79 €

Y0001068 Amlodipine impurity A 3 15 mg 1 3-ethyl 5-methyl (4RS)-4-(2-chlorophenyl)-2-[[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]methyl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate

1491 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 5For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0001069 Amlodipine impurity B 3 15 mg 1 3-ethyl 5-methyl (4RS)-4-(2-chlorophenyl)-6-methyl-2-[[2-[[2-(methylcarbamoyl)benzoyl]amino]ethoxy]methyl]-1,4-dihydropyridine-3,5-dicarboxylate

1491 +5°C ± 3°C A1A 79 €

Y0001070 Amlodipine impurity G 3 10 mg 1 dimethyl 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

1491 +5°C ± 3°C A1a 79 €

Y0001067 Amlodipine for peak identification 3 15 mg 1 1491 +5°C ± 3°C A1A 79 €

Y0000302 Ammonio methacrylate copolymer(type A) - reference spectrum

1 n/a 1 2081 L 79 €

Y0000303 Ammonio methacrylate copolymer(type B) - reference spectrum

1 n/a 1 2082 L 79 €

A0650000 Amobarbital - * psy 1 500 mg 1 0594 +5°C ± 3°C A2A 79 €

A0700000 Amobarbital sodium - * psy 1 500 mg 1 0166 +5°C ± 3°C A2A 79 €

Y0001794 Amorolfine Hydrochloride 1 10 mg 1 2756 +5°C ± 3°C A1a 79 €

Y0001795 Amorolfine for system suitability 1 10 mg 1 2756 +5°C ± 3°C A1a 79 €

A0800000 Amoxicillin trihydrate 5 200 mg 1 See leaflet CŒÿHŒ„N–O—S 0167,0168,0260,

0577,0578,0813, 1140,1653

+5°C ± 3°C A1A 79 €

Y0001521 Amoxicillin trihydrate for performance verification

2 5000 mg 1 See leaflet; This reference standard will be deleted from monographs 07/2015:20232, 07/2015:20512 and 01/2016:20532 on 2018/04/01 and replaced by Sodium aminosalicylate dihydrate for equipment qualification CRS Y0001816. ; Batch 1 is valid until 30 April 2017 Batch 2 is valid until 31 March 2018

20232, 20512, 20532

+5°C ± 3°C A1A 79 €

Y0000005 Amphotericin B 5 100 mg 1 See leaflet 1292 -20°C ± 5°C

C1a 79 €

Y0001361 Amphotericin B for microbiological assay 2 100 mg 1 See leaflet ; Batch 1 is valid until 30 November 2017 20702 -20°C ± 5°C

C1A 79 €

Y0001014 Amphotericin B for peak identification 2 10 mg 1 1292 -20°C ± 5°C

C1A 79 €

A1000000 Ampicillin (anhydrous) 5 220 mg 1 See leaflet CŒÿHŒ„N–O÷S 0167,0168,0578, 1168,1169

+5°C ± 3°C A1A 79 €

A1100000 Ampicillin trihydrate 2 150 mg 1 0168,0260,0577,

0578,0808,2211, 2212

+5°C ± 3°C A1A 79 €

Y0001244 Amylmetacresol 2 300 mg 1 See leaflet CŒœHŒ‡O ; Batch 1 is valid until 31 December 2017 2405 +5°C ± 3°C A1A 79 €

Y0001245 Amylmetacresol for peak identification 1 10 mg 1 2405 +5°C ± 3°C A1A 79 €

Y0001522 Anastrozole 1 100 mg 1 See leaflet CŒŸHŒ„N— 2406 +5°C ± 3°C A1a 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 6For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0001531 Anastrozole impurity E 1 10 mg 1 2,2'-[5-(hydroxymethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile)

2406 +5°C ± 3°C A1a 79 €

Y0001870 Andrographis herb HRS 1 2050 mg 1 2712 +5°C ± 3°C A1a 79 €

Y0001866 Andrographolide 1 15 mg 1 see leaflet CœÐH–ÐO— 2712 +5°C ± 3°C A1a 79 €

Y0001753 Anemarrhena rhizome for system suitability HRS

1 150 mg 1 2661 +5°C ± 3°C A1a 79 €

Y0001386 Angelica dahurica root HRS 1 160 mg 1 2556 +5°C ± 3°C A1A 79 €

Y0001385 Angelica pubescens root 1 500 mg 1 2557 +5°C ± 3°C A1A 79 €

A1200000 Anhydrotetracycline hydrochloride 5 25 mg 1 See leaflet ; Batch 4 is valid until 28 February 2017 0210,0211,1654

+5°C ± 3°C A1a 79 €

Y0001466 Anhydrous Docetaxel 1 15 mg 1 2593 +5°C ± 3°C A1A 79 €

A1210000 Antazoline hydrochloride 1 50 mg 1 0972 +5°C ± 3°C A1A 79 €

Y0001777 Apigenin 7-glucoside 1 25 mg 1 see leaflet CœŒHœÐOŒÐ 0404 +5°C ± 3°C A1a 79 €

Y0001465 Apomorphine hydrochloride hemihydrate 1 15 mg 1 0136 +5°C ± 3°C A1A 79 €

Y0001471 Apomorphine impurity B (morphine sulfate) -* narc

1 40 mg 1 See leaflet; 7,8-didehydro-4,5α-epoxy-17-methylmorphinan-3,6α-diol (morphine)

0136 +5°C ± 3°C A2A 90 €

Y0001825 Aprepitant 1 150 mg 1 see leaflet Cœ–HœŒFŸN÷O– 2757 +5°C ± 3°C A1a 79 €

Y0001826 Aprepitant for system suitability 1 15 mg 1 2757 +5°C ± 3°C A1a 79 €

Y0001154 Aprotinin for system suitability 1 2.7 mg 1 0580, 0579 +5°C ± 3°C A1A 79 €

A1250000 Aprotinin solution BRP 4 0.5 mL 1 See leaflet 0579,0580 +5°C ± 3°C A1A 79 €

A1269000 L-Arabinitol 2 10 mg 1 1381 +5°C ± 3°C A1A 79 €

Y0000806 Arbutin 2 110 mg 1 See leaflet CŒœHŒÿOŸ 1054 +5°C ± 3°C A1A 79 €

A1270000 Arginine 4 60 mg 1 See leaflet 0806, 1654, 2114, 2566

+5°C ± 3°C A1A 79 €

Y0000304 Arginine aspartate 1 20 mg 1 2096 +5°C ± 3°C A1A 79 €

A1271000 Arginine hydrochloride 3 60 mg 1 0805,0885 +5°C ± 3°C A1A 79 €

Y0001649 Aripiprazole 2 170 mg 1 See leaflet ; Batch 1 is valid until 31 March 2017 2617 +5°C ± 3°C A1A 79 €

Y0001650 Aripiprazole impurity F 2 15 mg 1 7-[4-[4-(2,3-dichlorophenyl)-1-oxidopiperazin-1-yl]butoxy]-3,4-dihydroquinolin-2(1H)-one

2617 +5°C ± 3°C A1A 79 €

Y0001323 Aristolochia 1 140 mg 1 See leaflet 20821 +5°C ± 3°C A1A 79 €

Y0001185 Aristolochic acid I 1 11 mg 1 See leaflet 20821 +5°C ± 3°C A1A 79 €

Y0001175 Aristolochic acid for system suitability 1 1 mg 1 20821 +5°C ± 3°C A1A 79 €

Y0000079 Articaine hydrochloride 3 200 mg 1 1688 +5°C ± 3°C A1A 79 €

Y0000080 Articaine impurity A 3 25 mg 1 methyl 4-methyl-3-[[2-(propylamino)acetyl]amino]thiophene-2-carboxylate (acetamidoarticaine)

1688 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 7For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000081 Articaine impurity E 2 10 mg 1 methyl 4-methyl-3-[[(2RS)-2-[(1-methylethyl)amino]propanoyl]amino]thiophene-2-carboxylate (isopropylarticaine)

1688 +5°C ± 3°C A1A 79 €

Y0001091 Artichoke leaf dry extract HRS 1 60 mg 1 2389, 1866 -20°C ± 5°C

C1A 79 €

A1300000 Ascorbic acid 4 100 mg 1 Vitamin C 0253,0958,1791

+5°C ± 3°C A1A 79 €

Y0001024 Ascorbic acid impurity C 3 20 mg 1 see leaflet CÿHŒÐOŸ; L-xylo-hex-2-ulosonic acid (L-sorbosonic acid) 0253,1791 +5°C ± 3°C A1A 79 €

Y0001170 Ascorbic acid impurity D 2 10 mg 1 methyl L-xylo-hex-2-ulosonate (methyl L-sorbosonate) 0253,1791 +5°C ± 3°C A1A 79 €

Y0000800 Ascorbyl palmitate 1 10 mg 1 0807 +5°C ± 3°C A1A 79 €

Y0001206 Asiaticoside 1 40 mg 1 see leaflet C÷‡HŸ‡OŒ„ 1498 +5°C ± 3°C A1A 79 €

Y0000305 Asparagine monohydrate 2 60 mg 1 2086 +5°C ± 3°C A1A 79 €

A1320000 Aspartame 2 40 mg 1 0973 +5°C ± 3°C A1A 79 €

A1321000 Aspartame impurity A 5 10 mg 1 2-[(2S,5S)-5-benzyl-3,6-dioxopiperazin-2-yl]acetic acid ; Batch 4 is valid until 30 June 2017

0973 +5°C ± 3°C A1A 79 €

A1330000 Aspartic acid 2 50 mg 1 0750,0797 +5°C ± 3°C A1A 79 €

Y0001171 Astragaloside IV 2 40 mg 1 See leaflet C÷ŒHÿ‡OŒ÷ ; Batch 1 is valid until 19 July 2017 2435 -20°C ± 5°C

C1A 79 €

A1340000 Atenolol 3 100 mg 1 0703 +5°C ± 3°C A1A 79 €

Y0001089 Atenolol for system suitability 2 5 mg 1 0703 +5°C ± 3°C A1a 79 €

Y0001586 Atomoxetine hydrochloride 1 110 mg 1 See leaflet CŒŸHœœClNO 2640 +5°C ± 3°C A1A 79 €

Y0001588 Atomoxetine impurity B 1 10 mg 1 (3S)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1- amine

2640 +5°C ± 3°C A1A 79 €

Y0001589 Atomoxetine impurity D 1 5 mg 1 (3R)-N-methyl-3-(3-methylphenoxy)-3-phenylpropan-1- amine

2640 +5°C ± 3°C A1A 79 €

Y0001587 Atomoxetine for impurity A identification 1 10 mg 1 N-methyl-3-phenoxy-3-phenylpropan-1-amine 2640 +5°C ± 3°C A1A 79 €

Y0001327 Atorvastatin calcium trihydrate 3 150 mg 1 See leaflet CÿÿHÿ‡CaFœN÷OŒÐ 2191 +5°C ± 3°C A1a 79 €

Y0001328 Atorvastatin impurity A 3 5 mg 1 (3R,5R)-3,5-dihydroxy-7-[5-(1-methylethyl)-2,3-diphenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]heptanoic acid (desfluoroatorvastatin) ; Batch 2 is valid until 31 July 2017

2191 +5°C ± 3°C A1A 79 €

Y0001329 Atorvastatin impurity B 4 10 mg 1 (3RS,5SR)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid ; Batch 3 is valid until 30 June 2017

2191 +5°C ± 3°C A1A 79 €

New Y0001330 Atorvastatin impurity C 3 5 mg 1 (3R,5R)-7-[2,3-bis(4-fluorophenyl)-5-(1-methylethyl)-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid (fluoroatorvastatin) ; Batch 2 is valid until 30 June 2018

2191 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 8For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0001331 Atorvastatin impurity D 5 5 mg 1 3-[(4-fluorophenyl)carbonyl]-2-(2-methylpropanoyl)-N,3-diphenyloxirane-2-carboxamide ; Batch 3 is valid until 30 April 2017 Batch 4 is valid until 31 March 2018

2191 +5°C ± 3°C A1A 79 €

Y0001332 Atorvastatin impurity E 4 5 mg 1 (3S,5S)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid (ent-atorvastatin) ; Batch 3 is valid until 4 May 2017

2191 +5°C ± 3°C A1A 79 €

Y0001572 Atovaquone 1 270 mg 1 See leaflet CœœHŒ„ClO– 2192 +5°C ± 3°C A1A 79 €

Y0001573 Atovaquone for system suitability 2 10 mg 1 Batch 1 is valid until 31 March 2018 2192 +5°C ± 3°C A1A 79 €

Y0000424 Atracurium besilate 3 120 mg 1 see leaflet Cÿ—H‡œNœOŒ‡Sœ ; Batch 2 is valid until 30 September 2017 1970 +5°C ± 3°C B1A 79 €

Y0000503 Atracurium for impurity F identification 1 5 mg 1 1970 +5°C ± 3°C B1A 79 €

Y0000504 Atracurium for peak identification 1 5 mg 1 1970 +5°C ± 3°C B1A 79 €

Y0000878 Atropine 1 30 mg 1 2056 +5°C ± 3°C A1A 79 €

Y0000816 Atropine impurity B 2 10 mg 1 (1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl (2RS)-3-hydroxy-2-phenylpropanoate (noratropine)

0068,2056 +5°C ± 3°C A1A 79 €

Y0000845 Atropine for peak identification 3 0.25 mg 1 Batch 2 is valid until 31 January 2018 0068,2056 +5°C ± 3°C A1A 79 €

A1400000 Atropine sulfate 4 20 mg 1 0068 +5°C ± 3°C A1A 79 €

Y0000029 Azaperone 1 50 mg 1 1708 +5°C ± 3°C A1A 79 €

A1500000 Azathioprine 1 100 mg 1 0369 +5°C ± 3°C A1A 79 €

Y0001240 Azathioprine impurity A 1 10 mg 1 1-methyl-4-nitro-1H-imidazol-5-amine 0369 +5°C ± 3°C A1A 79 €

Y0001246 Azathioprine impurity G 2 5 mg 1 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purin-2-amine (thiamiprine)

0369 +5°C ± 3°C A1A 79 €

Y0000326 Azelastine hydrochloride 1 25 mg 1 1633 +5°C ± 3°C A1A 79 €

Y0000327 Azelastine impurity B 1 5 mg 1 N'-[(4RS)-1-methylhexahydro-1H-azepin-4-yl]benzohydrazide 1633 +5°C ± 3°C A1A 79 €

Y0000328 Azelastine impurity D 1 5 mg 1 4-[(4-chlorophenyl)methyl]phthalazin-1(2H)-one 1633 +5°C ± 3°C A1A 79 €

Y0000329 Azelastine impurity E 1 5 mg 1 (3E)-3-[(4-chlorophenyl)methylidene]-2-benzofuran-1(3H)-one 1633 +5°C ± 3°C A1A 79 €

Y0000306 Azithromycin 4 200 mg 1 See leaflet C–‡HŸœNœOŒœ 1649 +5°C ± 3°C A1A 79 €

Y0000307 Azithromycin impurity A 3 10 mg 1 6-demethylazithromycin ; Batch 2 is valid until 30 November 2017 1649 +5°C ± 3°C A1A 79 €

Y0000637 Azithromycin for peak identification 3 15 mg 1 1649 +5°C ± 3°C A1A 79 €

Y0000641 Azithromycin for system suitability 9 0.05 mg 1 Batch 8 is valid until 30 June 2017 1649 +5°C ± 3°C A1A 79 €

Y0000285 B19 virus DNA for NAT testing BRP 1 150 mg 5 See leaflet 0557, 1527,1646

-20°C ± 5°C

D1B UN2814 242 €

B0070000 Bacampicillin hydrochloride 3 120 mg 1 See leaflet CœŒHœ‡ClN–OŸS 0808,0852 +5°C ± 3°C A1A 79 €

Y0001867 Bacitracin for system suitability 1 40 mg 1 0465,0466 -20°C ± 5°C

C1a 79 €

B0100000 Bacitracin zinc 3 150 mg 1 See leaflet 20702 -20°C ± 5°C

C1a 79 €

B0200000 Baclofen 2 130 mg 1 0653 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 9For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

B0200050 Baclofen impurity A 4 60 mg 1 (4RS)-4-(4-chlorophenyl)pyrrolidin-2-one 0653 +5°C ± 3°C A1A 79 €

Y0001273 Baicalin 1 10 mg 1 See leaflet CœŒHŒ‡OŒŒ 2438 +5°C ± 3°C A1A 79 €

B0250000 Bambuterol hydrochloride 1 100 mg 1 1293 +5°C ± 3°C A1A 79 €

B0300000 Barbital - * psy 1 500 mg 1 0170 +5°C ± 3°C A2A 79 €

Y0001525 Basic butylated methacrylate copolymer 1 20 mg 1 1975 +5°C ± 3°C A1A 79 €

B0305000 Beclometasone dipropionate anhydrous 4 150 mg 1 See leaflet Cœ‡H–ŸClOŸ 0654,1449, 1709

+5°C ± 3°C A1A 79 €

Y0000469 Beclometasone dipropionate for peak identification

2 10 mg 1 0654,1709 +5°C ± 3°C A1A 79 €

Y0000352 Beclometasone dipropionate for system suitability

3 15 mg 1 0654,1709 +5°C ± 3°C A1A 79 €

Y0001073 Beclometasone dipropionate impurities F and N

2 0.052 mg 1 0654,1709 +5°C ± 3°C A1A 79 €

Y0000351 Beclometasone dipropionate monohydrate 1 10 mg 1 1709 +5°C ± 3°C A1A 79 €

Y0001607 Belamcanda chinensis rhizome HRS 1 110 mg 1 2561 +5°C ± 3°C A1A 79 €

Y0001025 Benazepril hydrochloride 1 160 mg 1 See leaflet Cœ÷Hœ„ClNœO— 2388 +5°C ± 3°C A1A 79 €

Y0001026 Benazepril impurity A 2 10 mg 1 [(3R)-3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid

2388 +5°C ± 3°C A1a 79 €

Y0001038 Benazepril for system suitability 2 0.016 mg 1 Batch 1 is valid until 30 April 2017 2388 +5°C ± 3°C A1A 79 €

B0400000 Bendroflumethiazide 1 100 mg 1 0370 +5°C ± 3°C A1A 79 €

Y0000564 Bendroflumethiazide impurity A 1 5 mg 1 4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide 0370 +5°C ± 3°C A1A 79 €

B0470000 Benperidol 1 100 mg 1 1010,1172,1254, 1708

+5°C ± 3°C A1A 79 €

B0477000 Benserazide hydrochloride 1 50 mg 1 1173 +5°C ± 3°C A1A 79 €

B0477010 Benserazide impurity A 2 15 mg 1 (2RS)-2-amino-3-hydroxypropanohydrazide 1173 +5°C ± 3°C A1A 79 €

Y0001071 Benserazide impurity C 1 10 mg 1 (2RS)-2-amino-3-hydroxy-2'-[(1EZ)-(2,3,4-trihydroxybenzylidene)]propanohydrazide

1173 +5°C ± 3°C A1A 79 €

Y0001079 Benserazide for peak identification 1 10 mg 1 1173 +5°C ± 3°C A1A 79 €

Y0001064 Benzaldehyde 2 150 mg 1 0372,0371,1740

+5°C ± 3°C A1A 79 €

Y0001060 Benzalkonium chloride for system suitability 4 20 mg 1 0371,0372 +5°C ± 3°C A1a 79 €

B0490000 Benzarone 1 10 mg 1 (2-ethylbenzofuran-3-yl)(4-hydroxyphenyl)methanone 1393 +5°C ± 3°C A1A 79 €

New B0500000 Benzathine benzylpenicillin 3 200 mg 1 See leaflet ; Batch 2 is valid until 31 May 2018 0373 +5°C ± 3°C A1A 79 €

Y0000775 Benzbromarone 1 10 mg 1 1393 +5°C ± 3°C A1A 79 €

B0550000 Benzethonium chloride 1 100 mg 1 0974 +5°C ± 3°C A1A 79 €

B0600000 Benzocaine 1 50 mg 1 0011,1088 +5°C ± 3°C A1a 79 €

New Y0001470 Benzoic acid 2 30 mg 1 Batch 1 is valid until 31 May 2018 0934 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 10For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000647 Benzophenone 2 40 mg 1 1784 +5°C ± 3°C A1A 79 €

Y0000167 Benzyl alcohol 3 70 mg 1 See leaflet ; Batch 2 is valid until 31 October 2017 0256,0371,0372,1827

+5°C ± 3°C A1A 79 €

B0670000 Benzyl benzoate - reference spectrum 1 n/a 1 0705 L 79 €

B0680000 S-Benzylmercaptoacetyltriglycine 1 10 mg 1 1372 +5°C ± 3°C A1A 79 €

Y0001889 Benzylpenicillin for system suitability 1 10 mg 1 0113,0114 +5°C ± 3°C A1a 79 €

B0700000 Benzylpenicillin potassium 2 100 mg 1 0113,0148,0149

+5°C ± 3°C A1A 79 €

B0900000 Benzylpenicillin sodium 8 200 mg 1 See leaflet CŒÿHŒŸNœNaO÷S ; Batch 7 is valid until 30 April 2018 0113,0114 +5°C ± 3°C A1A 79 €

Y0001149 Berberine chloride 1 20 mg 1 See leaflet CœÐHŒ‡ClNO÷ 1831,2500, 2715

+5°C ± 3°C A1A 79 €

B0950000 Betadex 4 200 mg 1 See leaflet [CÿHŒÐO—]Ÿ 1070,1487,1804,2769

+5°C ± 3°C A1A 79 €

Y0000391 Betahistine dihydrochloride 2 50 mg 1 1665 +5°C ± 3°C A1A 79 €

B0990000 Betahistine mesilate 2 50 mg 1 1071 +5°C ± 3°C A1A 79 €

B1000000 Betamethasone 5 60 mg 1 0312,0354,0388, 0811

+5°C ± 3°C A1A 79 €

B1030000 Betamethasone acetate 2 100 mg 1 0548,0975 +5°C ± 3°C A1A 79 €

B1040000 Betamethasone dipropionate 4 200 mg 1 See leaflet Cœ‡H–ŸFOŸ 0809 +5°C ± 3°C A1A 79 €

Y0001416 Betamethasone dipropionate for peak identification

1 10 mg 1 0809 +5°C ± 3°C A1A 79 €

B1045000 Betamethasone sodium phosphate 4 100 mg 1 0549,0810 +5°C ± 3°C A1A 79 €

Y0001925 Betamethasone dipropionate for system suitability A

1 10 mg 1 0809 +5°C ± 3°C A1a 79 €

B1054000 Betamethasone 17-valerate 3 100 mg 1 0322,0811 +5°C ± 3°C A1A 79 €

B1055000 Betamethasone 21-valerate 3 15 mg 1 0811 +5°C ± 3°C A1A 79 €

Y0001027 Betamethasone valerate for system suitability 2 20 mg 1 Batch 1 is valid until 31 January 2018 0811 +5°C ± 3°C A1A 79 €

Y0001065 Betamethasone valerate impurity mixture 2 0.018 mg 1 0811 +5°C ± 3°C A1A 79 €

B1103000 Betaxolol hydrochloride 2 60 mg 1 1072 +5°C ± 3°C A1A 79 €

B1103100 Betaxolol impurity A 3 10 mg 1 (2RS)-1-(4-ethylphenoxy)-3-[(1-methylethyl)amino]propan-2-ol ; Batch 2 is valid until 28 February 2017

1072 +5°C ± 3°C A1A 79 €

Y0001354 Betaxolol impurity C 1 5 mg 1 (2RS)-2-[[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]methyl]oxirane 1072 -20°C ± 5°C

C1A 79 €

Y0001360 Betaxolol for peak identification 1 15 mg 1 1072 +5°C ± 3°C A1A 79 €

B1115000 Bezafibrate 2 100 mg 1 Batch 1 is valid until 31 August 2017 1394 +5°C ± 3°C A1A 79 €

Y0001444 Bicalutamide 1 100 mg 1 See leaflet CŒ‡HŒ÷F÷NœO÷S 2196 +5°C ± 3°C A1A 79 €

Y0001448 Bicalutamide for system suitability 1 15 mg 1 2196 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 11For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0001078 Bicisate labelling kit 1 24 mg 1 2123 +5°C ± 3°C A1A 79 €

B1110000 Bifonazole 2 50 mg 1 1395 +5°C ± 3°C A1a 79 €

Y0001421 Bifonazole for system suitability 1 10 mg 1 1395 +5°C ± 3°C A1A 79 €

Y0001788 Bilberry dry extract HRS 2 400 mg 1 See leaflet ; Batch 1 is valid until 31 December 2017 2394,1588,1602

-20°C ± 5°C

C1A 79 €

B1116000 Biotin 2 20 mg 1 Vitamin H 1073 +5°C ± 3°C A1A 79 €

New Y0001978 Biotin for system suitability 1 10 mg 1 1073 +5°C ± 3°C A1a 79 €

B1120000 Biperiden hydrochloride 1 60 mg 1 1074 +5°C ± 3°C A1A 79 €

B1121000 Biperiden impurity A 2 20 mg 1 (1RS)-1-[(1SR,2SR,4SR)-bicyclo[2.2.1]hept-5-en-2-yl]-1-phenyl- 3-(piperidin-1-yl)propan-1-ol (endo form)

1074 +5°C ± 3°C A1A 79 €

B1140000 Bisacodyl 3 50 mg 1 0595 +5°C ± 3°C A1a 79 €

Y0000608 Bisacodyl for peak identification 1 10 mg 1 0595 +5°C ± 3°C A1A 79 €

Y0000694 Bisacodyl for system suitability 2 5 mg 1 0595 +5°C ± 3°C A1A 79 €

Y0000812 Bisoprolol fumarate 1 50 mg 1 1710 +5°C ± 3°C A1A 79 €

Y0000877 Bisoprolol for peak identification 3 1.007 mg 1 Bisoprolol for system suitability method A CRS has been renamed as Bisoprolol for peak identification CRS.

1710 +5°C ± 3°C A1A 79 €

Y0000813 Bisoprolol for system suitability 4 1.003 mg 1 Bisoprolol for system suitability method B CRS has been renamed as Bisoprolol for system suitability CRS ; Batch 3 is valid until 31 October 2017

1710 +5°C ± 3°C A1A 79 €

B1141000 Bleomycin sulfate 2 7 mg 1 See leaflet 0976,20702 -20°C ± 5°C

D1A 79 €

Y0000434 Boldine 3 30 mg 1 See leaflet 1396, 1816 +5°C ± 3°C A1a 79 €

Y0001780 Boldo leaf dry extract HRS 1 550 mg 1 1816,1396 -20°C ± 5°C

C1a 79 €

B1142000 Bordetella pertussis mouse antiserum BRP 1 0.5 mg 1 See leaflet See leaflet,20716

-20°C ± 5°C

C1A 90 €

Y0001634 Brimonidine for system suitability 1 1.3 mg 1 2760 +5°C ± 3°C A1A 79 €

Y0001658 Brimonidine tartrate 1 5 mg 1 2760 +5°C ± 3°C A1A 79 €

B1143000 Bromazepam - * psy 4 60 mg 1 0778,0879 +5°C ± 3°C A2A 79 €

Y0000645 Bromazepam for system suitability - * psy 2 10 mg 1 0879 +5°C ± 3°C A2A 79 €

B1145000 Bromhexine hydrochloride 4 200 mg 1 Batch 3 is valid until 31 March 2017 0706 +5°C ± 3°C A1A 79 €

Y0001757 Bromhexine for system suitability 2 15 mg 1 Batch 1 is valid until 30 September 2017 0706 -20°C ± 5°C

C1a 79 €

B1150000 Bromocriptine mesilate 2 30 mg 1 0596 -20°C ± 5°C

C1A 79 €

Y0000677 Bromocriptine mesilate for system suitability 2 5 mg 1 Batch 1 is valid until 28 February 2018 0596 -20°C ± 5°C

C1A 79 €

B1152000 Bromperidol 1 100 mg 1 0616,1178 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 12For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

B1152050 Bromperidol decanoate 1 60 mg 1 1397,1431 +5°C ± 3°C A1A 79 €

B1153000 Brompheniramine maleate 1 100 mg 1 0977,1196 +5°C ± 3°C A1A 79 €

Y0000468 Brotizolam - * psy 1 10 mg 1 2197 +5°C ± 3°C A2A 79 €

Y0000470 Brotizolam impurity B 1 10 mg 1 2-bromo-4-(2-chlorophenyl)-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine (desmethylbrotizolam)

2197 +5°C ± 3°C A1A 79 €

Y0001196 Brucine 1 40 mg 1 see leaflet 2513,2514 +5°C ± 3°C A1A 79 €

B1157300 Budesonide 5 110 mg 1 See leaflet Cœ—H–÷Oÿ 1075 +5°C ± 3°C A1A 79 €

Y0001148 Budesonide for system suitability 1 10 mg 1 1075 +5°C ± 3°C A1A 79 €

B1156000 Bufexamac 1 100 mg 1 1179 +5°C ± 3°C A1A 79 €

Y0001729 Bufexamac impurity A 1 10 mg 1 2-(4-butoxyphenyl)acetic acid 1179 +5°C ± 3°C A1A 79 €

Y0001730 Bufexamac impurity B 1 15 mg 1 methyl 2-(4-butoxyphenyl)acetate 1179 +5°C ± 3°C A1A 79 €

B1157400 Buflomedil hydrochloride 2 100 mg 1 1398 +5°C ± 3°C A1A 79 €

Y0001731 Bufexamac impurity C 1 15 mg 1 butyl 2-(4-butoxyphenyl)acetate 1179 +5°C ± 3°C A1A 79 €

Y0001732 Bufexamac impurity D 1 10 mg 1 2-(4-butoxyphenyl)acetamide 1179 +5°C ± 3°C A1A 79 €

B1157410 Buflomedil impurity B 3 20 mg 1 1-(4-hydroxy-2,6-dimethoxyphenyl)-4-(pyrrolidin-1-yl)butan-1-one 1398 +5°C ± 3°C A1A 79 €

Y0001529 Buflomedil for peak identification 1 0.45 mg 1 1398 +5°C ± 3°C A1A 79 €

B1158000 Bumetanide 1 150 mg 1 1076 +5°C ± 3°C A1A 79 €

Y0000309 Bumetanide impurity A 1 5 mg 1 3-nitro-4-phenoxy-5-sulphamoylbenzoic acid 1076 +5°C ± 3°C A1A 79 €

Y0000310 Bumetanide impurity B 1 5 mg 1 3-amino-4-phenoxy-5-sulphamoylbenzoic acid 1076 +5°C ± 3°C A1A 79 €

B1160000 Bupivacaine hydrochloride 2 100 mg 1 0541, 2335 +5°C ± 3°C A1A 79 €

Y0000088 Bupivacaine impurity B 3 20 mg 1 (2RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide 0541 +5°C ± 3°C A1a 79 €

Y0000089 Bupivacaine impurity E 3 20 mg 1 6-(butylamino)-N-(2,6-dimethylphenyl)hexanamide 0541 +5°C ± 3°C A1A 79 €

Y0001575 Bupivacaine impurity F 1 70 mg 1 2,6-dimethylaniline 0541 +5°C ± 3°C A1a 79 €

Y0001108 Buprenorphine - * psy 1 10 mg 1 1180 +5°C ± 3°C A2A 79 €

Y0001122 Buprenorphine for system suitability - * psy 2 10 mg 1 1180,1181 +5°C ± 3°C A2A 79 €

Y0001109 Buprenorphine hydrochloride - * psy 1 10 mg 1 1181 +5°C ± 3°C A2A 79 €

B1168000 Buserelin 2 2 mg 1 See leaflet CÿÐH‡ÿNŒÿOŒ– 1077 -20°C ± 5°C

C1A 79 €

Y0001814 Buserelin for NMR identification 1 2 mg 1 1077 -20°C ± 5°C

C1a 79 €

Y0001740 Buserelin for peak identification 1 1 mg 1 1077 -20°C ± 5°C

C1A 79 €

B1168020 D-His-Buserelin 2 0.5 mg 1 1077 -20°C ± 5°C

C1A 79 €

Y0000131 Buspirone hydrochloride 1 5 mg 1 1711 +5°C ± 3°C A1A 79 €

Y0000471 Buspirone for system suitability 2 2.018 mg 1 1711 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 13For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

B1170000 Busulfan 3 50 mg 1 Batch 2 is valid until 31 March 2017 0542 +5°C ± 3°C A1A 79 €

Y0001487 Butyl methacrylate 1 100 mg 1 1975 +5°C ± 3°C A1A 79 €

Y0001304 Butyl methanesulfonate 1 30 µL 1 20537,20538, 20539,

20540,20541

+5°C ± 3°C A1a 79 €

B1217000 Butyl parahydroxybenzoate 3 150 mg 1 See leaflet 0881,1216 +5°C ± 3°C A1A 79 €

Y0001357 Butyl parahydroxybenzoate impurity E 1 15 mg 1 2-methylpropyl 4-hydroxybenzoate (iso-butyl parahydroxybenzoate) 0881 +5°C ± 3°C A1A 79 €

B1212000 Butylhydroxyanisole 4 60 mg 1 0880 +5°C ± 3°C A1A 79 €

B1215000 Butylhydroxytoluene 1 50 mg 1 Plastic additive 07 0581,30103, 30105,30106,

30107

+5°C ± 3°C A1A 79 €

Y0000472 Cabergoline 2 160 mg 1 See leaflet 1773 -20°C ± 5°C

C1A 79 €

New Y0001997 Cadmium solution 1 10 mL 1 20420 Room temp. +20°C

A1A 79 €

C0100000 Caffeine 4 70 mg 1 See leaflet 0267,0268,1504,2412,2668,2

669,2678

+5°C ± 3°C A1A 79 €

Y0000787 Caffeine for system suitability 4 10 mg 1 0267, 0268 +5°C ± 3°C A1A 79 €

C0166000 Calcifediol 6 5 mg 1 See leaflet ; Batch 5 is valid until 30 June 2017 1295 -20°C ± 5°C

C1A 150 €

C0166001 Calcifediol - reference spectrum 1 n/a 1 1295 L 79 €

Y0000499 Calcipotriol (anhydrous) - reference spectrum 1 n/a 1 2011 L 79 €

New Y0000473 Calcipotriol monohydrate 3 10 mg 1 See leaflet CœŸH÷ÐO– ; Batch 2 is valid until 31 July 2018 2011,2284 -20°C ± 5°C

C1A 79 €

Y0000474 Calcipotriol monohydrate - reference spectrum 1 n/a 1 2284 L 79 €

C0200000 Calcitonin (salmon) 11 1 mg 2 See leaflet 0471 -20°C ± 5°C

C1A 79 €

Y0000632 Calcitonin-Gly 2 1 ml 1 About 0.9 mg per ml 0471 -20°C ± 5°C

C1A 79 €

C0200010 N-acetyl-cys1-calcitonin 5 0.1 mg 1 See leaflet 0471 -20°C ± 5°C

C1A 79 €

C0225000 Calcitriol 9 10 mg 1 See leaflet 0883 -20°C ± 5°C

C1A 1000 €

C0226000 Calcitriol - reference spectrum 1 n/a 1 0883 L 79 €

C0249000 Calcium ascorbate - reference spectrum 1 n/a 1 1182 L 79 €

C0250000 Calcium folinate 7 130 mg 1 See leaflet ; Batch 6 is valid until 31 October 2017 0978,1606 +5°C ± 3°C A1A 79 €

C0299000 Calcium glucoheptonate 2 60 mg 1 1399 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 14For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

C0300000 Calcium gluconate 3 50 mg 1 Calcium digluconate ; Batch 2 is valid until 30 April 2017 0172,0658,0979,1399,2161,2162,2164,2364

+5°C ± 3°C A1A 79 €

C0340000 Calcium levulinate dihydrate 1 250 mg 1 1296 +5°C ± 3°C A1A 79 €

C0350000 Calcium oxalate monohydrate 1 500 mg 1 See leaflet 20234 +5°C ± 3°C A1A 79 €

C0400000 Calcium pantothenate 4 50 mg 1 0470 +5°C ± 3°C A1A 79 €

C0405000 Camphor (racemic) 2 50 mg 1 0655,1400 +5°C ± 3°C A1A 79 €

Y0001388 Candesartan cilexetil 1 60 mg 1 2573 +5°C ± 3°C A1A 79 €

Y0001387 Candesartan cilexetil for peak identification 2 10 mg 1 2573 +5°C ± 3°C A1A 79 €

Y0001389 Candesartan cilexetil for system suitability 1 10 mg 1 2573 +5°C ± 3°C A1A 79 €

C0410000 Canrenone 4 15 mg 1 0688 +5°C ± 3°C A1A 79 €

Y0001858 Cape jasmine fruit for system suitability 1 260 mg 1 2565 +5°C ± 3°C A1a 79 €

Y0001642 Capecitabine 1 150 mg 1 See leaflet CŒÐHœœFN–Oÿ 2762 +5°C ± 3°C A1A 79 €

Y0001643 Capecitabine impurity A 1 5 mg 1 4-amino-1-(5-deoxy-β-D-ribofuranosyl)-5-fluoropyrimidin-2(1H)-

one (5ʹ-deoxy-5-fluorocytidine)

2762 +5°C ± 3°C A1A 79 €

Y0001644 Capecitabine impurity B 1 5 mg 1 1-(5-deoxy-β-D-ribofuranosyl)-5-fluoropyrimidine-2,4(1H,3H)-

dione (5ʹ-deoxy-5-fluorouridine)

2762 +5°C ± 3°C A1A 79 €

Y0001645 Capecitabine impurity D 1 10 mg 1 (2RS)-2-methylbutyl [1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate

2762 +5°C ± 3°C A1A 79 €

C0426000 Caprylic acid 2 100 mg 1 1401,1471 +5°C ± 3°C A1A 79 €

Y0000671 Capsaicin 2 50 mg 1 See leaflet CŒ‡HœŸNO– ; (E)-N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide

1859,2336,2337, 2529

+5°C ± 3°C A1a 79 €

C0430000 Captopril 2 10 mg 1 1079 +5°C ± 3°C A1A 79 €

Y0001219 Captopril impurity B 1 10 mg 1 See leaflet C„HŒ÷BrNO–; (2S)1-[(2S)-3-bromo-2-methylpropanoyl]pyrrolidine-2-carboxylic acid

1079 +5°C ± 3°C A1A 79 €

Y0001220 Captopril impurity C 2 15 mg 1 See leaflet C÷H‡OœS; (2RS)-2-methyl-3-sulfanylpropanoic acid 1079 -20°C ± 5°C

C1A 79 €

Y0001221 Captopril impurity D 2 15 mg 1 See leaflet C÷HŸBrOœ; (2RS)-3-bromo-2-methylpropanoic acid ; Batch 1 is valid until 30 September 2017

1079 +5°C ± 3°C A1A 79 €

Y0000435 Captopril impurity E 1 10 mg 1 (2S)-1-(2-methylpropanoyl)pyrrolidine-2-carboxylic acid 1079 +5°C ± 3°C A1A 79 €

Y0001450 Captopril impurity J 2 10 mg 1 See leaflet CŒŒHŒŸNO÷S; (2S)-1-[(2S)-3-(acetylsulfanyl)-2-methylpropanoyl]pyrrolidine-2-carboxylic acid (acetylcaptopril) ; Batch 1 is valid until 31 May 2017

1079 +5°C ± 3°C A1A 79 €

Y0001182 Captopril for system suitability 2 20 mg 1 1079 +5°C ± 3°C A1A 79 €

Y0000113 Carbachol 1 50 mg 1 1971 +5°C ± 3°C A1A 79 €

C0450000 Carbamazepine 5 200 mg 1 See leaflet CŒ—HŒœNœO 0543 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 15For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000033 Carbamazepine impurity A 6 20 mg 1 10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide (10,11-dihydrocarbamazepine)

0543 +5°C ± 3°C A1A 79 €

C0451000 Carbasalate calcium - reference spectrum 1 n/a 1 1185 L 79 €

Y0001161 Carbasalate impurity B 1 5 mg 1 2-[[2-(acetyloxy)benzoyl]oxy]benzoic acid (acetylsalicylsalicylic acid)

1185 +5°C ± 3°C A1A 79 €

C0455000 Carbenicillin sodium 2 50 mg 1 0956 -20°C ± 5°C

C1a 79 €

C0460000 Carbidopa 2 50 mg 1 0755 +5°C ± 3°C A1A 79 €

Y0001713 Carbidopa for system suitability 1 10 mg 1 0755 +5°C ± 3°C A1A 79 €

Y0001716 Carbidopa impurity mixture 2 0.008 mg 1 Batch 1 is valid until 30 November 2017 0755 +5°C ± 3°C A1A 79 €

C0465000 Carbimazole 2 120 mg 1 See leaflet CŸHŒÐNœOœS 0884 +5°C ± 3°C A1A 79 €

C0470000 Carbocisteine 2 60 mg 1 0885 +5°C ± 3°C A1A 79 €

C0499900 Carbon dioxide - reference spectrum 1 n/a 1 0375 L 79 €

New Y0001353 Carbon monoxide - reference spectrum 1 n/a 1 2048 L 79 €

C0550000 Carboplatin - reference spectrum 1 n/a 1 1081 L 79 €

New Y0000475 Carboprost trometamol 2 40 mg 1 See leaflet Cœ—H÷ŸNO‡ ; Batch 1 is valid until 31 May 2018 1712 -20°C ± 5°C

C1A 79 €

Y0000536 Carboprost trometamol - reference spectrum 1 n/a 1 1712 L 79 €

Y0000035 Carisoprodol 1 50 mg 1 1689 +5°C ± 3°C A1A 79 €

Y0000036 Carisoprodol impurity A 2 10 mg 1 (2RS)-2-(hydroxymethyl)-2-methylpentyl(1-methylethyl)- carbamate

1689 +5°C ± 3°C A1A 79 €

Y0001214 Carmellose 1 10 mg 1 2360 +5°C ± 3°C A1A 79 €

C0580004 Carmustine - reference spectrum 1 n/a 1 1187 L 79 €

C0580010 Carmustine impurity A 1 20 mg 1 1,3-bis(2-chloroethyl)urea 1187 -20°C ± 5°C

C1A 79 €

Y0000846 Carprofen 1 30 mg 1 2201 +5°C ± 3°C A1A 79 €

Y0000884 Carprofen for system suitability 1 5 mg 1 2201 +5°C ± 3°C A1A 79 €

Y0000192 Carteolol hydrochloride - reference spectrum 1 n/a 1 1972 L 79 €

Y0000193 Carteolol for system suitability 1 30 mg 1 1972 +5°C ± 3°C A1A 79 €

New Y0001427 Carvedilol 2 50 mg 1 Batch 1 is valid until 30 July 2018 1745 +5°C ± 3°C A1A 79 €

Y0000103 Carvedilol impurity C 2 15 mg 1 (2RS)-1-[benzyl[2-(2-methoxyphenoxy)ethyl]amino]-3-(9H- carbazol-4-yloxy)propan-2-ol

1745 +5°C ± 3°C A1A 79 €

Y0001426 Carvedilol for system suitability 2 10 mg 1 1745 +5°C ± 3°C A1A 79 €

C0600000 Casein BRP 3 100000 mg 1 0350 +5°C ± 3°C A1a 131 €

C0630000 Cefaclor 3 450 mg 1 See leaflet CŒ—HŒ÷ClN–O÷S 0986 +5°C ± 3°C A1A 79 €

C0640000 Delta-3-Cefaclor 4 20 mg 1 0986 -20°C ± 5°C

C1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 16For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

C0650000 Cefadroxil 3 250 mg 1 see leaflet 0260,0577,0813,2342

+5°C ± 3°C A1A 79 €

C0675000 Cefalexin monohydrate 4 150 mg 1 See leaflet 0708,0814 +5°C ± 3°C A1A 79 €

C0682000 Cefalotin sodium 3 170 mg 1 See leaflet 0987 +5°C ± 3°C A1A 79 €

Y0000505 Cefalotin for impurity B identification 1 10 mg 1 0987 +5°C ± 3°C A1A 79 €

C0682300 Cefamandole nafate 3 125 mg 1 See leaflet CŒ„HŒŸNÿNaOÿSœ 1402 +5°C ± 3°C A1A 79 €

Y0000240 Cefapirin sodium 2 100 mg 1 See leaflet CŒŸHŒÿN–NaOÿSœ 1650 +5°C ± 3°C A1A 79 €

C0682400 Cefatrizine propylene glycol 2 150 mg 1 see leaflet CŒ‡HŒ‡NÿO—Sœ 1403 +5°C ± 3°C A1A 79 €

C0682410 Cefatrizine impurity A 1 60 mg 1 acide (6R,7R)-7-amino-8-oxo-3-[[(1H-1,2,3-triazol-4-yl)sulfanyl]méthyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ène-2-carboxylique (7-ACA triazole)

1403 +5°C ± 3°C A1A 79 €

New C0682800 Cefazolin 4 150 mg 1 See leaflet CŒ÷HŒ÷N‡O÷S– ; Batch 3 is valid until 31 July 2018 0988 +5°C ± 3°C A1A 79 €

Y0000633 Cefepime dihydrochloride monohydrate 3 150 mg 1 See leaflet 2126 +5°C ± 3°C A1A 79 €

Y0001336 Cefepime impurity E 1 10 mg 1 (6R,7R)-7-amino-3-[(1-methylpyrrolidinio)methyl]-8-oxo-5- thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

2126 -20°C ± 5°C

C1A 79 €

Y0000634 Cefepime dihydrochloride monohydrate for system suitability

2 15 mg 1 2126 +5°C ± 3°C A1A 79 €

C0684000 Cefixime 4 200 mg 1 See leaflet CŒÿHŒ—N—OŸSœ ; Batch 3 is valid until 30 June 2017 1188 -20°C ± 5°C

C1A 79 €

C0684750 Cefoperazone dihydrate 2 100 mg 1 See leaflet Cœ—HœŸN„O‡Sœ 1404 +5°C ± 3°C A1A 79 €

C0684800 Cefoperazone sodium - reference spectrum 1 n/a 1 1404 L 79 €

C0685000 Cefotaxime sodium 5 20 mg 1 0708,0989 +5°C ± 3°C A1A 79 €

Y0000420 Cefotaxime acid 2 20 mg 1 See leaflet CŒÿHŒŸN—OŸSœ 0989 +5°C ± 3°C A1A 79 €

New Y0000506 Cefotaxime for peak identification 2 10 mg 1 Batch 1 is valid until 30 June 2018 0989 +5°C ± 3°C A1A 79 €

C0688000 Cefoxitin sodium 3 100 mg 1 See leaflet CŒÿHŒÿN–NaOŸSœ 0990 +5°C ± 3°C A1A 79 €

Y0001496 Cefoxitin for peak identification 1 15 mg 1 0990 +5°C ± 3°C A1A 79 €

Y0001305 Cefpodoxime proxetil 1 70 mg 1 See leaflet CœŒHœŸN—O„Sœ 2341 -20°C ± 5°C

C1A 79 €

Y0001318 Cefpodoxime proxetil for impurity H identification

1 10 mg 1 2341 -20°C ± 5°C

C1A 79 €

Y0001306 Cefpodoxime proxetil for peak identification 1 10 mg 1 2341 -20°C ± 5°C

C1A 79 €

Y0001371 Cefprozil 1 120 mg 1 See leaflet 2342 +5°C ± 3°C A1a 79 €

Y0001372 Cefprozil impurity A 1 20 mg 1 (2R)-2-amino-2-(4-hydroxyphenyl)acetic acid (p-hydroxyphenylglycine)

2342 +5°C ± 3°C A1A 79 €

Y0001367 Cefprozil for peak identification 2 10 mg 1 2342 +5°C ± 3°C A1A 79 €

Y0001368 Cefprozil impurity mixture 2 10 mg 1 Batch 1 is valid until 30 April 2017 2342 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 17For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

C0690000 Cefradine 5 300 mg 1 See leaflet ; Batch 4 is valid until 31 August 2017

0167,0168,0578, 0708,0814

+5°C ± 3°C A1A 79 €

Y0000568 Cefradine for peak identification 2 15 mg 1 0814 +5°C ± 3°C A1A 79 €

Y0001174 Cefradine impurity mixture 1 0.04 mg 1 0814 +5°C ± 3°C A1A 79 €

C0690500 Ceftazidime 3 200 mg 1 See leaflet CœœHœœNÿOŸSœ ; Batch 2 is valid until 31 July 2017 1405, 2344 +5°C ± 3°C A1A 79 €

Y0001111 Ceftazidime for peak identification 2 13 mg 2 1405, 2344 +5°C ± 3°C A1a 79 €

New C0691000 Ceftriaxone sodium 4 100 mg 1 See leaflet CŒ‡HŒÿN‡NaœOŸS– ; Batch 3 is valid until 31 May 2018 0991 +5°C ± 3°C A1A 79 €

C0692000 Ceftriaxone impurity A 5 10 mg 1 (6R,7R)-7-[[(2E)-(2-aminothiazol-4-yl)(methoxyimino)acetyl]amino]-3-[[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ((E)-isomer) ; Batch 4 is valid until 30 September 2017

0991 +5°C ± 3°C A1A 79 €

C0694990 Cefuroxime axetil 4 60 mg 1 See leaflet CœÐHœœN÷OŒÐS 1300 +5°C ± 3°C A1a 79 €

C0695000 Cefuroxime sodium 4 70 mg 1 See leaflet CŒÿHŒ—N÷NaO‡S 0988,0992 +5°C ± 3°C A1A 79 €

Y0001445 Celecoxib 2 200 mg 1 See leaflet 2591 +5°C ± 3°C A1a 79 €

Y0001446 Celecoxib impurity A 2 10 mg 1 4-[5-(3-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide

2591 +5°C ± 3°C A1A 79 €

Y0001447 Celecoxib impurity B 2 10 mg 1 4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide

2591 +5°C ± 3°C A1A 79 €

Y0000311 Celiprolol hydrochloride 1 10 mg 1 1632 +5°C ± 3°C A1A 79 €

Y0000312 Celiprolol impurity I 1 0.02 mg 1 1-acetyl-1-(4-ethoxyphenyl)-3,3-diethylurea 1632 +5°C ± 3°C A1A 79 €

Y0000239 Celiprolol for peak identification 2 20 mg 1 1632 +5°C ± 3°C A1A 79 €

Y0000784 Cellulose acetate 1 40 mg 1 0887 +5°C ± 3°C A1A 79 €

Y0001585 Cellulose acetate butyrate 1 60 mg 1 1406 +5°C ± 3°C A1A 79 €

Y0001054 Cellulose acetate phthalate 1 10 mg 1 0314 +5°C ± 3°C A1a 79 €

Y0001764 Centella dry extract 1 150 mg 1 1498 -20°C ± 5°C

C1a 79 €

C0700000 Cephaeline hydrochloride 4 15 mg 1 0081,0093, 0094,1530,187

5

+5°C ± 3°C A1A 79 €

C0980650 Cetirizine dihydrochloride 4 100 mg 1 1084 +5°C ± 3°C A1A 79 €

C0980651 Cetirizine impurity A 5 10 mg 1 (RS)-1-[(4-chlorophenyl)phenylmethyl]piperazine 1084 +5°C ± 3°C A1A 79 €

Y0001197 Cetirizine for peak identification 2 1.01 mg 1 1084 +5°C ± 3°C A1A 79 €

C0984100 Cetostearyl isononanoate - reference spectrum

1 n/a 1 1085 L 79 €

New C0990000 Cetyl alcohol 3 300 mg 1 See leaflet CŒÿH–÷O ; Batch 2 is valid until 31 May 2018 0540,0702,0801,

0802,0847,0969, 1411

+5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 18For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000073 Cetyl palmitate 15 1 60 mg 1 1906 +5°C ± 3°C A1A 79 €

Y0000074 Cetyl palmitate 95 2 50 mg 1 Batch 1 is valid until 31 July 2017 1906 +5°C ± 3°C A1A 79 €

C1000000 Cetylpyridinium chloride 2 20 mg 1 0379 +5°C ± 3°C A1A 79 €

C1050000 Chenodeoxycholic acid 4 125 mg 1 Batch 3 is valid until 31 October 2017 1189,1275 +5°C ± 3°C A1A 79 €

Y0000104 Chitosan hydrochloride 1 30 mg 1 1774 +5°C ± 3°C A1A 79 €

C1100000 Chlorambucil 1 100 mg 1 0137 +5°C ± 3°C A1A 79 €

Y0001298 Chlorambucil for system suitability 1 10 mg 1 0137 +5°C ± 3°C A1A 79 €

Y0001299 Chlorambucil with impurity G 1 10 mg 1 0137 +5°C ± 3°C A1A 79 €

C1200000 Chloramphenicol 4 100 mg 1 Batch 3 is valid until 31 March 2017 0071,0473,0709

+5°C ± 3°C A1A 79 €

C1300000 Chloramphenicol dipalmitate 1 100 mg 1 0473 +5°C ± 3°C A1A 79 €

C1350000 Chloramphenicol disodium disuccinate 3 25 mg 1 See leaflet CŒ„HŒ‡ClœNœNaœOŒŒ 0709 +5°C ± 3°C A1A 79 €

Y0001869 Chloramphenicol for peak identification 1 15 mg 1 0071 +5°C ± 3°C A1a 79 €

C1400000 Chloramphenicol palmitate isomer 1 100 mg 1 0473 +5°C ± 3°C A1A 79 €

C1425000 Chloramphenicol sodium succinate 2 30 mg 1 0709 +5°C ± 3°C A1A 79 €

C1435000 Chlorcyclizine hydrochloride 1 100 mg 1 1086 +5°C ± 3°C A1A 79 €

C1450000 Chlordiazepoxide - * psy 1 50 mg 2 0656,1974 +5°C ± 3°C A2A 79 €

C1500000 Chlordiazepoxide hydrochloride - * psy 1 100 mg 1 0474 +5°C ± 3°C A2A 79 €

Y0000476 Chlordiazepoxide impurity A 2 10 mg 1 7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one 4-oxide 0474,0656 +5°C ± 3°C A1A 79 €

C1510000 Chlorhexidine 5 50 mg 1 Batch 4 is valid until 30 September 2017 0658 +5°C ± 3°C A1A 79 €

C1520000 Chlorhexidine diacetate 2 10 mg 1 01/2015:0657 +5°C ± 3°C A1A 79 €

C1540000 Chlorhexidine dihydrochloride 2 50 mg 1 0659 +5°C ± 3°C A1A 79 €

Y0001545 Chlorhexidine for system suitability 2 10 mg 1 Batch 1 is valid until 31 December 2017 0658, 0657, 0659

+5°C ± 3°C A1A 79 €

Y0001653 Chlormadinone acetate 1 120 mg 1 See leaflet 2702 +5°C ± 3°C A1A 79 €

Y0001656 Chlormadinone acetate impurity G 2 10 mg 1 3,20-dioxopregn-4-en-17-yl acetate ; Batch 1 is valid until 31 July 2017

2702 +5°C ± 3°C A1a 79 €

Y0001638 Chlormadinone acetate for system suitability 1 10 mg 1 2702 +5°C ± 3°C A1A 79 €

Y0000569 Chlorogenic acid 3 25 mg 1 See leaflet CŒÿHŒ‡O„ ; (1S,3R,4R,5R)-3-[(3,4-Dihydroxycinnamoyl)oxy]-1,4,5-trihydroxycyclohexanecarboxylic acid ; Batch 2 is valid until 31 December 2017

1821,1822,1823,

1824,1866,1897, 2389

+5°C ± 3°C A1A 79 €

C1650000 Chloroquine sulfate 3 200 mg 1 0544,0545 +5°C ± 3°C A1A 79 €

C1700000 Chlorothiazide 3 10 mg 1 0394 +5°C ± 3°C A1A 79 €

C1800000 Chlorphenamine maleate 2 20 mg 1 0386,0977,1084, 1196

+5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 19For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000436 Chlorphenamine impurity A 4 0.01 mg 1 2-(4-chlorophenyl)-4-(dimethylamino)-2-[2-(dimethylamino) ethyl]butanenitrile

0386 +5°C ± 3°C A1A 79 €

Y0000437 Chlorphenamine impurity C 2 10 mg 1 (3RS)-3-(4-chlorophenyl)-N-methyl-3-(pyridin-2-yl)propan-1-amine 0386 +5°C ± 3°C A1a 79 €

C1900000 Chlorpromazine hydrochloride 1 200 mg 1 0475 +5°C ± 3°C A1A 79 €

Y0000507 Chlorpromazine impurity A 1 15 mg 1 3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1- amine S-oxide (chlorpromazine sulphoxide)

0475 +5°C ± 3°C A1A 79 €

Y0000479 Chlorpromazine impurity D 1 10 mg 1 3-(2-chloro-10H-phenothiazin-10-yl)-N-methypropan-1-amine (desmethylchlorpromazine)

0475 +5°C ± 3°C A1A 79 €

Y0000508 Chlorpromazine impurity E 1 10 mg 1 2-chloro-10H-phenothiazine 0475 +5°C ± 3°C A1A 79 €

Y0001449 Chlorpromazine impurity F 1 2 mg 1 3-(4-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine 0475 +5°C ± 3°C A1A 79 €

C1905000 Chlorpropamide 1 100 mg 1 1087 +5°C ± 3°C A1A 79 €

C1905020 Chlorpropamide impurity B 2 30 mg 1 1,3-Dipropylurea ; Batch 1 is valid until 31 December 2017 1087 +5°C ± 3°C A1A 79 €

C1915000 Chlorprothixene hydrochloride 5 50 mg 1 See leaflet 0815,1365 +5°C ± 3°C A1A 79 €

C1950000 Chlortalidone 3 150 mg 1 See leaflet CŒ÷HŒŒClNœO÷S 0546 +5°C ± 3°C A1A 79 €

Y0000779 Chlortalidone for peak identification 3 1.017 mg 1 0546 +5°C ± 3°C A1A 79 €

C2000000 Chlortetracycline hydrochloride 5 100 mg 1 See leaflet 0173 +5°C ± 3°C A1A 79 €

Y0001451 Chlortetracycline for system suitability 2 10 mg 1 0173 +5°C ± 3°C A1a 79 €

C2100000 Cholecalciferol 9 500 mg 1 See leaflet; Vitamin D3 0072, 0574, 0575, 0598, 1192, 1193,

2398

-20°C ± 5°C

C1A 79 €

C2150000 Cholecalciferol for system suitability 7 1 mL 1 0072, 0574, 0575,0598

-20°C ± 5°C

C1a 79 €

C2155000 Cholesterol 4 100 mg 1 See leaflet 0593, 0993, 2397

+5°C ± 3°C A1a 79 €

C2158000 Cholic acid 2 60 mg 1 1189 +5°C ± 3°C A1A 79 €

Y0000280 Chondroitin sulfate sodium 2 250 mg 1 See leaflet HœO(CŒ÷HŒ„NNaœOŒ÷S)¨ 2064,2090 +5°C ± 3°C A1a 79 €

Y0000593 Chondroitin sulfate sodium (marine) 1 100 mg 1 2064 +5°C ± 3°C A1A 79 €

C2160000 Chymotrypsin BRP 3 100 mg 1 See leaflet ; Batch 2 is valid until 30 November 2017 0476,0694 +5°C ± 3°C A1a 79 €

Y0001553 Ciclesonide 1 150 mg 1 See leaflet C–œH÷÷OŸ 2703 +5°C ± 3°C A1A 79 €

New Y0001554 Ciclesonide containing impurity A 2 15 mg 1 (2′S)-2′-cyclohexyl-11β-hydroxy-3,20-dioxo-16βH-[1,3]dioxolo[4′,5′:16,17]pregna-1,4-dien-21-yl 2-methylpropanoate (S-epimer of ciclesonide) ; Batch 1 is valid until 30 June 2018

2703 +5°C ± 3°C A1a 79 €

Y0001555 Ciclesonide impurity B 1 10 mg 1 (2'R)-2'-cyclohexyl-11β,21-dihydroxy-16βH-[1,3]dioxolo[4',5':16,17]pregna-1,4-diene-3,20-dione

2703 +5°C ± 3°C A1A 79 €

Y0001556 Ciclesonide impurity C 1 10 mg 1 (2′R)-2′-[(1RS)-cyclohex-3-enyl]-11β-hydroxy-3,20-dioxo-16βH-

[1,3]dioxolo[4′,5′:16,17]pregna-1,4-dien-21-yl 2-methylpropanoate

2703 +5°C ± 3°C A1a 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 20For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000040 Ciclopirox 2 75 mg 1 Batch 1 is valid until 30 November 2017 1407 +5°C ± 3°C A1A 79 €

C2162701 Ciclopirox impurity A 4 40 mg 1 [(5RS)-3-cyclohexyl-5-methyl-4,5-dihydro-1,2-oxazol-5-yl]acetic acid ; Batch 3 is valid until 31 July 2017

1302,1407 +5°C ± 3°C A1A 79 €

C2162702 Ciclopirox impurity B 4 40 mg 1 6-cyclohexyl-4-methyl-2H-pyran-2-one ; Batch 3 is valid until 30 April 2018

1302,1407 -20°C ± 5°C

C1A 79 €

C2162700 Ciclopirox olamine 2 150 mg 1 1302 +5°C ± 3°C A1A 79 €

C2163000 Ciclosporin 3 120 mg 1 See leaflet 0994 +5°C ± 3°C A1A 79 €

Y0000361 Ciclosporin for system suitability 1 5 mg 1 0994 +5°C ± 3°C A1A 79 €

C2170000 Cilastatin sodium 2 10 mg 1 1408 +5°C ± 3°C A1A 79 €

Y0001651 Cilastatin for system suitability 1 1 5 mg 1 1408 +5°C ± 3°C A1A 79 €

Y0001652 Cilastatin for system suitability 2 1 5 mg 1 1408 +5°C ± 3°C A1A 79 €

C2174000 Cilazapril 1 50 mg 1 1499 +5°C ± 3°C A1A 79 €

C2174002 Cilazapril impurity A 1 25 mg 1 1,1-dimethylethyl (1S,9S)-9-[[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-10-oxooctahydro-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylate

1499 +5°C ± 3°C A1A 79 €

C2174005 Cilazapril impurity D 1 10 mg 1 (1S,9S)-9-[[(R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-10-oxooctahydro-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid

1499 +5°C ± 3°C A1A 79 €

C2175000 Cimetidine 1 50 mg 1 0756 +5°C ± 3°C A1A 79 €

C2175500 Cimetidine hydrochloride 1 100 mg 1 1500 +5°C ± 3°C A1A 79 €

Y0001130 Cimetidine for peak identification 1 10 mg 1 0756, 1500 +5°C ± 3°C A1A 79 €

Y0001146 Cimetidine for system suitability 1 0.5085 mg 1 0756, 1500 +5°C ± 3°C A1A 79 €

C2177000 Cinchocaine hydrochloride 2 60 mg 1 1088 +5°C ± 3°C A1A 79 €

Y0000176 Cineole 2 180 mg 1 1973 +5°C ± 3°C A1A 79 €

C2180000 Cinnarizine 2 100 mg 1 0816 +5°C ± 3°C A1A 79 €

Y0000362 Ciprofibrate 1 5 mg 1 2013 +5°C ± 3°C A1A 79 €

Y0000363 Ciprofibrate for system suitability 2 5 mg 1 Batch 1 is valid until 31 March 2018 2013 +5°C ± 3°C A1A 79 €

Y0000198 Ciprofloxacin 1 20 mg 1 1089 +5°C ± 3°C A1A 79 €

C2190000 Ciprofloxacin hydrochloride 6 100 mg 1 See leaflet ; Batch 5 is valid until 30 November 2017 0888,1353 +5°C ± 3°C A1A 79 €

New Y0000199 Ciprofloxacin hydrochloride for peak identification

3 10 mg 1 Batch 2 is valid until 31 May 2018 0888,1089 +5°C ± 3°C A1A 79 €

C2190050 Ciprofloxacin impurity A 5 25 mg 1 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (fluoroquinolonic acid)

0888,1089,2229

+5°C ± 3°C A1A 79 €

Y0001766 Cisatracurium besilate 1 170 mg 1 See leaflet 2763 -20°C ± 5°C

C1a 79 €

Y0001768 Cisatracurium for peak identification 1 5 mg 1 2763 -20°C ± 5°C

C1a 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 21For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0001767 cisatracurium for system suitability 1 5 mg 1 2763 -20°C ± 5°C

C1a 79 €

C2210000 Cisplatin 6 100 mg 1 See leaflet [PtClœ(NH–)œ] 0599 +5°C ± 3°C A1A 79 €

Y0001018 Cisplatin impurity A 2 15 mg 1 trans-diamminedichloroplatinum(II) (transplatin), ; Batch 1 is valid until 31 May 2017

0599 +5°C ± 3°C A1A 79 €

Y0001019 Cisplatin impurity B 2 15 mg 1 See leaflet [PtCl–(NH–)]-; amminetrichloroplatinate(-) 0599 +5°C ± 3°C A1A 79 €

Y0001008 Citalopram hydrobromide 1 5 mg 1 2288,2758,2733

+5°C ± 3°C A1A 79 €

Y0001007 Citalopram hydrochloride 1 5 mg 1 2203 +5°C ± 3°C A1A 79 €

Y0000855 Citalopram for system suitability 3 0.065 mg 1 2203,2288 +5°C ± 3°C A1A 79 €

A1202000 Citric acid (anhydrous) 2 50 mg 1 0455 +5°C ± 3°C A1A 79 €

C2219000 Citric acid monohydrate 1 50 mg 1 0456 +5°C ± 3°C A1A 79 €

Y0000639 Cladribine 2 50 mg 1 See leaflet CŒÐHŒœClN—O– 2174 -20°C ± 5°C

C1A 79 €

Y0000610 Cladribine impurity C 1 5 mg 1 2-chloro-7H-purin-6-amine (2-chloroadenine) 2174 -20°C ± 5°C

C1A 79 €

Y0000609 Cladribine for peak identification 1 10 mg 1 2174 -20°C ± 5°C

C1A 79 €

Y0000320 Clarithromycin 3 160 mg 1 See leaflet C–‡Hÿ„NOŒ– 1651 +5°C ± 3°C A1A 79 €

Y0000321 Clarithromycin for peak identification 3 10 mg 1 Batch 2 is valid until 31 December 2017 1651 +5°C ± 3°C A1A 79 €

Y0001193 Clazuril 1 10 mg 1 1714 +5°C ± 3°C A1A 79 €

Y0000269 Clazuril for system suitability 1 10 mg 1 1714 +5°C ± 3°C A1A 79 €

C2221000 Clebopride malate 1 100 mg 1 1303 +5°C ± 3°C A1A 79 €

C2223000 Clemastine fumarate 1 100 mg 1 1190 +5°C ± 3°C A1A 79 €

Y0001613 Clemastine for system suitability 1 0.165 mg 1 1190 +5°C ± 3°C A1A 79 €

C2248000 Clenbuterol hydrochloride 2 30 mg 1 1409 +5°C ± 3°C A1A 79 €

New C2248010 Clenbuterol impurity B 3 10 mg 1 1-(4-amino-3,5-dichlorophenyl)-2-[(1,1-dimethylethyl)amino] ethanone ; Batch 2 is valid until 31 July 2018

1409 +5°C ± 3°C A1A 79 €

C2250000 Clindamycin hydrochloride 5 200 mg 1 See leaflet 0582 +5°C ± 3°C A1A 79 €

New C2269000 Clindamycin phosphate 3 250 mg 1 see leaflet ; Batch 2 is valid until 30 July 2018 0996 +5°C ± 3°C A1A 79 €

Y0001680 Clindamycin phosphate for system suitability 1 10 mg 1 0996 +5°C ± 3°C A1A 79 €

Y0000364 Clioquinol 1 5 mg 1 2111 +5°C ± 3°C A1A 79 €

Y0000205 Clobazam - reference spectrum 1 n/a 1 1974 L 79 €

Y0000241 Clobazam impurity A 1 10 mg 1 7-chloro-5-phenyl-1,5-dihydro-3H-1,5-benzodiazepine-2,4-dione 1974 +5°C ± 3°C A1A 79 €

Y0000559 Clobetasol propionate 2 50 mg 1 See leaflet Cœ—H–œClFO— 2127 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 22For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000571 Clobetasol impurity J 3 0.4 mg 1 (17R)-4'-chloro-5'-ethyl-9-fluoro-11ß-hydroxy-16ß-methylspiro[androsta-1,4-diene-17,2'(3'H)-furan]-3,3'-dione (17 alpha-spiro compound) ; Batch 2 is valid until 30 September 2017

2127 +5°C ± 3°C A1A 79 €

Y0000570 Clobetasol for peak identification 3 2 mg 1 Batch 2 is valid until 30 September 2017 2127 +5°C ± 3°C A1A 79 €

C2285000 Clobetasone butyrate 1 50 mg 1 1090 +5°C ± 3°C A1A 79 €

Y0001137 Clobetasone butyrate for system suitability 1 30 mg 1 1090 +5°C ± 3°C A1a 79 €

Y0000888 Clodronate disodium tetrahydrate 1 5 mg 1 1777 +5°C ± 3°C A1A 79 €

Y0000885 Clodronate impurity D 1 5 mg 1 (chloromethylene)bis(phosphonic acid) 1777 +5°C ± 3°C A1A 79 €

Y0000313 Clofazimine 1 150 mg 1 2054 +5°C ± 3°C A1A 79 €

Y0000358 Clofazimine for system suitability 1 10 mg 1 2054 +5°C ± 3°C A1A 79 €

C2300000 Clofibrate 1 0.5 ml 1 0318 +5°C ± 3°C A1A 79 €

C2320000 Clomifene citrate 2 50 mg 1 See leaflet C–œH–ÿClNO‡ 0997,1046 +5°C ± 3°C A1A 79 €

C2332000 Clomifene citrate for performance test 1 50 mg 1 0997 +5°C ± 3°C A1A 79 €

C2360000 Clomipramine hydrochloride 1 100 mg 1 0889 +5°C ± 3°C A1A 79 €

Y0000132 Clomipramine impurity C 2 20 mg 1 3-(3-chloro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine

0889 +5°C ± 3°C A1A 79 €

Y0000133 Clomipramine impurity D 2 10 mg 1 See leaflet CŒ„HœœClœNœ; 3-(3,7-dichloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine

0889 +5°C ± 3°C A1A 79 €

Y0000134 Clomipramine impurity F 1 5 mg 1 3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine 0889 +5°C ± 3°C A1A 79 €

C2385000 Clonazepam - * psy 1 50 mg 1 1974,0415 +5°C ± 3°C A2A 79 €

Y0000286 Clonazepam - reference spectrum 1 n/a 1 0890 L 79 €

C2385015 Clonazepam impurity B 2 5 mg 1 3-amino-4-(2-chlorophenyl)-6-nitroquinolin-2(1H)-one 0890 +5°C ± 3°C A1A 79 €

C2400000 Clonidine hydrochloride 1 100 mg 1 0477 +5°C ± 3°C A1A 79 €

Y0000801 Clonidine impurity B 1 20 mg 1 1-acetyl-2-[(2,6-dichlorophenyl)amino]-4,5-dihydro-1H-imidazole 0477 +5°C ± 3°C A1A 79 €

Y0000833 Clopamide 1 40 mg 1 1747 +5°C ± 3°C A1A 79 €

Y0000848 Clopamide for system suitability 1 10 mg 1 1747 +5°C ± 3°C A1A 79 €

Y0001852 Clopidogrel besilate 1 10 mg 1 2790 +5°C ± 3°C A1a 79 €

Y0001334 Clopidogrel for system suitability 2 100 mg 1 2531,2790,2791

+5°C ± 3°C A1A 79 €

Y0001857 Clopidogrel hydrochloride 1 100 mg 1 see leaflet 2790,2791 +5°C ± 3°C A1a 79 €

Y0001333 Clopidogrel hydrogen sulfate 1 60 mg 1 2531 +5°C ± 3°C A1a 79 €

Y0001335 Clopidogrel impurity A 2 10 mg 1 (2S)-2-(2-chlorophenyl)-2-[6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]acetic ac

2531,2790,2791

+5°C ± 3°C A1A 79 €

Y0000392 Closantel sodium dihydrate 1 20 mg 1 1716 +5°C ± 3°C A1A 79 €

Y0000393 Closantel for system suitability 1 20 mg 1 1716 +5°C ± 3°C A1A 79 €

C2424400 Clostridia (multi-component) rabbit antiserum(for vaccines-vet.use)BRP

1 1 mg 1 See leaflet 0362,0363,0364, 0697

-20°C ± 5°C

C1A 90 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 23For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

C2424550 Clostridium tetani guinea pig antiserum (for vaccines - human use) BRP

1 1 mg 3 See leaflet 20708 -20°C ± 5°C

C1A 90 €

C2424500 Clostridium tetani guinea pig antiserum (for vaccines - vet. use) BRP

1 1 mg 1 See leaflet See leaflet,0697

-20°C ± 5°C

C1A 90 €

C2425600 Clostridium tetani rabbit antiserum (for vaccines - vet. use) BRP

1 1 mg 1 See leaflet See leaflet,0697

-20°C ± 5°C

C1A 90 €

C2430000 Clotrimazole 4 100 mg 1 Batch 3 is valid until 28 February 2017 0757 +5°C ± 3°C A1A 79 €

Y0000818 Clotrimazole impurity E 3 15 mg 1 (2-chlorophenyl)phenylmethanone (2-chlorobenzophenone) ; Batch 2 is valid until 30 September 2017

0757 +5°C ± 3°C A1A 79 €

Y0000849 Clotrimazole for peak identification 3 1.005 mg 1 Batch 2 is valid until 30 April 2018 0757 +5°C ± 3°C A1A 79 €

C2450000 Cloxacillin sodium 5 230 mg 1 See leaflet ; Batch 4 is valid until 31 December 2017 0661, 0663, 0668, 2260,

2346

+5°C ± 3°C A1A 79 €

C2460000 Clozapine 2 60 mg 1 1191 +5°C ± 3°C A1A 79 €

Y0000758 Clozapine for peak identification 2 0.41 mg 1 1191 +5°C ± 3°C A1A 79 €

Y0001472 Coagulation Factors V, VIII, XI and XIII plasma 1 1 mg 2 See leaflet 0903,1646,20740,20722

-20°C ± 5°C

D1A 90 €

Y0000162 Cocaine hydrochloride - reference spectrum 1 n/a 1 0073 L 79 €

C2480000 Cocoyl caprylocaprate 1 40 mg 1 1411 +5°C ± 3°C A1A 79 €

Y0000722 Codeine - * narc 1 20 mg 1 See leaflet 0074,0076,0777,1839,1840,1

841

+5°C ± 3°C A2A 79 €

C2500000 Codeine - reference spectrum 1 n/a 1 0074,0075 L 79 €

New Y0001984 Codeine for system suitability *-narc 1 10 mg 1 0074, 0076, 1412

+5°C ± 3°C A2a 79 €

Y0000334 Codeine impurity A 4 15 mg 1 7,8-didehydro-4,5α-epoxy-3,6α-dimethoxy-17-methylmorphinan (methylcodeine) This reference standard will be deleted from monographs 04/2008:0076 corrected 7.0, 01/2008:1412, 01/2011:0074, 01/2008:0075 corrected 6.0 on 2018/07/01. ; Batch 4 is valid until 30 June 2018

0074,0075,0076, 1412

+5°C ± 3°C A1A 79 €

C2500100 Codeine hydrochloride dihydrate - reference spectrum

1 n/a 1 1412 L 79 €

C2510000 Codergocrine mesilate 2 60 mg 1 1416,2060 +5°C ± 3°C A1A 79 €

Y0001500 Coix seed HRS 1 1300 mg 1 2454 +5°C ± 3°C A1A 79 €

C2580000 Colchicine 2 15 mg 1 0758 +5°C ± 3°C A1A 79 €

Y0000209 Colchicine for system suitability 2 10 mg 1 This reference standard will be deleted from monograph 01/2008:0758 corrected 7.2 on 2018/04/01 and replaced by Colchicine for system suitability A CRS Y0001958. ; Batch 2 is valid until 31 March 2018

0758 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 24For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

New Y0001958 Colchicine for system suitability A 1 10 mg 1 0758 +5°C ± 3°C A1a 79 €

Y0000374 Colestyramine 1 10 mg 1 1775 +5°C ± 3°C A1A 79 €

C2600000 Colistimethate sodium 2 20 mg 1 See leaflet 0319,20702 +5°C ± 3°C A1A 79 €

Y0001888 Colistimethate sodium for peak identification 1 20 mg 1 0319, 20702 +5°C ± 3°C A1a 79 €

Y0000277 Colistin sulfate 4 25 mg 1 See leaflet 0320 -20°C ± 5°C

C1a 79 €

C2700000 Colistin sulfate for microbiological assay 3 25 mg 1 See leaflet; For microbiological assay only ; Batch 2 is valid until 31 December 2017

0320 -20°C ± 5°C

C1a 79 €

C2725000 Copovidone - reference spectrum 1 n/a 1 0891 L 79 €

Y0001748 Copper tetramibi tetrafluoroborate 1 15 mg 1 2547 -20°C ± 5°C

C1a 79 €

C2800000 Cortisone acetate 6 250 mg 1 0321,0736,0767

+5°C ± 3°C A1A 79 €

Y0001307 Costunolide 1 10 mg 1 See leaflet CŒ—HœÐOœ 1797 -20°C ± 5°C

C1A 79 €

C2900000 Cotton wool standard for neps 1 1000 mg 1 0036 +5°C ± 3°C A1A 79 €

Y0000438 Coumarin 1 110 mg 1 See leaflet C„HÿOœ 2120 +5°C ± 3°C A1A 79 €

Y0001053 Crospovidone 4 25 mg 1 see leaflet ; Batch 1 is valid until 30 September 2017 0892 +5°C ± 3°C A1a 79 €

C2970000 Crotamiton 3 100 mg 1 see leaflet CŒ–HŒŸNO 1194 -20°C ± 5°C

C1A 79 €

C2970005 Crotamiton impurity A 5 35 mg 1 See leaflet; N-ethyl-N-(2-methylphenyl)but-3-enamide 1194 -20°C ± 5°C

C1A 79 €

Y0001061 Cyanidin chloride 3 25 mg 1 See leaflet CŒ—HŒŒClOÿ 2394 +5°C ± 3°C A1A 79 €

C3000000 Cyanocobalamin 5 20 mg 1 Vitamin B12 0269,0270,0547, 0710,1505

+5°C ± 3°C A1A 79 €

C3090000 Cyclizine hydrochloride 1 50 mg 1 1092 +5°C ± 3°C A1A 79 €

Y0000886 Cyclizine impurity A 1 15 mg 1 1-methylpiperazine 1092 +5°C ± 3°C B1A 79 €

Y0000887 Cyclizine impurity B 1 15 mg 1 diphenylmethanol (benzhydrol) 1092 +5°C ± 3°C A1A 79 €

C3200000 Cyclobenzaprine hydrochloride 1 100 mg 1 0408,0464 +5°C ± 3°C A1A 79 €

C3230000 Cyclohexa-1,4-dienylglycine 3 15 mg 1 (2R)-amino(cyclohexa-1,4-dienyl)acetic acid (d-dihydrophenylglycine)

0814 -20°C ± 5°C

C1A 79 €

C3245000 Cyclopentolate hydrochloride 2 50 mg 2 1093 +5°C ± 3°C A1A 79 €

Y0001088 Cyclopentolate for system suitability 2 20 mg 1 1093 +5°C ± 3°C A1A 79 €

C3250000 Cyclophosphamide 3 50 mg 1 0711 +5°C ± 3°C A1A 79 €

C3280000 Cyproheptadine hydrochloride 2 15 mg 1 0817,0846 +5°C ± 3°C A1A 79 €

Y0001095 Cyproheptadine impurity C 1 5 mg 1 5-(1-methylpiperidin-4-yl)-5H-dibenzo[a,d][7]annulen-5-ol 0817 +5°C ± 3°C A1A 79 €

C3283000 Cyproterone acetate 2 30 mg 1 1094 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 25For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0001390 Cyproterone acetate for peak identification 1 5 mg 1 1094 +5°C ± 3°C A1A 79 €

Y0001223 Cyproterone impurity mixture 2 0.01 mg 1 1094 +5°C ± 3°C A1A 79 €

C3290000 Cysteine hydrochloride monohydrate 2 100 mg 1 0895 +5°C ± 3°C A1A 79 €

C3300000 Cystine 2 100 mg 1 0998 +5°C ± 3°C A1A 79 €

C3350000 Cytarabine 2 150 mg 1 0760 +5°C ± 3°C A1a 79 €

Y0000733 Dacarbazine 1 20 mg 1 1691 +5°C ± 3°C B1A 79 €

Y0000734 Dacarbazine impurity A 2 20 mg 1 See leaflet C÷H–N—O; 3,7-dihydro-4H-imidazo[4,5-d]-1,2,3-triazin-4-one (2-azahypoxanthine)

1691 +5°C ± 3°C B1A 79 €

Y0000735 Dacarbazine impurity B 1 10 mg 1 See leaflet; 5-amino-1H-imidazole-4-carboxamide 1691 +5°C ± 3°C B1A 79 €

D0070000 Dalteparin sodium 3 250 mg 1 1195 +5°C ± 3°C A1a 79 €

Y0000600 Danaparoid sodium 2 10.5 mg 1 See leaflet 2090 +5°C ± 3°C B1A 79 €

D0100000 Dapsone 2 100 mg 1 0077 +5°C ± 3°C A1A 79 €

D0125000 Daunorubicin hydrochloride 4 120 mg 1 See leaflet CœŸH–ÐClNOŒÐ 0662 +5°C ± 3°C A1A 79 €

D0120000 Daunorubicinone 3 10 mg 1 Daunorubicin aglycone 0662 +5°C ± 3°C A1A 79 €

New Y0001976 Deferiprone 1 120 mg 1 2236,2487,2986

+5°C ± 3°C A1a 79 €

D0160000 Deferoxamine mesilate 2 30 mg 1 0896 +5°C ± 3°C A1A 79 €

Y0001934 Deferoxamine for system suitability 1 15 mg 1 0896 -20°C ± 5°C

C1a 79 €

Y0001937 Deferoxamine for peak identification CRS 1 1 20 mg 1 0896 -20°C ± 5°C

C1a 79 €

D0201000 Dehydrohexetidine 2 50 mg 1 2-ethyl-N-[[1-(2-ethylhexyl)-4-methyl-4,5-dihydro-1H-imidazol-4-yl]methyl]hexan-1-amine

1221 +5°C ± 3°C A1A 79 €

Y0000611 Dembrexine hydrochloride monohydrate 1 10 mg 1 2169 +5°C ± 3°C A1A 79 €

Y0001707 Demeclocycline for system suitability 1 10 mg 1 0176 +5°C ± 3°C A1A 79 €

D0300000 Demeclocycline hydrochloride 4 100 mg 1 see leaflet 0211,0210,0176, 0173,1654

+5°C ± 3°C A1A 79 €

D0350000 N-Demethylerythromycin A 3 15 mg 1 0274 +5°C ± 3°C A1a 79 €

Y0000228 Demethylflumazenil - reference spectrum 1 n/a 1 1917 L 79 €

D0406200 Deptropine citrate 1 60 mg 1 1308 +5°C ± 3°C A1A 79 €

D0430000 Dequalinium chloride 1 50 mg 1 1413 +5°C ± 3°C A1A 79 €

D0431000 Dequalinium chloride for performance test 1 50 mg 1 1413 +5°C ± 3°C A1A 79 €

New Y0001321 Dermatan sulfate and over-sulfated chondroitin sulfate

3 1 mL 1 See leaflet ; Batch 2 is valid until 31 July 2018 0332,0333 -20°C ± 5°C

C1A 79 €

D0480000 Desacetylvinblastine 1 1 mg 2 1276 -80°C ± 10°C

D1A 79 €

Y0000879 Desflurane - reference spectrum 1 n/a 1 1666 L 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 26For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000807 Desflurane impurity A 2 1 mL 1 1,1'-oxybis(1,2,2,2-tetrafluoroethane) 1666 +5°C ± 3°C B1A 79 €

D0500000 Desipramine hydrochloride 1 100 mg 1 0481 +5°C ± 3°C A1A 79 €

D0600000 Deslanoside 2 150 mg 1 See leaflet C÷ŸHŸ÷OŒ„ 0482 +5°C ± 3°C A1A 79 €

Y0001584 Desloratadine 2 100 mg 1 See leaflet 2570 +5°C ± 3°C A1A 79 €

D0630000 Desmethylmetrifonate 2 25 mg 1 1133 +5°C ± 3°C A1a 79 €

Y0001582 Desloratadine for system suitability 1 5 mg 1 2570 +5°C ± 3°C A1A 79 €

D0650000 Desmopressin 9 1 mg 1 See leaflet C÷ÿHÿ÷NŒ÷OŒœSœ ; Batch 8 is valid until 30 June 2017 0712 -20°C ± 5°C

C1A 79 €

Y0000509 Desogestrel 1 50 mg 1 See leaflet CœœH–ÐO 1717 +5°C ± 3°C A1A 79 €

Y0000510 Desogestrel for system suitability 2 10 mg 1 1717 +5°C ± 3°C A1A 79 €

D0400000 Desoxycortone acetate 4 100 mg 1 Batch 2 is valid until 31 December 2017 0322, 1327 +5°C ± 3°C A1A 79 €

Y0000001 Detomidine hydrochloride 2 100 mg 1 1414 +5°C ± 3°C A1A 79 €

D0660020 Detomidine impurity B 1 20 mg 1 (RS)-(1-benzyl-1H-imidazol-5-yl)(2,3-dimethylphenyl)methanol 1414 +5°C ± 3°C A1A 79 €

D0700000 Dexamethasone 5 50 mg 1 0312,0388,0548,

0768,1376,2237,0549

+5°C ± 3°C A1A 79 €

Y0001593 Dexamethasone for peak identification 1 10 mg 1 0388 +5°C ± 3°C A1A 79 €

Y0001177 Dexamethasone for system suitability 2 10 mg 1 0388 +5°C ± 3°C A1A 79 €

D0710000 Dexamethasone acetate 4 100 mg 2 Batch 3 is valid until 31 May 2017 0548,0933,0975, 2237

+5°C ± 3°C A1A 79 €

Y0001842 Dexamethasone acetate for peak identification 1 10 mg 1 0548 +5°C ± 3°C A1a 79 €

Y0001169 Dexamethasone acetate impurity E 1 0.013 mg 1 9-fluoro-11β,17-dihydroxy-16α-methyl-3,20-dioxopregn-4-en-21-yl acetate

0548 +5°C ± 3°C A1A 79 €

Y0000538 Dexamethasone isonicotinate 1 10 mg 1 2237 +5°C ± 3°C A1A 79 €

Y0000511 Dexamethasone isonicotinate for impurity C identification

1 10 mg 1 2237 +5°C ± 3°C A1A 79 €

D0718000 Dexamethasone pivalate 1 50 mg 1 1327 +5°C ± 3°C A1A 79 €

D0720000 Dexamethasone sodium phosphate 7 130 mg 1 See leaflet ; Batch 6 is valid until 31 March 2018 0549,0735,0810

+5°C ± 3°C A1A 79 €

Y0001477 Dexamethasone sodium phosphate for peak identification

1 10 mg 1 0549 +5°C ± 3°C A1A 79 €

D0720800 Dexchlorpheniramine maleate 1 60 mg 1 1196 +5°C ± 3°C A1A 79 €

D0730000 Dexpanthenol 5 5 mg 1 0761 +5°C ± 3°C A1A 79 €

D0731000 Dextran 1 25 mg 1 0999,1000,1001

+5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 27For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

D0731005 Dextran 1 1 50 mg 1 See leaflet; Average molecule mass : 930-1000 Fraction with less than 3 glucose units : 8.0 to 10.5% Fraction with more than 9 glucose units : 10.0 to 12.5%

1506 +5°C ± 3°C A1A 79 €

D0733000 Dextran 4 for calibration 1 50 mg 1 See leaflet 20239 +5°C ± 3°C A1A 79 €

D0734000 Dextran 10 for calibration 1 50 mg 1 See leaflet 20239 +5°C ± 3°C A1A 79 €

D0735000 Dextran 40 for calibration 1 50 mg 1 See leaflet 20239 +5°C ± 3°C A1A 79 €

D0738000 Dextran 40 for performance test 1 50 mg 1 20239 +5°C ± 3°C A1A 79 €

D0739000 Dextran 60/70 for performance test 1 50 mg 1 20239 +5°C ± 3°C A1A 79 €

D0736000 Dextran 70 for calibration 1 50 mg 1 See leaflet 20239 +5°C ± 3°C A1A 79 €

D0737000 Dextran 250 for calibration 1 50 mg 1 See leaflet 20239 +5°C ± 3°C A1A 79 €

D0732000 Dextran Vo 1 10 mg 1 20239 +5°C ± 3°C A1A 79 €

Y0000744 Dextranomer 1 50 mg 1 2238 +5°C ± 3°C A1A 79 €

New D0740000 Dextromethorphan hydrobromide 5 100 mg 1 Batch 4 is valid until 30 June 2018 0020 +5°C ± 3°C A1A 79 €

Y0000261 Dextromethorphan impurity A 2 5 mg 1 ent-3-methoxymorphinan 0020 +5°C ± 3°C A1A 79 €

Y0001058 Dextropropoxyphene hydrochloride - * narc 1 10 mg 1 0713 +5°C ± 3°C A2A 79 €

Y0001150 Dextropropoxyphene for system suitability - * narc

1 5 mg 1 0713 +5°C ± 3°C A2A 79 €

Y0001595 Diacerein 3 150 mg 1 See leaflet CŒ„HŒœO‡ ; Batch 1 is valid until 30 April 2018 2409 +5°C ± 3°C A1A 79 €

Y0001596 Diacerein impurity B 2 20 mg 1 see leaflet; 1,8-dihydroxy-3-(hydroxymethyl)-anthracene-9,10-dione (aloe-emodin) ; Batch 1 is valid until 31 January 2018

2409 +5°C ± 3°C A1a 79 €

Y0001597 Diacerein impurity mixture 1 0.014 mg 1 2409 -20°C ± 5°C

C1A 79 €

Y0000454 Diacetylfluorescein 3 120 mg 1 See leaflet ; Batch 1 is valid until 31 March 2018 1213 +5°C ± 3°C A1A 79 €

D0940000 Diazepam - * psy 1 30 mg 1 0022 +5°C ± 3°C A2A 79 €

Y0000596 Diazepam for system suitability - * psy 2 0.5 mg 1 0022 +5°C ± 3°C A2A 79 €

D0950000 Diazoxide 1 50 mg 1 0550 +5°C ± 3°C A1A 79 €

D0970000 Dibenzocycloheptene 3 20 mg 1 0817 +5°C ± 3°C A1A 79 €

D1000000 Dibenzosuberone 3 30 mg 1 Batch 2 is valid until 31 October 2017 0464,0817,0941

+5°C ± 3°C A1A 79 €

Y0000480 Dibrompropamidine diisetionate 1 10 mg 1 2300 +5°C ± 3°C A1A 79 €

Y0000481 Dibrompropamidine for system suitability 1 20 mg 1 2300 +5°C ± 3°C A1A 79 €

D1010000 Dibutyl phthalate 1 1 ml 1 0762 +5°C ± 3°C A1A 79 €

Y0001620 2,4-dichlorobenzyl alcohol 1 250 mg 1 See leaflet CŸHÿClœO 2410 +5°C ± 3°C A1A 79 €

Y0001621 2,4-Dichlorobenzyl alcohol impurity A 1 25 mg 1 (2,5-dichlorophenyl)methanol 2410 +5°C ± 3°C A1A 79 €

Y0001622 2,4-Dichlorobenzyl alcohol impurity C 1 25 mg 1 (3,4-dichlorophenyl)methanol 2410 +5°C ± 3°C A1A 79 €

Y0000275 Dichlorodiaminocyclohexaneplatinum 5 15 mg 1 2017 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 28For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000264 Diclazuril for veterinary use - reference spectrum

1 n/a 1 1718 L 79 €

Y0000259 Diclazuril for system suitability 1 20 mg 1 1718 +5°C ± 3°C A1A 79 €

D1039990 Diclofenac potassium 3 70 mg 1 1508 +5°C ± 3°C A1A 79 €

S0765000 Diclofenac sodium 4 100 mg 1 1002,1281 +5°C ± 3°C A1A 79 €

Y0001635 Diclofenac for system suitability 2 1 mg 1 1002,1508 +5°C ± 3°C A1A 79 €

D1050000 Dicloxacillin sodium 5 250 mg 1 See leaflet CŒ„HŒÿClœN–NaO—S 0661, 0663, 0668, 2346

-20°C ± 5°C

C1A 79 €

D1060000 Dicycloverine hydrochloride 2 100 mg 1 1197 +5°C ± 3°C A1A 79 €

Y0001864 Dicycloverine for system suitability 1 15 mg 1 1197 +5°C ± 3°C A1a 79 €

Y0001900 Dicycloverine impurity A 1 20 mg 1 1197 +5°C ± 3°C A1a 79 €

Y0000439 Didanosine 1 10 mg 1 2200 +5°C ± 3°C A1A 79 €

Y0000441 Didanosine impurity A 1 10 mg 1 1,7-dihydro-6H-purin-6-one (hypoxanthine) 2200 +5°C ± 3°C A1A 79 €

Y0000442 Didanosine impurity G 1 10 mg 1 9-(2,3-dideoxy-ß-D-glycero-pentofuranosyl)-9H-purin-6-amine (2',3'-dideoxyadenosine)

2200 +5°C ± 3°C A1A 79 €

Y0000440 Didanosine for system suitability 1 10 mg 1 2200 +5°C ± 3°C A1A 79 €

D1200000 Dienestrol 3 150 mg 1 See leaflet CŒ‡HŒ‡Oœ 0484 +5°C ± 3°C A1A 79 €

Y0001785 Dienogest 1 80 mg 1 See leaflet CœÐHœ—NOœ 2732 +5°C ± 3°C A1a 79 €

Y0001782 Dienogest for system suitability 1 10 mg 1 2732 +5°C ± 3°C A1a 79 €

D1410000 Diethyl phthalate 2 1 mL 1 Batch 1 is valid until 31 July 2017 0897 +5°C ± 3°C A1A 79 €

D1300000 Diethylcarbamazine citrate 2 250 mg 1 See leaflet CŒÿHœ„N–O‡ 0271 +5°C ± 3°C A1A 79 €

Y0000217 Diethylene glycol (monoethyl ether) - reference spectrum

1 n/a 1 1198 L 79 €

D1500000 Diethylstilbestrol 1 100 mg 1 See leaflet CŒ‡HœÐOœ 0484 +5°C ± 3°C A1A 79 €

D1600000 Diethylstilbestrol dimethyl ether 1 10 mg 1 0484 +5°C ± 3°C A1A 79 €

D1700000 Diethylstilbestrol monomethyl ether 1 10 mg 1 0484 +5°C ± 3°C A1A 79 €

Y0001423 Difloxacin hydrochloride 1 60 mg 1 2239 +5°C ± 3°C A1A 79 €

Y0001429 Difloxacin impurity G 1 15 mg 1 7-chloro-6-fluoro-1-(4-fluorophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

2239 +5°C ± 3°C A1A 79 €

D1750000 Diflunisal 1 30 mg 1 0864 +5°C ± 3°C A1A 79 €

D1800000 Digitoxin 4 200 mg 1 See leaflet C÷ŒHÿ÷OŒ– 0078,0117 +5°C ± 3°C A1A 79 €

Y0000640 Digoxigenin 3 10 mg 1 See leaflet 0079 +5°C ± 3°C A1A 79 €

D1900000 Digoxin 7 30 mg 1 See leaflet C÷ŒHÿ÷OŒ÷ 0079 +5°C ± 3°C A1A 79 €

New Y0000554 Digoxin for peak identification 2 10 mg 1 Batch 1 is valid until 31 May 2018 0079 +5°C ± 3°C A1a 79 €

D1940001 Dihydralazine sulfate (hydrated) - reference spectrum

1 n/a 1 1310 L 79 €

Y0000232 Dihydralazine for system suitability 1 10 mg 1 1310 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 29For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000216 Dihydrocodeine hydrogen tartrate - reference spectrum

1 n/a 1 1776 L 79 €

Y0000053 17 alpha-dihydroequilin 1 10 mg 1 See leaflet 1512 -20°C ± 5°C

C1A 79 €

D1945000 Dihydroergocristine mesilate 3 250 mg 1 1416,2060 +5°C ± 3°C A1A 79 €

D1950000 Dihydroergotamine mesilate 4 50 mg 1 0551 +5°C ± 3°C A1A 79 €

Y0000831 Dihydroergotamine for peak identification 1 10 mg 1 0551 +5°C ± 3°C A1A 79 €

D1952000 Dihydroergotamine tartrate 2 150 mg 1 0600 +5°C ± 3°C A1A 79 €

D1954000 Dihydrostreptomycin sulfate 5 25 mg 1 See leaflet C÷œH‡‡NŒ÷O–ÿS– 0485 -20°C ± 5°C

C1a 79 €

Y0000544 Dihydrotachysterol 2 30 mg 1 See leaflet Cœ‡H÷ÿO 2014 -20°C ± 5°C

C1A 79 €

Y0000482 Dihydrotachysterol for system suitability 2 5 mg 1 Batch 1 is valid until 30 April 2018 2014 -20°C ± 5°C

C1A 79 €

D1980000 Diltiazem hydrochloride 5 300 mg 1 1004 +5°C ± 3°C A1A 79 €

Y0001439 Diltiazem impurity F 2 15 mg 1 (2S,3S)-5-[2-(dimethylamino)ethyl]-3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one ; Batch 1 is valid until 31 March 2017

1004 +5°C ± 3°C A1A 79 €

Y0001141 Diltiazem for system suitability 2 10 mg 1 Replaces Diltiazem impurity A CRS 1004 +5°C ± 3°C A1A 79 €

D2000000 Dimenhydrinate 1 100 mg 1 0601 +5°C ± 3°C A1A 79 €

Y0001103 Dimenhydrinate for peak identification 2 1 mg 1 Batch 1 is valid until 30 April 2017 0601 +5°C ± 3°C A1A 79 €

Y0000234 N,N-Dimethylacetamide - reference spectrum 1 n/a 1 1667 L 79 €

D2050000 Dimethyl sulfoxide 3 1 mL 1 0763 +5°C ± 3°C A1a 79 €

Y0001489 2-(Dimethylamino)ethyl methacrylate 1 50 mg 1 1975 +5°C ± 3°C A1a 79 €

Y0001879 (25R)-spirost-5-en-3-one 1 10 mg 1 2890 +5°C ± 3°C A1a 79 €

D2200000 Dimeticone 4 200 mg 1 See leaflet 0138,1470 +5°C ± 3°C A1A 79 €

D2205000 Dimetindene maleate 1 50 mg 1 1417 +5°C ± 3°C A1A 79 €

D2255000 Dinoprost trometamol 1 60 mg 1 See leaflet Cœ÷H÷—NO‡ 1312 -20°C ± 5°C

C1A 79 €

D2250000 Dinoprostone 3 60 mg 1 See leaflet CœÐH–œO ; Batch 2 is valid until 30 November 2017 1311 -20°C ± 5°C

C1A 79 €

D2250015 Dinoprostone impurity C 2 10 mg 1 (E)-7-[(1R,2R,3R)-3-hydroxy-2-[(E)-(3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid (5-trans-PGE2; (5E)-PGE2)

1311,1488 -20°C ± 5°C

C1A 240 €

Y0001871 Diosgenin 1 15 mg 1 see leaflet CœŸH÷œO– 2890 +5°C ± 3°C A1a 79 €

Y0000094 Diosmin 5 70 mg 1 See leaflet ; Batch 4 is valid until 17 June 2017 1611 +5°C ± 3°C A1A 79 €

Y0000095 Diosmin for system suitability 2 5 mg 1 1611 +5°C ± 3°C A1A 79 €

D2600000 Diphenhydramine hydrochloride 1 100 mg 1 0023,0601 +5°C ± 3°C A1A 79 €

Y0000135 Diphenhydramine impurity A 4 10 mg 1 2-(diphenylmethoxy)-N-methylethanamine 0023,0601 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 30For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0001415 Diphenoxylate hydrochloride - * narc 1 15 mg 1 0819 +5°C ± 3°C A2A 79 €

D2630000 Diphenoxylate hydrochloride - reference spectrum

1 n/a 1 0819 L 79 €

Y0001430 Diphenoxylate for system suitability - * narc 1 10 mg 1 0819 +5°C ± 3°C A2A 79 €

Y0000258 Diphtheria toxin BRP 1 1 ml 1 See leaflet See leaflet,0443

+5°C ± 3°C B1A 90 €

D2700000 Diphtheria vaccine (adsorbed) BRP 4 32 mg 1 See leaflet See leaflet,20706

-20°C ± 5°C

C1A 90 €

Y0000376 Dipivefrine hydrochloride 1 100 mg 1 See leaflet CŒ„H–ÐClNO— 1719 +5°C ± 3°C A1A 79 €

Y0000394 Dipivefrine for system suitability 1 10 mg 1 1719 +5°C ± 3°C A1A 79 €

D2750100 Dipotassium clorazepate - reference spectrum 1 n/a 1 0898 L 79 €

D2800000 Diprophylline 1 100 mg 1 0486 +5°C ± 3°C A1A 79 €

D2850000 Dipyridamole 1 50 mg 1 1199 +5°C ± 3°C A1A 79 €

Y0000802 Dipyridamole for peak identification 3 2 mg 1 See leaflet ; Batch 2 is valid until 31 March 2018 1199 +5°C ± 3°C A1A 79 €

D2880000 Dirithromycin 1 100 mg 1 See leaflet C÷œHŸ‡NœOŒ÷ 1313 +5°C ± 3°C A1A 79 €

D2900000 Disodium edetate 1 100 mg 1 0232 +5°C ± 3°C A1A 79 €

D2920000 Disopyramide 1 100 mg 1 1006 +5°C ± 3°C A1A 79 €

D2922000 Disopyramide phosphate 1 100 mg 1 1005 +5°C ± 3°C A1A 79 €

D2950000 Disulfiram 1 100 mg 1 0603 +5°C ± 3°C A1a 79 €

D2953000 Dithranol 3 55 mg 1 1007 +5°C ± 3°C A1a 79 €

D2953025 Dithranol impurity C 4 15 mg 1 See leaflet; 4,4',5,5'-tetrahydroxy-9,9'-bianthracenyl-10,10'(9H,9'H)-dione

1007 +5°C ± 3°C A1a 79 €

D2953050 Dithranol impurity D 4 20 mg 1 1-hydroxyanthracen-9(10H)-one 1007 +5°C ± 3°C A1a 79 €

D2954000 Dobutamine hydrochloride 1 100 mg 1 1200 +5°C ± 3°C A1A 79 €

Y0001239 Dobutamine impurity mixture 1 0.1 mg 1 1200 -20°C ± 5°C

C1a 79 €

Y0001133 Docetaxel trihydrate 3 160 mg 1 See leaflet C÷–H—–NOŒ÷.3HœO ; Batch 2 is valid until 31 July 2017 2449, 2593 +5°C ± 3°C A1A 79 €

Y0001155 Docetaxel for system suitability 2 10 mg 1 2449,2593 +5°C ± 3°C A1A 79 €

Y0001452 Docetaxel impurity E 2 15 mg 1 5ß,20-epoxy-4-(acetyloxy)-1,7ß,10ß,13¶-tetrahydroxy-9-oxotax-11-en-2¶-yl benzoate (10-desacetyl-baccatin III) ; Batch 1 is valid until 31 March 2018

2593 +5°C ± 3°C A1A 79 €

D2954600 Docosahexaenoic acid ethyl ester 5 150 mg 1 See leaflet 20429 -20°C ± 5°C

C1a 79 €

Y0001567 Docusate sodium 1 10 mg 1 1418 +5°C ± 3°C A1A 79 €

Y0000365 Dodecyl gallate 1 30 mg 1 2078 +5°C ± 3°C A1A 79 €

D2955000 Domperidone 3 120 mg 1 1009 +5°C ± 3°C A1A 79 €

D2957000 Domperidone maleate 2 150 mg 1 Batch 1 is valid until 30 November 2017 1008 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 31For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

D2960000 Dopamine hydrochloride 2 20 mg 1 0664,1200 +5°C ± 3°C A1A 79 €

Y0000612 Dopexamine dihydrochloride 1 10 mg 1 1748 +5°C ± 3°C A1A 79 €

Y0000613 Dopexamine impurity B 1 10 mg 1 2-methoxy-4-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]phenol

1748 -20°C ± 5°C

C1A 79 €

Y0000614 Dopexamine impurity F 1 10 mg 1 4-chloro-5-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]benzene-1,2-diol

1748 -20°C ± 5°C

C1A 79 €

Y0000726 Dorzolamide hydrochloride 1 50 mg 1 2359 +5°C ± 3°C A1A 79 €

Y0000727 Dorzolamide impurity A 2 5 mg 1 (4R,6R)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulphonamide 7,7-dioxide

2359 +5°C ± 3°C A1A 79 €

Y0000750 Dorzolamide for system suitability 1 5 mg 1 2359 +5°C ± 3°C A1A 79 €

Y0001965 Dosulepin for system suitability 1 15 mg 1 1314 +5°C ± 3°C A1a 79 €

D2962000 Dosulepin hydrochloride 1 100 mg 1 1314 +5°C ± 3°C A1A 79 €

D2962005 Dosulepin impurity A 2 30 mg 1 (E)-3-(5-oxo-5λ4-dibenzo[b,e]thiepin-11(6H)-ylidene)-N,N-dimethylpropan-1-amine

1314 +5°C ± 3°C A1A 79 €

D2963000 Doxapram hydrochloride 1 50 mg 1 1201 +5°C ± 3°C A1A 79 €

Y0000208 Doxapram impurity B 2 10 mg 1 (4RS)-1-ethyl-4-[2-[(2-hydroxyethyl)amino]ethyl]-3,3-diphenylpyrolidin-2-one

1201 +5°C ± 3°C A1a 79 €

Y0000553 Doxazosin mesilate 1 60 mg 1 See leaflet 2125 +5°C ± 3°C A1A 79 €

Y0000551 Doxazosin impurity D 1 10 mg 1 6,7-dimethoxyquinazoline-2,4(1H,3H)-dione 2125 +5°C ± 3°C A1A 79 €

Y0000552 Doxazosin impurity F 3 15 mg 1 2-chloro-6,7-dimethoxyquinazolin-4-amine ; Batch 2 is valid until 31 January 2018

2125 +5°C ± 3°C A1A 79 €

Y0000838 Doxepin hydrochloride 1 5 mg 1 1096 +5°C ± 3°C A1a 79 €

Y0000851 Doxepin for system suitability 1 1 mg 1 1096 +5°C ± 3°C A1A 79 €

D2975000 Doxorubicin hydrochloride 7 150 mg 1 See leaflet CœŸH–ÐClNOŒŒ 0714,0662,1590

-20°C ± 5°C

C1A 79 €

D3000000 Doxycycline hyclate 6 50 mg 1 see leaflet 0272, 0820 +5°C ± 3°C A1a 79 €

Y0001714 Doxycycline for system suitability 3 10 mg 1 Batch 2 is valid until 30 September 2017 0272,0820 -20°C ± 5°C

C1A 79 €

Y0001562 Doxylamine hydrogen succinate 1 60 mg 1 1589 +5°C ± 3°C A1A 79 €

Y0000163 Doxylamine hydrogen succinate - reference spectrum

1 n/a 1 1589 L 79 €

Y0001492 Doxylamine for system suitability 4 110 mg 1 Batch 3 is valid until 31 March 2018 1589 +5°C ± 3°C A1A 79 €

D3100000 Droperidol 3 150 mg 1 1008,1009,1010, 1172

+5°C ± 3°C A1A 79 €

Y0001105 Drospirenone 1 60 mg 1 See leaflet Cœ÷H–ÐO– 2404 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 32For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0001115 Drospirenone impurity E 1 0.06 mg 1 3-oxo-6α,7α,15α,16α-tetrahydro-3′H,3″H dicyclopropa[6,7:15,16]pregn-4-ene-21,17-carbolactone (17-epidrospirenone)

2404 +5°C ± 3°C A1A 79 €

Y0001718 Drospirenone for peak identification 1 10 mg 1 2404 +5°C ± 3°C A1A 79 €

Y0001453 Duloxetine hydrochloride 2 120 mg 1 See leaflet CŒ‡HœÐClNOS 2594 +5°C ± 3°C A1A 79 €

Y0001455 Duloxetine impurity A 2 10 mg 1 (3R)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine

2594 +5°C ± 3°C A1A 79 €

Y0001454 Duloxetine for system suitability 1 40 mg 1 2594 +5°C ± 3°C A1A 79 €

Y0001598 Dutasteride 2 150 mg 1 See leaflet ; Batch 1 is valid until 30 November 2017 2641 +5°C ± 3°C A1A 79 €

Y0001603 Dutasteride for system suitability 1 10 mg 1 2641 +5°C ± 3°C A1A 79 €

Y0001004 Dydrogesterone 1 50 mg 1 See leaflet CœŒHœ‡Oœ 2357 +5°C ± 3°C A1A 79 €

Y0001005 Dydrogesterone impurity A 1 6 mg 1 9β,10α-pregna-4,6,8(14)-triene-3,20-dione 2357 +5°C ± 3°C A1A 79 €

Y0001006 Dydrogesterone impurity B 1 5 mg 1 pregna-4,6-diene-3,20-dione 2357 +5°C ± 3°C A1A 79 €

Y0001887 E1 Colistimethate sodium for peak identification

2 5 mg 1 Batch 1 is valid until 31 March 2018 0319 +5°C ± 3°C A1a 79 €

Y0001886 E2 Colistimethate sodium for peak identification

2 5 mg 1 Batch 1 is valid until 31 March 2018 0319 +5°C ± 3°C A1a 79 €

Y0000249 Ebastine - reference spectrum 1 n/a 1 2015 L 79 €

Y0000247 Ebastine impurity C 1 10 mg 1 4-(diphenylmethoxy)piperidine 2015 +5°C ± 3°C A1A 79 €

Y0000248 Ebastine impurity D 1 10 mg 1 1-[4-(1,1-dimethylethyl)phenyl]-4-(4-hydroxypiperidin-1-yl)butan-1-one

2015 +5°C ± 3°C A1A 79 €

Y0001236 Econazole 1 10 mg 1 2049 +5°C ± 3°C A1A 79 €

Y0000254 Econazole for system suitability 1 20 mg 1 0665,2049 +5°C ± 3°C A1A 79 €

E0050000 Econazole nitrate 3 100 mg 1 0513,0665,0921, 0935,

1017,1018

+5°C ± 3°C A1A 79 €

Y0001738 Edrophonium chloride 1 10 mg 1 2106 +5°C ± 3°C A1A 79 €

E0085000 Eicosapentaenoic acid ethyl ester 5 200 mg 1 See leaflet CœœH–÷Oœ ; Batch 4 is valid until 28 February 2018 20429 -20°C ± 5°C

C1A 79 €

Y0000537 Emedastine difumarate 1 10 mg 1 2242 +5°C ± 3°C A1A 79 €

Y0000512 Emedastine impurity E 1 10 mg 1 1-(2-ethoxyethyl)-2-(hexahydro-1H-1,4-diazepin-1-yl)-1H-benzimidazole

2242 +5°C ± 3°C A1A 79 €

E0100000 Emetine hydrochloride 2 100 mg 1 0081,0093, 0094,1530,187

5

+5°C ± 3°C A1A 79 €

Y0001837 Emodin 1 15 mg 1 see leaflet CŒ—HŒÐO— 2724 +5°C ± 3°C A1a 79 €

E0109000 Enalapril maleate 3 15 mg 1 1420 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 33For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

E0110000 Enalapril for system suitability 2 10 mg 1 1420 +5°C ± 3°C A1A 79 €

Y0001853 Enalapril impurity mixture A 2 0.024 mg 1 Batch 1 is valid until 31 October 2017 1420 +5°C ± 3°C A1a 79 €

Y0001829 Enalapril impurity G 1 15 mg 1 (2S)-2-[[(1S)-3-cyclohexyl-1-(ethoxycarbonyl)propyl]amino]propanoic acid

1420 +5°C ± 3°C A1a 79 €

Y0000615 Enalaprilat dihydrate 1 100 mg 1 1749 +5°C ± 3°C A1A 79 €

Y0000678 Enalaprilat impurity G 1 0.005 mg 1 (2SR)-2-[(3SR,8aRS)-3-methyl-1,4-dioxohexahydropyrrolo[1,2-a] pyrazin-2(1H)-yl]-4-phenylbutanoic acid

1749 +5°C ± 3°C A1A 79 €

Y0000629 Enalaprilat for system suitability 1 10 mg 1 1749 +5°C ± 3°C A1A 79 €

E0150000 Endotoxin standard BRP 5 10 mg 1 See leaflet 20614, 20630 -20°C ± 5°C

C1a 79 €

Y0000136 Enilconazole 1 60 mg 1 1720 +5°C ± 3°C A1a 79 €

Y0000137 Enilconazole impurity E 1 20 mg 1 (1RS)-1-(2,4-dichlorophenyl)-2-(-1H-imidazol-1-yl)ethanol 1720 +5°C ± 3°C A1A 79 €

E0180000 Enoxaparin sodium 5 200 mg 1 1097 +5°C ± 3°C A1a 79 €

E0180500 Enoxolone 3 220 mg 1 Batch 2 is valid until 30 September 2017 1511 +5°C ± 3°C A1a 79 €

Y0001259 Enrofloxacin 1 5 mg 1 2229 +5°C ± 3°C A1A 79 €

Y0001160 Enrofloxacin for system suitability 1 10 mg 1 2229 +5°C ± 3°C A1A 79 €

Y0001249 Entacapone 1 160 mg 1 See leaflet CŒ÷HŒ—N–O— 2574 +5°C ± 3°C A1a 79 €

Y0001250 Entacapone impurity A 1 10 mg 1 (2Z)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide

2574 +5°C ± 3°C A1A 79 €

Y0001800 Entecavir monohydrate 1 160 mg 1 see leaflet CŒœHŒ—N—O–,HœO 2815 +5°C ± 3°C A1a 79 €

Y0001802 Entecavir impurity F 2 10 mg 1 Batch 1 is valid until 31 May 2017 2815 +5°C ± 3°C A1a 79 €

Y0001801 Entecavir for system suitability 1 1 mg 1 2815 +5°C ± 3°C A1a 79 €

E0200000 Enterokinase BRP 2 200 mg 1 0350 +5°C ± 3°C A1A 79 €

E0300000 Ephedrine hydrochloride - * Drug Precursor 3 150 mg 1 See leaflet 0487,0488,0489,1367,2451

+5°C ± 3°C A3A 79 €

E0305000 Ephedrine hydrochloride (racemic) - * Drug Precursor

1 50 mg 1 0715 +5°C ± 3°C A3A 79 €

E0400000 4-Epianhydrotetracycline hydrochloride 7 25 mg 1 See leaflet ; Batch 6 is valid until 31 July 2017 0210,0211,1654

+5°C ± 3°C A1A 79 €

Y0001139 Epinastine hydrochloride 1 20 mg 1 2411 +5°C ± 3°C A1A 79 €

Y0001128 Epinastine for system suitability 1 10 mg 1 2411 +5°C ± 3°C A1A 79 €

E0550000 Epirubicin hydrochloride 6 100 mg 1 See leaflet CœŸH–ÐClNOŒŒ 0662,0714,1590

-20°C ± 5°C

C1A 79 €

E0600000 4-Epitetracycline hydrochloride 9 30 mg 1 0210,0211,1654

+5°C ± 3°C A1A 79 €

Y0001704 Eplerenone 1 75 mg 1 see leaflet Cœ÷H–ÐOÿ 2765 +5°C ± 3°C A1A 79 €

Y0001706 Eplerenone for peak identification 1 10 mg 1 2765 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 34For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0001705 Eplerenone for system suitability 1 10 mg 1 2765 +5°C ± 3°C A1A 79 €

P1609010 trans-Epoxyphytomenadione 3 5 mg 1 1036 +5°C ± 3°C A1A 79 €

E0850010 Eq Influenza Subtype 1 Strain A/eq/Newmarket/77 Horse Antiserum BRP

2 1 mg 3 See leaflet; Common standard OIE Strain A/eq/Newmarket/77

See leaflet,0249

-20°C ± 5°C

C1A 90 €

E0850021 Eq Influenza Subtype 2 American-like/Newmarket Horse Antiserum BRP

2 1 mg 3 See leaflet; Common standard OIE Strain A/eq/Newmarket/1/93

See leaflet,0249

-20°C ± 5°C

C1A 90 €

Y0000712 Eq Influenza Subtype 2 American-like/South Africa Horse Antiserum BRP

1 1 mg 3 See leaflet See leaflet,0249

-20°C ± 5°C

C1A 90 €

E0850022 Eq Influenza Subtype 2 European-like/Newmarket Horse Antiserum BRP

2 1 mg 3 See leaflet; Common standard OIE Strain A/eq/Newmarket/2/93

See leaflet,0249

-20°C ± 5°C

C1A 90 €

Y0000052 Equilin 1 15 mg 1 See leaflet CŒ‡HœÐOœ 1512 -20°C ± 5°C

C1A 79 €

Y0001325 Equisetum palustre 1 200 mg 1 1825 +5°C ± 3°C A1A 79 €

E0900000 Ergocalciferol 9 150 mg 1 See leaflet; Vitamin D2 0082,0574,0575,

0598,1192,1193, 2398

-20°C ± 5°C

C1a 79 €

Y0001375 Ergocalciferol for system suitability 1 10 mg 1 0082 -20°C ± 5°C

C1A 79 €

E1000000 Ergometrine maleate - * Drug Precursor 2 50 mg 1 0223 +5°C ± 3°C A3A 79 €

E1100000 Ergosterol 6 20 mg 1 See leaflet Cœ‡H÷÷O 0082 -20°C ± 5°C

C1A 79 €

Y0001851 Ergotamine for system suitability - * Drug precursor

1 10 mg 1 0224 -20°C ± 5°C

C3a 79 €

E1200000 Ergotamine tartrate - * Drug Precursor 2 100 mg 1 0224, 0551 +5°C ± 3°C A3A 79 €

Y0000051 Erysipelas ELISA coating antigen BRP 1 0.4 mg 1 See leaflet See leaflet,0064

-20°C ± 5°C

C1A 90 €

Y0000177 Erythritol 1 1000 mg 1 See leaflet C÷HŒÐO÷ 1803 +5°C ± 3°C A1A 79 €

E1400000 Erythromycin estolate 1 100 mg 1 0552 +5°C ± 3°C A1A 79 €

E1500000 Erythromycin ethylsuccinate 2 10 mg 1 0274 +5°C ± 3°C A1A 79 €

E1500800 Erythromycin stearate 1 50 mg 1 0490 +5°C ± 3°C A1A 79 €

Y0001848 Erythromycin lactobionate 1 15 mg 1 1098 +5°C ± 3°C A1a 79 €

Y0001912 Erythromycin A 4 250 mg 1 see leaflet 0179, 0274, 0293, 0490, 0552, 1098

-20°C ± 5°C

C1a 79 €

E1310000 Erythromycin B 4 50 mg 1 See leaflet 0179,0274,0490, 0552,1098

-20°C ± 5°C

C1a 79 €

Y0001849 Erythromycin stearate for impurity S identification

1 15 mg 1 0490 +5°C ± 3°C A1a 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 35For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

E1320000 Erythromycin C 6 25 mg 1 See leaflet ; Batch 5 is valid until 31 August 2017 0179,0274,0490, 0552,1098

-20°C ± 5°C

C1a 79 €

Y0001845 Erythromycin ethylsuccinate for impurity P identification

1 15 mg 1 0274 +5°C ± 3°C A1a 79 €

New Y0001846 Erythromycin for impurity M identification 2 10 mg 1 Batch 1 is valid until 30 June 2018 0179 -20°C ± 5°C

C1a 79 €

E1300000 Erythromycin for microbiological assay 5 100 mg 1 See leaflet 20702 -20°C ± 5°C

C1a 79 €

Y0001847 Erythromycin for system suitability 1 15 mg 1 0179, 0552, 0274, 1098,

0490

-20°C ± 5°C

C1a 79 €

E1515000 Erythropoietin BRP 4 15 mg 1 see leaflet 1316 -20°C ± 5°C

C1a 500 €

Y0001725 Erythropoietin for physicochemical tests 1 0.1 mg 3 1316 -20°C ± 5°C

C1a 500 €

Y0001844 Escitalopram 1 10 mg 1 2758 +5°C ± 3°C A1a 79 €

Y0001797 Escitalopram for system suitability 1 15 mg 1 2733 +5°C ± 3°C A1a 79 €

Y0001796 Escitalopram oxalate 1 10 mg 1 2733 +5°C ± 3°C A1a 79 €

Y0001611 Esculetin 1 25 mg 1 See leaflet C„HÿO÷ 2452 +5°C ± 3°C A1A 79 €

Y0001612 Esculin 1 25 mg 1 See leaflet CŒ—HŒÿO„ 2452 +5°C ± 3°C A1A 79 €

Y0000324 Esketamine hydrochloride - reference spectrum

1 n/a 1 1742 L 79 €

Y0000338 Esketamine impurity D - * narc 1 10 mg 1 (2R)-2-(2-chlorophenyl)-2-(methylamino)cyclohexanone ((R)-ketamine)

1742 +5°C ± 3°C A2a 79 €

Y0001660 Esomeprazole magnesium dihydrate 1 15 mg 1 2787 +5°C ± 3°C A1A 79 €

Y0001028 Esomeprazole magnesium trihydrate 2 5 mg 1 2372 +5°C ± 3°C A1A 79 €

Y0000749 Essential oil 2 1000 mg 1 2098 +5°C ± 3°C A1A 79 €

E1600000 Estradiol benzoate 2 250 mg 1 0139 +5°C ± 3°C A1A 79 €

Y0000852 Estradiol benzoate for system suitability 1 10 mg 1 0139 +5°C ± 3°C A1A 79 €

E1620000 Estradiol hemihydrate 3 100 mg 1 This reference standard will be deleted from monograph 07/2011:1203 on 2018/07/01.

0821,1203 +5°C ± 3°C A1A 79 €

Y0000314 Estradiol for peak identification 2 10 mg 1 0821 +5°C ± 3°C A1A 79 €

Y0000046 Estradiol valerate 2 120 mg 1 See leaflet Cœ–H–œO– 1614 +5°C ± 3°C A1A 79 €

Y0001823 Estradiol valerate for system suitability 2 10 mg 1 1614 +5°C ± 3°C A1A 79 €

E1680000 Estriol 3 50 mg 1 Batch 2 is valid until 31 March 2017 1203 +5°C ± 3°C A1A 79 €

New Y0001971 Estriol for system suitability 1 10 mg 1 1203 +5°C ± 3°C A1a 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 36For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

E1680005 Estriol impurity A 2 20 mg 1 See leaflet; estra-1,3,5(10),9(11)-tetraene-3,16α,17β-triol (9,11-didehydroestriol) This reference standard will be deleted from monograph 07/2011:1203 on 2018/07/01. ; Batch 2 is valid until 30 June 2018

1203 +5°C ± 3°C A1A 79 €

E1700000 Estrone 5 20 mg 1 See leaflet 1512,0140 +5°C ± 3°C A1a 79 €

E1800000 Etacrynic acid 1 100 mg 1 0457 +5°C ± 3°C A1A 79 €

Y0001263 Etacrynic acid for system suitability 1 10 mg 1 0457 +5°C ± 3°C A1A 79 €

E1830000 Etamsylate 2 10 mg 1 1204 +5°C ± 3°C A1a 79 €

E1840000 Ethacridine lactate monohydrate 1 50 mg 1 1591 +5°C ± 3°C A1A 79 €

New E1850000 Ethambutol hydrochloride 4 250 mg 1 Batch 3 is valid until 31 May 2018 0553 +5°C ± 3°C A1A 79 €

Y0000803 Ethambutol for system suitability 2 10 mg 1 0553 +5°C ± 3°C A1A 79 €

A1202800 Ethanol (anhydrous) - reference spectrum 1 n/a 1 1318 L 79 €

E1860100 Ethanol 96% - reference spectrum 1 n/a 1 1317 L 79 €

E1900000 Ethinylestradiol 5 200 mg 1 See leaflet 0140, 0821, 0940, 0926

+5°C ± 3°C A1A 79 €

New Y0001124 Ethinylestradiol for system suitability 3 1.01 mg 1 Batch 2 is valid until 31 July 2018 0140 +5°C ± 3°C A1A 79 €

E2000000 Ethionamide 1 100 mg 1 0141 +5°C ± 3°C A1A 79 €

Y0001686 Ethionamide for system suitability 1 10 mg 1 0141 +5°C ± 3°C A1A 79 €

E2150000 Ethosuximide 2 55 mg 1 Batch 1 is valid until 30 April 2018 0764 +5°C ± 3°C A1A 79 €

E2250000 Ethosuximide impurity A 4 30 mg 1 (2RS)-2-ethyl-2-methylbutanedioic acid 0764 +5°C ± 3°C A1a 79 €

E2195000 Ethyl acetate - reference spectrum 1 n/a 1 0899 L 79 €

Y0000617 Ethyl indole-3-carboxylate 1 10 mg 1 2102 +5°C ± 3°C A1A 79 €

E2425000 Ethyl parahydroxybenzoate 3 150 mg 1 See leaflet C„HŒÐO– 0409,0431,0900,

1262,1263,2134

+5°C ± 3°C A1A 79 €

Y0001633 Ethylcellulose 1 100 mg 1 0822 +5°C ± 3°C A1A 79 €

E2202000 1-N-Ethylgaramine sulfate 3 50 mg 1 See leaflet 1351 +5°C ± 3°C A1A 79 €

E2205500 1,1'-Ethylidenebistryptophan 7 0.002 mg 2 See leaflet Cœ÷HœÿN÷O÷ ; Batch 5 is valid until 30 June 2017 1272,1383 +5°C ± 3°C A1A 79 €

E2300000 Ethylmorphine hydrochloride - reference spectrum

1 n/a 1 0491 L 79 €

E2400000 Ethylnicotinamide 1 150 mg 1 0233 +5°C ± 3°C A1A 79 €

Y0000572 Etidronate disodium 1 10 mg 1 1778 +5°C ± 3°C A1A 79 €

E2450000 Etifenin 1 25 mg 2 0585 +5°C ± 3°C A1A 79 €

E2451000 Etilefrine hydrochloride 2 75 mg 1 1205 +5°C ± 3°C A1A 79 €

E2451010 Etilefrine impurity A 1 20 mg 1 2-(ethylamino)-1-(3-hydroxyphenyl)ethanone (etilefrone) 1205 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 37For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

E2470000 Etodolac 1 60 mg 1 1422 +5°C ± 3°C A1A 79 €

E2470050 Etodolac impurity H 1 10 mg 1 2-(7-ethyl-1H-indol-3-yl)ethanol 1422 +5°C ± 3°C A1A 79 €

Y0000768 Etodolac for peak identification 2 0.41 mg 1 1422 +5°C ± 3°C A1A 79 €

New E2499900 Etofenamate 2 50 mg 1 Batch 1 is valid until 31 July 2018 1513 +5°C ± 3°C A1A 79 €

E2499914 Etofenamate impurity G 3 25 mg 1 2-hydroxyethyl 2-[[3-(trifluoromethyl)phenyl]amino]-benzoate 1513 +5°C ± 3°C A1A 79 €

E2499901 Etofenamate for peak identification 2 20 mg 1 1513 +5°C ± 3°C A1A 79 €

E2500000 Etofylline 1 100 mg 1 0486 +5°C ± 3°C A1A 79 €

E2503000 Etomidate 2 50 mg 1 1514 +5°C ± 3°C A1A 79 €

E2503004 Etomidate impurity B 1 25 mg 1 methyl 1-[(1RS)-1-phenylethyl]-1H-imidazole-5-carboxylate (metomidate)

1514 +5°C ± 3°C A1A 79 €

E2600000 Etoposide 7 150 mg 1 See leaflet 0823 +5°C ± 3°C A1A 79 €

Y0001365 Etoposide for system suitability 1 10 mg 1 0823 +5°C ± 3°C A1A 79 €

Y0001747 Exemestane 1 70 mg 1 see lealet CœÿH–‡O÷ 2766 +5°C ± 3°C A1a 79 €

Y0001605 Eucommia bark HRS 1 2100 mg 1 2412 +5°C ± 3°C A1a 79 €

E5000000 Eugenol 2 500 µl 1 1100 +5°C ± 3°C A1A 79 €

Y0001756 Exemestane for system suitability 1 10 mg 1 2766 +5°C ± 3°C A1a 79 €

Y0001908 Evodiamine 1 15 mg 1 see leaflet 2718 +5°C ± 3°C A1a 79 €

New F0005000 Famotidine 3 110 mg 1 Batch 2 is valid until 31 July 2018 1012 +5°C ± 3°C A1A 79 €

New Y0000409 Famotidine impurity D 3 10 mg 1 3-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]propanamide ; Batch 2 is valid until 31 July 2018

1012 +5°C ± 3°C A1A 79 €

Y0000382 Famotidine for system suitability 2 15 mg 1 1012 +5°C ± 3°C A1A 79 €

Y0000556 Febantel 2 150 mg 1 See leaflet 2176 +5°C ± 3°C A1A 79 €

Y0000660 Febantel for system suitability 1 10 mg 1 2176 +5°C ± 3°C A1A 79 €

Y0000731 Felbinac 1 10 mg 1 2304 +5°C ± 3°C A1A 79 €

Y0000732 Felbinac impurity A 1 20 mg 1 4-acetyl biphenyl 2304 +5°C ± 3°C A1A 79 €

F0030000 Felodipine 2 120 mg 1 1013 +5°C ± 3°C A1A 79 €

Y0000415 Felypressin 1 0.994 mg 1 See leaflet C÷ÿHÿ—NŒ–OŒŒSœ 1634 -20°C ± 5°C

C1A 79 €

F0040000 Fenbendazole 3 150 mg 1 1208,1458 +5°C ± 3°C A1A 79 €

F0040010 Fenbendazole impurity A 1 20 mg 1 methyl(1§-benzimidazol-2-yl)carbamate 1208 +5°C ± 3°C A1A 79 €

F0040020 Fenbendazole impurity B 1 25 mg 1 methyl (5-chloro-1H-benzimidazol-2-yl)carbamate 1208 +5°C ± 3°C A1A 79 €

F0041000 Fenbufen 1 100 mg 1 1209 +5°C ± 3°C A1A 79 €

F0048000 Fenofibrate 3 100 mg 1 See leaflet CœÐHœŒClO÷ 1322 +5°C ± 3°C A1A 79 €

F0048005 Fenofibrate impurity A 4 15 mg 1 (4-chlorophenyl)(4-hydroxyphenyl)methanone 1322 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 38For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

F0048010 Fenofibrate impurity B 4 10 mg 1 2[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid (fenofibric acid)

1322 +5°C ± 3°C A1A 79 €

F0048035 Fenofibrate impurity G 5 25 mg 1 1-methylethyl 2-[[2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoyl] oxy]-2-methylpropanoate ; Batch 4 is valid until 28 February 2018

1322 +5°C ± 3°C A1A 79 €

F0050000 Fenoterol hydrobromide 3 50 mg 1 0901 +5°C ± 3°C A1A 79 €

Y0000756 Fenoterol for peak identification 3 1.2 mg 1 Batch 1 is valid until 31 January 2018 0901 +5°C ± 3°C A1A 79 €

New Y0001985 Fentanyl - * narc 1 30 mg 1 1210 +5°C ± 3°C A2a 79 €

F0054990 Fentanyl - reference spectrum 1 n/a 1 This reference standard will be deleted from monograph 04/2016:1210 on 2018/04/01 and will be replaced by Fentanyl CRS Y0001985. ; Batch 1 is valid until 31 March 2018

1210 L 79 €

New Y0001963 Fentanyl citrate - * narc 1 15 mg 1 1103 +5°C ± 3°C A2a 79 €

F0055000 Fentanyl citrate - reference spectrum 1 n/a 1 This reference standard will be deleted from monograph 01/2013:1103 on 2018/04/01 and will be replaced by Fentanyl citrate CRS Y0001963. ; Batch 1 is valid until 31 March 2018

1103 L 79 €

Y0001509 Fentanyl for system suitability - * narc 3 15 mg 1 This reference standard will be deleted from monographs 04/2016:1210 and 01/2013:1103 on 2018/04/01 and replaced by Fentanyl impurity mixture CRS Y0001967. ; Batch 2 is valid until 31 October 2017 Batch 3 is valid until 31 March 2018

1210,1103 +5°C ± 3°C A2a 79 €

New Y0001967 Fentanyl impurity mixture -*narc 1 0.02 mg 1 1103, 1210 +5°C ± 3°C A2a 79 €

F0060000 Fenticonazole nitrate 1 50 mg 1 1211 +5°C ± 3°C A1A 79 €

F0060040 Fenticonazole impurity D 2 0.01 mg 1 (¢£)-1-[2-(2,4-dichlorophenyl)-2-hydroxyethyl]-3-[4-(phenylsufanyl)benzyl]imidazolium nitrate

1211 +5°C ± 3°C A1A 79 €

F0100000 Ferrous gluconate 1 100 mg 1 0493 +5°C ± 3°C A1A 79 €

Y0001013 Ferulic acid 1 20 mg 1 See leaflet CŒÐHŒÐO÷ 1834,2558 +5°C ± 3°C A1A 79 €

Y0000789 Fexofenadine hydrochloride 1 60 mg 1 See leaflet C–œH÷ÐClNO÷ 2280 +5°C ± 3°C A1A 79 €

Y0000751 Fexofenadine impurity A 2 5 mg 1 2-[4-[4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butanoyl]phenyl]-2-methylpropanoic acid ; Batch 1 is valid until 28 February 2017

2280 +5°C ± 3°C A1A 79 €

New Y0000752 Fexofenadine impurity B 2 0.01 mg 1 2-[3-[(1RS)-1-hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid ; Batch 1 is valid until 30 June 2018

2280 +5°C ± 3°C A1A 79 €

Y0000753 Fexofenadine impurity C 1 5 mg 1 (1RS)-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]-1-[4-(1-methylethyl)phenyl]butan-1-ol

2280 +5°C ± 3°C A1A 79 €

Y0001173 Filgrastim 2 0.2 mL 1 See leaflet 2206 -80°C ± 10°C

D1A 79 €

Y0000090 Finasteride 3 120 mg 1 See leaflet 1615 +5°C ± 3°C A1a 79 €

Y0001604 Finasteride for peak identification 1 15 mg 1 1615 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 39For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

New Y0001968 Fipronil 1 170 mg 1 See leaflet CŒœH÷ClœFÿN÷OS 2869 +5°C ± 3°C A1a 79 €

New Y0001990 Fipronil for system suitability 1 5 mg 1 2869 +5°C ± 3°C A1a 79 €

Y0000736 Flavoxate hydrochloride 1 10 mg 1 1692 +5°C ± 3°C A1A 79 €

Y0000737 Flavoxate impurity A 1 10 mg 1 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic acid 1692 +5°C ± 3°C A1A 79 €

Y0000738 Flavoxate impurity B 1 10 mg 1 ethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate 1692 +5°C ± 3°C A1A 79 €

F0120000 Flecainide acetate 2 10 mg 1 1324 +5°C ± 3°C A1A 79 €

F0120005 Flecainide impurity A 4 20 mg 1 (8aRS)-3-[2,5-bis(2,2,2-trifluoroethoxy)phenyl]-1,5,6,7,8,8a-hexahydroimidazo[1,5-a]pyridine ; Batch 3 is valid until 31 March 2017

1324 +5°C ± 3°C A1A 79 €

F0120010 Flecainide impurity B 1 25 mg 1 (RS)-(piperidin-2-yl)methanamine 1324 +5°C ± 3°C A1A 79 €

Y0001274 Flecainide for system suitability 1 10 mg 1 1324 +5°C ± 3°C A1A 79 €

Y0001606 Fleeceflower root HRS 1 300 mg 1 2433 +5°C ± 3°C A1A 79 €

Y0000138 Flubendazole 1 25 mg 1 1721 +5°C ± 3°C A1A 79 €

Y0000139 Flubendazole for system suitability 1 20 mg 1 1721 +5°C ± 3°C A1A 79 €

Y0000892 Flucloxacillin magnesium octahydrate 1 5 mg 1 2346 +5°C ± 3°C A1A 79 €

Y0000889 Flucloxacillin impurity C 1 5 mg 1 (2S,5R,6R)-6-amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid (6-aminopenicillanic acid)

2346 +5°C ± 3°C A1A 79 €

Y0000890 Flucloxacillin impurity D 1 5 mg 1 3-(2-chloro-6-fluorophenyl)-5-methylisoxazole-4-carboxylic acid 2346 +5°C ± 3°C A1A 79 €

Y0000891 Flucloxacillin impurity E 1 5 mg 1 (2S,5R,6R)-6-[[[(2S,5R,6R)-6-[[[3-(2-chloro-6-fluorophenyl)-5-methylisoxazol-4-yl]carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-yl]carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid (6-APA flucloxacillin amide)

2346 -20°C ± 5°C

C1A 79 €

F0150000 Flucloxacillin sodium 8 250 mg 1 See leaflet CŒ„HŒÿClFN–NaO—S ; Batch 7 is valid until 30 April 2017 0661,0663,0668,2346

-20°C ± 5°C

C1A 79 €

Y0000557 Fluconazole 2 50 mg 1 2287 +5°C ± 3°C A1A 79 €

Y0000573 Fluconazole impurity B 4 10 mg 1 See leaflet; 2-[2-fluoro-4-(1H-1,2,4-triazol-1-yl)phenyl]-1,3-bis(1H-1,2,4 -triazol-1-yl)propan-2-ol ; Batch 3 is valid until 30 April 2018

2287 +5°C ± 3°C A1A 79 €

Y0000574 Fluconazole impurity C 3 5 mg 2 1,1'-(1,3-phenylene)di-1H-1,2,4-triazole 2287 +5°C ± 3°C A1A 79 €

Y0000558 Fluconazole for peak identification 1 10 mg 1 2287 +5°C ± 3°C A1A 79 €

F0175000 Flucytosine 2 50 mg 1 0766 +5°C ± 3°C A1a 79 €

Y0001262 Flucytosine for system suitability 1 0.3 mg 1 0766 +5°C ± 3°C A1a 79 €

Y0000419 Fludarabine phosphate 3 120 mg 1 see leaflet 1781 +5°C ± 3°C A1A 79 €

Y0001536 Fludarabine for system suitability 1 15 mg 1 1781 +5°C ± 3°C A1A 79 €

F0180000 Fludrocortisone acetate 2 100 mg 1 0767 +5°C ± 3°C A1A 79 €

F0188000 Flumazenil - reference spectrum 1 n/a 1 1326 L 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 40For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000335 Flumazenil impurity B 2 5 mg 1 ethyl 8-hydroxy-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate

1326 +5°C ± 3°C A1a 79 €

F0189000 Flumequine 1 60 mg 1 1517 +5°C ± 3°C A1A 79 €

F0189020 Flumequine impurity B 2 0.1 mg 1 ethyl(RS)-9-fluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-benzo[i,j]quinolizine-2-carboxylate

1517 +5°C ± 3°C A1A 79 €

F0188500 Flumetasone pivalate 2 100 mg 1 Batch 1 is valid until 31 May 2017 1327 +5°C ± 3°C A1a 79 €

F0189900 Flunarizine dihydrochloride 3 100 mg 1 0816 +5°C ± 3°C A1A 79 €

Y0000265 Flunarizine dihydrochloride - reference spectrum

1 n/a 1 1722 L 79 €

Y0000266 Flunarizine dihydrochloride for system suitability

1 20 mg 1 1722 +5°C ± 3°C A1A 79 €

F0190000 Flunitrazepam - * psy 2 100 mg 1 1280 +5°C ± 3°C A2A 79 €

Y0000169 Flunitrazepam - reference spectrum 1 n/a 1 0717 L 79 €

Y0000443 Flunixin meglumine 1 10 mg 1 1696 +5°C ± 3°C A1A 79 €

Y0000444 Flunixin impurity B 2 10 mg 1 2-methyl-3-(trifluoromethyl)aniline ; Batch 1 is valid until 31 March 2018

1696 +5°C ± 3°C A1A 79 €

Y0000445 Flunixin impurity C 2 55 mg 1 ethyl 2-chloropyridine-3-carboxylate 1696 +5°C ± 3°C A1A 79 €

F0200000 Fluocinolone acetonide 5 110 mg 1 see leaflet 0494 +5°C ± 3°C A1A 79 €

Y0001711 Fluocinolone acetonide for peak identification 1 10 mg 1 0494 +5°C ± 3°C A1A 79 €

Y0001710 Fluocinolone acetonide for system suitability 1 10 mg 1 0494 +5°C ± 3°C A1A 79 €

F0230000 Fluocortolone pivalate 1 100 mg 1 1212 +5°C ± 3°C A1A 79 €

Y0000796 Fluorescein 1 120 mg 1 See leaflet CœÐHŒœO— 2348 +5°C ± 3°C A1A 79 €

Y0000804 Fluorescein impurity C 1 0.01 mg 1 2-(2,4-dihydroxybenzoyl)benzoic acid 2348 +5°C ± 3°C A1A 79 €

F0245000 Fluoresceine sodium - reference spectrum 1 n/a 1 1213 L 79 €

F0250000 Fluorouracil 3 40 mg 1 0611,0766 +5°C ± 3°C A1A 79 €

Y0000762 Fluorouracil impurity A 1 10 mg 1 pyrimidine-2,4,6(1H,3H,5H)-trione (barbituric acid) 0611 +5°C ± 3°C A1A 79 €

Y0000763 Fluorouracil impurity B 1 15 mg 1 dihydropyrimidine-2,4,5(3H)-trione (isobarbituric acid or 5-hydroxyuracil)

0611 +5°C ± 3°C A1A 79 €

Y0000764 Fluorouracil impurity C 1 10 mg 1 pyrimidine-2,4(1H,3H)-dione (uracil) 0611 +5°C ± 3°C A1A 79 €

Y0000765 Fluorouracil impurity F 1 10 mg 1 2-ethoxy-5-fluoropyrimidin-4(1H)-one (2-ethoxy-5-fluorouracil) 0611 +5°C ± 3°C A1A 79 €

Y0000791 Fluorouracil impurity mixture 2 0.0002 mg 1 Batch 1 is valid until 30 June 2017 0611 +5°C ± 3°C A1A 79 €

F0253000 Fluoxetine hydrochloride 5 250 mg 1 See leaflet 1104 +5°C ± 3°C A1A 79 €

F0253020 Fluoxetine impurity B 6 10 mg 1 N-methyl-3-phenylpropan-1-amine 1104 +5°C ± 3°C A1A 79 €

F0253030 Fluoxetine impurity C 4 5 mg 1 (3RS)-N-methyl-3-phenyl-3-[3-(trifluoromethyl)phenoxy]propan-1-amine

1104 +5°C ± 3°C A1A 79 €

Y0000064 Flupentixol dihydrochloride 1 100 mg 1 See leaflet 1693 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 41For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000067 Flupentixol impurity D 2 15 mg 1 2-[2-[4-[3-[(EZ)-2-(trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl]piperazin-1-yl]ethoxy]ethanol

1693 +5°C ± 3°C A1A 79 €

Y0000078 Flupentixol impurity F 2 25 mg 1 See leaflet Cœ–Hœ—F–NœOS; mixture of 2-[4-[(E)-3-[(9RS)-2-(trifluoromethyl)-9H-thioxanthen-9-yl]prop-2-enyl]piperazin-1-yl]ethanol and 2-[4-[(Z)-3-[(9RS)-2-(trifluoromethyl)-9H-thioxanthen-9-yl]prop-2-enyl]piperazin-1-yl]ethanol

1693 +5°C ± 3°C A1A 79 €

F0260000 Fluphenazine decanoate 3 100 mg 1 1014,1015 +5°C ± 3°C B1A 79 €

F0280000 Fluphenazine dihydrochloride 2 50 mg 1 0904,1014 +5°C ± 3°C A1A 79 €

Y0000708 Fluphenazine impurity mixture 1 0.07 mg 1 0904 +5°C ± 3°C A1A 79 €

Y0000009 Fluphenazine enantate 3 100 mg 1 1014,1015 +5°C ± 3°C A1A 79 €

Y0000298 Fluphenazine octanoate 4 20 mg 1 1014,1015 +5°C ± 3°C A1A 79 €

Y0000299 Fluphenazine sulfoxide 2 15 mg 1 0904,1014,1015

+5°C ± 3°C A1A 79 €

Y0000211 Flurazepam monohydrochloride - reference spectrum

1 n/a 1 0905 L 79 €

F0285200 Flurbiprofen 1 50 mg 1 1519 +5°C ± 3°C A1A 79 €

F0285202 Flurbiprofen impurity A 2 25 mg 1 (2RS)-2-(biphenyl-4-yl)propanoic acid 1519 +5°C ± 3°C A1A 79 €

Y0000236 Fluspirilene 1 20 mg 1 1723 +5°C ± 3°C A1A 79 €

Y0000375 Fluspirilene impurity C 1 10 mg 1 8-[4,4-bis(4-fluorophenyl)butyl]-3-(hydroxymethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one

1723 +5°C ± 3°C A1A 79 €

F0285600 Flutamide 2 100 mg 1 See leaflet 1423 +5°C ± 3°C A1A 79 €

Y0001591 Flutamide for system suitability 1 10 mg 1 1423 +5°C ± 3°C A1a 79 €

Y0000284 Fluticasone propionate 4 100 mg 1 See leaflet Cœ—H–ŒF–O—S 1750 +5°C ± 3°C A1A 79 €

Y0001754 Fluticasone propionate for impurity C identification

1 5 mg 1 1750 +5°C ± 3°C A1a 79 €

Y0000221 Fluticasone impurity D 3 5 mg 1 6α,9-difluoro-11β-hydroxy-16α-methyl-17-

[(methylsulfanyl)carbonyl]-3-oxoandrosta-1,4-dien-17α-yl propanoate

1750 +5°C ± 3°C A1A 79 €

Y0001755 Fluticasone propionate for impurity G identification

1 5 mg 1 1750 +5°C ± 3°C A1a 79 €

F0290000 Flutrimazole 1 100 mg 1 1424 +5°C ± 3°C A1A 79 €

F0290010 Flutrimazole impurity B 1 60 mg 1 (RS)-(2-fluorophenyl)(4-fluorophenyl)phenylmethanol 1424 +5°C ± 3°C A1A 79 €

Y0001090 Fluvastatin sodium 1 110 mg 1 2333 +5°C ± 3°C A1A 79 €

Y0001082 Fluvastatin for system suitability 1 0.5 mg 1 2333 +5°C ± 3°C A1A 79 €

Y0000854 Fluvoxamine maleate 1 5 mg 1 1977 +5°C ± 3°C A1A 79 €

Y0000853 Fluvoxamine for system suitability 1 1.004 mg 1 1977 +5°C ± 3°C A1A 79 €

Y0000916 Fluvoxamine impurity D 1 10 mg 1 5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one 1977 +5°C ± 3°C A1A 79 €

Y0000386 Foeniculin for peak identification 1 100 mg 1 Anise oil 0804 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 42For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

F0300000 Folic acid 9 310 mg 1 See leaflet CŒ„HŒ„NŸOÿ ; Batch 8 is valid until 31 March 2018 0067 +5°C ± 3°C A1A 79 €

Y0001242 Folic acid impurity A 1 15 mg 1 (2S)-2-[(4-aminobenzoyl)amino]pentanedioic acid (N-(4-aminobenzoyl)-L-glutamic acid)

0067 +5°C ± 3°C A1A 79 €

Y0001243 Folic acid impurity D 3 70 mg 1 4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino]benzoic acid (pteroic acid)

0067 +5°C ± 3°C A1A 79 €

New Y0001629 Follitropin 2 0.2 mg 1 See leaflet ; Batch 1 is valid until 31 May 2018 2285, 2286 -20°C ± 5°C

D1A 79 €

Y0001627 Follitropin for peptide mapping and glycan analysis

1 0.5 mL 1 2285,2286 -20°C ± 5°C

D1A 79 €

F0372000 Formoterol fumarate dihydrate 2 10 mg 1 1293,1724 +5°C ± 3°C A1a 79 €

New Y0001970 Formic acid 1 0.5 mL 1 2809 +5°C ± 3°C A1a 79 €

Y0000339 Formoterol for impurity I identification 2 10 mg 1 1724 +5°C ± 3°C A1a 79 €

Y0000340 Formoterol fumarate for system suitability 2 10 mg 1 1724 +5°C ± 3°C A1a 79 €

F0380000 Formylfolic acid 3 30 mg 1 See leaflet CœÐHŒ„NŸOŸ; 10-Formylfolic acid 0978,1606 -20°C ± 5°C

C1A 79 €

New F0389000 Foscarnet sodium hexahydrate 2 50 mg 1 Batch 1 is valid until 30 June 2018 1520 +5°C ± 3°C A1A 79 €

F0389004 Foscarnet impurity B 1 10 mg 1 disodium (ethoxyoxydophosphanyl)formate 1520 +5°C ± 3°C A1A 79 €

Y0001222 Foscarnet impurity D 1 50 mg 1 ethyl (diethoxyphosphoryl)formate 1520 +5°C ± 3°C A1A 79 €

Y0001213 Foscarnet impurity mixture 1 0.012 mg 1 1520 +5°C ± 3°C A1A 79 €

Y0000782 Fosfomycin calcium 1 10 mg 1 1328 +5°C ± 3°C A1A 79 €

F0399950 Fosfomycin sodium - reference spectrum 1 n/a 1 1329 L 79 €

New F0400000 Fosfomycin trometamol 4 1500 mg 1 See leaflet ; Batch 3 is valid until 30 June 2018 1425 +5°C ± 3°C A1A 79 €

Y0001227 Fosinopril sodium 1 60 mg 1 1751 +5°C ± 3°C A1A 79 €

Y0001228 Fosinopril impurity A 1 5 mg 1 (2S,4S)-4-cyclohexyl-1-[[(R)-hydroxy(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid

1751 +5°C ± 3°C A1A 79 €

Y0001229 Fosinopril impurity B 1 5 mg 1 (2RS,4RS)-4-cyclohexyl-1-[[(RS)-[(1SR)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid

1751 +5°C ± 3°C A1A 79 €

Y0001230 Fosinopril impurity C 1 10 mg 1 mixture of (2S,4S)-4-cyclohexyl-1-[[(S)-[(1S)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid and (2S,4S)-4-cyclohexyl-1-[[(R)-[(1R)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid

1751 +5°C ± 3°C A1A 79 €

Y0001231 Fosinopril impurity D 1 10 mg 1 (2S,4R)-4-cyclohexyl-1-[[(R)-[(1S)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid

1751 +5°C ± 3°C A1A 79 €

Y0001232 Fosinopril impurity I 1 5 mg 1 [(RS)-[(1SR)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphoryl]acetic acid

1751 +5°C ± 3°C A1a 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 43For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0001233 Fosinopril impurity K 1 5 mg 1 (2S,4S)-4-cyclohexyl-1-(2,2-dimethyl-1-oxopropyl)pyrrolidine-2-carboxylic acid

1751 +5°C ± 3°C A1A 79 €

Y0001212 Fosinopril impurity mixture 1 0.02 mg 1 1751 +5°C ± 3°C A1A 79 €

F0450000 Framycetin sulfate 7 25 mg 2 See leaflet ; Batch 6 is valid until 28 February 2017 0180,0197,20702

-20°C ± 5°C

C1a 79 €

F0550000 Fructose 1 100 mg 1 0188, 0924 +5°C ± 3°C A1A 79 €

Y0001399 Fulvestrant 1 120 mg 1 See leaflet C–œH÷ŸF—O–S 2443 +5°C ± 3°C A1A 79 €

New Y0001413 Fulvestrant for system suitability 2 40 mg 1 Batch 1 is valid until 31 July 2018 2443 +5°C ± 3°C A1A 79 €

F0600000 Fumaric acid 3 120 mg 1 0365,0902,1190

+5°C ± 3°C A1A 79 €

F0700000 Furosemide 2 100 mg 1 0391,2185 +5°C ± 3°C A1A 79 €

F0702000 Furosemide impurity A 4 5 mg 1 2-chloro-4-[(furan-2-ylmethyl)amino]-5-sulfamoylbenzoic acid 0391 +5°C ± 3°C A1A 79 €

Y0001493 Furosemide for peak identification 2 10 mg 1 0391 +5°C ± 3°C A1A 79 €

Y0001411 Fusidic acid 1 10 mg 1 0798 -20°C ± 5°C

C1A 79 €

Y0001394 Fusidic acid for peak identification 1 5 mg 1 0798,0848 -20°C ± 5°C

C1A 79 €

Y0001384 Fusidic acid impurity mixture 2 0.048 mg 1 0798,0848 -20°C ± 5°C

C1A 79 €

Y0001280 Gabapentin 2 300 mg 1 See leaflet C„HŒŸNOœ 2173 +5°C ± 3°C A1A 79 €

Y0001281 Gabapentin impurity A 1 20 mg 1 2-azaspiro[4.5]decan-3-one 2173 +5°C ± 3°C A1A 79 €

Y0001348 Gabapentin impurity B 2 20 mg 1 (1-cyanocyclohexyl)acetic acid 2173 -20°C ± 5°C

C1a 79 €

Y0001349 Gabapentin impurity D 2 20 mg 1 [1-[(3-oxo-2-azaspiro[4.5]dec-2-yl)methyl]cyclohexyl]acetic acid ; Batch 1 is valid until 30 April 2018

2173 +5°C ± 3°C A1A 79 €

Y0001803 Gadobutrol monohydrate 1 210 mg 1 See leaflet CŒ‡H–ŒGdN÷O„,HœO 2735 +5°C ± 3°C A1a 79 €

Y0001804 Gadobutrol for peak identification 1 20 mg 1 2735 +5°C ± 3°C A1a 79 €

Y0001875 Gadodiamide 1 300 mg 1 see leaflet 2225 +5°C ± 3°C B1a 79 €

Y0001876 Gadodiamide impurity A 1 15 mg 1 see leaflet; hydrogen[3,6-bis(carboxylatomethyl)-9-[(methylcarbamoyl)

methyl]-3,6,9-triazaundecanedioato-κ3N3,N6,N9-gadolinate](1-) (Gd-DTPA-MMA)

2225 +5°C ± 3°C B1a 79 €

Y0001877 Gadodiamide impurity B 1 15 mg 1 see leaflet; dihydrogen[3,6,9-tris(carboxylatomethyl)-3,6,9-

triazaundecanedioato-κ3N3,N6,N9-gadolinate](2-) (Gd-DTPA),

2225 +5°C ± 3°C B1a 79 €

G0049000 Galactitol 2 50 mg 1 1381 +5°C ± 3°C A1A 79 €

G0050000 Galactose 3 100 mg 1 See leaflet CÿHŒœ0ÿ 1215 +5°C ± 3°C A1A 79 €

Y0001279 Galantamine hydrobromide 1 10 mg 1 2366 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 44For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0001190 Galantamine natural for system suitability 1 10 mg 1 2366 +5°C ± 3°C A1A 79 €

Y0001201 Galantamine racemic mixture 1 10 mg 1 2366 +5°C ± 3°C A1A 79 €

Y0001191 Galantamine synthetic for system suitability 2 5 mg 1 Batch 1 is valid until 30 June 2017 2366 +5°C ± 3°C A1A 79 €

New Y0001936 (-)-Epigallocatechin-3-O-gallate 1 50 mg 1 2668 +5°C ± 3°C A1a 79 €

G0150000 Gammacyclodextrin 3 120 mg 1 See leaflet C÷‡H‡ÐOŒÐ ; Batch 2 is valid until 31 March 2018 1070,1487,2769

+5°C ± 3°C A1A 79 €

Y0001129 Ganciclovir 1 220 mg 1 1752 +5°C ± 3°C A1A 79 €

Y0001144 Ganciclovir impurity mixture 1 0.005 mg 1 1752 +5°C ± 3°C A1A 79 €

Y0001813 Gefitinib 1 100 mg 1 See leaflet CœœHœ÷ClFN÷O– 2866 +5°C ± 3°C A1a 79 €

Y0001809 Gefitinib for system suitability 1 0.351 mg 1 2866 +5°C ± 3°C A1a 79 €

Y0000675 Gemcitabine hydrochloride 1 50 mg 1 See leaflet 2306 +5°C ± 3°C A1A 79 €

Y0000676 Gemcitabine impurity A 1 20 mg 1 4-aminopyrimidin-2(1H)-one (cytosine) 2306 +5°C ± 3°C A1A 79 €

Y0001682 Gemcitabine impurity C 1 5 mg 1 1-(2-deoxy-2,2-difluoro-β-D-erythro-

pentofuranosyl)pyrimidin-2,4(1H,3H)-dione (2′-deoxy-2′,2′-difluorouridine) (β-uridine)

2306 +5°C ± 3°C A1a 79 €

Y0000513 Gemfibrozil 1 5 mg 1 1694 +5°C ± 3°C A1A 79 €

Y0000514 Gemfibrozil for system suitability 2 0.196 mg 1 1694 +5°C ± 3°C A1A 79 €

Y0001835 Geniposide 1 15 mg 1 See leaflet CŒŸHœ÷OŒÐ 2565 +5°C ± 3°C A1a 79 €

G0200000 Gentamicin sulfate 14 25 mg 2 see leaflet ; Batch 9 is valid until 28 February 2017 0331,20702 -20°C ± 5°C

C1A 79 €

Y0001363 Gentamicin for peak identification 3 10 mg 1 Batch 2 is valid until 31 March 2018 0331 -20°C ± 5°C

C1A 79 €

Y0001112 Gestodene 2 100 mg 1 see leaflet 1726 +5°C ± 3°C A1A 79 €

Y0001116 Gestodene impurity I 2 0.01 mg 1 13-ethyl-17-hydroxy-5-methoxy-18,19-dinor-5α,17α-pregn-15-en-20-yn-3-one (5-methoxy-gestodene) ; Batch 1 is valid until 31 October 2017

1726 +5°C ± 3°C A1A 79 €

Y0001110 Gestodene for system suitability 2 10 mg 1 Batch 1 is valid until 31 December 2017 1726 +5°C ± 3°C A1A 79 €

Y0001012 Ginkgo dry extract for peak identification 2 150 mg 1 1827 -20°C ± 5°C

C1A 79 €

Y0001010 Ginkgolic Acids 3 50 mg 1 See leaflet ; Batch 2 is valid until 30 November 2017 1827 -20°C ± 5°C

C1A 79 €

Y0001029 Ginseng dry extract HRS 1 500 mg 1 2356 -20°C ± 5°C

C1A 79 €

Y0001347 Ginsenoside Rb1 2 30 mg 1 See leaflet C—÷H„œOœ– ; Batch 1 is valid until 30 September 2017 2356 +5°C ± 3°C A1A 79 €

G0300000 Gitoxin 3 30 mg 1 0078,2168 +5°C ± 3°C A1A 79 €

G0325000 Glibenclamide 3 100 mg 1 0718 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 45For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

G0325010 Glibenclamide impurity A 4 10 mg 1 5-chloro-2-methoxy-N-[2-(4-sulfamoylphenyl)ethyl]benzamide ; Batch 3 is valid until 28 February 2017

0718 +5°C ± 3°C A1A 79 €

Y0000242 Glibenclamide impurity B 3 10 mg 1 methyl [[4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]phenyl]sulphonyl]carbamate

0718 +5°C ± 3°C A1A 79 €

Y0001511 Glibenclamide for peak identification 2 30 mg 1 Batch 1 is valid until 28 February 2018 0718 +5°C ± 3°C A1a 79 €

Y0001406 Glucosamine hydrochloride 1 15 mg 1 2446 +5°C ± 3°C A1A 79 €

G0326000 Gliclazide 2 20 mg 1 1524 +5°C ± 3°C A1A 79 €

G0326004 Gliclazide impurity B 4 50 mg 1 2-nitroso-octahydrocyclopenta[c]pyrrole ; Batch 3 is valid until 31 August 2017

1524 +5°C ± 3°C A1a 79 €

G0326012 Gliclazide impurity F 5 50 mg 1 1-(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-[(2-methylphenyl) sulphonyl]urea

1524 +5°C ± 3°C A1a 79 €

Y0001685 Glucosamine sulfate potassium chloride 1 10 mg 1 2708 +5°C ± 3°C A1A 79 €

Y0000515 Glimepiride 2 110 mg 1 See leaflet 2223 +5°C ± 3°C A1A 79 €

Y0001742 Glimepiride for impurity A identification 1 5 mg 1 2223 +5°C ± 3°C A1A 79 €

Y0000516 Glimepiride for system suitability 4 0.012 mg 1 Batch 3 is valid until 28 February 2017 2223 +5°C ± 3°C A1a 79 €

G0340000 Glipizide 1 50 mg 1 0906 +5°C ± 3°C A1A 79 €

G0342000 Glipizide impurity A 1 10 mg 1 5-methyl-N-[2-(4-sulfamoylphenyl)ethyl]pyrazine-2-carboxamide

0906 +5°C ± 3°C A1A 79 €

Y0000523 Glipizide impurity C 1 10 mg 1 ethyl [2-[4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl]ethyl] carbamate

0906 +5°C ± 3°C A1A 79 €

Y0000643 Glipizide impurity D 1 10 mg 1 6-methyl-N-[2-(4-sulphamoylfenyl)ethyl]pyrazine-2-carboxamide 0906 +5°C ± 3°C A1A 79 €

Y0001140 Glipizide impurity mixture 1 0.002 mg 1 0906 +5°C ± 3°C A1A 79 €

Y0001407 Glucosamine sulfate sodium chloride 1 15 mg 1 2447 +5°C ± 3°C A1A 79 €

Y0001381 Glucosamine for system suitability 2 3 mg 1 Batch 1 is valid until 30 September 2017 2446,2447,2708

+5°C ± 3°C A1A 79 €

Y0001745 Glucose monohydrate 1 750 mg 1 See leaflet CÿHŒœOÿ,HœO 0177,0178,0209

+5°C ± 3°C A1a 79 €

G0355000 Glutamic acid 2 50 mg 1 The reference standard G0355000 will be deleted from the monographs 01/2018:0797and 01/2018:1445 on 01/01/2018.

0750, 2076 +5°C ± 3°C A1A 79 €

Y0000517 Glutathione 1 10 mg 1 1670 +5°C ± 3°C A1A 79 €

G0360000 Glutethimide - * psy 1 50 mg 1 1291 +5°C ± 3°C A2A 79 €

G0400000 Glycerol (85 per cent) - reference spectrum 1 n/a 1 0496,0497 L 79 €

Y0001391 Glycerol formal 1 20 mg 2 1671 +5°C ± 3°C A1A 79 €

Y0000794 Glycerol monocaprylate 1 400 mg 1 2213 +5°C ± 3°C A1A 79 €

Y0000795 Glycerol monocaprylocaprate 2 500 mg 1 2392 +5°C ± 3°C A1A 79 €

G0400006 Glycerol monolinoleate 1 2000 mg 1 1429 +5°C ± 3°C A1A 79 €

G0400007 Glycerol mono-oleate 3 2500 mg 1 Batch 2 is valid until 28 February 2018 1430 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 46For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

G0400008 Glycerol monostearate 40-55 4 2000 mg 1 Batch 3 is valid until 31 March 2017 0495 +5°C ± 3°C A1A 79 €

Y0001786 Glyceryl trinitrate for system suitability 1 0.5 mL 1 1331 +5°C ± 3°C A1b UN1204 79 €

G0400100 Glyceryl trinitrate solution 3 0.5 mL 1 1331,1355 +5°C ± 3°C A1B UN1204 79 €

G0400101 Glyceryl trinitrate - reference spectrum 1 n/a 1 1331 L 79 €

G0450000 Glycine 3 50 mg 1 0614, 0813 +5°C ± 3°C A1A 79 €

Y0001308 Glycopyrronium bromide 1 10 mg 1 1783 +5°C ± 3°C A1a 79 €

Y0001358 Glycopyrronium impurity N 1 10 mg 1 See leaflet CŒ„Hœ‡BrNO–; (3RS)-3-[(2RS)-(2-cyclopentyl-2-hydroxy-2-phenylacetyl)oxy]-1,1-dimethylpyrrolidinium

1783 +5°C ± 3°C A1a 79 €

Y0000433 Ammonium glycyrrhizate 2 70 mg 1 1772 +5°C ± 3°C A1a 79 €

Y0001309 Glycopyrronium for peak identification 1 10 mg 1 1783 +5°C ± 3°C A1a 79 €

G0460000 Glycyrrhizate (monoammonium) 4 300 mg 1 see leaflet 0277, 2378 +5°C ± 3°C A1a 79 €

G0525000 Gonadorelin 5 5 mg 1 See leaflet C——HŸ—NŒŸOŒ– 0827 -20°C ± 5°C

C1A 79 €

Y0001546 Gonadorelin for NMR identification 1 6 mg 3 0827 -20°C ± 5°C

C1A 79 €

Y0001942 Gonadorelin for system suitability 1 1 mg 1 0827 -20°C ± 5°C

C1a 79 €

Y0000125 Goserelin 3 2 mg 1 See leaflet C—„H‡÷NŒ‡OŒ÷ 1636 -20°C ± 5°C

C1A 79 €

Y0000126 Gosereline - reference spectrum 1 n/a 1 1636 L 79 €

Y0001473 Goserelin for NMR identification 1 14 mg 1 1636 -20°C ± 5°C

C1A 79 €

Y0000194 Goserelin validation mixture 2 1 mg 1 Supplied with the Ph. Eur. reference chromatogram 1636 -20°C ± 5°C

C1A 79 €

Y0000019 4-D-Ser-goserelin 1 0.1 mg 1 1636 -20°C ± 5°C

C1A 79 €

G0550000 Gramicidin 1 250 mg 1 See leaflet 0907,1662,20702

+5°C ± 3°C A1A 79 €

Y0000396 Granisetron hydrochloride 2 120 mg 1 See leaflet 1695 +5°C ± 3°C A1A 79 €

Y0000477 Granisetron impurity A 3 1 mg 1 2-methyl-N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-2H-indazole-3-carboxamide

1695 +5°C ± 3°C A1A 79 €

Y0000478 Granisetron impurity B 3 1 mg 1 N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide

1695 +5°C ± 3°C A1A 79 €

Y0000395 Granisetron impurity E 3 15 mg 2 (1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine 1695 +5°C ± 3°C A1A 79 €

New Y0001935 Green tea dry extract HRS 1 110 mg 1 2668 +5°C ± 3°C A1a 79 €

G0600000 Griseofulvin 2 50 mg 1 0182 +5°C ± 3°C A1A 79 €

Y0000619 Guaiacol 2 1500 mg 1 See leaflet CŸH‡Oœ 1978 +5°C ± 3°C A1A 79 €

G0700000 Guaifenesin 3 120 mg 1 See leaflet CŒÐHŒ÷O÷ ; Batch 1 is valid until 31 March 2018 0615 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 47For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0001956 Guaifenesin for peak identification 1 10 mg 1 0615 +5°C ± 3°C A1a 79 €

Y0000117 Halofantrine hydrochloride 1 125 mg 1 See leaflet CœÿH–ŒCl–F–NO 1979 +5°C ± 3°C A1A 79 €

Y0000118 Halofantrine impurity C 1 10 mg 1 [1,3-dichloro-6-(trifluoromethyl)phenantren-9-yl]methanol 1979 +5°C ± 3°C A1A 79 €

H0100000 Haloperidol 2 60 mg 1 0616,1178 +5°C ± 3°C A1A 79 €

Y0001518 Haloperidol for peak identification 3 20 mg 1 Batch 2 is valid until 28 February 2018 0616 +5°C ± 3°C A1a 79 €

Y0001517 Haloperidol for system suitability 1 25 mg 1 0616 +5°C ± 3°C A1a 79 €

H0100100 Haloperidol decanoate 1 60 mg 1 1397,1431 +5°C ± 3°C A1A 79 €

H0150000 Halothane - reference spectrum 2 n/a 1 0393 L 79 €

Y0000673 Harpagoside 2 1.05 mg 1 See leaflet Cœ÷H–ÐOŒŒ ; Batch 1 is valid until 30 November 2017 1095, 1871 +5°C ± 3°C A1A 79 €

H0200000 Heparin sodium BRP 3 2 ml 1 See leaflet 0569, 20705 +5°C ± 3°C A1A 79 €

Y0001283 Heparin sodium for NMR identification 1 30 mg 1 0333 +5°C ± 3°C A1A 79 €

Y0001287 Heparin calcium for NMR identification 1 30 mg 1 0332 +5°C ± 3°C A1A 79 €

Y0001282 Heparin for physico-chemical analysis 2 300 mg 1 0332, 0333 +5°C ± 3°C A1A 79 €

H0185000 Heparin Low-Molecular-Mass for assay BRP 10 1 mg 5 See leaflet ; Batch 9 is valid until 30 April 2018 0828 +5°C ± 3°C B1A 90 €

H0190000 Heparin Low-Molecular-Mass for calibration CRS

4 10 mg 1 See leaflet ; Batch 3 is valid until 30 November 2017 0828 +5°C ± 3°C A1A 170 €

H0205010 Hepatitis A vaccine (inactivated, adsorbed) Type B BRP

2 0.5 ml 3 See leaflet; Please contact us for information on the type needed for your use

See leaflet,20714

+5°C ± 3°C B1A 90 €

Y0001192 Hepatitis A Vaccine (Inactivated, Non-Adsorbed) BRP

2 1 mL 1 To be stored below -50°C 20714,1526,1935, 1107

-80°C ± 10°C

D1A 90 €

Y0001624 Hepatitis A virus Coating Reagent for ELISA 1 1 mL 1 -20°C ± 5°C

C1A 79 €

Y0001623 Hepatitis A vaccine ELISA detection antibodies set - BRR

4 295 µL 1 See leaflet ; Batch 3 is valid until 31 December 2017 20714 -20°C ± 5°C

C1A 79 €

Y0001872 Hepatitis A virus RNA for NAT testing BRP 1 45 mg 5 See leaflet 1646 -20°C ± 5°C

D1b UN2814 242 €

Y0000389 Hepatitis B vaccine (rDNA) BRP method A (thiomersal free)

2 0.5 ml 2 See leaflet; Ph. Eur. BRPs are established in the context of specific methods. The method used to establish this BRP (refer to leaflet) is no longer available. Reference to the BRP has therefore been removed from the relevant monograph and general chapter of the Ph. Eur. and upon depletion of stocks this BRP will not be replaced. Users are encouraged to find alternative reference material to address their future needs.

See leaflet,20715

+5°C ± 3°C B1A 90 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 48For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

H0210010 Hepatitis B vaccine (rDNA) BRP method B 2 1 ml 2 See leaflet; Ph. Eur. BRPs are established in the context of specific methods. The method used to establish this BRP (refer to leaflet) is no longer available. Reference to the BRP has therefore been removed from the relevant monograph and general chapter of the Ph. Eur. and upon depletion of stocks this BRP will not be replaced. Users are encouraged to find alternative reference material to address their future needs.

See leaflet,1056

+5°C ± 3°C B1A 90 €

H0215000 Hepatitis C Virus RNA for NAT testing BRP 1 40 mg 5 See leaflet; For plasma pool testing by NAT See leaflet,20621

-20°C ± 5°C

D1b UN2814 242 €

Y0001873 Hepatitis E virus RNA for NAT testing BRP 1 45 mg 1 See leaflet 1646 -20°C ± 5°C

D1b UN2814 79 €

Y0000063 Heptaminol hydrochloride 2 150 mg 1 1980 +5°C ± 3°C A1A 79 €

Y0000057 Heptaminol impurity A 2 20 mg 1 See leaflet C‡HŒŸN; (2RS)-6-methylhept-5-en-2-amine 1980 +5°C ± 3°C A1A 79 €

Y0001203 Hesperidin 1 20 mg 1 See leaflet Cœ‡H–÷OŒ— 2430 +5°C ± 3°C A1A 79 €

H0330000 Hexamidine diisetionate 2 20 mg 1 1436 +5°C ± 3°C A1A 79 €

H0325000 Hexetidine 2 100 mg 1 1221 +5°C ± 3°C A1A 79 €

H0420000 Hexylresorcinol 1 100 mg 1 1437 +5°C ± 3°C A1a 79 €

Y0001746 Hexylresorcinol for system suitability 1 1 mg 1 1437 -20°C ± 5°C

C1a 79 €

H0500000 Hide powder 4 500 mg 1 20814 +5°C ± 3°C A1A 79 €

Y0001779 Histamine 1 15 mg 1 2671 -20°C ± 5°C

D1a 79 €

H0600000 Histamine dihydrochloride 3 250 mg 1 Batch 2 is valid until 30 April 2017 0143 +5°C ± 3°C A1A 79 €

H0750000 Histidine 3 25 mg 1 0911 +5°C ± 3°C A1A 79 €

H0755000 Histidine hydrochloride monohydrate 3 100 mg 1 Batch 2 is valid until 28 February 2018 0910,2671 +5°C ± 3°C A1A 79 €

H0800000 Homatropine hydrobromide 1 100 mg 1 0500,0720 +5°C ± 3°C A1A 79 €

H0830000 Homatropine methylbromide 1 25 mg 1 0720 +5°C ± 3°C A1A 79 €

H0837000 L-Homocysteine thiolactone hydrochloride - reference spectrum

1 n/a 1 1617 L 79 €

Y0001383 Homatropine methylbromide for system suitability

1 5 mg 1 0720 +5°C ± 3°C A1A 79 €

Y0001290 Honokiol 1 20 mg 1 See leaflet CŒ‡HŒ‡Oœ 2567,2568 -20°C ± 5°C

C1A 79 €

H0900000 Human albumin for electrophoresis BRP 3 50 mg 1 See leaflet ; Batch 2 is valid until 31 March 2017 0255 +5°C ± 3°C A1a 79 €

Y0000219 Human anti-D immunoglobulin BRP 1 40 mg 1 See leaflet See leaflet,20713

-20°C ± 5°C

C1A 90 €

Y0000667 Human coagulation factor VII concentrate BRP

2 25 mg 2 See leaflet See leaflet,20710

-20°C ± 5°C

C1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 49For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0001663 Human coagulation factor VIIa (rDNA) 1 42 mg 1 See leaflet 2534 -20°C ± 5°C

C1a 79 €

H0920000 Human coagulation factor VIII concentrate BRP

5 37 mg 3 See leaflet 20704 -20°C ± 5°C

C1A 90 €

H0920500 Human coagulation factor IX concentrate BRP 3 30 mg 3 See leaflet; Common standard with FDA and WHO (4th IS) 2.7.11 -20°C ± 5°C

C1a 90 €

Y0001659 Human coagulation factor IX (rDNA) 1 10 mg 1 see leaflet 2522, 2994 -20°C ± 5°C

C1A 79 €

Y0000191 Human glucagon 2 2.94 mg 2 See leaflet CŒ—–Hœœ—N÷–O÷„S 1635 -20°C ± 5°C

C1A 79 €

H0950000 Human hepatitis A immunoglobulin BRP 1 10 mg 3 See leaflet See leaflet,0338, 0769,

1646

-20°C ± 5°C

C1a 90 €

Y0001414 Human Hepatitis B immunoglobulin BRP 1 100 mg 1 See leaflet 0722, 1016 -20°C ± 5°C

C1A 90 €

Y0000488 Human immunoglobulin (molecular size) BRP 2 10 mL 3 Batch 1 is valid until 28 February 2018 0338, 0918,1928,278

8

+5°C ± 3°C A1A 90 €

New Y0001994 Human immunoglobulin for anticomplementary activity

1 10 g 1 20617, 918 +5°C ± 3°C B1a 79 €

H1000000 Human immunoglobulin for electrophoresis BRP

3 50 mg 1 See leaflet 0338,0918 +5°C ± 3°C A1A 79 €

Y0001966 Human immunoglobulin for Fc function BRP 1 10 mL 1 20709, 0918, 2788

+5°C ± 3°C A1A 90 €

H1005000 Human Plasma Pools for NAT validation 1 3502 mg 1 Set of 103 plasma pool samples See leaflet,20621

-20°C ± 5°C

C1A 400 €

H1100000 Human rabies immunoglobulin BRP 1 170 mg 3 See leaflet See leaflet,0723

-20°C ± 5°C

C1A 90 €

H1110000 Human tetanus immunoglobulin BRP 1 87 mg 1 See leaflet 0398 -20°C ± 5°C

C1A 90 €

Y0000502 Human vaccinia immunoglobulin 1 1 ml 3 See leaflet See leaflet -20°C ± 5°C

C1A 270 €

H1115000 Hyaluronidase BRP 2 50 mg 1 See leaflet 0912 +5°C ± 3°C A1a 79 €

H1120000 Hydralazine hydrochloride 1 20 mg 1 0829 +5°C ± 3°C A1A 79 €

Y0001151 Hydrastine hydrochloride 2 25 mg 1 See leaflet CœŒHœœClNOÿ ; Batch 1 is valid until 31 May 2017 1831,2500 -20°C ± 5°C

C1A 79 €

H1200000 Hydrochlorothiazide 8 300 mg 1 See leaflet CŸH‡ClN–O÷Sœ ; Batch 7 is valid until 30 November 2017 0394 +5°C ± 3°C A1A 79 €

Y0001494 Hydrochlorothiazide for peak identification 3 10 mg 1 0394 +5°C ± 3°C A1A 79 €

Y0000646 Hydrocodone hydrogen tartrate 2.5-hydrate - * narc

1 10 mg 1 1784 +5°C ± 3°C A2A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 50For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000710 Hydrocodone for peak identification - * narc 1 10 mg 1 1784 +5°C ± 3°C A2A 79 €

H1300000 Hydrocortisone 8 100 mg 1 0335 +5°C ± 3°C A1A 79 €

Y0001092 Hydrocortisone for peak identification 2 5 mg 1 0335 +5°C ± 3°C A1A 79 €

H1400000 Hydrocortisone acetate 9 125 mg 1 See leaflet 0321,0334,0335, 0734,0767

+5°C ± 3°C A1A 79 €

Y0001482 Hydrocortisone acetate for peak identification 2 15 mg 1 0334 +5°C ± 3°C A1A 79 €

H1425000 Hydrocortisone hydrogen succinate 2 100 mg 1 0768 -20°C ± 5°C

C1a 79 €

H1426000 Hydrogenated wool fat 1 250 mg 1 0969 +5°C ± 3°C A1A 79 €

Y0000446 Hydromorphone hydrochloride - * narc 1 10 mg 1 2099 +5°C ± 3°C A2A 79 €

B0650000 Hydrous benzoyl peroxide - reference spectrum

2 n/a 1 Batch 1 is valid until 30 November 2017 0704 L 79 €

H1428000 Hydroxocobalamin 1 10 mg 1 0913,0914,0915

-20°C ± 5°C

C1A 79 €

New Y0000119 Hydroxycarbamide 3 360 mg 1 See leaflet ; Batch 2 is valid until 30 June 2018 1616 +5°C ± 3°C A1A 79 €

Y0001841 Hydroxychloroquine for system suitability 1 15 mg 1 2849 +5°C ± 3°C A1a 79 €

Y0001839 Hydroxychloroquine sulfate 1 70 mg 1 see leaflet CŒ‡HœÿClN–O.HœSO÷ 2849 +5°C ± 3°C A1a 79 €

H1429400 Hydroxyethyl salicylate 1 125 mg 1 1225 +5°C ± 3°C A1A 79 €

Y0001322 Hydroxyethyl starch (high Mw) 1 800 mg 1 See leaflet 1785 +5°C ± 3°C A1A 79 €

Y0001277 Hydroxyethyl starch (medium MW) 1 1200 mg 1 See leaflet 1785 +5°C ± 3°C A1A 79 €

H1430000 D-alpha-(4-Hydroxy-phenyl)glycine 1 50 mg 1 (2R)-2-amino-2-(4-hydroxyphenyl)acetic acid - Cefadroxyl impurity A

0813 +5°C ± 3°C A1A 79 €

Y0001951 Hydroxyethylcellulose 1 60 mg 1 0336 +5°C ± 3°C A1a 79 €

Y0000186 Hydroxypropylbetadex 2 200 mg 1 1804 +5°C ± 3°C A1A 79 €

Y0001720 Hydroxypropylcellulose 1 150 mg 1 0337, 2083 +5°C ± 3°C A1A 79 €

Y0001798 Low-substituted hydroxypropylcellulose 1 100 mg 1 2083 +5°C ± 3°C A1a 79 €

H1435000 Hydroxyzine hydrochloride 3 600 mg 1 0916,1086 +5°C ± 3°C A1A 79 €

Y0000011 Hymecromone 1 100 mg 1 1786 +5°C ± 3°C A1A 79 €

Y0000012 Hymecromone impurity A 1 25 mg 1 benzene-1,3-diol (resorcinol) 1786 +5°C ± 3°C A1A 79 €

Y0000013 Hymecromone impurity B 2 25 mg 1 7-hydroxy-2-methyl-4H-1-benzopyran-4-one. 1786 +5°C ± 3°C A1A 79 €

Y0000483 Hyoscine 1 10 mg 1 2167 +5°C ± 3°C A1A 79 €

Y0000484 Hyoscine impurity A 1 15 mg 1 (1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (2S)-3-hydroxy-2-phenylpropanoate (norhyoscine)

2167 +5°C ± 3°C A1A 79 €

H1450000 Hyoscine butylbromide 2 20 mg 1 0737 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 51For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000447 Hyoscine butylbromide impurity E 1 10 mg 1 (1R,2R,4S,5S,7s)-9-butyl -3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate (N-butylhyoscine) This reference standard will be deleted from monograph 01/2008:0737 corrected 6.0 on 2018/07/01. ; Batch 1 is valid until 30 June 2018

0737 +5°C ± 3°C A1A 79 €

H1500000 Hyoscine hydrobromide 1 50 mg 1 0106,0500 +5°C ± 3°C A1A 79 €

Y0000448 Hyoscine hydrobromide impurity B 1 10 mg 1 (1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (2S)-3-hydroxy-2-phenylpropanoate (norhyoscine)

0106 +5°C ± 3°C A1A 79 €

H1600000 Hyoscyamine sulfate 1 100 mg 1 0501, 2489 +5°C ± 3°C A1A 79 €

Y0000449 Hyoscyamine impurity E 1 10 mg 1 (1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl (2S)-3-hydroxy-2-phenylpropanoate (norhyoscyamine)

0501 +5°C ± 3°C A1A 79 €

Y0000915 Hypromellose phthalate 1 10 mg 1 347 +5°C ± 3°C A1A 79 €

I0020000 Ibuprofen 5 250 mg 1 0721 +5°C ± 3°C A1A 79 €

B1220000 Ibuprofen impurity B 9 1.15 mL 1 See leaflet; (2RS)-2-(4-Butylphenyl)propanoic acid 0721 +5°C ± 3°C A1a 79 €

Y0000140 Ibuprofen impurity F 3 5 mg 1 3-[4-(2-methylpropyl)phenyl]propanoic acid ; Batch 2 is valid until 31 March 2018

0721 +5°C ± 3°C A1A 79 €

Y0000881 Ibuprofen for peak identification 7 0.09 mg 1 Batch 6 is valid until 31 March 2017 0721 +5°C ± 3°C A1A 79 €

I0050000 Idoxuridine 1 50 mg 1 0669 +5°C ± 3°C A1A 79 €

New I0060000 Ifosfamide 2 50 mg 1 See leaflet CŸHŒ—ClœNœOœP ; Batch 1 is valid until 30 June 2018 1529 +5°C ± 3°C A1A 79 €

I0060100 Ifosfamide - reference spectrum 1 n/a 1 1529 L 79 €

I0060002 Ifosfamide impurity A 4 100 mg 2 3-[(2-chloroethyl)amino]propyl dihydrogen phosphate 1529 -20°C ± 5°C

C1A 79 €

I0060004 Ifosfamide impurity B 3 40 mg 1 bis[3-[(2-chloroethyl)amino]propyl] dihydrogen diphosphate ; Batch 2 is valid until 31 January 2018

1529 +5°C ± 3°C A1A 79 €

New I0060010 Ifosfamide impurity E 2 40 mg 1 3-chloro-N-(2-chloroethyl)propan-1-amine ; Batch 1 is valid until 31 July 2018

1529 +5°C ± 3°C A1A 79 €

I0060012 Ifosfamide impurity F 2 10 mg 1 (RS)-2-chloro-3-(2-chloroethyl)-1,3,2-oxazaphosphinane 2-oxide 1529 +5°C ± 3°C B1A 79 €

Y0001691 Imatinib mesilate 2 120 mg 1 see leaflet C–ÐH–—NŸSO÷ ; Batch 1 is valid until 31 May 2017 2736 +5°C ± 3°C A1A 79 €

Y0001695 Imatinib impurity A 1 0.03 mg 1 (2E)-3-(dimethylamino)-1-(pyridin-3-yl)prop-2-ene-1-one 2736 -20°C ± 5°C

D1a 79 €

Y0001693 Imatinib impurity F 3 10 mg 1 4-methyl-N3-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine 2736 +5°C ± 3°C A1a 79 €

Y0001694 Imatinib impurity H 2 130 mg 1 1-(pyridin-3-yl)ethan-1-one ; Batch 1 is valid until 30 April 2018 2736 +5°C ± 3°C A1a 79 €

Y0001692 Imatinib for system suitability 1 5 mg 1 2736 +5°C ± 3°C A1A 79 €

I0086000 Imidazole 2 60 mg 1 0757,1424, 2270

+5°C ± 3°C A1A 79 €

I0090000 Imipenem 3 70 mg 1 See leaflet 1226 -20°C ± 5°C

C1A 79 €

I0100000 Imipramine hydrochloride 2 50 mg 1 0029, 0408, 0889,1787

+5°C ± 3°C A1a 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 52For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0001689 Immunoglobulin (anti-A, anti-B antibodies test) Negative control

1 50 mg 1 20620 -20°C ± 5°C

C1A 90 €

Y0001688 Immunoglobulin (anti-A, anti-B antibodies test) Positive control

1 46 mg 1 20620 -20°C ± 5°C

C1A 90 €

Y0000893 Imipramine for system suitability 1 10 mg 1 0029 +5°C ± 3°C A1A 79 €

Y0001153 Immunoglobulin for anti-A, anti-B antibodies limit test BRP

1 45 mg 1 20620 -20°C ± 5°C

C1A 90 €

Y0000540 Immunoglobulin panel for anti-D antibodies test BRP

1 2000 mg 1 See leaflet, 20626

-20°C ± 5°C

C1a 90 €

Y0001205 Imperatorin 1 20 mg 1 See leaflet CŒÿHŒ÷O÷ 2556 +5°C ± 3°C A1A 79 €

I0150000 Indapamide 6 150 mg 1 See leaflet CŒÿHŒÿClN–O–S ; Batch 5 is valid until 30 April 2018 1108 +5°C ± 3°C A1A 79 €

Y0001828 Indapamide Impurity C 1 25 mg 1 (2RS)-2-methyl-2,3-dihydro-1H-indol-1-amine 1108 +5°C ± 3°C A1a 79 €

I0150020 Indapamide impurity B 4 5 mg 1 4-chloro-N-(2-methyl-1H-indol-1-yl)-3-sulfamoylbenzamide 1108 +5°C ± 3°C A1A 79 €

Y0001752 Indigo 1 15 mg 1 see leaflet CŒÿHŒÐNœOœ 2727 +5°C ± 3°C A1a 79 €

Y0000788 Indinavir 1 100 mg 1 see leaflet 2214 +5°C ± 3°C A1A 79 €

Y0000880 Indinavir sulfate - reference spectrum 1 n/a 1 2214 L 79 €

Y0000746 Indinavir for system suitability 1 20 mg 1 2214 +5°C ± 3°C A1A 79 €

I0200000 Indometacin 3 70 mg 1 0092,0922,1686

+5°C ± 3°C A1A 79 €

Y0001640 Indometacine impurity mixture 1 0.002 mg 1 0092 +5°C ± 3°C A1A 79 €

Y0000349 Insulin aspart 3 8 mg 1 See leaflet ; Batch 2 is valid until 31 March 2018 2084 -20°C ± 5°C

C1A 90 €

I0305000 Insulin (bovine) 3 7.99 mg 1 See leaflet Cœ—÷H–ŸŸNÿ—OŸ—Sÿ 0854,1637 -20°C ± 5°C

C1A 90 €

Y0001542 Insulin glargine 3 15 mg 1 See leaflet ; Batch 1 is valid until 30 November 2017 Batch 2 is valid until 30 April 2018

2571 -20°C ± 5°C

C1A 79 €

Y0001544 Insulin glargine for peak identification 1 3.2 mg 1 2571 -20°C ± 5°C

C1A 79 €

I0310000 Insulin (human) 4 8 mg 1 see leaflet 0838, 0854, 1637, 1638

-20°C ± 5°C

C1A 90 €

Y0000348 Insulin lispro 2 5.75 mg 1 See leaflet Cœ—ŸH–‡–Nÿ—OŸŸSÿ 2085 -20°C ± 5°C

C1A 90 €

I0320000 Insulin (porcine) 4 9 mg 1 See leaflet Cœ—ÿH–‡ŒNÿ—OŸÿSÿ; For qualitative use see insulin porcine for system suitability CRS Y0001717

0854,1638 -20°C ± 5°C

C1A 90 €

Y0001717 Insulin porcine for system suitability 2 9 mg 1 For intended use: see leaflet. 0838,0854,1637, 1638

-20°C ± 5°C

C1A 79 €

I0320301 Interferon alfa-2b 6 200 µL 1 About 9.74 mg per mL 1110 -80°C ± 10°C

D1A 90 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 53For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0001101 Interferon beta-1a 3 0.6 mL 1 See leaflet 1639 -80°C ± 10°C

D1A 90 €

I0320330 Interferon gamma-1b 2 0.5 mL 2 about 1 mg per ml 1440 -80°C ± 10°C

D1A 90 €

Y0001664 Interferon gamma-1b for system suitability 1 0.6 mg 1 1440 -20°C ± 5°C

C1A 79 €

I0328000 Iobenguane sulfate 3 25 mg 1 See leaflet ; Batch 2 is valid until 31 May 2017 1111,1112,1113,2351

+5°C ± 3°C B1a 79 €

Y0000839 Iobenguane sulfate - reference spectrum 1 n/a 1 2351 L 79 €

Y0001294 Iodixanol 1 60 mg 1 2215 +5°C ± 3°C A1A 79 €

Y0001292 Iodixanol impurity C 1 10 mg 1 5-[acetyl[3-[[3,5-bis[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl]amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide

2215 +5°C ± 3°C A1A 79 €

Y0001291 Iodixanol impurity E 1 10 mg 1 5-[acetyl[3-[acetyl[3-carbamoyl-5-[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl]amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide

2215 +5°C ± 3°C A1A 79 €

Y0001293 Iodixanol impurity H 1 10 mg 1 5-[acetyl[3-[acetyl[3-[[3-[3-[acetyl[3,5-bis[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl]amino]-2-hydroxypropoxy]-2-hydroxypropyl]carbamoyl]-5-[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl]amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide

2215 +5°C ± 3°C A1A 79 €

I0320800 Iohexol 2 150 mg 1 1114 +5°C ± 3°C A1A 79 €

I0320810 Iohexol impurity A 1 50 mg 1 5-(acetylamino)-N,N′-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide

1114 +5°C ± 3°C A1A 79 €

I0320820 Iohexol impurity J 1 125 mg 1 5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide

1114,2215 +5°C ± 3°C A1A 79 €

Y0000672 Iohexol for peak identification 1 10 mg 1 1114 +5°C ± 3°C A1A 79 €

I0329000 Iopamidol 1 50 mg 1 1115 +5°C ± 3°C A1A 79 €

I0329010 Iopamidol impurity A 2 15 mg 1 5-amino-N,N’-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodobenzene-1,3-dicarboxamide

1115, 1754 +5°C ± 3°C A1A 79 €

Y0000406 Iopamidol impurity H 2 15 mg 1 4-chloro-N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[[(2S)-2-hydroxypropanoyl]amino]-2,6-diiodobenzene-1,3-dicarboxamide ; Batch 1 is valid until 23 September 2017

1115 +5°C ± 3°C A1A 79 €

I0330000 Iopanoic acid 1 100 mg 1 0700 +5°C ± 3°C A1A 79 €

Y0001297 Iopentol 1 10 mg 1 2215 +5°C ± 3°C B1A 79 €

Y0001020 Iopromide 1 100 mg 1 See leaflet CŒ‡Hœ÷I–N–O‡ 1753 +5°C ± 3°C A1A 79 €

Y0001077 Iopromide impurity A 1 0.125 mg 1 5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methylbenzene-1,3-dicarboxamide

1753 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 54For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0001021 Iopromide for system suitability 1 1 5 mg 1 1753 +5°C ± 3°C A1A 79 €

Y0001022 Iopromide for system suitability 2 1 5 mg 1 1753 +5°C ± 3°C A1A 79 €

Y0000555 Iotrolan 1 100 mg 1 See leaflet 1754 +5°C ± 3°C A1A 79 €

Y0000658 Iotrolan for system suitability 1 5 mg 1 1754 +5°C ± 3°C A1A 79 €

Y0000141 Ioxaglic acid 2 125 mg 1 2009 +5°C ± 3°C A1A 79 €

Y0000142 Ioxaglic acid impurity A 1 20 mg 1 3-amino-5-[(2-hydroxyethyl)carbamoyl]-2,4,6-triiodobenzoic acid 2009 +5°C ± 3°C A1A 79 €

I0360000 Ipratropium bromide 5 120 mg 1 0919 +5°C ± 3°C A1A 79 €

I0361000 Ipratropium impurity B 3 10 mg 1 (1R,3r,5S,8s)-3-[[(2RS)-3-hydroxy-2-phenylpropanoyl]oxy]-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane

0919 +5°C ± 3°C A1A 79 €

Y0000276 Ipratropium impurity A 3 15 mg 1 (1R,3r,5S,8r)-3-hydroxy-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane ; Batch 2 is valid until 31 August 2017

0919 +5°C ± 3°C A1A 79 €

Y0001166 Irbesartan 1 60 mg 1 2465 +5°C ± 3°C A1A 79 €

Y0001156 Irbesartan impurity A 3 10 mg 1 1-(pentanoylamino)-N-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]cyclopentane-1-carboxamide

2465 +5°C ± 3°C A1A 79 €

Y0001831 Irinotecan for peak identification 1 1 mg 1 2675 +5°C ± 3°C A1a 79 €

Y0001830 Irinotecan for system suitability 1 2 1.5 mg 1 Batch 1 is valid until 31 January 2018 2675 +5°C ± 3°C A1a 79 €

Y0001833 Irinotecan for system suitability 2 1 10 mg 1 2675 +5°C ± 3°C A1a 79 €

Y0001832 Irinotecan hydrochloride trihydrate 1 170 mg 1 see leaflet C––H–„ClN÷Oÿ,3HœO 2675 +5°C ± 3°C A1a 79 €

Y0001616 Irisflorentin 1 15 mg 1 See leaflet CœÐHŒ‡O‡ 2561 +5°C ± 3°C A1a 79 €

I0375000 Isoconazole 1 200 mg 1 1018 +5°C ± 3°C A1A 79 €

I0380000 Isoconazole nitrate 1 200 mg 1 1017 +5°C ± 3°C A1A 79 €

I0400000 Isoemetine hydrobromide 1 25 mg 1 0081 +5°C ± 3°C A1A 79 €

Y0000858 Isoflurane 2 1.4 mL 1 1666 +5°C ± 3°C B1a 79 €

Y0000037 Isoflurane - reference spectrum 1 n/a 1 1673 L 79 €

I0460000 Isoleucine 2 30 mg 1 0770 +5°C ± 3°C A1A 79 €

I0465000 Isomalt 5 3000 mg 1 See leaflet 1531 +5°C ± 3°C A1a 79 €

Y0000070 Isomaltooligosaccharide 1 0.9 mg 1 1506 +5°C ± 3°C A1A 79 €

I0500000 Isoniazid 1 100 mg 1 0146 +5°C ± 3°C A1A 79 €

I0599990 Isoprenaline hydrochloride 1 50 mg 1 1332 +5°C ± 3°C A1A 79 €

Y0001577 Isoprenaline impurity A 1 15 mg 1 1-(3,4-dihydroxyphenyl)-2-[(1-methylethyl)amino]ethanone 1332 +5°C ± 3°C A1A 79 €

I0600000 Isoprenaline sulfate 3 510 mg 1 0502 +5°C ± 3°C A1A 79 €

Y0001728 Isopropyl alcohol 1 100 mg 1 0970 +5°C ± 3°C A1A 79 €

I0725000 Isopropyl hexadecanoate 2 100 mg 1 See leaflet CŒ„H–‡Oœ 0839 +5°C ± 3°C A1A 79 €

Y0001907 Isopropyl isostearate 1 0.5 mL 1 2867 +5°C ± 3°C A1a 79 €

I0750000 Isopropyl tetradecanoate 4 2 ml 1 See leaflet CŒŸH–÷Oœ 0725 +5°C ± 3°C A1A 79 €

Y0001568 Isoquercitroside 1 15 mg 1 See leaflet CœŒHœÐOŒœ 2528 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 55For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0001836 Isorhynchophylline 1 15 mg 1 see leaflet 2729 -20°C ± 5°C

C1a 79 €

I0775000 Isosorbide dinitrate 4 350 mg 1 See leaflet CÿH‡NœO‡ ; Batch 3 is valid until 28 February 2017 1117,1118 +5°C ± 3°C A1B UN2907 79 €

I0775010 Isosorbide mononitrate 5 150 mg 1 See leaflet CÿH„NOÿ; Isosorbide-5-nitrate. Can only be sent by road. ; Batch 4 is valid until 30 September 2017

1117,1118 +5°C ± 3°C A1B UN3251 79 €

New I0775020 Isosorbide-2-nitrate 4 50 mg 1 Batch 3 is valid until 30 June 2018 1117,1118 +5°C ± 3°C A1A 79 €

I0800000 Isotretinoin 5 50 mg 1 0693,1019 +5°C ± 3°C B1A 79 €

Y0001218 Isotretinoin for peak identification 2 10 mg 1 This reference standard will be deleted from monograph 01/2017:1019 corrected 6.0 on 2018/07/01. ; Batch 2 is valid until 30 June 2018

1019 +5°C ± 3°C B1A 79 €

I0900000 Isoxsuprine hydrochloride 1 50 mg 1 1119 +5°C ± 3°C A1A 79 €

Y0000366 Isradipine 1 125 mg 1 See leaflet CŒ„HœŒN–O— 2110 +5°C ± 3°C A1A 79 €

Y0000367 Isradipine impurity D 1 5 mg 1 methyl 1-methylethyl 4-(2,1,3-benzoxadiazol-4-yl) -2,6-dimethylpyridine-3,5-dicarboxylate

2110 +5°C ± 3°C A1A 79 €

I7000000 Itraconazole 3 20 mg 1 1335 +5°C ± 3°C A1A 79 €

Y0001100 Itraconazole for system suitability 3 25 mg 1 Batch 2 is valid until 31 October 2017 1335 +5°C ± 3°C A1A 79 €

I8000010 Ivermectin 2 150 mg 1 See leaflet 1336 +5°C ± 3°C A1A 79 €

Y0001592 Ivy leaf dry extract HRS 1 70 mg 1 See leaflet 2148 -20°C ± 5°C

C1A 79 €

Y0000041 Josamycin 2 150 mg 1 See leaflet 1982,1983,20702

-20°C ± 5°C

C1A 79 €

Y0001315 Josamycin for peak identification 1 25 mg 1 1983 +5°C ± 3°C A1A 79 €

Y0000042 Josamycin propionate 3 150 mg 1 See leaflet 1982,1983,20702

-20°C ± 5°C

C1A 79 €

K0100000 Kanamycin B sulfate 3 20 mg 1 0032,0033,0645

+5°C ± 3°C A1A 79 €

K0200000 Kanamycin monosulfate 3 150 mg 1 See leaflet CŒ‡H–‡N÷OŒ—S,HœO 0032,0033,0053,

0485,0645,1289, 1290,20702

+5°C ± 3°C A1A 79 €

Y0000450 Ketamine hydrochloride - * narc 1 10 mg 1 1020 +5°C ± 3°C A2A 79 €

K0551000 Ketamine impurity A 3 20 mg 1 1-(2-chloro-N-methylbenzimidoyl)cyclopentanol ; Batch 2 is valid until 30 September 2017

1020,1742 +5°C ± 3°C A1A 79 €

Y0000246 Ketobemidone hydrochloride - reference spectrum

1 n/a 1 1746 L 79 €

Y0000244 Ketobemidone impurity B 1 5 mg 1 1-[4-(3-hydroxyphenyl)-1-methylpiperidin-4-yl]ethanone 1746 +5°C ± 3°C A1A 79 €

Y0000245 Ketobemidone impurity C 1 5 mg 1 1-[4-(3-hydroxyphenyl)piperidin-4-yl]propan-1-one 1746 +5°C ± 3°C A1A 79 €

K0600000 Ketoconazole 2 150 mg 1 0921,1270 +5°C ± 3°C A1a 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 56For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

K2000000 Ketoprofen 2 50 mg 1 0922,1157,1209

+5°C ± 3°C A1A 79 €

K2000010 Ketoprofen impurity A 5 10 mg 1 1-(3-benzoylphenyl)ethanone 0922 +5°C ± 3°C A1A 79 €

K2000015 Ketoprofen impurity C 4 15 mg 1 3-[(1RS)-1-carboxyethyl]benzoic acid ; Batch 3 is valid until 31 May 2017

0922 +5°C ± 3°C A1A 79 €

Y0000486 Ketorolac trometamol 2 10 mg 1 Batch 1 is valid until 31 December 2017 1755 +5°C ± 3°C A1A 79 €

Y0000626 Ketorolac trometamol for peak identification 2 5 mg 1 1755 +5°C ± 3°C A1A 79 €

Y0001619 Ketotifen hydrogen fumarate 1 10 mg 1 1592 +5°C ± 3°C A1A 79 €

Y0000161 Ketotifen impurity G 5 0.0225 mg 1 4-(1-methylpiperidin-4-ylidene)-4H-benzo(4,5)cyclohepta(1,2-b)thiophen-9,10-dione

1592 +5°C ± 3°C A1a 79 €

Y0001617 Ketotifen for peak identification 1 15 mg 1 1592 +5°C ± 3°C A1A 79 €

Y0001200 Kudzuvine root dry extract 1 200 mg 1 See leaflet 2434,2483 -20°C ± 5°C

C1A 79 €

L0050000 Labetalol hydrochloride 2 120 mg 1 See leaflet CŒ„Hœ—ClNœO– 0923 +5°C ± 3°C A1A 79 €

Y0001548 Labetalol impurity A 1 10 mg 1 mixture of 4 stereoisomers of 2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]benzoic acid

0923 +5°C ± 3°C A1A 79 €

New Y0001972 Lacosamide impurity A 1 5 mg 1 2992 +5°C ± 3°C A1a 79 €

New Y0001989 Lacosamide impurity F 1 5 mg 1 2989, 2990, 2991, 2992

+5°C ± 3°C A1a 79 €

L0129000 Lactitol monohydrate 2 60 mg 1 See leaflet CŒœHœ÷OŒŒ 1337 +5°C ± 3°C A1A 79 €

Y0000257 Lactobionic acid 2 100 mg 1 Batch 1 is valid until 30 September 2017 1647 +5°C ± 3°C A1A 79 €

A1206000 Lactose (anhydrous) 2 30 mg 1 1061 +5°C ± 3°C A1A 79 €

New Y0001750 Lactose monohydrate 2 100 mg 1 Batch 1 is valid until 31 May 2018 0187 +5°C ± 3°C A1a 79 €

L0130000 Lactulose 4 3000 mg 1 See leaflet 0924,1230 +5°C ± 3°C A1A 79 €

Y0001510 Lactulose for peak identification 1 2600 mg 1 0924 +5°C ± 3°C A1A 79 €

Y0000425 Lamivudine 2 150 mg 1 See leaflet C‡HŒŒN–O–S ; Batch 1 is valid until 31 July 2017 2217 +5°C ± 3°C A1A 79 €

Y0000518 Lamivudine for system suitability 1 1 10 mg 1 2217 +5°C ± 3°C A1A 79 €

Y0000426 Lamivudine for system suitability 2 2 10.3 mg 1 2217 +5°C ± 3°C A1A 79 €

Y0001030 Lamotrigine 1 10 mg 1 1756 +5°C ± 3°C A1A 79 €

Y0001032 Lamotrigine impurity E 1 15 mg 1 2,3-dichlorobenzoic acid 1756 +5°C ± 3°C A1A 79 €

Y0001031 Lamotrigine for peak identification 1 20 mg 1 1756 +5°C ± 3°C A1A 79 €

Y0001085 Lamotrigine for system suitability 2 10 mg 1 1756 +5°C ± 3°C A1A 79 €

Y0000773 Lansoprazole 1 60 mg 1 2219 +5°C ± 3°C A1A 79 €

Y0000774 Lansoprazole for peak identification 2 1.01 mg 1 2219 +5°C ± 3°C A1A 79 €

Y0001765 Laudanosine 1 15 mg 1 2763 +5°C ± 3°C A1a 79 €

Y0001474 Lauric acid 1 1500 mg 1 see leaflet 1848, 2579 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 57For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

New Y0001996 Lead solution 1 10 mL 1 20420 Room temp. +20°C

A1a 79 €

Y0000654 Leflunomide 1 100 mg 1 See leaflet 2330 +5°C ± 3°C A1A 79 €

Y0000487 Leflunomide impurity A 2 25 mg 1 4-(trifluoromethyl)aniline 2330 +5°C ± 3°C A1A 79 €

Y0000674 Leflunomide for peak identification 2 1 mg 1 Batch 1 is valid until 30 April 2018 2330 +5°C ± 3°C A1A 79 €

Y0000685 Letrozole 1 70 mg 1 See leaflet CŒŸHŒŒN— 2334 +5°C ± 3°C A1A 79 €

New L0375000 Leucine 3 50 mg 1 Batch 2 is valid until 31 May 2018 0771,0874 +5°C ± 3°C A1A 79 €

L0376000 Leuprorelin 5 1 mg 1 See leaflet C—„H‡÷NŒÿOŒœ 1442 -20°C ± 5°C

C1A 79 €

L0376001 Leuprorelin - reference spectrum 1 n/a 1 1442 L 79 €

Y0000048 Levamisole - reference spectrum 1 n/a 1 1728 L 79 €

L0380000 Levamisole hydrochloride 1 50 mg 1 0726 +5°C ± 3°C A1A 79 €

Y0000047 Levamisole hydrochloride for system suitability 5 15 mg 1 0726,1728 +5°C ± 3°C A1a 79 €

Y0001253 Levetiracetam 3 120 mg 1 See leaflet ; Batch 2 is valid until 31 March 2017 2535 +5°C ± 3°C A1A 79 €

New Y0001254 Levetiracetam impurity A 4 10 mg 1 (2RS)-2-(2-oxopyrrolidin-1-yl)butanoic acid ; Batch 3 is valid until 31 July 2018

2535 +5°C ± 3°C A1A 79 €

Y0001255 Levetiracetam impurity B 2 15 mg 1 (2Z)-2-(2-oxopyrrolidin-1-yl)but-2-enamide This reference standard will be deleted from monograph 01/2017:2535 on 2018/04/01. ; Batch 2 is valid until 31 March 2018

2535 +5°C ± 3°C A1A 79 €

Y0001256 Levetiracetam impurity C 2 15 mg 1 pyridin-2-ol 2535 +5°C ± 3°C A1A 79 €

Y0001257 Levetiracetam impurity D 3 15 mg 1 (2R)-2-(2-oxopyrrolidin-1-yl)butanamide ((R)-etiracetam) 2535 +5°C ± 3°C A1A 79 €

L0390000 Levocabastine hydrochloride 1 125 mg 1 1484 +5°C ± 3°C A1A 79 €

New Y0001962 Levetiracetam impurity E 1 10 mg 1 (1R)-1-phenylethan-1-amine 2535 +5°C ± 3°C A1a 79 €

New Y0001948 Levetiracetam impurity G 1 10 mg 1 2535 +5°C ± 3°C A1a 79 €

Y0001636 Levocabastine for system suitability 1 1 5.028 mg 1 1484 +5°C ± 3°C A1A 79 €

Y0001637 Levocabastine for system suitability 2 1 5.005 mg 1 1484 +5°C ± 3°C A1A 79 €

L0399900 Levocarnitine 3 125 mg 1 1339 +5°C ± 3°C A1A 79 €

L0399905 Levocarnitine impurity A 4 50 mg 1 (E)- or (Z)-4-(trimethylammonio)but-2-enoate 1339 +5°C ± 3°C A1A 79 €

L0400000 Levodopa 3 20 mg 1 Batch 2 is valid until 31 May 2017 0038 +5°C ± 3°C A1A 79 €

New L0420000 Levodropropizine 2 60 mg 1 Batch 1 is valid until 31 May 2018 1535 +5°C ± 3°C A1A 79 €

New L0420002 Levodropropizine impurity A 4 25 mg 1 (2R)-3-(4-phenylpiperazin-1-yl)propan-1,2-diol (dextrodropropizine) ; Batch 3 is valid until 31 July 2018

1535 +5°C ± 3°C A1A 79 €

Y0001033 Levodropropizine impurity B 1 50 mg 1 1-phenylpiperazine 1535 +5°C ± 3°C A1A 79 €

Y0001048 Levodropropizine impurity C 1 300 mg 1 [(2RS)-oxiran-2-yl]methanol (glycidol) 1535 -20°C ± 5°C

C1A 79 €

L0500000 Levomepromazine hydrochloride 2 30 mg 1 Batch 1 is valid until 30 April 2018 0505 +5°C ± 3°C A1A 79 €

L0505000 Levomepromazine maleate 1 50 mg 1 0925 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 58For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

L0551000 Levonorgestrel 2 30 mg 1 0926 +5°C ± 3°C A1A 79 €

Y0001379 Levonorgestrel impurity B 2 15 mg 1 13-ethyl-17-hydroxy-18,19-dinor-17α-pregn-5(10)-en-20-yn-3-one 0926 +5°C ± 3°C A1A 79 €

Y0001431 Levonorgestrel for system suitability 1 2 10 mg 1 0926 +5°C ± 3°C A1A 79 €

Y0001618 Levonorgestrel for system suitability 2 1 10 mg 1 0926 +5°C ± 3°C A1A 79 €

L0570000 Levothyroxine sodium 4 100 mg 1 see leaflet 0401,0728 -20°C ± 5°C

C1A 79 €

Y0001382 Levothyroxine for peak identification 1 10 mg 1 0401 -20°C ± 5°C

C1A 79 €

L0595000 Lidocaine 2 10 mg 1 0727 +5°C ± 3°C A1A 79 €

L0600000 Lidocaine hydrochloride 3 40 mg 1 0227,1242,1363

+5°C ± 3°C A1A 79 €

L0650000 Lincomycin hydrochloride 4 100 mg 1 See leaflet 0582,0583,0996

+5°C ± 3°C A1A 79 €

Y0001393 Lincomycin hydrochloride for system suitability 2 10 mg 1 0583 -20°C ± 5°C

C1A 79 €

L0700000 Liothyronine sodium 8 60 mg 1 See leaflet 0401,0728 -20°C ± 5°C

C1A 79 €

Y0000860 Liothyronine for peak identification 1 0.0046 mg 1 0728 -20°C ± 5°C

C1A 79 €

L0702000 Lisinopril dihydrate 2 50 mg 1 1120 +5°C ± 3°C A1A 79 €

Y0001234 Lisinopril impurity F 2 0.01 mg 1 (2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-cyclohexylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid (cyclohexyl analogue)

1120 +5°C ± 3°C A1A 79 €

Y0001701 Lisinopril for peak identification 1 10 mg 1 1120 +5°C ± 3°C A1A 79 €

Y0001709 Lisinopril for system suitability A 1 10 mg 1 1120 +5°C ± 3°C A1A 79 €

L0720000 Lithium clavulanate 8 125 mg 1 See leaflet; 1 mg of C‡H‡LiNO— corresponds to 1.157 mg of C‡H‡KNO—

1140,1653 +5°C ± 3°C A1A 79 €

L0720800 Lithocholic acid 3 60 mg 1 Batch 2 is valid until 31 October 2017 1189,1275 +5°C ± 3°C A1a 79 €

Y0000112 Lobeline hydrochloride 1 50 mg 1 1988 +5°C ± 3°C A1A 79 €

L0745000 Lomustine 2 50 mg 1 0928 +5°C ± 3°C A1A 79 €

Y0001438 Long pepper for system suitability HRS 1 600 mg 1 2477, 2453 +5°C ± 3°C A1A 79 €

L0750000 Loperamide hydrochloride 2 50 mg 1 0921,0929,1729

+5°C ± 3°C A1A 79 €

Y0000322 Loperamide hydrochloride for system suitability

2 15 mg 1 0929 +5°C ± 3°C A1A 79 €

Y0000341 Loperamide oxide monohydrate 1 20 mg 1 1729 +5°C ± 3°C A1A 79 €

Y0001498 Lopinavir 1 200 mg 1 See leaflet C–ŸH÷‡N÷O— 2615 +5°C ± 3°C A1A 79 €

Y0001506 Lopinavir for peak identification 1 10 mg 1 2615 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 59For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0001505 Lopinavir for system suitability 1 10 mg 1 2615 +5°C ± 3°C A1A 79 €

Y0000688 Loratadine 4 60 mg 1 2124 +5°C ± 3°C A1A 79 €

New Y0000604 Loratadine impurity F 2 10 mg 1 ethyl 4-[(11RS)-8-chloro-11-fluoro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]piperidine-1-carboxylate ; Batch 1 is valid until 31 May 2018

2124 +5°C ± 3°C A1A 79 €

Y0000605 Loratadine impurity H 2 50 mg 1 ethyl 4-oxopiperidine-1-carboxylate 2124 +5°C ± 3°C A1A 79 €

Y0000603 Loratadine for system suitability 2 15 mg 1 2124 +5°C ± 3°C A1A 79 €

L0750500 Lorazepam - * psy 2 15 mg 1 1121 +5°C ± 3°C A2A 79 €

Y0000718 Lorazepam impurity D 2 10 mg 1 (5RS)-7-chloro-5-(2-chlorophenyl)-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione

1121 +5°C ± 3°C A1A 79 €

Y0000576 Lorazepam for system suitability - * psy 2 0.8 mg 1 1121 +5°C ± 3°C A2A 79 €

Y0001062 Losartan potassium 2 50 mg 1 Batch 1 is valid until 30 April 2017 2232 +5°C ± 3°C A1A 79 €

Y0001072 Losartan impurity D 4 10 mg 1 2-butyl-4-chloro-1H-imidazole-5-carbaldehyde ; Batch 3 is valid until 30 November 2017

2232 +5°C ± 3°C A1a 79 €

Y0001076 Losartan for system suitability 3 0.0015 mg 1 2232 +5°C ± 3°C A1A 79 €

L0790000 Lovastatin 4 60 mg 1 See leaflet Cœ÷H–ÿO— ; Batch 3 is valid until 31 July 2017 1538,1563 -20°C ± 5°C

C1A 79 €

Y0001136 Lovastatin for peak identification 1 20 mg 1 1538 -20°C ± 5°C

C1A 79 €

Y0001284 Lufenuron 1 140 mg 1 See leaflet CŒŸH‡ClœF‡NœO– 2177 +5°C ± 3°C A1A 79 €

Y0001261 Lufenuron for peak identification 1 0.4028 mg 1 2177 +5°C ± 3°C A1A 79 €

Y0001265 Lufenuron impurity G 1 15 mg 1 2,5-dichloro-4-[[[(2,6-difluorophenyl)carbonyl]carbamoyl]amino]phenyl phenyl carbonate

2177 +5°C ± 3°C A1A 79 €

L0800000 Lynestrenol 1 50 mg 1 0558 +5°C ± 3°C A1A 79 €

Y0001034 Lynestrenol for peak identification 1 20 mg 1 0558 +5°C ± 3°C A1A 79 €

Y0000397 Lysine acetate 2 60 mg 1 2114 +5°C ± 3°C A1A 79 €

L0900000 Lysine hydrochloride 3 50 mg 1 0930, 1654 +5°C ± 3°C A1A 79 €

Y0001904 Lysophosphatidylcholine from egg yolk 1 200 mg 1 See leaflet 2315 -20°C ± 5°C

C1a 79 €

Y0001369 Macrogol 30 dipolyhydroxystearate 1 100 mg 1 2584 +5°C ± 3°C A1A 79 €

Y0000745 Macrogol 40 sorbitol heptaoleate 1 20 mg 1 2396 +5°C ± 3°C A1A 79 €

Y0001684 High-molecular-mass macrogol CRS 1 10 mg 1 2444 +5°C ± 3°C A1A 79 €

Y0001157 Macrogol polyvinyl alcohol grafted copolymer 1 400 mg 1 2523 +5°C ± 3°C A1A 79 €

M0088000 Magnesium aspartate dihydrate 1 60 mg 1 1445 +5°C ± 3°C A1A 79 €

Y0001923 Magnolia biondii flower for system suitability 1 260 mg 1 2742 +5°C ± 3°C A1a 79 €

Y0001918 Magnolin 1 15 mg 1 2742 +5°C ± 3°C A1a 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 60For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0001289 Magnolol 1 20 mg 1 See leaflet CŒ‡HŒ‡Oœ 2567,2568 -20°C ± 5°C

C1A 79 €

M0120000 Malathion 3 250 mg 1 See leaflet CŒÐHŒ„OÿPSœ 1343 -20°C ± 5°C

C1a 79 €

M0120005 Malathion impurity A 3 15 mg 1 see leaflet; diethyl (2RS)-2-[(methoxy)(methylsulfanyl)-S-phosphinothioyl]butanedioate (isomalathion)

1343 -20°C ± 5°C

C1A 79 €

M0120010 Malathion impurity B 3 10 mg 1 diethyl (2RS)-2-(dimethoxy-S-phosphinothioyl)-butanedioate (maloxon)

1343 -20°C ± 5°C

C1A 79 €

M0100000 Maleic acid 2 100 mg 1 0365,0925 +5°C ± 3°C A1a 79 €

Y0000143 Malic acid - reference spectrum 1 n/a 1 2080 L 79 €

M0160000 Maltitol 4 1200 mg 1 See leaflet CŒœHœ÷OŒŒ 1235,1236 +5°C ± 3°C A1A 79 €

Y0001751 Mangiferin 1 15 mg 1 see leaflet CŒ„HŒ‡OŒŒ 2661 +5°C ± 3°C A1a 79 €

M0200000 Mannitol 5 1200 mg 1 See leaflet CÿHŒ÷Oÿ 0435,0559,1381, 1531

+5°C ± 3°C A1a 79 €

M0206000 Maprotiline hydrochloride 1 100 mg 1 1237 +5°C ± 3°C A1A 79 €

M0206040 Maprotiline impurity D 1 25 mg 1 3-(9,10-ethanoanthracen-9(10H)-yl)-N-methylprop-2-en-1-amine (dehydromaprotiline)

1237 +5°C ± 3°C A1A 79 €

Y0000819 Marbofloxacin 1 10 mg 1 2233 +5°C ± 3°C A1A 79 €

Y0000820 Marbofloxacin for peak identification 1 20 mg 1 2233 +5°C ± 3°C A1A 79 €

M0210000 Measles vaccine (live) BRP 1 400 mg 1 See leaflet; One sale unit is composed of a bag of 5 vials. The unit quantity of each vial is 80 mg.

1057,0213,2442

-20°C ± 5°C

C1A 90 €

M0215000 Mebendazole 1 20 mg 1 1208,1254, 0845

+5°C ± 3°C A1A 79 €

Y0000144 Mebendazole for system suitability 1 20 mg 1 0845 +5°C ± 3°C A1A 79 €

Y0001086 Mebrofenin 1 120 mg 1 2393 +5°C ± 3°C A1A 79 €

M0220000 Meclozine dihydrochloride 2 150 mg 1 0622 +5°C ± 3°C A1A 79 €

Y0001310 Meclozine impurity B 1 15 mg 1 (RS)-(4-chlorophenyl)phenylmethanol 0622 +5°C ± 3°C A1A 79 €

Y0001311 Meclozine impurity H 1 15 mg 1 1-[(RS)-(4-chlorophenyl)phenylmethyl]piperazine 0622 +5°C ± 3°C A1A 79 €

Y0001770 Medronate for radiochemical purity testing 1 5 mg 1 0641 +5°C ± 3°C A1a 79 €

M0240000 Medronic acid 2 20 mg 1 2350 +5°C ± 3°C A1A 79 €

Y0001107 Medronic acid impurity A 2 60 µL 1 see leaflet C„HœŒO–P; Tris(1-methylethoxy)phosphane 2350 -20°C ± 5°C

C1a 79 €

Y0001106 Medronic acid impurity B 1 40 µl 1 Tetrakis(1-methylethyl)methylenediphosphonate 2350 -20°C ± 5°C

C1a 79 €

M0250000 Medroxyprogesterone acetate 3 100 mg 1 0673 +5°C ± 3°C A1A 79 €

Y0001484 Medroxyprogesterone acetate for peak identification

1 25 mg 1 0673 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 61For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000598 Medroxyprogesterone acetate for system suitability

2 10 mg 1 0673 -20°C ± 5°C

C1A 79 €

M0252600 Mefenamic acid 2 50 mg 1 1240 +5°C ± 3°C A1A 79 €

Y0001081 Mefenamic acid impurity A 1 100 mg 1 2,3-dimethylaniline 1240 +5°C ± 3°C A1A 79 €

M0253000 Mefloquine hydrochloride 2 100 mg 1 1241 +5°C ± 3°C A1A 79 €

Y0001514 Megestrol acetate 1 120 mg 1 See leaflet Cœ÷H–œO÷ 1593 +5°C ± 3°C A1A 79 €

Y0001594 Megestrol acetate for impurity K identification 1 0.01 mg 1 1593 +5°C ± 3°C A1A 79 €

Y0001507 Megestrol acetate for peak identification 1 25 mg 1 1593 +5°C ± 3°C A1A 79 €

Y0001524 Megestrol acetate for system suitability 2 50 mg 1 Batch 1 is valid until 31 October 2017 1593 +5°C ± 3°C A1A 79 €

Y0001209 Meglumine 1 10 mg 1 2055 +5°C ± 3°C A1A 79 €

Y0001670 Meldonium dihydrate 1 10 mg 1 2624 +5°C ± 3°C A1A 79 €

Y0001671 Meldonium impurity A 1 25 mg 1 N,N-dimethylmethanaminium 2624 +5°C ± 3°C A1A 79 €

Y0001672 Meldonium impurity B 1 25 mg 1 1,1,1-trimethylhydrazin-1-ium 2624 +5°C ± 3°C A1A 79 €

Y0001673 Meldonium impurity C 1 25 mg 1 see leaflet CŸHŒŸNœOœBr; 2-(3-methoxy-3-oxopropyl)-1,1,1-trimethylhydrazin-1-ium

2624 +5°C ± 3°C A1A 79 €

Y0001674 Meldonium impurity D 1 25 mg 1 see leaflet C‡HŒ„NœOœBr; 2-(3-ethoxy-3-oxopropyl)-1,1,1-trimethylhydrazin-1-ium

2624 +5°C ± 3°C A1A 79 €

Y0001675 Meldonium impurity E 1 25 mg 1 see leaflet C„HœŒBrNœOœ; 1,1,1-trimethyl-2-[3-(1-methylethoxy)-3-oxopropyl]hydrazin-1-ium

2624 +5°C ± 3°C A1a 79 €

Y0001676 Meldonium impurity F 1 25 mg 1 see leaflet C—HŒÐNœO; 1,1-dimethyl-4,5-dihydro-1H-pyrazol-1-ium-3-olate

2624 +5°C ± 3°C A1A 79 €

Y0001080 Meloxicam 1 50 mg 1 2373 +5°C ± 3°C A1A 79 €

Y0001035 Meloxicam impurity A 2 5 mg 1 ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide

2373 +5°C ± 3°C A1a 79 €

Y0001036 Meloxicam impurity B 2 5 mg 1 5-methylthiazol-2-amine 2373 +5°C ± 3°C A1A 79 €

Y0001037 Meloxicam impurity C 3 10 mg 1 N-[(2Z)-3,5-dimethylthiazol-2(3H)-ylidene]-4-hydroxy-2-methyl-2H-1,2- benzothiazine-3-carboxamide 1,1-dioxide

2373 +5°C ± 3°C A1A 79 €

Y0001039 Meloxicam impurity D 3 5 mg 1 N-[(2Z)-3-ethyl-5-methylthiazol-2(3H)-ylidene]-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide

2373 +5°C ± 3°C A1A 79 €

Y0001158 Melphalan hydrochloride 2 100 mg 1 see leaflet ; Batch 1 is valid until 28 February 2017 1698 +5°C ± 3°C A1A 79 €

Y0001513 Melphalan - reference spectrum 1 1 uc 1 1698 L 79 €

Y0001457 Melphalan for system suitability 1 10 mg 1 1698 +5°C ± 3°C A1A 79 €

M0300000 Menadione 1 100 mg 1 0507 +5°C ± 3°C A1A 79 €

M0350000 Menthol 5 150 mg 1 0619,0623 +5°C ± 3°C A1A 79 €

M0370000 Mepivacaine hydrochloride 1 100 mg 1 1242 +5°C ± 3°C A1A 79 €

New M0370020 Mepivacaine impurity B 2 40 mg 1 (RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide ; Batch 1 is valid until 30 June 2018

1242 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 62For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

M0400000 Meprobamate - * psy 1 100 mg 1 0407,1689 +5°C ± 3°C A2A 79 €

M0500000 Mepyramine maleate 1 1000 mg 1 0278 +5°C ± 3°C A1A 79 €

Y0000679 Mepyramine impurity A 1 10 mg 1 N-(4-methoxybenzyl)pyridin-2-amine 0278 +5°C ± 3°C A1A 79 €

New Y0002003 Mercury solution 1 10 mL 1 20420 Room temp. +20°C

B1a 79 €

Y0000680 Mepyramine impurity C 1 10 mg 1 pyridin-2-amine 0278 +5°C ± 3°C A1A 79 €

Y0001252 Meropenem trihydrate 1 110 mg 1 See leaflet 2234 +5°C ± 3°C A1A 79 €

Y0000297 Mesalazine 3 50 mg 1 Batch 2 is valid until 28 February 2018 1699,1993 +5°C ± 3°C A1a 79 €

Y0001563 Mesalazine impurity A 2 15 mg 1 4-aminophenol ; Batch 1 is valid until 30 September 2017

1699 +5°C ± 3°C A1a 79 €

New Y0001569 Mesalazine impurity C 2 15 mg 1 2-aminophenol ; Batch 1 is valid until 31 July 2018 1699 +5°C ± 3°C A1a 79 €

Y0001574 Mesalazine for system suitability 4 10 mg 1 1699 +5°C ± 3°C A1a 79 €

Y0001040 Mesityl oxide 2 100 mg 1 see leaflet CÿHŒÐO ; Batch 1 is valid until 31 July 2017 2358 +5°C ± 3°C B1a 79 €

Y0000337 Mesna - reference spectrum 1 n/a 1 1674 L 79 €

Y0000316 Mesna impurity C 1 10 mg 1 2-(acetylsulfanyl)ethanesulfonic acid 1674 +5°C ± 3°C A1A 79 €

Y0000317 Mesna impurity D 1 10 mg 1 2,2'-(disulfanediyl)bis(ethanesulfonic acid) 1674 +5°C ± 3°C A1A 79 €

Y0000227 Meso-rich exametazime 1 0.5 mg 1 1925 +5°C ± 3°C A1A 79 €

Y0000097 Mesterolone 2 120 mg 1 See leaflet CœÐH–œOœ 1730 +5°C ± 3°C A1A 79 €

Y0000096 Mesterolone impurity A 1 30 mg 1 17β-hydroxy-1α-methylandrost-4-en-3-one 1730 +5°C ± 3°C A1A 79 €

M0600000 Mestranol 1 100 mg 1 0509 +5°C ± 3°C A1A 79 €

Y0000301 Metacresol - reference spectrum 1 n/a 1 2077 L 79 €

M0600900 Metamizole sodium 4 10 mg 1 1346 +5°C ± 3°C A1A 79 €

M0600905 Metamizole impurity A 4 15 mg 1 4-(formylamino)-1,5-dimethyl-2-phenyl-2,3-dihydro-1H-pyrazol-3-one

1346 +5°C ± 3°C A1A 79 €

Y0001481 Metamizole impurity E 4 0.01 mg 1 [(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino]methanesulfonic acid (4-N-desmethylmetamizole). ; Batch 3 is valid until 31 January 2018

1346 +5°C ± 3°C A1a 79 €

M0605000 Metformin hydrochloride 3 50 mg 1 0931 +5°C ± 3°C A1A 79 €

New Y0001590 Metformin impurity A 2 25 1 Cyanoguanidine ; Batch 1 is valid until 31 May 2018 0931 +5°C ± 3°C A1A 79 €

Y0001600 Metformin impurity F 2 2 mL 1 N-methylmethanamine (dimethylamine) 0931 +5°C ± 3°C A1A 79 €

Y0001820 Methacrylic acid - methylmethacrylate copolymer (1:1)

1 120 mg 1 1127 +5°C ± 3°C A1a 79 €

Y0001821 Methacrylic acid - methylmethacrylate copolymer (1:2)

1 120 mg 1 1130 +5°C ± 3°C A1a 79 €

Y0000770 Methacrylic acid-ethyl acrylate copolymer (1:1) - type A

1 200 mg 1 1128 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 63For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000323 Methacrylic acid-ethyl acrylate copolymer (1:1) - type B

1 200 mg 1 1128 +5°C ± 3°C A1A 79 €

M0610030 Methacrylic acid-ethylacrylate copolymer (1:1), dispersion 30%-ref.sp

1 n/a 1 1129 L 79 €

M0800000 Methadone hydrochloride - reference spectrum

1 n/a 1 0408,1787 L 79 €

Y0000428 Methanol - reference spectrum 1 n/a 1 1989 L 79 €

Y0000754 Methenamine 1 10 mg 1 1545 +5°C ± 3°C A1a 79 €

M0960000 Methionine 2 50 mg 1 0788,1027 +5°C ± 3°C A1A 79 €

M0950000 DL-Methionine 1 50 mg 1 0624 +5°C ± 3°C A1A 79 €

M1000000 Methotrexate 8 100 mg 1 See leaflet CœÐHœœN‡O— ; Batch 7 is valid until 28 February 2018 0560 +5°C ± 3°C A1A 79 €

Y0000663 Methotrexate impurity C 3 10 mg 1 (2S)-2-[[4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]methylamino]benzoyl]amino]pentanedioic acid (N-methylfolic acid, methopteridine) ; Batch 2 is valid until 31 October 2017

0560 +5°C ± 3°C A1a 79 €

M1000008 Methotrexate impurity D 4 10 mg 1 4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]methylamino]benzoic acid (N10-methylpteroic acid)

0560 +5°C ± 3°C A1A 79 €

Y0000664 Methotrexate impurity E 1 10 mg 1 4-[[(2,4-diaminopteridin-6-yl)methyl]methylamino]benzoic acid (4-amino-N10-methylpteroic acid, APA)

0560 +5°C ± 3°C A1A 79 €

Y0000602 Methotrexate for peak identification 1 20 mg 1 0560 +5°C ± 3°C A1A 79 €

Y0001668 Methotrexate for system suitability 1 100 mg 1 0560 +5°C ± 3°C A1A 79 €

M1470000 Methyl 2-(4-chlorophenoxy)-2-methylpropionate

1 0.5 ml 1 0318 +5°C ± 3°C A1A 79 €

M1556000 Methyl 12-hydroxystearate 2 100 mg 1 1497 +5°C ± 3°C A1A 79 €

Y0001488 Methyl methacrylate 1 50 mg 1 1975 +5°C ± 3°C A1A 79 €

Y0000398 Methyl nicotinate 1 25 mg 1 2129 +5°C ± 3°C A1A 79 €

M1650000 Methyl parahydroxybenzoate 4 150 mg 1 See leaflet 0409,1262,2134,1999

+5°C ± 3°C A1A 79 €

M1770180 Methyl ricinoleate 3 125 mg 1 0051,2367 +5°C ± 3°C A1A 79 €

M1770200 Methyl stearate 3 100 mg 1 0051,1497, 2367

+5°C ± 3°C A1A 79 €

M1300000 Methylatropine bromide 1 100 mg 1 0919 +5°C ± 3°C A1A 79 €

New M1500000 Methyldopa 3 50 mg 1 ; Batch 2 is valid until 31 May 2018

0045 +5°C ± 3°C A1A 79 €

Y0001083 Methyldopa for system suitability 2 0.024 mg 1 Batch 1 is valid until 31 May 2017 0045 +5°C ± 3°C A1A 79 €

Y0001374 Racemic methyldopa 1 5 mg 1 0045 +5°C ± 3°C A1A 79 €

New M1550000 Methylene chloride 4 1.5 mL 1 Batch 3 is valid until 17 November 2017 0932 +5°C ± 3°C A1a 79 €

Y0000776 Methylergometrine maleate 1 10 mg 1 1788 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 64For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000777 Methylergometrine for system suitability -* Drug Precursor -*narc

1 0.53 mg 1 1788 +5°C ± 3°C A2a 79 €

M1625000 Methylnitrosoindoline 3 110 mg 1 1108 +5°C ± 3°C A1A 79 €

Y0001017 Methylphenidate hydrochloride - * narc 1 40 mg 1 2235 +5°C ± 3°C A2A 79 €

Y0001490 Methylphenidate impurity C 1 10 mg 1 (2RS)-2-phenyl-2-[(2RS)-piperidin-2-yl]acetamide 2235 +5°C ± 3°C A1A 79 €

Y0000910 Methylphenidate impurity mixture 1 0.04 mg 1 2235 +5°C ± 3°C A1A 79 €

M1700000 Methylphenobarbital - * psy 1 500 mg 1 0189 +5°C ± 3°C A2A 79 €

M1750000 Methylprednisolone 4 240 mg 1 See leaflet ; Batch 3 is valid until 31 December 2017 0312,0561 -20°C ± 5°C

C1A 79 €

Y0001799 Methylprednisolone for system suitability A 1 10 mg 1 0561 -20°C ± 5°C

C1a 79 €

M1755000 Methylprednisolone acetate 2 110 mg 1 See leaflet Cœ÷H–œOÿ 0933 +5°C ± 3°C A1A 79 €

Y0001736 Methylprednisolone acetate for peak identification

1 0.01 mg 1 0933 +5°C ± 3°C A1A 79 €

Y0001760 Methylprednisolone acetate for system suitability

1 10 mg 1 0933 +5°C ± 3°C A1a 79 €

M1755200 Methylprednisolone hydrogen succinate 3 60 mg 1 See leaflet CœÿH–÷O‡ 0768,1131 +5°C ± 3°C A1A 79 €

Y0001759 Methylprednisolone hydrogen succinate for peak identification

1 10 mg 1 1131 +5°C ± 3°C A1a 79 €

M1755220 Methylprednisolone hydrogen succinate for performance test

2 20 mg 1 Batch 1 is valid until 31 August 2017 1131 +5°C ± 3°C A1A 79 €

Y0001376 2-methylpyrazine 1 100 mg 1 2446,2447,2708

+5°C ± 3°C A1A 79 €

Y0000190 N-Methylpyrrolidone - reference spectrum 1 n/a 1 1675 L 79 €

Y0000418 Methylrosanilinium chloride 1 40 mg 1 1990 +5°C ± 3°C A1A 79 €

Y0000407 Methylrosanilinium for system suitability 1 10 mg 1 1990 +5°C ± 3°C A1A 79 €

M1800000 Methyltestosterone 2 10 mg 1 Batch 1 is valid until 28 February 2017 0410 +5°C ± 3°C A1A 79 €

Y0000861 Methyltestosterone for system suitability 1 10 mg 1 0410 +5°C ± 3°C A1A 79 €

M1800900 Methylthioninium chloride 2 130 mg 1 See leaflet CŒÿHŒ‡ClN–S,xHœO 1132 +5°C ± 3°C A1A 79 €

Y0001744 Methylthioninium for system suitability 1 15 mg 1 1132 +5°C ± 3°C A1a 79 €

M1808000 Metixene hydrochloride 1 75 mg 1 1347 +5°C ± 3°C A1A 79 €

M1824990 Metoclopramide 1 100 mg 1 1348 +5°C ± 3°C A1A 79 €

M1825000 Metoclopramide hydrochloride 3 50 mg 1 Batch 2 is valid until 31 January 2018 0674,0856,1303

+5°C ± 3°C A1a 79 €

M1824995 Metoclopramide impurity A 2 25 mg 1 4-(acetylamino)-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide

1348, 0674 +5°C ± 3°C A1A 79 €

M1825010 Metoclopramide impurity E 2 40 mg 1 N,N-diethylethane-1,2-diamine ; Batch 1 is valid until 31 October 2017

1575 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 65For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000701 Metolazone 1 80 mg 1 See leaflet CŒÿHŒÿClN–O–S 1757 +5°C ± 3°C A1A 79 €

Y0000702 Metolazone for system suitability 1 10 mg 1 1757 +5°C ± 3°C A1A 79 €

Y0000171 Metoprolol succinate - reference spectrum 1 n/a 1 1448 L 79 €

M1830000 Metoprolol tartrate 2 60 mg 1 1028 +5°C ± 3°C A1A 79 €

Y0000145 Metoprolol impurity A 4 5 mg 1 (2RS)-1-(ethylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol 1028,1448 +5°C ± 3°C A1a 79 €

M1845000 Metrifonate 1 100 mg 1 1133 +5°C ± 3°C A1a 79 €

M1850000 Metronidazole 2 50 mg 1 0675,0934 +5°C ± 3°C A1a 79 €

Y0000087 Metronidazole impurity A 3 10 mg 1 2-methyl-4-nitroimidazole 0675, 0934 +5°C ± 3°C A1A 79 €

M1851000 Metronidazole benzoate 1 50 mg 1 1424 +5°C ± 3°C A1A 79 €

Y0000069 Metronidazole benzoate - reference spectrum 1 n/a 1 0934 L 79 €

M1860000 Mexiletine hydrochloride 1 100 mg 1 1029 +5°C ± 3°C A1A 79 €

Y0000202 Mexiletine impurity C 3 10 mg 1 see leaflet CœœH–œNœOœ; 1,1'-[(3,3',5,5'-tetramethylbiphenyl-4,4'-diyl)bisoxy]dipropan-2-amine ; Batch 2 is valid until 31 July 2017

1029 +5°C ± 3°C A1a 79 €

Y0000203 Mexiletine impurity D 1 2 mg 1 (2RS)-2-(2,6-dimethylphenoxy)propan-1-amine 1029 +5°C ± 3°C A1A 79 €

M1875000 Mianserin hydrochloride 3 100 mg 1 0846 +5°C ± 3°C A1A 79 €

Y0001041 Mianserin impurity B 2 10 mg 1 (14bRS)-2-methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine-8-sulfonic acid ; Batch 1 is valid until 30 April 2018

0846 +5°C ± 3°C A1A 79 €

Y0000862 Mianserin for system suitability 1 1.01 mg 1 0846 +5°C ± 3°C A1A 79 €

M1880000 Miconazole 1 70 mg 1 0935 +5°C ± 3°C A1A 79 €

M1900000 Miconazole nitrate 2 100 mg 1 0513,1148 +5°C ± 3°C A1A 79 €

M2200000 Midazolam - * psy 3 50 mg 1 Batch 2 is valid until 28 February 2017 0936,1065 +5°C ± 3°C A2A 79 €

Y0000562 Midazolam impurity C 3 0.08 mg 1 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid

0936 +5°C ± 3°C A1A 79 €

Y0000599 Midazolam for system suitability - * psy 3 1 mg 1 0936 +5°C ± 3°C A2A 79 €

Y0001882 Milbemycin oxime for system suitability 1 10 mg 1 2536 +5°C ± 3°C A1a 79 €

Y0001893 Milbemycin oxime 1 100 mg 1 2536 +5°C ± 3°C A1a 79 €

Y0001687 Milk thistle dry extract HRS 2 120 mg 1 See leaflet 1860,2071 -20°C ± 5°C

C1A 79 €

Y0001878 Minocycline for system suitability 1 10 mg 1 1030 +5°C ± 3°C A1a 79 €

Y0001930 Minocycline hydrochloride 4 100 mg 1 1030 +5°C ± 3°C A1a 79 €

M2300000 Minoxidil 1 50 mg 1 0937 +5°C ± 3°C A1A 79 €

Y0001432 Minoxidil for system suitability 1 10 mg 1 0937 +5°C ± 3°C A1A 79 €

Y0000705 Mirtazapine 1 10 mg 1 2338 +5°C ± 3°C A1A 79 €

Y0000721 Mirtazapine for system suitability 1 10 mg 1 2338 +5°C ± 3°C A1A 79 €

Y0000490 Misoprostol 3 60 mg 1 See leaflet CœœH–‡O— 1731 -20°C ± 5°C

C1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 66For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0001162 Misoprostol for system suitability 1 5 mg 1 1731 -20°C ± 5°C

C1A 79 €

Y0000378 Mitomycin 2 120 mg 1 See leaflet CŒ—HŒ‡N÷O— 1655 +5°C ± 3°C A1a 79 €

M2305000 Mitoxantrone hydrochloride 4 60 mg 1 See leaflet 1243 +5°C ± 3°C A1a 79 €

M2305005 Mitoxantrone impurity A 4 5 mg 1 1-amino-5,8-dihydroxy-4-[[2-[(2-hydroxyethyl)amino]ethyl] amino]anthracene-9,10-dione ; Batch 3 is valid until 30 June 2017

1243 +5°C ± 3°C A1A 79 €

Y0000635 Modafinil 1 110 mg 1 See leaflet CŒ—HŒ—NOœS 2307 +5°C ± 3°C A1A 79 €

Y0000636 Modafinil for system suitability 1 0.1 mg 1 2307 +5°C ± 3°C A1A 79 €

Y0000251 Molgramostim 1 0.3 ml 1 13.45 mg protein per ml Cÿ–„HŒÐПNŒŸŒOŒ„ÿS‡ 1641 -80°C ± 10°C

D1A 79 €

Y0000821 Molsidomine 1 5 mg 1 1701 +5°C ± 3°C A1A 79 €

Y0000822 Molsidomine impurity B 1 10 mg 1 4-nitrosomorpholine 1701 +5°C ± 3°C B1A 79 €

Y0000823 Molsidomine impurity D 1 10 mg 1 morpholine-4-carbaldehyde 1701 +5°C ± 3°C A1A 79 €

M2900000 Mometasone furoate 3 60 mg 1 1449 +5°C ± 3°C A1A 79 €

New Y0001977 Mometasone furoate for system suitability 1 10 mg 1 1449, 2858 +5°C ± 3°C A1a 79 €

Y0001436 Montelukast dicyclohexylamine 2 150 mg 1 See leaflet 2583 +5°C ± 3°C A1A 79 €

Y0001433 Montelukast racemate 3 0.1 mg 1 2583 +5°C ± 3°C A1A 79 €

Y0001434 Montelukast sodium 2 20 mg 1 2583 +5°C ± 3°C A1A 79 €

Y0001435 Montelukast for peak identification 3 20 mg 1 2583 +5°C ± 3°C A1A 79 €

Y0000028 Morantel hydrogen tartrate 2 50 mg 1 1546 +5°C ± 3°C A1A 79 €

Y0000451 Morphine hydrochloride trihydrate - * narc 3 25 mg 1 See leaflet 1839, 1840, 0777, 1841,

0097

+5°C ± 3°C A2A 79 €

Y0000452 Morphine sulfate - * narc 1 40 mg 1 1244,1784 +5°C ± 3°C A2A 79 €

Y0000830 Morphine for system suitability - * narc 3 15 mg 1 1244, 0097 +5°C ± 3°C A2A 79 €

New Y0000772 Moxidectin 4 70 mg 1 See leaflet ; Batch 3 is valid until 31 July 2018 1656 -20°C ± 5°C

C1A 79 €

Y0000747 Moxidectin for system suitability 2 10 mg 1 1656 +5°C ± 3°C A1A 79 €

Y0000703 Moxifloxacin hydrochloride 3 120 mg 1 See leaflet CœŒHœ—ClFN–O÷ 2254 +5°C ± 3°C A1A 79 €

Y0000717 Moxifloxacin for peak identification 2 10 mg 1 2254 +5°C ± 3°C A1A 79 €

Y0000226 Moxonidine 2 50 mg 1 See leaflet C„HŒœClN—O ; Batch 1 is valid until 30 June 2017 1758 +5°C ± 3°C A1A 79 €

Y0000222 Moxonidine impurity A 1 10 mg 1 4,6-dichloro-N-(imidazolidin-2-ylidene)-2-methylpyrimidin-5-amine (6-chloromoxonidine)

1758 +5°C ± 3°C A1A 79 €

M3600000 Mumps vaccine (live) BRP 1 165 mg 1 See leaflet 0538,1057, 2442

-80°C ± 10°C

D1A 90 €

M3805000 Mupirocin - reference spectrum 1 n/a 1 1450 L 79 €

M3805500 Mupirocin calcium - reference spectrum 1 n/a 1 1451 L 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 67For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

M3806000 Mupirocin lithium 3 110 mg 1 See leaflet CœÿH÷–O„Li ; Batch 2 is valid until 28 February 2018 1450,1451 +5°C ± 3°C A1A 79 €

Y0000489 Mycophenolate mofetil 3 30 mg 1 1700 +5°C ± 3°C A1A 79 €

Y0000519 Mycophenolate mofetil for peak identification 6 10 mg 1 1700 +5°C ± 3°C A1A 79 €

Y0001810 Mycophenolate sodium 1 200 mg 1 See leaflet CŒŸHœÐOÿNa 2813 +5°C ± 3°C A1a 79 €

Y0000692 Mycoplasma fermentans BRP 1 1 ml 1 20607 -80°C ± 10°C

D1A 120 €

Y0000690 Mycoplasma hyorhinis BRP 1 1 ml 1 20607 -80°C ± 10°C

D1A 120 €

Y0000691 Mycoplasma orale BRP 1 1 ml 1 20607 -80°C ± 10°C

D1A 120 €

Y0000689 Mycoplasma synoviae BRP 1 1 ml 1 20607 -80°C ± 10°C

D1A 120 €

Y0000485 Myo-inositol 1 1020 mg 1 See leaflet 1805 +5°C ± 3°C A1A 79 €

N0020000 Nabumetone 1 60 mg 1 See leaflet CŒ—HŒÿOœ 1350 +5°C ± 3°C A1A 79 €

N0020020 Nabumetone impurity D 3 10 mg 1 (E)-4-(6-methoxynaphthalen-2-yl)but-3-en-2-one ; Batch 2 is valid until 31 October 2017

1350 +5°C ± 3°C A1A 79 €

N0020030 Nabumetone impurity F 5 10 mg 1 See leaflet; 6,6'-dimethoxy-2,2'-binaphthalenyl 1350 +5°C ± 3°C A1a 79 €

Y0000146 Nadolol 1 100 mg 1 1789 +5°C ± 3°C A1A 79 €

Y0001215 Nadolol impurity mixture 1 0.01 mg 1 1789 +5°C ± 3°C A1A 79 €

N0025000 Nadroparin calcium 3 450 mg 1 Batch 2 is valid until 31 July 2017 0828,1134 +5°C ± 3°C A1A 79 €

Y0000077 Naftidrofuryl - reference spectrum 1 n/a 1 1594 L 79 €

Y0000120 Naftidrofuryl impurity A 2 10 mg 1 2-[(naphtalen-1-yl)methyl]-3-(tetrahydrofuran-2-yl)propanoic acid ; Batch 1 is valid until 31 December 2017

1594 +5°C ± 3°C A1A 79 €

Y0000121 Naftidrofuryl impurity B 2 25 mg 1 ethyl 2-[(naphtalen-1-yl)methyl]- 3-(tetrahydrofuran-2-yl)propanoate

1594 +5°C ± 3°C A1A 79 €

Y0000331 Naftidrofuryl impurity F 1 10 mg 1 2-(diethylamino)ethyl 2-[(naphthalen-2-yl)methyl]-3- (tetrahydrofuran-2-yl)propanoate

1594 +5°C ± 3°C A1A 79 €

N0050000 Nalidixic acid 1 100 mg 1 0701 +5°C ± 3°C A1A 79 €

Y0001792 Nalidixic acid impurity C 1 20 mg 1 diethyl (ethoxymethylidene)propanedioate 0701 +5°C ± 3°C A1a 79 €

N0075000 Naloxone hydrochloride dihydrate 3 100 mg 1 Batch 2 is valid until 28 February 2017 0729,2099 +5°C ± 3°C A1A 79 €

Y0001571 Naloxone impurity D 2 25 mg 1 7,8-didehydro-4,5α-epoxy-3,14-dihydroxy-17-(prop-2-enyl)morphinan-6-one (7,8-didehydronaloxone)

0729 +5°C ± 3°C A1a 79 €

Y0000695 Naloxone for peak identification 3 5.1 mg 1 Batch 2 is valid until 31 May 2017 0729 +5°C ± 3°C A1A 79 €

Y0000400 Naltrexone hydrochloride 2 50 mg 1 1790 +5°C ± 3°C A1A 79 €

Y0000410 Naltrexone impurity C 1 15 mg 1 17-but-3-enyl-4,5α-epoxy-3,14-dihydroxymorphinan-6-one 1790 +5°C ± 3°C A1A 79 €

Y0000542 Nandrolone decanoate 1 5 mg 1 1992 -20°C ± 5°C

C1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 68For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000547 Nandrolone decanoate for peak identification 1 10 mg 1 1992 -20°C ± 5°C

C1A 79 €

Y0000548 Nandrolone decanoate for system suitability 1 10 mg 1 1992 -20°C ± 5°C

C1A 79 €

N0080000 Naphazoline hydrochloride 3 50 mg 1 0730,1162 +5°C ± 3°C A1A 79 €

N0100000 Naphazoline nitrate 2 10 mg 1 0147 +5°C ± 3°C A1A 79 €

N0200000 Naphazoline impurity A 5 15 mg 1 N-(2-aminoethyl)-2-(naphthalen-1-yl)acetamide (naphthylacetylethylenediamine)

0147,0730 +5°C ± 3°C A1A 79 €

N0250000 Naproxen 3 50 mg 1 0731,1702 +5°C ± 3°C A1a 79 €

Y0000399 Naproxen (racemic) 1 10 mg 1 0731,1702 +5°C ± 3°C A1A 79 €

Y0000631 Naproxen impurity L 1 10 mg 1 1-(6-methoxynaphthalen-2-yl)ethanone 0731,1702 +5°C ± 3°C A1A 79 €

Y0001378 Naringin 1 20 mg 1 See leaflet CœŸH–œOŒ÷ 2563 +5°C ± 3°C A1A 79 €

Y0001437 Nateglinide 1 200 mg 1 See leaflet CŒ„HœŸNO– 2575 +5°C ± 3°C A1A 79 €

Y0001440 Nateglinide impurity A 1 10 mg 1 trans-4-(1-methylethyl)cyclohexanecarboxylic acid 2575 +5°C ± 3°C A1A 79 €

Y0001441 Nateglinide impurity B 1 15 mg 1 N-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-Lphenylalanine (L-phenylalanine isomer)

2575 +5°C ± 3°C A1A 79 €

Y0001442 Nateglinide impurity C 1 10 mg 1 N-[[cis-4-(1-methylethyl)cyclohexyl]carbonyl]-D-phenylalanine (cis-isomer)

2575 +5°C ± 3°C A1A 79 €

New N0300000 Neamine 6 0.5 mg 1 see leaflet ; Batch 5 is valid until 30 April 2018 0180,0197 +5°C ± 3°C A1A 79 €

N0399000 Neohesperidin-dihydrochalcone 2 125 mg 1 See leaflet Cœ‡H–ÿOŒ— 1547 -20°C ± 5°C

C1a 79 €

N0399004 Neohesperidin-dihydrochalcone impurity B 2 10 mg 1 See leaflet Cœ‡H–œOŒ— ; 7-[[2-O-(6-deoxy-¶-L-mannopyranosyl) -ß-D-glucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one (neodiosmin)

1547 +5°C ± 3°C A1A 79 €

N0400000 Neomycin sulfate 3 50 mg 1 Not to be used for microbiological assay 0032,0033,0053,

0180,0197,0485, 0645

-20°C ± 5°C

C1a 79 €

N0401000 Neomycin sulfate for microbiological assay 5 25 mg 1 See leaflet ; Batch 4 is valid until 31 May 2017 20702 -20°C ± 5°C

C1a 79 €

N0500000 Neostigmine bromide 1 50 mg 1 0046 +5°C ± 3°C A1A 79 €

N0550000 Neostigmine metilsulfate 1 50 mg 1 0626 +5°C ± 3°C A1A 79 €

Y0001639 Neostigmine impurity A 1 0.0025 mg 1 3-hydroxy-N,N,N-trimethylanilinium 0046,0626 +5°C ± 3°C A1A 79 €

Y0001890 Netilmicin for peak identification 1 15 mg 1 1351, 20702 -20°C ± 5°C

C1a 79 €

N0559000 Netilmicin sulfate 1 25 mg 2 See leaflet; 20702 -20°C ± 5°C

C1a 79 €

Y0001894 Netilmicin sulfate for LC assay 1 25 mg 2 See leaflet 1351, 20702 -20°C ± 5°C

C1a 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 69For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000520 Nevirapine (Anhydrous) 1 30 mg 1 See leaflet CŒ—HŒ÷N÷O 2255, 2479 +5°C ± 3°C A1a 79 €

Y0001499 Nevirapine hemihydrate 1 15 mg 1 2479 +5°C ± 3°C A1A 79 €

Y0000521 Nevirapine for peak identification 1 0.058 mg 1 2255, 2479 +5°C ± 3°C A1A 79 €

Y0000388 Newcastle Disease Vaccine (inactivated) BRP 1 40 mg 1 The kit contains :1 vial BRP1 NDV reference antigen, 1 vial BRP1 NDV control antigen, 1 vial BRP1 NDV coating antibody, 1 vial BRP1 NDV conjugated, detection antibody

0870 -20°C ± 5°C

C1A 180 €

Y0001917 Nicardipine for system suitability 1 10 mg 1 2776 +5°C ± 3°C A1a 79 €

Y0001924 Nicardipine hydrochloride 1 20 mg 1 2776 +5°C ± 3°C A1a 79 €

Y0001373 Nicergoline 1 50 mg 1 1998 +5°C ± 3°C A1A 79 €

Y0001356 Nicergoline impurity D 1 20 mg 1 5-bromopyridine-3-carboxylic acid 1998 +5°C ± 3°C A1A 79 €

Y0001362 Nicergoline for peak identification 1 1 mg 1 1998 +5°C ± 3°C A1a 79 €

Y0001352 Nicergoline for system suitability 1 10 mg 1 1998 +5°C ± 3°C A1A 79 €

N0560000 Niclosamide (anhydrous) 3 50 mg 1 0679,0680 +5°C ± 3°C A1a 79 €

Y0001761 Nicorandil 1 5 mg 1 2332 -20°C ± 5°C

C1a 79 €

Y0001762 Nicorandil impurity A 1 5 mg 1 2-[(pyridin-4-ylcarbonyl)amino]ethyl nitrate 2332 -20°C ± 5°C

C1a 79 €

N0600000 Nicotinamide 1 50 mg 1 0047 +5°C ± 3°C A1A 79 €

N0590000 Nicotine - reference spectrum 1 n/a 1 1452,1792 L 79 €

N0590200 Nicotine ditartrate 5 120 mg 1 See leaflet CŒÐHŒ÷Nœ x 2 C÷HÿOÿ 1792 +5°C ± 3°C A1a 79 €

Y0001425 Nicotine ditartrate dihydrate 1 15 mg 1 2599 +5°C ± 3°C A1A 79 €

Y0001023 Nicotine for system suitability 4 1 mg 1 1452, 1792, 2599

-20°C ± 5°C

C1a 79 €

N0700000 Nicotinic acid 1 100 mg 1 0459 +5°C ± 3°C A1A 79 €

Y0001268 Nicotinic acid impurity mixture 1 0.12 mg 1 0459 +5°C ± 3°C A1A 79 €

N0750000 Nifedipine 1 50 mg 1 0627,1013 +5°C ± 3°C A1A 79 €

N0750010 Nifedipine impurity A 1 25 mg 1 Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxylate (nitrophenylpyridine analogue)

0627 +5°C ± 3°C A1A 79 €

N0750015 Nifedipine impurity B 1 25 mg 1 Dimethyl 2,6-dimethyl-4-(2-nitrosophenyl)pyridine-3,5-dicarboxylate (nitrosophenylpyridine analogue)

0627 +5°C ± 3°C A1A 79 €

Y0000824 Niflumic acid 1 10 mg 1 2115 +5°C ± 3°C A1A 79 €

Y0000825 Niflumic acid impurity A 1 10 mg 1 2-chloropyridine-3-carboxylic acid 2115 +5°C ± 3°C A1A 79 €

Y0000826 Niflumic acid impurity B 1 10 mg 1 2-hydroxy-N-(3-(trifluoromethyl)phenyl)pyridine-3-carboxamide 2115 +5°C ± 3°C A1A 79 €

Y0000827 Niflumic acid impurity E 1 15 mg 1 6-((3-(trifluoromethyl)phenyl)amino)pyridine-3-carboxylic acid 2115 +5°C ± 3°C A1A 79 €

Y0000836 Nifuroxazide 1 10 mg 1 1999 +5°C ± 3°C A1A 79 €

New N0800000 Nikethamide 2 1 mL 1 Batch 1 is valid until 31 July 2018 0233 +5°C ± 3°C A1A 79 €

Y0000829 Nilutamide 1 110 mg 1 See leaflet CŒœHŒÐF–N–O÷ 2256 +5°C ± 3°C A1a 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 70For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000894 Nilutamide impurity B 1 5 mg 1 4-nitro-3-(trifluoromethyl)aniline (nifeline) 2256 +5°C ± 3°C A1A 79 €

N0845000 Nimesulide 2 100 mg 1 1548 +5°C ± 3°C A1A 79 €

N0845008 Nimesulide impurity D 5 0.004 mg 1 4-nitro-2-phenoxyaniline 1548 +5°C ± 3°C A1A 79 €

Y0001237 Nimesulide for peak identification 1 10 mg 1 1548 +5°C ± 3°C A1A 79 €

N0850000 Nimodipine 2 50 mg 1 1245 +5°C ± 3°C A1A 79 €

Y0001784 Nimodipine for peak identification 1 15 mg 1 1245 +5°C ± 3°C A1a 79 €

N0850010 Nimodipine impurity A 4 1 mL 1 2-methoxyethyl 1-methylethyl 2,6-dimethyl-4-(3-nitrophenyl) pyridine-3,5-dicarboxylate

1245 +5°C ± 3°C A1A 79 €

N0900000 Nitrazepam - * psy 2 100 mg 1 0415,0898 +5°C ± 3°C A2a 79 €

N0905000 Nitrendipine 2 60 mg 1 1246 +5°C ± 3°C A1A 79 €

N0905005 Nitrendipine impurity A 3 30 mg 1 ethyl methyl-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5- dicarboxylate

1246 +5°C ± 3°C A1A 79 €

Y0001456 Nitrendipine for peak identification 1 10 mg 1 1246 +5°C ± 3°C A1A 79 €

N0930000 Nitric oxide - reference spectrum 1 n/a 1 1550 L 79 €

N0950000 Nitrofural 2 150 mg 1 See leaflet CÿHÿN÷O÷ 1135 +5°C ± 3°C A1a 79 €

Y0001570 Nitrofural impurity B 1 30 mg 1 See leaflet C„H„OŸN; (5-nitrofuran-2-yl)methylene diacetate 1135 +5°C ± 3°C A1A 79 €

Y0001377 Nitrofural for peak identification 1 0.11 mg 1 1135 +5°C ± 3°C A1A 79 €

N1000000 Nitrosotriaminopyrimidine 2 20 mg 1 See leaflet C÷HÿNÿO ; Batch 1 is valid until 31 March 2018 0058 +5°C ± 3°C A1A 79 €

N1090000 Nizatidine 1 250 mg 1 See leaflet CŒœHœŒN—OœSœ 1453 +5°C ± 3°C A1A 79 €

N1090060 Nizatidine impurity F 1 10 mg 1 (EZ)-N-methyl-N'-[2-[[[4-[[[2-[[(EZ)-1-(methylamino)-2-nitroethenyl]amino]ethyl]sulfanyl]methyl]thiazol-2-yl]methyl]sulfanyl]ethyl]-2-nitroethene-1,1-diamine

1453 +5°C ± 3°C A1A 79 €

Y0001278 Nizatidine for system suitability 1 10 mg 1 1453 +5°C ± 3°C A1A 79 €

N1080000 Nomegestrol acetate 2 100 mg 1 1551 +5°C ± 3°C A1A 79 €

N1080005 Nomegestrol acetate impurity A 2 50 mg 1 6α-methyl-3,20-dioxo-19-norpregn-4-en-17-yl acetate 1551 +5°C ± 3°C A1A 79 €

Y0001314 1-nonadecanol 2 425 mg 1 0801,0802,0847

+5°C ± 3°C A1A 79 €

Y0000670 Nonivamide 1 10 mg 2 See leaflet CŒŸHœŸNO– 1859,2336,2337, 2529

+5°C ± 3°C A1a 79 €

Y0000755 Nonoxinol 9 1 10 mg 1 1454 +5°C ± 3°C A1A 79 €

N1100000 Noradrenaline tartrate 7 200 mg 1 Batch 6 is valid until 31 October 2017 0254,0285,0732, 2303

+5°C ± 3°C A1A 79 €

Y0000681 Noradrenaline impurity D 2 15 mg 1 4[(1R)-2-amino-1-methoxyethyl]benzene-1,2-diol (noradrenaline methyl ether)

0285,0732 +5°C ± 3°C A1A 79 €

Y0000682 Noradrenaline impurity E 1 10 mg 1 2-chloro-1-(3,4-dihydroxyphenyl)ethanone 0285,0732 +5°C ± 3°C A1A 79 €

Y0000686 Noradrenaline impurity F 1 10 mg 1 N-benzyl-1-phenylmethanamine 0285,0732 +5°C ± 3°C A1A 79 €

N1130000 Norcyclobenzaprine 1 25 mg 1 0941 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 71For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

N1140000 Nordazepam -* psy 1 50 mg 1 Dipotassium clorazepate impurity B 0898 +5°C ± 3°C A2A 79 €

N1200000 Norethisterone 3 25 mg 1 0234,1212,0926

+5°C ± 3°C A1A 79 €

Y0000522 Norethisterone for system suitability 1 10 mg 1 0234 -20°C ± 5°C

C1A 79 €

N1225000 Norethisterone acetate 2 110 mg 1 See leaflet CœœHœ‡O– 0850 +5°C ± 3°C A1A 79 €

Y0001532 Norethisterone acetate for system suitability 1 2.585 mg 1 0850 +5°C ± 3°C A1A 79 €

N1230000 Norfloxacin 2 20 mg 1 Batch 1 is valid until 20 June 2017 1248 +5°C ± 3°C A1A 79 €

N1230010 Norfloxacin impurity A 1 20 mg 1 7-chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

1460 +5°C ± 3°C A1A 79 €

Y0001301 Norfloxacin for peak identification 1 10 mg 1 1248 +5°C ± 3°C A1A 79 €

Y0001015 Norfloxacin for system suitability 3 10 mg 1 1248 +5°C ± 3°C A1A 79 €

Y0001609 Norflurane - reference spectrum 1 n/a 1 L 79 €

Y0000724 Norgestimate 1 10 mg 1 1732 +5°C ± 3°C A1A 79 €

Y0000725 Norgestimate for system suitability 1 5 mg 1 1732 +5°C ± 3°C A1A 79 €

N1250000 Norgestrel 1 30 mg 1 0940 +5°C ± 3°C A1a 79 €

N1279000 Norpseudoephedrine hydrochloride - * psy 2 50 mg 1 Cathine hydrochloride 0683 +5°C ± 3°C A2A 79 €

N1280000 Nortriptyline hydrochloride 2 10 mg 1 0941 +5°C ± 3°C A1A 79 €

Y0001296 Nortriptyline for system suitability 1 20 mg 1 0941 +5°C ± 3°C A1A 79 €

N1300000 Noscapine 2 100 mg 1 0102,0515,0516

+5°C ± 3°C A1A 79 €

N1400000 Nystatin 7 100 mg 1 See leaflet 0517,1292,20702

-20°C ± 5°C

C1A 79 €

O0100900 Octoxinol 10 3 310 mg 1 Batch 2 is valid until 24 June 2017 1553 +5°C ± 3°C A1A 79 €

Y0000368 Octyl gallate 1 30 mg 1 2057 +5°C ± 3°C A1A 79 €

O0101000 Octyldodecanol 5 500 mg 1 See leaflet CœÐH÷œO 1136 +5°C ± 3°C A1A 79 €

O0120000 Ofloxacin 1 50 mg 1 1455 +5°C ± 3°C A1A 79 €

O0120010 Ofloxacin impurity A 3 20 mg 1 (3RS)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid (FPA)

1455 +5°C ± 3°C A1a 79 €

O0120050 Ofloxacin impurity E 4 20 mg 1 (3RS)-9-fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid

1455 +5°C ± 3°C A1A 79 €

Y0001370 Olanzapine 2 200 mg 1 See leaflet 2258 +5°C ± 3°C A1a 79 €

Y0001392 Olanzapine impurity A 2 5 mg 1 5-methyl-2-[(2-nitrophenyl)amino]thiophene-3-carbonitrile 2258 +5°C ± 3°C A1A 79 €

Y0001380 Olanzapine for system suitability 2 10 mg 1 2258 +5°C ± 3°C A1A 79 €

Y0001204 Oleanolic acid 1 20 mg 2 See leaflet 2463,2472 +5°C ± 3°C A1A 79 €

Y0001479 Oleic acid 2 2000 mg 1 See leaflet CŒ‡H–÷Oœ ; Batch 1 is valid until 31 December 2017 2579, 1848 +5°C ± 3°C A1A 79 €

Y0000805 Oleuropein 2 25 mg 1 See leaflet Cœ—H–œOŒ– 1878 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 72For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0001405 Olmesartan medoxomil 3 100 mg 1 see leaflet ; Batch 2 is valid until 30 June 2017 2600 +5°C ± 3°C A1A 79 €

Y0001424 Olmesartan medoxomil for system suitability 3 10 mg 1 Batch 2 is valid until 31 August 2017 2600 +5°C ± 3°C A1A 79 €

O0146000 Olsalazine sodium 2 70 mg 1 1457 +5°C ± 3°C A1A 79 €

O0146010 Olsalazine sodium for performance test 1 60 mg 1 1457 +5°C ± 3°C A1A 79 €

O0150000 Omeprazole 5 50 mg 1 See leaflet ; Batch 4 is valid until 28 February 2018 0942,1032,2372, 2374,2787

-20°C ± 5°C

C1A 79 €

Y0001043 Omeprazole magnesium 1 10 mg 1 2374 +5°C ± 3°C A1A 79 €

O0151000 Omeprazole impurity D 3 15 mg 1 5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfonyl]-1H-benzimidazole (omeprazole sulfone) ; Batch 2 is valid until 31 January 2018

0942,1032, 2372, 2374,

2787

-20°C ± 5°C

C1A 79 €

Y0000218 Ondansetron hydrochloride dihydrate 4 200 mg 1 See leaflet CŒ‡HœÐClN–O 2016 +5°C ± 3°C A1A 79 €

Y0001042 Omeprazole for peak identification 2 10 mg 1 Batch 1 is valid until 31 July 2017 0942, 1032, 2372, 2374,

2787

-20°C ± 5°C

C1A 79 €

Y0001345 Ondansetron impurity A 2 10 mg 1 (3RS)-3-[(dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one

2016 +5°C ± 3°C A1A 79 €

Y0000195 Ondansetron impurity D 4 15 mg 1 9-methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one ; Batch 3 is valid until 28 February 2018

2016 +5°C ± 3°C A1A 79 €

Y0001326 Ondansetron impurity E 2 10 mg 1 1H-imidazole ; Batch 1 is valid until 30 November 2017

2016 +5°C ± 3°C A1A 79 €

Y0001320 Ondansetron impurity F 1 10 mg 1 2-methyl-1H-imidazole 2016 +5°C ± 3°C A1A 79 €

Y0001346 Ondansetron impurity G 2 10 mg 1 (3RS)-3-[(1H-imidazol-1-yl)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one (C-desmethylondansetron)

2016 +5°C ± 3°C A1A 79 €

Y0000197 Ondansetron for LC system suitability 1 10 mg 1 2016 +5°C ± 3°C A1A 79 €

Y0000196 Ondansetron for TLC system suitability 2 30 mg 1 2016 +5°C ± 3°C A1A 79 €

Y0001125 Orbifloxacin 1 200 mg 1 2259 +5°C ± 3°C A1A 79 €

Y0001147 Orbifloxacin impurity mixture 1 0.0008 mg 1 2259 +5°C ± 3°C A1A 79 €

O0180000 Orciprenaline sulfate 3 100 mg 1 Batch 2 is valid until 31 March 2017 1033,1332 +5°C ± 3°C A1A 79 €

Y0000895 Orciprenaline for system suitability 1 5 mg 1 1033 +5°C ± 3°C A1A 79 €

Y0001501 Orientvine stem HRS 1 600 mg 1 2450 +5°C ± 3°C A1A 79 €

Y0000101 Orphenadrine citrate 1 100 mg 1 1759 +5°C ± 3°C A1A 79 €

Y0000100 Orphenadrine hydrochloride 1 100 mg 1 1760 +5°C ± 3°C A1A 79 €

Y0000102 Orphenadrine impurity E 2 60 mg 1 (RS)-N,N-dimethyl-2-[(3-methylphenyl)phenylmethoxy] ethanamine (meta-methylbenzyl isomer)

1759,1760 +5°C ± 3°C A1A 79 €

Y0001181 Orphenadrine for peak identification 2 0.44 mg 1 1759,1760 +5°C ± 3°C A1A 79 €

Y0001337 Oseltamivir phosphate (impurity B-free) 2 300 mg 1 See leaflet CŒÿH–ŒNœO‡P ; Batch 1 is valid until 30 September 2017 2422 +5°C ± 3°C A1A 79 €

Y0001338 Oseltamivir impurity A 2 10 mg 1 (3R,4R,5S)-5-acetamido-4-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1-carboxylic acid ; Batch 1 is valid until 30 June 2017

2422 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 73For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0001339 Oseltamivir impurity B 1 10 mg 1 ethyl (1R,2R,3S,4R,5S)-4-acetamido-5-amino-2-azido-3- (1-ethylpropoxy)cyclohexanecarboxylate

2422 +5°C ± 3°C A1A 79 €

Y0001340 Oseltamivir impurity C 2 10 mg 1 See leaflet CŒ÷HœœNœO÷; (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1-carboxylic acid

2422 +5°C ± 3°C A1A 79 €

Y0001341 Oseltamivir impurity H 1 30 mg 1 tributylphosphane oxide 2422 +5°C ± 3°C A1A 79 €

Y0001207 Osthole 1 20 mg 1 See leaflet CŒ—HŒÿO– 2557 +5°C ± 3°C A1A 79 €

O0200000 Ouabain 2 150 mg 1 See leaflet Cœ„H÷÷OŒœ 0048 +5°C ± 3°C A1A 79 €

Y0000638 Oxacillin sodium monohydrate 1 110 mg 1 See leaflet CŒ„HŒ‡N–NaO—S 2260 +5°C ± 3°C A1A 79 €

Y0000560 Oxacillin for peak identification 1 10 mg 1 2260 -20°C ± 5°C

C1A 79 €

Y0000271 Oxaliplatin 4 250 mg 1 See leaflet C‡HŒ÷NœO÷Pt 2017 +5°C ± 3°C A1A 79 €

Y0000272 Oxaliplatin impurity B 10 22 mg 1 See leaflet CœÐHœ‡NœOÿPtSœ; (SP-4-2)-diaqua[(1R,2R)-

cyclohexane-1,2-diamineκN,κN′]platinum (diaquodiaminocyclohexaneplatinum)

2017 +5°C ± 3°C A1A 79 €

Y0000273 Oxaliplatin impurity C 6 25 mg 1 (OC-6-33)-[(1R,2R)-cyclohexane-1,2-diamineκN,κN′][ethanedioato(2-)-κO1,κO2]dihydroxyplatinum

2017 +5°C ± 3°C A1a 79 €

Y0000274 Oxaliplatin impurity D 5 15 mg 1 (SP-4-2)-[(1S,2S)-cyclohexane-1,2-diamine-κN,κN']

[ethanedioato(2-)-κO1,κO2]platinum (S,S-enantiomer of oxaliplatin)

2017 +5°C ± 3°C A1A 79 €

O0225000 Oxazepam - * psy 2 50 mg 1 0778 +5°C ± 3°C A2A 79 €

Y0000543 Oxazepam for peak identification 2 0.008 mg 1 0778 +5°C ± 3°C A1A 79 €

Y0001576 Oxcarbazepine 1 120 mg 1 See leaflet CŒ—HŒœNœOœ 2577 +5°C ± 3°C A1A 79 €

Y0001549 Oxcarbazepine impurity mixture 1 0.008 mg 1 2577 +5°C ± 3°C A1A 79 €

Y0000350 Oxeladin hydrogen citrate 1 50 mg 1 1761 +5°C ± 3°C A1A 79 €

Y0000404 Oxeladin impurity C 1 10 mg 1 2-(diethylamino)ethyl 2-ethyl-2-phenylbutanoate 1761 +5°C ± 3°C A1A 79 €

Y0000390 Oxeladin impurity D 1 20 mg 1 2-[2-(diethylamino)ethoxy]ethyl (2RS)-2-phenylbutanoate 1761 +5°C ± 3°C A1A 79 €

O0225800 Oxfendazole CRS 2 50 mg 1 1458 +5°C ± 3°C A1A 79 €

Y0000224 Oxfendazole impurity B 2 10 mg 1 See leaflet; methyl [5-(phenylsulfonyl)-1H-benzimidazole-2-yl]carbamate

1458 +5°C ± 3°C A1A 79 €

Y0000225 Oxfendazole with impurity D 1 10 mg 1 1458 +5°C ± 3°C A1A 79 €

O0260000 Oxibendazole 2 100 mg 1 This reference standard will be deleted from monograph 01/2008:1386 corrected 6.0 on 2018/04/01. ; Batch 2 is valid until 31 March 2018

1386 +5°C ± 3°C A1A 79 €

Y0001771 Oxidronate for radiochemical purity testing 1 34 mg 1 2376 +5°C ± 3°C A1a 79 €

Y0000709 Oxitropium bromide 1 50 mg 1 2170 +5°C ± 3°C A1A 79 €

Y0000715 Oxitropium bromide impurity B 1 15 mg 1 (1R,2R,4S,5S,7s)-7-[[(2S)-3-hydroxy-2-phenylpropanoyl]oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane (methylhyoscine)

2170 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 74For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000713 Oxitropium bromide impurity D 1 10 mg 1 (1R,2R,4S,5S,7s,9s)-9-ethyl-9-methyl-7-[(2-phenylacryloyl)oxy]-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane (apo-N-ethylhyoscine

2170 +5°C ± 3°C A1A 79 €

O0240000 Oxolinic acid 1 50 mg 1 1353 +5°C ± 3°C A1A 79 €

O0240005 Oxolinic acid impurity A 1 20 mg 1 8-hydroxy-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid 1353 +5°C ± 3°C A1A 79 €

O0240010 Oxolinic acid impurity B 1 20 mg 1 ethyl 5-ethyl-8-oxo-5,8-dihydro-1,3-dioxolo[4,5-g]quinoline-7- carboxylate

1353 +5°C ± 3°C A1A 79 €

O0250000 Oxprenolol hydrochloride 1 50 mg 1 0628,0876,1072

+5°C ± 3°C A1A 79 €

O0270000 Oxybuprocaine hydrochloride 2 100 mg 1 1251 +5°C ± 3°C A1A 79 €

O0288000 Oxybutynin hydrochloride 2 50 mg 1 1354 +5°C ± 3°C A1A 79 €

O0288005 Oxybutynin impurity A 4 20 mg 1 See leaflet CœœH–ÿClNO–; 4-(diethylamino)but-2-ynyl(RS)-2-(cyclohex-3-enyl)-2- cyclohexyl-2-hydroxyacetate

1354 +5°C ± 3°C A1A 79 €

Y0000492 Oxycodone hydrochloride - * narc 1 100 mg 1 1784, 1793 +5°C ± 3°C A2A 79 €

New Y0000453 Oxycodone impurity D 4 50 mg 1 7,8-didehydro-4,5α-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one (14-hydroxycodeinone) ; Batch 3 is valid until 31 May 2018

1793 +5°C ± 3°C A1A 79 €

O0290000 Oxymetazoline hydrochloride 2 80 mg 1 0943 +5°C ± 3°C A1A 79 €

Y0001044 Oxymetazoline impurity A 2 15 mg 1 N-(2-aminoethyl)-2-[4-(1,1-dimethylethyl)-3-hydroxy-2,6-dimethylphenyl]acetamide ; Batch 1 is valid until 31 October 2017

0943 +5°C ± 3°C A1A 79 €

Y0001896 Oxytetracycline 8 100 mg 1 see leaflet; This reference standard is suitable for use with monographs 01/2017:0199 and 01/2017:0198.

0198, 0199 +5°C ± 3°C A1a 79 €

Y0001850 Oxytetracycline for system suitability 2 15 mg 1 Batch 1 is valid until 31 October 2017 0198,0199 +5°C ± 3°C A1a 79 €

O0500000 Oxytetracycline hydrochloride 4 20 mg 1 0198,1030 +5°C ± 3°C A1A 79 €

O0700000 Oxytocin 5 41 mg 1 see leaflet 0779,0780 -20°C ± 5°C

C1A 90 €

O0770000 Oxytocin/Desmopressin validation mixture 4 20 mg 1 0712,0779,0780

-20°C ± 5°C

C1A 79 €

Y0000698 Paclitaxel 3 40 mg 1 See leaflet C÷ŸH—ŒNOŒ÷ 1794 +5°C ± 3°C A1A 79 €

Y0000699 Paclitaxel impurity C 2 10 mg 1 N-debenzoyl-N-hexanoylpaclitaxel (paclitaxel C) 1794 +5°C ± 3°C A1a 79 €

Y0000700 Paclitaxel natural for peak identification 1 10 mg 1 1794 +5°C ± 3°C A1A 79 €

Y0000719 Paclitaxel semi-synthetic for peak identification 2 10 mg 1 1794 +5°C ± 3°C A1A 79 €

Y0000739 Paclitaxel semi-synthetic for system suitability 2 1.013 mg 1 1794 +5°C ± 3°C A1A 79 €

Y0001856 Paeoniflorin 1 15 mg 1 see leaflet Cœ–Hœ‡OŒŒ 2424, 2425, 2474

+5°C ± 3°C A1a 79 €

P0090000 Palmitic acid 4 100 mg 1 0229,0882,1474,1663,2058

+5°C ± 3°C A1A 79 €

Y0000524 Pamidronate disodium pentahydrate 1 10 mg 1 1779 +5°C ± 3°C A1A 79 €

Y0001632 Pancreas powder (amylase) BRP 4 2000 mg 1 See leaflet 0350 +5°C ± 3°C A1a 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 75For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0001631 Pancreas powder (lipase) BRP 4 2000 mg 1 See leaflet 0350 +5°C ± 3°C A1a 79 €

P0200000 Pancreas powder (protease) BRP 4 2000 mg 1 See leaflet 0350 +5°C ± 3°C A1A 79 €

P0250000 Pancuronium bromide 2 20 mg 1 Vecuronium impurity B 0681,1769 +5°C ± 3°C A1A 79 €

Y0000577 Pancuronium bromide for system suitability 1 20 mg 1 0681 +5°C ± 3°C A1A 79 €

Y0000835 Pantoprazole sodium sesquihydrate 1 20 mg 1 2296 +5°C ± 3°C A1A 79 €

Y0001001 Pantoprazole for system suitability 7 0.51 mg 1 Batch 6 is valid until 30 September 2017 2296 +5°C ± 3°C A1a 79 €

P0270000 Papaverine hydrochloride 1 25 mg 1 0102,0573,0515

+5°C ± 3°C A1A 79 €

P0300000 Paracetamol 4 50 mg 1 0049 +5°C ± 3°C A1A 79 €

Y0001781 Paracetamol for equipment qualification 1 250 mg 1 20248 +5°C ± 3°C A1a 79 €

New Y0001955 Paracetamol impurity K 1 15 mg 1 4-aminophenol 0049 +5°C ± 3°C A1a 79 €

New Y0001945 Paracetamol impurity J 1 15 mg 1 Chloroacetanilide 0049 +5°C ± 3°C A1a 79 €

Y0000780 Paraffin (hard) 1 10 mg 1 1034 +5°C ± 3°C A1A 79 €

Y0000058 Paraffin (liquid) - reference spectrum 1 n/a 1 0239,0240 L 79 €

Y0000913 Paraffin (White soft) 1 10 mg 1 1799 +5°C ± 3°C A1A 79 €

Y0000912 Paraffin (Yellow soft) 1 10 mg 1 1554 +5°C ± 3°C A1A 79 €

P0305000 Parnaparin sodium 2 200 mg 1 1252 +5°C ± 3°C A1A 79 €

Y0000578 Paroxetine hydrochloride (anhydrous) 1 100 mg 1 2283 +5°C ± 3°C A1A 79 €

Y0000579 Paroxetine hydrochloride (anhydrous) impurity C

1 10 mg 1 (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-1-benzyl-4-(4-fluorophenyl)piperidine (N-benzylparoxetine)

2283 +5°C ± 3°C A1A 79 €

Y0000581 Paroxetine hydrochloride (anhydrous) impurity H

1 10 mg 1 [(3S,4R)-1-benzyl-4-(4-fluorophenyl)piperidin-3-yl]methanol 2283 +5°C ± 3°C A1a 79 €

Y0000281 Paroxetine hydrochloride hemihydrate 3 200 mg 1 See leaflet CŒ„HœŒClFNO– 2018,2283 +5°C ± 3°C A1A 79 €

Y0000233 Paroxetine impurity A 5 15 mg 1 (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-phenylpiperidine (desfluoroparoxetine)

2018,2283 +5°C ± 3°C A1A 79 €

Y0000256 Paroxetine impurity D 3 10 mg 1 See leaflet; (3R,4S)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine ((+)-trans-paroxetine)

2018,2283 +5°C ± 3°C A1a 79 €

Y0000580 Paroxetine impurity E 2 5 mg 1 (3RS,4RS)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine (cis-paroxetine) ; Batch 1 is valid until 31 January 2018

2283 +5°C ± 3°C A1A 79 €

Y0000630 Paroxetine for system suitability 1 5 mg 1 2018 +5°C ± 3°C A1a 79 €

P0309000 Pefloxacin mesilate dihydrate 1 200 mg 1 1460 +5°C ± 3°C A1A 79 €

P0309020 Pefloxacin impurity B 1 10 mg 1 6-chloro-1-ethyl-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (chlorinated homologue of pefloxacin)

1460 +5°C ± 3°C A1A 79 €

P0309030 Pefloxacin impurity C 2 0.01 mg 1 1-ethyl-6-fluoro-5-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (isopefloxacin)

1460 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 76For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0001539 Pemetrexed disodium heptahydrate 2 200 mg 1 See leaflet 2637 +5°C ± 3°C A1A 79 €

Y0001538 Pemetrexed for system suitability 1 20 mg 1 2637 +5°C ± 3°C A1A 79 €

Y0001535 Pemetrexed impurity mixture 2 0.002 mg 1 2637 +5°C ± 3°C A1A 79 €

P0307000 Penbutolol sulfate 1 100 mg 1 1461 +5°C ± 3°C A1A 79 €

P0307005 Penbutolol impurity A 2 20 mg 1 See leaflet CŒ‡HœŸNOœ; (2S)-1-[2-(cyclopent-1-enyl)phenoxy]-3-[(1,1-dimethylethyl) amino]propan-2-ol

1461 +5°C ± 3°C A1A 79 €

P0310000 Penicillamine 1 100 mg 1 0566 +5°C ± 3°C A1A 79 €

P0320000 Penicillamine disulfide 3 100 mg 1 See leaflet CŒÐHœÐNœO÷Sœ; 3,3-(disulphanediyl)bis[(2S)-2-amino-3-methylbutanoic] acid

0566 +5°C ± 3°C A1A 79 €

P0400100 Pentaerythrityl tetranitrate diluted 2 600 mg 1 See leaflet C—H‡N÷OŒœ 1355 +5°C ± 3°C A1b UN3344 79 €

P0405000 Pentamidine diisetionate 2 30 mg 1 1137,1436 +5°C ± 3°C A1A 79 €

P0405500 Pentazocine - reference spectrum 1 n/a 1 1462 L 79 €

P0405510 Pentazocine hydrochloride - reference spectrum

1 n/a 1 1463 L 79 €

Y0000417 Pentazocine lactate - reference spectrum 1 n/a 1 2000 +5°C ± 3°C A1a 79 €

Y0001051 Pentetate sodium calcium 1 100 mg 1 2353 +5°C ± 3°C A1A 79 €

P0500000 Pentobarbital - * psy 1 500 mg 1 0200,0419 +5°C ± 3°C A2A 79 €

P0510000 Pentoxifylline 2 100 mg 1 0851 +5°C ± 3°C A1A 79 €

Y0000076 Pentoxyverine hydrogen citrate - reference spectrum

1 n/a 1 1621 L 79 €

Y0000098 Pentoxyverine impurity A 1 10 mg 1 1-phenylcyclopentanecarboxylic acid 1621 +5°C ± 3°C A1A 79 €

Y0000099 Pentoxyverine impurity B 1 10 mg 1 2-(diethylamino)ethyl 1-phenylcyclopentanecarboxylate (caramiphen)

1621 +5°C ± 3°C A1A 79 €

P0525000 Pepsin powder BRP 2 2000 mg 1 See leaflet 0682 +5°C ± 3°C A1A 79 €

Y0000010 Pergolide mesilate 1 150 mg 1 See leaflet CœÐH–ÐNœO–Sœ 1555 +5°C ± 3°C A1A 79 €

Y0000238 Perindopril tert-butylamine 3 40 1 Batch 2 is valid until 31 March 2017 2019 +5°C ± 3°C A1A 79 €

Y0000237 Perindopril impurity A 3 15 mg 1 (2S,3aS,7aS)-octahydro-1H-indole-2-carboxylic acid ; Batch 2 is valid until 31 January 2018

2019 +5°C ± 3°C A1A 79 €

Y0000771 Perindopril for peak identification 1 5 mg 1 2019 +5°C ± 3°C A1A 79 €

Y0000207 Perindopril for stereochemical purity 2 40 mg 1 2019 +5°C ± 3°C A1A 79 €

Y0001733 Permethrin (25:75) 1 350 mg 1 see leaflet 1762 +5°C ± 3°C A1A 79 €

Y0001741 Permethrin for system suitability 2 60 mg 1 1762 +5°C ± 3°C A1A 79 €

P0550000 Perphenazine 1 100 mg 1 0629,0904 +5°C ± 3°C A1A 79 €

Y0001045 Perphenazine for system suitability 1 5 mg 1 0629 +5°C ± 3°C A1A 79 €

Y0000021 Pertussis toxin BRP 1 0.05 mg 2 See leaflet See leaflet, 1356, 1595,

20633

-20°C ± 5°C

D1A 90 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 77For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

P0600000 Pethidine hydrochloride - reference spectrum 1 n/a 1 0420 L 79 €

P0600002 Pethidine impurity A 2 20 mg 1 1-methyl-4-phenylpiperidine (MPP) ; Batch 1 is valid until 28 February 2017

0420 +5°C ± 3°C A1a 79 €

P0800000 Phenazone 2 20 mg 1 0421 +5°C ± 3°C A1A 79 €

Y0001138 Phenazone impurity A 1 20 mg 1 5-methyl-2-phenyl-2,4-dihydro-3§-pyrazol-3-one 0421 +5°C ± 3°C A1A 79 €

P0850000 Pheniramine maleate 3 250 mg 1 Batch 2 is valid until 30 June 2017 1357, 0977 +5°C ± 3°C A1A 79 €

Y0001428 Pheniramine impurity A 1 20 mg 1 2-benzylpyridine 1357 +5°C ± 3°C A1A 79 €

P0900000 Phenobarbital - * psy 5 200 mg 1 See leaflet CŒœHŒœNœO– 0189,0201,0630

+5°C ± 3°C A2A 79 €

New Y0001350 Phenobarbital impurity A 2 15 mg 1 (5RS)-5-ethyl-2,6-diimino-5-phenyltetrahydropyrimidin-4(1H)-one ; Batch 1 is valid until 30 June 2018

0201,0630 +5°C ± 3°C A1A 79 €

Y0001351 Phenobarbital impurity B 1 15 mg 1 (5RS)-5-ethyl-6-imino-5-phenyldihydropyrimidine-2,4(1H,3H)-dione

0201,0630 +5°C ± 3°C A1A 79 €

P0950000 Phenoxyethanol 5 1 mL 1 0781 +5°C ± 3°C A1A 79 €

P1000000 Phenoxymethylpenicillin 2 250 mg 1 0148 +5°C ± 3°C A1A 79 €

Y0001868 Phenoxymethylpenicillin for system suitability 1 25 mg 1 0148,0149 +5°C ± 3°C A1a 79 €

P1100000 Phenoxymethylpenicillin potassium 4 250 mg 1 See leaflet CŒÿHŒŸKNœO—S 0113,0114,0148, 0149

+5°C ± 3°C A1A 79 €

Y0001127 Phentolamine mesilate 1 10 mg 1 1138 +5°C ± 3°C A1A 79 €

P1109000 Phentolamine mesilate - reference spectrum 1 n/a 1 1138 L 79 €

Y0001251 Phentolamine for system suitability 1 10 mg 1 1138 +5°C ± 3°C A1A 79 €

P1150000 Phenylalanine 4 60 mg 1 0782,2575 +5°C ± 3°C A1A 79 €

P1200000 Phenylbutazone 1 100 mg 1 0422,1574 +5°C ± 3°C A1A 79 €

Y0000147 Phenylbutazone impurity B 2 20 mg 1 4-butyl-4-hydroxy-1,2-diphenylpyrazolidine-3,5-dione ; Batch 1 is valid until 30 September 2017

0422 +5°C ± 3°C A1A 79 €

P1240000 Phenylephrine 2 60 mg 1 1035 +5°C ± 3°C A1A 79 €

P1250000 Phenylephrine hydrochloride 3 50 mg 1 0632,1205 +5°C ± 3°C A1A 79 €

Y0000683 Phenylephrine hydrochloride for peak identification

5 2 mg 1 Batch 4 is valid until 30 November 2017 0632,1035 +5°C ± 3°C A1A 79 €

Y0000229 Phenylmercuric acetate - reference spectrum 1 n/a 1 2042 L 79 €

P1255100 Phenylmercuric borate - reference spectrum 1 n/a 1 0103 L 79 €

New P1260000 Phenylpropanolamine hydrochloride - * Drug Precursor

2 50 mg 1 Norephedrin hydrochloride ; Batch 1 is valid until 31 May 2018 0683 +5°C ± 3°C A3A 79 €

P1290000 Phenytoin 1 100 mg 1 1253,1988 +5°C ± 3°C A1A 79 €

P1300000 Phenytoin sodium 2 250 mg 1 0521 +5°C ± 3°C A1A 79 €

Y0001167 Phenytoin for system suitability 1 20 mg 1 0521,1253 +5°C ± 3°C A1A 79 €

Y0000493 Phloroglucinol (anhydrous) 2 220 mg 1 2301,2302 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 78For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000761 Pholcodine - * narc 1 10 mg 1 0522 +5°C ± 3°C A2A 79 €

Y0001865 Pholcodine for impurity G identification - * narc 1 15 mg 1 0522 +5°C ± 3°C A2a 79 €

Y0001905 Phosphatidylcholine from egg yolk 1 250 mg 1 See leaflet 2315 -20°C ± 5°C

C1a 79 €

Y0000798 Pholcodine for peak identification - * narc 1 10 mg 1 0522 +5°C ± 3°C A2A 79 €

Y0001903 Phosphatidylethanolamine from egg yolk 1 200 mg 1 See leaflet 2315 -20°C ± 5°C

C1a 79 €

Y0000766 Phthalic acid 1 20 mg 1 benzene-1,2-dicarboxylic acid 2348 +5°C ± 3°C A1A 79 €

P1500000 Phthalylsulfathiazole 1 100 mg 1 0352 +5°C ± 3°C A1A 79 €

P1600000 Physostigmine salicylate 2 100 mg 1 0286 +5°C ± 3°C A1A 79 €

P1609000 Phytomenadione 4 150 mg 1 see leaflet; Vitamin K1 1036 +5°C ± 3°C A1A 79 €

Y0001104 Picosulfate for system suitability 2 0.5 mg 1 Batch 1 is valid until 28 February 2017 1031 +5°C ± 3°C A1A 79 €

P1645000 Picotamide monohydrate 1 125 mg 1 1358 +5°C ± 3°C A1A 79 €

P1645005 Picotamide impurity A 1 25 mg 1 4-methoxybenzene-1,3-dicarboxylic acid 1358 +5°C ± 3°C A1A 79 €

Y0001508 Picrotin 1 40 mg 1 2486 +5°C ± 3°C A1A 79 €

Y0001528 Picrotoxinin 1 40 mg 1 See leaflet CŒ—HŒÿOÿ 2486 +5°C ± 3°C A1A 79 €

Y0000124 Pidolate impurity B 3 110 mg 1 (2S)-2-[[[(2S)-5-oxopyrrolidin-2-yl]carbonyl]amino]pentanedioic acid

1619 +5°C ± 3°C A1A 79 €

Y0000123 Pidolic acid 2 125 mg 1 Batch 1 is valid until 30 April 2017 1619 +5°C ± 3°C A1A 79 €

P1650000 Pilocarpine hydrochloride 2 50 mg 1 0633 +5°C ± 3°C A1A 79 €

P1700000 Pilocarpine nitrate 1 50 mg 1 0104 +5°C ± 3°C A1A 79 €

Y0000106 Pilocarpine nitrate for system suitability 1 20 mg 1 0104,0633 +5°C ± 3°C A1A 79 €

Y0000525 Pimobendan 1 10 mg 1 2179 +5°C ± 3°C A1A 79 €

Y0000401 Pimobendan for system suitability 2 0.1 mg 1 2179 +5°C ± 3°C A1A 79 €

P1750000 Pimozide 1 150 mg 1 1254 +5°C ± 3°C A1A 79 €

P1800000 Pindolol 1 100 mg 1 0634,0871 +5°C ± 3°C A1A 79 €

Y0001520 Pioglitazone hydrochloride 1 120 mg 1 See leaflet CŒ„HœŒClNœO–S 2601 +5°C ± 3°C A1A 79 €

Y0001519 Pioglitazone for system suitability 1 15 mg 1 2601 +5°C ± 3°C A1A 79 €

Y0001476 Pipemidic acid trihydrate 1 15 mg 1 1743 +5°C ± 3°C A1A 79 €

Y0000061 Pipemidic acid trihydrate - reference spectrum 1 n/a 1 1743 L 79 €

P1890000 Piperacillin 5 100 mg 1 See leaflet Cœ–HœŸN—OŸS ; Batch 4 is valid until 31 January 2018 1168,1169 +5°C ± 3°C A1a 79 €

P1900000 Piperazine adipate 1 250 mg 1 0423 +5°C ± 3°C A1A 79 €

P2000000 Piperazine citrate 1 250 mg 1 0424 +5°C ± 3°C A1A 79 €

P2100000 Piperazine hydrate 1 250 mg 1 0425 +5°C ± 3°C A1A 79 €

Y0001217 Piperine 1 30 mg 1 See leaflet CŒŸHŒ„NO– 2453,2477 +5°C ± 3°C A1A 79 €

Y0000288 Piracetam 3 150 mg 1 See leaflet CÿHŒÐNœOœ 1733 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 79For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000038 Pirenzepine dihydrochloride monohydrate 1 250 mg 1 2001 +5°C ± 3°C A1A 79 €

P2120000 Piretanide 1 100 mg 1 1556 +5°C ± 3°C A1A 79 €

Y0001458 Piretanide for system suitability 1 10 mg 1 1556 +5°C ± 3°C A1A 79 €

Y0001769 Pirfenidone 1 120 mg 1 See Leaflet CŒœHŒŒNO 2856 +5°C ± 3°C A1a 79 €

P2130000 Piroxicam 3 50 mg 1 0944 +5°C ± 3°C A1a 79 €

Y0001475 Piroxicam for system suitability 5 15 mg 1 0944 +5°C ± 3°C A1a 79 €

P2150000 Pivampicillin 1 125 mg 2 See leaflet 0808,0852 +5°C ± 3°C A1A 79 €

P2152000 Pivmecillinam hydrochloride 2 100 mg 1 See leaflet CœŒH–÷ClN–O—S 1359 -20°C ± 5°C

C1A 79 €

P2152015 Pivmecillinam impurity C 2 10 mg 1 methylene 2,2-dimethylpropanoate (2RS,4S)-2-[[[(hexahydo- 1H-azepin-1-yl)methylene]amino]methyl]-5,5-dimethylthiazolidin-4-carboxylate

1359 +5°C ± 3°C A1A 79 €

P2155001 Plastic additive 01 1 2 ml 1 (2RS)-2-ethylhexyl) benzene-1,2-dicarboxylate 90001,90002, 30114

+5°C ± 3°C A1A 79 €

P2155003 Plastic additive 03 1 100 mg 1 N,N'-ethylenedialcanamide 90001,30114 +5°C ± 3°C A1A 79 €

E0800000 Plastic additive 04 1 500 mg 1 Epoxidised soya oil 90001,30114 +5°C ± 3°C A1A 79 €

P2155005 Plastic additive 05 1 500 mg 1 Epoxidised linseed oil 90001,30114 +5°C ± 3°C A1A 79 €

P2155008 Plastic additive 08 3 500 mg 1 ethylene bis[3,3-bis[3-(1,1-dimethylethyl)-4-hydroxyphenyl]butanoate]

30103,30104, 30105,30106

+5°C ± 3°C A1A 79 €

P2155009 Plastic additive 09 3 250 mg 1 See leaflet; pentaerythrityl tetrakis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate]

30103,30105, 30106,30107

+5°C ± 3°C A1a 79 €

P2155010 Plastic additive 10 2 250 mg 1 4,4',4''-(2,4,6-trimethylbenzene-1,3,5-triyltrismethylene)trio[2,6-bis(1,1-dimethylethyl)phenol]

30103,30105, 30106,30107

+5°C ± 3°C A1A 79 €

P2155011 Plastic additive 11 3 300 mg 1 Octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)-propionate ; Batch 2 is valid until 31 March 2018

30103,30105, 30106,30107

+5°C ± 3°C A1A 79 €

P2155012 Plastic additive 12 4 250 mg 1 Tris (2,4-di-1,1-dimethylethylphenyl) phosphite R ; Batch 3 is valid until 30 June 2017

30103,30105, 30106,30107

+5°C ± 3°C A1A 79 €

P2155013 Plastic additive 13 2 250 mg 1 1,3,5-tris(3,5-di-1,1-dimethylethyl-4-hydroxybenzyl)-1H,3H,5H-1,3,5-triazine-2,4,6-trione

30103,30105, 30106

+5°C ± 3°C A1A 79 €

P2155014 Plastic additive 14 2 250 mg 1 2,2'-Di(octadecycloxy)-5,5'-spirobi(1,3,2-dioxaphosphorinane) R 30103,30105, 30106

+5°C ± 3°C A1A 79 €

P2155015 Plastic additive 15 2 500 mg 1 Dioctadecyl disulphide 30103,30104, 30105,30106

+5°C ± 3°C A1A 79 €

P2155016 Plastic additive 16 2 250 mg 1 Didodecyl 3,3'-thiodipropionate R 30103,30105, 30106

+5°C ± 3°C A1A 79 €

P2155017 Plastic additive 17 2 250 mg 1 Dioctadecyl 3,3'-thiodipropionate R 30103,30105, 30106

+5°C ± 3°C A1A 79 €

P2155018 Plastic additive 18 2 50 mg 1 30103 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 80For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

O0140000 Plastic additive 20 1 100 mg 1 Oleamide R 30103,30105, 30106,30107

+5°C ± 3°C A1A 79 €

E1260000 Plastic additive 21 1 100 mg 1 Erucamide R 30103, 30105, 30106, 30107

+5°C ± 3°C A1A 79 €

P2155022 Plastic additive 22 1 100 mg 1 Copolymer of dimethyl butanedioate and 1-(2-hydroxyethyl)-2,2,6,6-tetramethylpiperidin-4-ol Synonyms: copolymer of dimethyl succinate and (4-hydroxy-2,2,6,6-tetramethylpiperidin-1-yl)ethanol

30103 +5°C ± 3°C A1A 79 €

P2155023 Plastic additive 23 3 200 mg 1 di(isooctyl)2,2'-[(dioctylstannylene)bis(thio)]diacetate containing about 27% of (tri(isooctyl)2,2',2''- [monooctyl- stannylidyne)tris(thio)] triacetate. ; Batch 2 is valid until 28 February 2017

30110,30111 +5°C ± 3°C A1A 79 €

P2160000 Poliomyelitis vaccine (inactivated) BRP 3 0.6 mL 3 See leaflet ; Batch 2 is valid until 28 February 2017 0214,2066,2065,

2328,2061,2067,

1934,2329,20720

-80°C ± 10°C

D1A 90 €

P2163920 Poloxamer 124 2 500 mg 1 Batch 1 is valid until 31 March 2017 1464 +5°C ± 3°C A1A 79 €

P2164009 Poloxamer 188 2 50 mg 1 1464 +5°C ± 3°C A1A 79 €

P2164020 Poloxamer 237 1 100 mg 1 1464 +5°C ± 3°C A1A 79 €

P2164021 Poloxamer 338 2 100 mg 1 1464 +5°C ± 3°C A1A 79 €

P2164030 Poloxamer 407 1 100 mg 1 1464 +5°C ± 3°C A1A 79 €

Y0001557 Poly (vinyl acetate) 1 100 mg 1 1962 +5°C ± 3°C A1A 79 €

Y0000792 Poly(vinyl acetate) dispersion 30 per cent 1 1500 mg 1 2152 +5°C ± 3°C B1A 79 €

Y0001550 Poly(vinyl alcohol) 1 100 mg 1 1961 +5°C ± 3°C A1A 79 €

P2600000 Poly(vinyl chloride) 1 100 mg 1 90001,90002, 30114

+5°C ± 3°C A1A 79 €

P2170000 Polyacrylate - reference spectrum 1 n/a 1 0733 L 79 €

Y0001855 Polydatin 1 15 mg 1 see leaflet CœÐHœœO‡ 2724 +5°C ± 3°C A1a 79 €

Y0001860 Polygonum orientale fruit for system suitability 1 510 mg 1 2726 +5°C ± 3°C A1a 79 €

P2400000 Polymyxin B sulfate 6 25 mg 1 see leaflet 0203 +5°C ± 3°C A1A 79 €

Y0000355 Polymyxin B sulfate for microbiological assay 2 25 mg 1 See leaflet 20702 -20°C ± 5°C

C1a 79 €

Y0001712 Polyoxypropylene stearyl ether 1 250 mg 1 2602 +5°C ± 3°C A1A 79 €

Y0000289 Polysorbate 20 - reference spectrum 1 n/a 1 0426 L 79 €

Y0000290 Polysorbate 40 - reference spectrum 1 n/a 1 1914 L 79 €

Y0000291 Polysorbate 60 - reference spectrum 1 n/a 1 0427 L 79 €

Y0000007 Polysorbate 80 - reference spectrum 1 n/a 1 0428 L 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 81For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

P2649610 Potassium clavulanate - reference spectrum 1 n/a 1 1140 L 79 €

Y0001168 Potassium clavulanate impurity G 2 5 mg 1 4-[[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]amino]-4-oxobutanoic acid (N-(hydrogensuccinyl)tyrosine)

1653,1140 -20°C ± 5°C

C1A 79 €

Y0000315 Potassium hydrogen aspartate hemihydrate 1 50 mg 1 2076 +5°C ± 3°C A1A 79 €

P2650000 Potassium sorbate 2 100 mg 1 0618 +5°C ± 3°C A1A 79 €

New Y0001275 Potassium sucrose octasulfate 2 100 mg 1 1796 +5°C ± 3°C A1A 79 €

P2660000 Povidone 2 50 mg 1 0685 +5°C ± 3°C A1A 79 €

Y0000466 Povidone (iodinated) 1 10 mg 1 1142 +5°C ± 3°C A1a 79 €

Y0001266 Pramipexole dihydrochloride monohydrate 1 5 mg 1 2416 +5°C ± 3°C A1A 79 €

Y0001267 Pramipexole impurity D 2 5 mg 1 (6R)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine 2416 +5°C ± 3°C A1a 79 €

Y0001187 Pramipexole for system suitability 1 15 mg 1 2416 +5°C ± 3°C A1A 79 €

Y0000215 Pravastatin sodium - reference spectrum 1 n/a 1 2059 L 79 €

Y0000223 Pravastatin impurity A 6 0.1 mg 1 (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8-[[(2S)-2-methylbutanoyl]oxy]-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid (6'-epipravastatin) ; Batch 5 is valid until 31 March 2018

2059 -20°C ± 5°C

C1A 79 €

Y0000204 Pravastatin 1,1,3,3-tetramethylbutylamine 2 30 mg 1 See leaflet Cœ–H–ÿOŸ 2059 -20°C ± 5°C

C1A 79 €

P2669000 Prazepam -* psy 1 50 mg 1 1466 +5°C ± 3°C A2A 79 €

P2670000 Praziquantel 4 200 mg 1 See leaflet ; Batch 3 is valid until 31 March 2018 0855 +5°C ± 3°C A1A 79 €

Y0001533 Praziquantel for system suitability 1 10 mg 1 0855 +5°C ± 3°C A1A 79 €

P2680000 Prazosin hydrochloride 2 30 mg 1 0856 +5°C ± 3°C A1A 79 €

P2698000 Prednicarbate 3 110 mg 1 See leaflet CœŸH–ÿO‡ ; Batch 2 is valid until 31 January 2018 1467 +5°C ± 3°C A1A 79 €

Y0001630 Prednicarbate for system suitability A 1 10 mg 1 1467 +5°C ± 3°C A1A 79 €

P2700000 Prednisolone 9 100 mg 1 See leaflet; ; Batch 8 is valid until 31 December 2017

0335,0353,0735

+5°C ± 3°C A1A 79 €

Y0001359 Prednisolone for peak identification 2 10 mg 1 Batch 1 is valid until 31 December 2017 0353 +5°C ± 3°C A1A 79 €

Y0001355 Prednisolone for system suitability 2 10 mg 1 0353 +5°C ± 3°C A1A 79 €

P2800000 Prednisolone acetate 4 120 mg 1 0734,0736,0975,1467,0334

+5°C ± 3°C A1A 79 €

Y0000582 Prednisolone acetate for peak identification 1 10 mg 1 0734 +5°C ± 3°C A1A 79 €

P2804000 Prednisolone hexanoate 1 10 mg 1 1212 +5°C ± 3°C A1A 79 €

P2805000 Prednisolone pivalate 2 120 mg 1 0734,0736 +5°C ± 3°C A1A 79 €

P2810000 Prednisolone sodium phosphate 4 100 mg 1 0549,0735,0810

+5°C ± 3°C A1a 79 €

P2900000 Prednisone 5 110 mg 1 See leaflet CœŒHœÿO— ; Batch 4 is valid until 31 December 2017 0354 +5°C ± 3°C A1A 79 €

Y0001921 Prednisone for peak identification 1 15 mg 1 0354 +5°C ± 3°C A1a 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 82For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0001920 Prednisone impurity B 1 20 mg 1 0354 +5°C ± 3°C A1a 79 €

Y0001805 Pregabalin 2 260 mg 1 See leaflet C‡HŒŸNOœ ; Batch 1 is valid until 30 April 2017 2777 +5°C ± 3°C A1a 79 €

Y0001806 Pregabalin impurity A 1 0.25 mg 1 See leaflet C‡HŒ—NO; (4S)-4-(2-methylpropyl)pyrrolidin-2-one 2777 +5°C ± 3°C A1a 79 €

Y0001808 Pregabalin impurity D 2 10 mg 1 1-methylethyl (2RS)-2-hydroxy-2-phenylacetate ; Batch 1 is valid until 31 January 2018

2777 +5°C ± 3°C A1a 79 €

P2920000 Pregnenolone isobutyrate 7 260 mg 1 Batch 6 is valid until 28 February 2018 0593,0993,2397

-20°C ± 5°C

C1a 79 €

Y0000263 Prekallikrein activator in albumin BRP 6 200 mg 3 See leaflet ; Batch 5 is valid until 30 April 2018 See leaflet,20615

-20°C ± 5°C

C1A 90 €

P2939000 Prilocaine 1 150 mg 1 1362 +5°C ± 3°C A1A 79 €

P2939060 Prilocaine hydrochloride 1 100 mg 1 1363 +5°C ± 3°C A1A 79 €

Y0001408 Prilocaine impurity B 1 80 mg 1 2-methylbenzenamine (o-toluidine) 1362,1363 +5°C ± 3°C A1A 79 €

P2939025 Prilocaine impurity E 1 25 mg 1 (2RS)-N-(4-methylphenyl)-2-(propylamino)propanamide 1362,1363 +5°C ± 3°C A1A 79 €

Y0001681 Prilocaine for peak identification 1 20 mg 1 1363 +5°C ± 3°C A1A 79 €

P2940000 Primaquine diphosphate 3 500 mg 1 0635 +5°C ± 3°C A1A 79 €

P2950000 Primidone 3 150 mg 1 See leaflet ; Batch 2 is valid until 28 February 2018 0584 +5°C ± 3°C A1A 79 €

Y0000369 Primidone for peak identification 1 10 mg 1 0584 +5°C ± 3°C A1A 79 €

P3000000 Probenecid 1 100 mg 1 0243 +5°C ± 3°C A1A 79 €

P3050000 Procainamide hydrochloride 1 100 mg 1 0567 +5°C ± 3°C A1A 79 €

P3090000 Procaine benzylpenicillin 4 250 mg 1 See leaflet 0115 +5°C ± 3°C A1A 79 €

P3100000 Procaine hydrochloride 1 100 mg 1 0050 +5°C ± 3°C A1A 79 €

Y0001941 Raltegravir for peak identification 1 10 mg 1 2887 +5°C ± 3°C A1a 79 €

P3200000 Prochlorperazine maleate 1 100 mg 1 0244 +5°C ± 3°C A1A 79 €

Y0001949 Raltegravir impurity E 1 10 mg 1 2887,2938,2939

+5°C ± 3°C A1a 79 €

P3300000 Progesterone 4 120 mg 1 See leaflet ; Batch 3 is valid until 30 September 2017 0429 +5°C ± 3°C A1A 79 €

Y0001667 Progesterone for impurity H identification 2 20 mg 1 see leaflet 0429 +5°C ± 3°C A1A 79 €

Y0001666 Progesterone for peak identification 1 5 mg 1 0429 +5°C ± 3°C A1A 79 €

Y0001665 Progesterone for system suitability 1 5 mg 1 0429 +5°C ± 3°C A1A 79 €

Y0001885 Proguanil for system suitability 1 15 mg 1 2002 +5°C ± 3°C A1a 79 €

Y0001901 Proguanil hydrochloride 1 10 mg 1 2002 +5°C ± 3°C A1a 79 €

Y0000179 Proguanil hydrochloride - reference spectrum 1 n/a 1 2002 L 79 €

Y0001909 Proguanil impurity B 1 15 mg 1 4-chloroaniline 2002 +5°C ± 3°C A1a 79 €

P3350000 Proline 3 60 mg 1 0785 +5°C ± 3°C A1A 79 €

P3390000 Promazine hydrochloride 2 40 mg 1 0475,1365 +5°C ± 3°C A1A 79 €

P3400000 Promethazine hydrochloride 2 50 mg 1 0524 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 83For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000769 Promethazine impurity D 3 35 mg 1 (2RS)-N,N-dimethyl-1-(10H-phenothiazin-10-yl)propan-2-amine S-oxide ; Batch 2 is valid until 31 December 2017

0524 +5°C ± 3°C A1A 79 €

Y0000797 Promethazine for peak identification 2 5 mg 1 0524 +5°C ± 3°C A1A 79 €

P3490000 Propacetamol hydrochloride - reference spectrum

1 n/a 1 1366 L 79 €

Y0000455 Propafenone hydrochloride 1 10 mg 1 2103 +5°C ± 3°C A1A 79 €

Y0000456 Propafenone impurity B 1 10 mg 1 (2E)-1-[2-[(2RS)-2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylprop-2-en-1-one

2103 +5°C ± 3°C A1A 79 €

Y0000278 Propanol - reference spectrum 1 n/a 1 2036 L 79 €

Y0000016 Propofol 6 650 mg 1 See leaflet 1558 +5°C ± 3°C A1A 79 €

Y0000018 Propofol impurity J 4 20 mg 1 2,6-bis(1-methylethyl)benzene-1,4-dione 1558 +5°C ± 3°C A1A 79 €

Y0000017 Propofol for peak identification 3 0.1 ml 1 1558 +5°C ± 3°C A1A 79 €

P3500000 Propranolol hydrochloride 2 30 mg 1 0568,0923 +5°C ± 3°C A1A 79 €

P3600000 Propranolol hydrochloride for performance test 3 15 mg 1 0568 +5°C ± 3°C A1A 79 €

Y0001547 Propylene glycol 1 150 mg 1 1403,1804,2645

+5°C ± 3°C A1A 79 €

Y0000318 Propylene glycol dilaurate 1 100 mg 1 2087 +5°C ± 3°C A1A 79 €

Y0000319 Propylene glycol monolaurate 1 100 mg 1 1915 +5°C ± 3°C A1A 79 €

P3640000 Propyl gallate 3 50 mg 1 1039 +5°C ± 3°C A1a 79 €

P3650000 Propyl parahydroxybenzoate 4 150 mg 1 See leaflet CŒÐHŒœO– 0431,0852,1263

+5°C ± 3°C A1A 79 €

P3700000 Propylthiouracil 2 30 mg 1 0525 +5°C ± 3°C A1A 79 €

P3750000 Propyphenazone 4 200 mg 1 0636 +5°C ± 3°C A1A 79 €

P3760000 Protirelin 3 5.03 mg 2 See leaflet CŒÿHœœNÿO÷ 1144 -20°C ± 5°C

C1A 79 €

P3760020 D-His-Protirelin 2 0.1 mg 1 approx. 0.1 mg per vial 1144 -20°C ± 5°C

C1A 79 €

P3800000 Proxyphylline 1 100 mg 1 0526 +5°C ± 3°C A1A 79 €

P3850000 Pseudoephedrine hydrochloride - * Drug Precursor

3 50 mg 1 0487,1367 +5°C ± 3°C A3A 79 €

Y0000387 Pseudoisoeugenyl 2-methylbutyrate for peak identification

1 100 mg 1 Star anise oil 2108 +5°C ± 3°C A1A 79 €

Y0001537 Purified quillaia saponins 1 30 mg 1 1843 -20°C ± 5°C

C1A 79 €

P3900000 Purpureaglycoside A 1 25 mg 1 0117 +5°C ± 3°C A1A 79 €

P4000000 Purpureaglycoside B 1 25 mg 1 0117 +5°C ± 3°C A1A 79 €

Y0000402 Pyrantel embonate 1 10 mg 1 1680 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 84For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000403 Pyrantel impurity A 2 20 mg 1 1-methyl-2-[(Z)-2-(thiophen-2-yl)eth-1-en-1-yl]-1,4,5,6-tetrahydropyrimidine

1680 +5°C ± 3°C A1A 79 €

Y0001817 Pyrantel impurity D 1 20 mg 1 1,2-dimethyl-1,4,5,6,-tetrahydropyrimidine 1680 +5°C ± 3°C A1a 79 €

P4050000 Pyrazinamide 2 30 mg 1 0859 +5°C ± 3°C A1A 79 €

P4099900 Pyridostigmine bromide 4 30 mg 1 1255 +5°C ± 3°C A1a 79 €

P4099910 Pyridostigmine impurity A 1 20 mg 1 pyridin-3-yl-dimethylcarbamate 1255 +5°C ± 3°C A1A 79 €

Y0001486 Pyridostigmine impurity B 1 10 mg 1 3-hydroxy-1-methylpyridinium 1255 +5°C ± 3°C A1a 79 €

P4100000 Pyridoxine hydrochloride 2 100 mg 1 0245 +5°C ± 3°C A1A 79 €

Y0001226 Pyridoxine impurity A 3 5 mg 1 6-methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol 0245 +5°C ± 3°C A1A 79 €

P4200000 Pyrimethamine 1 250 mg 1 0288 +5°C ± 3°C A1A 79 €

Y0000659 Pyrrolidone 2 20 mg 1 Batch 1 is valid until 23 September 2017 2180 +5°C ± 3°C A1A 79 €

Y0001009 Quercetin dihydrate 3 25 mg 1 See leaflet CŒ—HŒÐOŸ 1827 +5°C ± 3°C A1A 79 €

Y0001657 Quetiapine fumarate 2 50 mg 1 Batch 1 is valid until 31 August 2017 2541 +5°C ± 3°C A1A 79 €

Y0001931 Quercitrin 1 15 mg 1 See leaflet CœŒHœÐOŒŒ 2722 +5°C ± 3°C A1a 79 €

Y0001419 Quetiapine for system suitability 3 2.005 mg 1 2541 +5°C ± 3°C A1A 79 €

Y0001564 Quillaia saponin for assay 1 30 mg 1 See leaflet C÷œHÿ—NOŒÿ; monoammonium glycyrrhizate 1843 +5°C ± 3°C A1A 79 €

Y0001491 Quinapril hydrochloride 1 30 mg 1 1763 +5°C ± 3°C A1A 79 €

Y0001502 Quinapril for peak identification 1 5.075 mg 1 1763 +5°C ± 3°C A1A 79 €

Y0001503 Quinapril for system suitability 1 5.125 mg 1 1763 +5°C ± 3°C A1A 79 €

Q0100000 Quinidine sulfate 1 300 mg 1 0017,0018,0019

+5°C ± 3°C A1A 79 €

Q0200000 Quinine sulfate 2 300 mg 1 0017,0018,0019

+5°C ± 3°C A1A 79 €

Y0001783 Rabeprazole sodium hydrate 1 100 mg 1 See leaflet CŒ‡HœÐNaN–O–S 2331,2868 +5°C ± 3°C A1a 79 €

R0100000 Rabies vaccine (inactivated) for veterinary use BRP

5 86 mg 2 See leaflet 0451 -20°C ± 5°C

C1A 90 €

Y0000896 Racecadotril 2 120 mg 1 See leaflet CœŒHœ–NO÷S 2171 +5°C ± 3°C A1a 79 €

Y0000897 Racecadotril impurity A 3 1.5 mL 1 ethanethioic acid (thioacetic acid) 2171 +5°C ± 3°C A1a 79 €

Y0000898 Racecadotril impurity G 1 10 mg 1 benzyl [[(2RS)-2-benzyl-3-sulfanylpropanoyl]amino]acetate 2171 +5°C ± 3°C A1A 79 €

Y0000902 Racecadotril for peak identification 1 5 mg 1 2171 +5°C ± 3°C A1A 79 €

Y0001134 Raloxifene hydrochloride 1 110 mg 1 See leaflet Cœ‡Hœ‡ClNO÷S 2375 +5°C ± 3°C A1A 79 €

Y0001135 Raloxifene for peak identification 1 10 mg 1 2375 +5°C ± 3°C A1A 79 €

New Y0001943 Raltegravir potassium 1 100 mg 1 See leaflet CœÐHœŒFNÿO—K 2887,2938,2939

+5°C ± 3°C A1a 79 €

R0145000 Ramipril 2 20 mg 1 1368 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 85For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

R0145005 Ramipril impurity A 4 10 mg 1 (2S,3aS,6aS)-1-[(2S)-2-[[(1S)-1-(methoxycarbonyl)-3-phenylpropyl]amino]propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (ramipril methyl ester)

1368 +5°C ± 3°C A1A 79 €

R0145010 Ramipril impurity B 3 10 mg 1 (2S,3aS,6aS)-1-[(2S)-2-[[(1S)-1-[(1-methylethoxy)carbonyl]-3-phenylpropyl]amino]propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (ramipril isopropyl ester)

1368 +5°C ± 3°C A1A 79 €

R0145015 Ramipril impurity C 3 10 mg 1 (2S,3aS,6aS)-1-[(2S)-2-[[(1S)-3-cyclohexyl-1-(ethoxycarbonyl)-propyl]amino]propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (hexahydroramipril)

1368 +5°C ± 3°C A1A 79 €

R0145020 Ramipril impurity D 4 10 mg 1 ethyl (2S)-2-[(3S,5aS,8aS,9aS)-3-methyl-1,4-dioxodecahydro-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-2-yl]-4-phenylbutanoate (ramipril diketopiperazine)

1368 +5°C ± 3°C A1A 79 €

R0150000 Ranitidine hydrochloride 3 100 mg 1 0946,1453 +5°C ± 3°C A1A 79 €

Y0000416 Ranitidine impurity J 7 0.00025 mg

1 1,1'-N-[methylenebis(sulfanediylethylene)]bis(N'-methyl-2-nitroethene-1,1-diamine)

0946 -20°C ± 5°C

C1a 79 €

Y0001787 Ranitidine for impurity A identification 1 15 mg 1 0946 +5°C ± 3°C A1A 79 €

Y0001565 Recombinant Major Allergen rBet v 1 1 0.01025 mg

1 See leaflet 1063 -20°C ± 5°C

C1A 90 €

Y0001566 Recombinant Major Allergen rPhl p 5a 1 0.00856 mg

1 See leaflet 1063 -20°C ± 5°C

C1A 90 €

Y0001892 Remifentanil hydrochloride - * narc 1 100 mg 1 2644 +5°C ± 3°C A2a 79 €

Y0001884 Remifentanil impurity mixture - *narc 1 15 mg 1 2644 +5°C ± 3°C A2a 79 €

Y0000457 Repaglinide 1 20 mg 1 2135 +5°C ± 3°C A1A 79 €

Y0000459 Repaglinide impurity E 3 10 mg 1 2-ethoxy-4-[2-[[(1R)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]amino]-2-oxoethyl]benzoic acid

2135 +5°C ± 3°C A1A 79 €

Y0000458 Repaglinide for system suitability 3 6 mg 1 2135 +5°C ± 3°C A1a 79 €

R0200000 Reserpine 3 100 mg 1 See leaflet C––H÷ÐNœO„ 0528 +5°C ± 3°C A1A 79 €

R0250000 Residual solvent solution class 1 7 1.4 mL 1 Batch 6 is valid until 31 August 2017 20424 +5°C ± 3°C A1A 79 €

Y0000767 Resorcinol 1 20 mg 1 benzene-1,3-diol 2348 +5°C ± 3°C A1A 79 €

Y0001194 Resveratrol 1 20 mg 1 See leaflet CŒ÷HŒœO– 2433 -20°C ± 5°C

C1A 79 €

R0300000 Retinol acetate 7 500 mg 1 See leaflet 0218,0219,0220,1192,1193,2

398

-20°C ± 5°C

C1a 79 €

R0290000 Retinol esters 1 100 mg 1 0217,0218,0219, 0220

+5°C ± 3°C A1A 79 €

Y0000377 Ribavirin 3 150 mg 2 See leaflet C‡HŒœN÷O— 2109 +5°C ± 3°C A1A 79 €

New R0600000 Riboflavin 5 130 mg 1 Vitamin B2 ; Batch 4 is valid until 31 May 2018 0292,0786 +5°C ± 3°C A1A 79 €

Y0000757 Riboflavin for peak identification 4 0.12 mg 1 Batch 3 is valid until 30 April 2017 0292 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 86For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

R0630000 Riboflavin sodium phosphate 2 250 mg 1 0786 +5°C ± 3°C A1A 79 €

Y0000662 Ribonucleic acid 1 100 mg 1 See leaflet 2090 +5°C ± 3°C A1A 79 €

Y0000149 Rifabutin 2 150 mg 1 See leaflet C÷—HÿœN÷OŒŒ 1657 +5°C ± 3°C A1A 79 €

Y0000184 Rifabutin impurity A 1 20 mg 1 1-(2-methylpropyl)piperidin-4-one 1657 +5°C ± 3°C A1A 79 €

R0700000 Rifampicin 2 100 mg 1 0052 +5°C ± 3°C A1A 79 €

R0800000 Rifampicin quinone 4 100 mg 1 0052 +5°C ± 3°C A1A 79 €

R1000000 Rifamycin sodium 4 150 mg 1 see leaflet C–ŸH÷ÿNNaOŒœ 0432,20702 -20°C ± 5°C

C1A 79 €

R0900000 Rifamycin B 3 25 mg 1 See leaflet C–„H÷„NOŒ÷; Rifamycin impurity A 0432 +5°C ± 3°C A1A 79 €

R0950000 Rifamycin S 3 100 mg 1 0432 +5°C ± 3°C A1A 79 €

Y0001074 Rifaximin 2 160 mg 1 See leaflet 2362 +5°C ± 3°C A1A 79 €

Y0001075 Rifaximin for system suitability 1 10 mg 1 2362 +5°C ± 3°C A1A 79 €

Y0000250 Rilmenidine dihydrogenophosphate - reference spectrum

1 n/a 1 2020 L 79 €

Y0000187 Rilmenidine for system suitability 1 30 mg 1 2020 +5°C ± 3°C A1A 79 €

Y0001541 Risedronate sodium 2.5-hydrate 1 15 mg 1 2572 +5°C ± 3°C A1A 79 €

Y0001558 Risedronate impurity A 1 15 mg 1 See leaflet; [(3RS,6RS and 3R,6S-meso)-2,5-dihydroxy-2,5-

dioxo-3,6-bis[(pyridin-3-yl)methyl]-1,4,2λ5,5λ5-dioxadiphosphinane-3,6-diyl]bis(phosphonic acid)

2572 +5°C ± 3°C A1A 79 €

Y0001540 Risedronate impurity E 1 15 mg 1 [2-(pyridin-3-yl)ethylidene]bis(phosphonic acid) 2572 +5°C ± 3°C A1A 79 €

R1000600 Risperidone 2 50 mg 1 1559 +5°C ± 3°C A1A 79 €

New Y0001276 Risperidone impurity K 3 0.015 mg 1 3-[2-[4-(1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (desfluoro risperidone) ; Batch 2 is valid until 31 May 2018

1559 +5°C ± 3°C A1A 79 €

Y0000370 Risperidone for system suitability 5 20 mg 1 1559 +5°C ± 3°C A1A 79 €

Y0000714 Ritonavir 1 80 mg 1 See leaflet C–ŸH÷‡NÿO—Sœ 2136 +5°C ± 3°C A1A 79 €

Y0000706 Ritonavir for peak identification 1 10 mg 1 2136 +5°C ± 3°C A1A 79 €

Y0001516 Rivastigmine hydrogen tartrate 2 350 mg 1 See leaflet CŒ‡Hœ‡NœO‡ 2629,2630 +5°C ± 3°C A1a 79 €

Y0001515 Rivastigmine impurity D 1 10 mg 1 3-[(1R)-1-(dimethylamino)ethyl]phenyl ethyl(methyl)carbamate ((R)-enantiomer)

2629,2630 +5°C ± 3°C A1A 79 €

Y0001485 Rivastigmine for system suitability 1 1.0114 mg 1 2629,2630 +5°C ± 3°C A1A 79 €

Y0001302 Rizatriptan benzoate 1 200 mg 1 See leaflet CœœHœ—N—Oœ 2585 +5°C ± 3°C A1A 79 €

Y0001303 Rizatriptan for system suitability 1 15 mg 1 2585 +5°C ± 3°C A1A 79 €

R1300000 RK 13 cells 1 1 ml 2 cell lines (kidney, rabbit) titration of live measles, mumps and rubella vaccines

0162,1057 Liquid nitrogen

D1A 100 €

Y0001580 Rocuronium bromide 1 10 mg 1 1764 -20°C ± 5°C

C1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 87For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000527 Rocuronium for peak identification 1 10 mg 1 1764 -20°C ± 5°C

C1a 79 €

Y0001773 Ropinirole hydrochloride 1 125 mg 1 See leaflet CŒÿHœ—ClNœO 2604 +5°C ± 3°C A1a 79 €

Y0001774 Ropinirole impurity A 1 25 mg 1 4-[2-(dipropylamino)ethyl]-1H-indole-2,3-dione 2604 +5°C ± 3°C A1a 79 €

Y0001775 Ropinirole for peak identification 1 1 15 mg 1 2604 +5°C ± 3°C A1a 79 €

Y0001776 Ropinirole for peak identification 2 1 15 mg 1 2604 +5°C ± 3°C A1a 79 €

Y0000742 Ropivacaine hydrochloride monohydrate 1 10 mg 1 2335 +5°C ± 3°C A1A 79 €

Y0000743 Ropivacaine impurity G 2 5 mg 1 (+)-(2R)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide ((R)-ropivacaine) ; Batch 1 is valid until 31 March 2017

2335 +5°C ± 3°C A1A 79 €

Y0000786 Rosmarinic acid 3 50 mg 1 See leaflet CŒ‡HŒÿO‡ 1447,2382, 2524,1229,

2723

+5°C ± 3°C A1a 79 €

Y0001719 Rosuvastatin Calcium 2 100 mg 1 See leaflet C÷÷H—÷CaFœNÿOŒœSœ 2631 +5°C ± 3°C A1A 79 €

Y0001721 Rosuvastatin for system suitability 3 15 mg 1 Batch 2 is valid until 31 May 2017 2631 +5°C ± 3°C A1A 79 €

Y0001722 Rosuvastatin impurity G 2 0.004 mg 1 (3S,5R,6E)-7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid

2631 +5°C ± 3°C A1A 79 €

R1500000 Roxithromycin 5 125 mg 1 See leaflet C÷ŒHŸÿNœOŒ— 1146 +5°C ± 3°C A1A 79 €

Y0000220 Roxithromycin for system suitability 2 10 mg 1 1146 +5°C ± 3°C A1A 79 €

R2000000 Rubella vaccine (live) BRP 1 90 mg 1 See leaflet; One sale unit is composed of a bag of 5 vials. The unit quantity of each vial is 18 mg.

1057,0162,2442

-80°C ± 10°C

D1A 90 €

Y0001919 Rupatadine for system suitability 1 10 mg 1 2888 +5°C ± 3°C A1a 79 €

Y0001922 Rupatadine fumarate 1 10 mg 1 2888 +5°C ± 3°C A1a 79 €

Y0000494 Ruscogenins 1 10 mg 1 See leaflet 1847 +5°C ± 3°C A1A 79 €

Y0000105 Rutoside trihydrate 3 100 mg 1 See leaflet CœŸH–ÐOŒÿ 1795,1874,2184, 2427,2639

+5°C ± 3°C A1A 79 €

S0040000 Saccharin 1 30 mg 1 0947 +5°C ± 3°C A1A 79 €

S0050000 Saccharin sodium 2 50 mg 1 Batch 1 is valid until 31 July 2017 0787 +5°C ± 3°C A1A 79 €

New Y0001932 Saikosaponin A 1 25 mg 1 See leaflet C÷œHÿ‡OŒ– 2562 +5°C ± 3°C A1a 79 €

S0100000 Salbutamol 2 50 mg 1 0529,1033 +5°C ± 3°C A1A 79 €

Y0000030 Salbutamol impurity B 6 5 mg 1 (1RS)-2-[(1,1-dimethylethyl)amino]-1-(4-hydroxyphenyl)ethanol ; Batch 5 is valid until 31 December 2017

0529 +5°C ± 3°C A1A 79 €

Y0000071 Salbutamol impurity D 6 10 mg 1 5-[(1RS)-2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-2-hydroxybenzaldehyde

0529,0687 +5°C ± 3°C A1A 79 €

Y0000031 Salbutamol impurity F 8 10 mg 1 See leaflet; 1,1'-[oxybis[methylene(4-hydroxy-1,3-phenylene)]]bis[2-[(1,1- dimethylethyl)amino]ethanol] ; Batch 5 is valid until 31 May 2017 Batch 6 is valid until 31 January 2018

0529,0687 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 88For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000034 Salbutamol impurity G 4 10 mg 1 See leaflet CœÐHœ—NO–; 2-[benzyl(1,1-dimethylethyl)amino]-1-[4-hydroxy-3-(hydroxymethyl)phenyl]ethanone ; Batch 3 is valid until 31 March 2017

0529 +5°C ± 3°C A1A 79 €

Y0000032 Salbutamol impurity I 4 0.006 mg 1 (1RS)-2-[(1,1-dimethylethyl)amino]-1-[4-(benzyloxy)-3-(hydroxymethyl)phenyl]ethanol

0529 +5°C ± 3°C A1A 79 €

Y0001186 Salbutamol impurity J 3 0.00045 mg

1 2-[(1,1-dimethylethyl)amino]-1-[4-hydroxy-3-(hydroxymethyl)phenyl]ethanone (salbutamone) ; Batch 2 is valid until 31 July 2017

0687 +5°C ± 3°C A1A 79 €

S0150000 Salbutamol sulfate 3 50 mg 1 0687 +5°C ± 3°C A1A 79 €

Y0001288 Salbutamol sulfate for system suitability 3 10 mg 1 Batch 2 is valid until 30 April 2018 0687 +5°C ± 3°C A1A 79 €

Y0000669 Salicin 1 50 mg 1 See leaflet CŒ–HŒ‡OŸ 2312,1583 +5°C ± 3°C A1A 79 €

New S0200000 Salicylic acid 3 100 mg 1 Batch 2 is valid until 31 May 2018 0366,1185 +5°C ± 3°C A1A 79 €

Y0000405 Salicylic acid impurity B 2 10 mg 1 4-hydroxyisophthalic acid 0366 +5°C ± 3°C A1A 79 €

Y0000422 Salmeterol xinafoate 3 70 mg 1 see leaflet ; Batch 2 is valid until 31 August 2017 1765 +5°C ± 3°C A1A 79 €

Y0001625 Salmeterol xinafoate for peak identification 1 15 mg 1 1765 +5°C ± 3°C A1A 79 €

Y0000423 Salmeterol xinafoate for system suitability 2 25 mg 1 1765 +5°C ± 3°C A1A 79 €

Y0001559 Salvianolic acid B 2 15 mg 1 See leaflet C–ÿH–ÐOŒÿ 2663 -20°C ± 5°C

C1A 79 €

Y0001052 Santonin 1 20 mg 1 See leaflet 1391,1809 +5°C ± 3°C A1A 79 €

Y0001049 Saquinavir mesilate 1 70 mg 1 See leaflet C–„H—÷NÿO‡S 2267 +5°C ± 3°C A1A 79 €

Y0001056 Saquinavir for system suitability 1 0.3033 mg 1 2267 +5°C ± 3°C A1A 79 €

Y0001483 Saw palmetto extract HRS 1 8000 mg 1 1848, 2579 Room temp. +20°C

A1a 79 €

Y0001818 Schisandrin 1 15 mg 1 See leaflet Cœ÷H–œOŸ 2428 +5°C ± 3°C A1a 79 €

Y0000814 Selamectin 2 120 mg 1 see leaflet 2268 +5°C ± 3°C A1A 79 €

Y0001734 Selamectin for peak identification 1 5 mg 1 2268 +5°C ± 3°C A1A 79 €

Y0001661 Selamectin impurity B 1 0.005 mg 1 (2aE,2'S,4E,5'S,6S,6'R,7S,8E,11R,15S,17aR,20Z,20aR,20bS)-6'-

cyclohexyl-7-[(2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl)oxy]-20b-hydroxy-20-(hydroxyimino)-5',6,8,19-tetramethyl-5',6,6',7,10,11,14,15,17a,20,20a,20b-dodecahydrospiro[2H,17H-11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-17-one ((5Z,25R)-25-

cyclohexyl-4'-O-de(2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl)-5-demethoxy-25-de(1-methylpropyl)-5-(hydroxyimino)avermectin A1a)

2268 +5°C ± 3°C A1A 79 €

S0360000 Selegiline hydrochloride 2 50 mg 2 Batch 1 is valid until 30 November 2017 1260 +5°C ± 3°C A1A 79 €

S0360090 (RS)-Selegiline hydrochloride 2 25 mg 1 1260 +5°C ± 3°C A1A 79 €

S0400000 Senna extract 1 50 mg 1 0206,0207,0208, 1261

-20°C ± 5°C

C1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 89For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

S0450000 Serine 2 50 mg 1 Batch 1 is valid until 31 December 2017 0788 +5°C ± 3°C A1A 79 €

S0460000 Sertaconazole nitrate 2 125 mg 1 1148 +5°C ± 3°C A1A 79 €

Y0000828 Sertraline hydrochloride 3 200 mg 1 See leaflet 1705 +5°C ± 3°C A1A 79 €

Y0001285 Sertraline impurity E 1 15 mg 1 (2R)-hydroxyphenylacetic acid ((R)-mandelic acid) 1705 +5°C ± 3°C A1A 79 €

Y0000866 Sertraline for peak identification 5 5.4 mg 1 Batch 4 is valid until 31 March 2017 1705 +5°C ± 3°C A1A 79 €

Y0000867 Sertraline for system suitability 3 6.2 mg 1 1705 +5°C ± 3°C A1A 79 €

Y0000371 Sestamibi labelling kit 3 22 mg 1 1926 +5°C ± 3°C A1A 79 €

Y0001046 Sevoflurane 2 1 mL 1 2269 +5°C ± 3°C B1A 79 €

New Y0001993 Sevoflurane for system suitability 1 1 mL 1 2269 +5°C ± 3°C B1A 79 €

Y0001578 Sildenafil citrate 1 100 mg 1 See leaflet 2270 +5°C ± 3°C A1A 79 €

Y0001891 Sildenafil for peak identification 1 15 mg 1 2270 +5°C ± 3°C A1a 79 €

Y0001579 Sildenafil impurity A 1 10 mg 1 5-[2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl]-1-methyl-3-(2-methylpropyl)-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one

2270 +5°C ± 3°C A1a 79 €

S0500000 Silicone elastomer 3 2000 mg 1 30109 +5°C ± 3°C A1A 79 €

S0600000 Silicone oil 2 1 mL 1 30108 +5°C ± 3°C A1A 79 €

S0650000 Simvastatin 6 200 mg 1 See leaflet ; Batch 5 is valid until 30 November 2017 1563 -20°C ± 5°C

C1A 79 €

Y0001066 Simvastatin for peak identification 1 10 mg 1 1563 -20°C ± 5°C

C1a 79 €

Y0001208 Sinomenine 1 20 mg 1 See leaflet CŒ„Hœ–NO÷ 2450 +5°C ± 3°C A1A 79 €

S0660000 Sisomicin sulfate 3 60 mg 1 See leaflet C–‡H‡÷NŒÐO–÷S— 0331,1351 -20°C ± 5°C

C1a 79 €

Y0001615 Beta-sitosterol 1 25 mg 1 See leaflet Cœ„H—ÐO 2579 -20°C ± 5°C

C1A 79 €

Y0001812 Sitagliptin phosphate monohydrate 1 160 mg 1 See leaflet CŒÿHŒ‡FÿN—O—, HœO 2778,2927 +5°C ± 3°C A1a 79 €

Y0001811 Sitagliptin containing impurity A 1 15 mg 1 2778 +5°C ± 3°C A1a 79 €

Y0001727 Sodium alendronate trihydrate 2 150 mg 1 see leaflet C÷HŒœNNaOŸPœ,3HœO 1564 +5°C ± 3°C A1A 79 €

Y0001678 Sodium alendronate for system suitability 1 5 mg 1 1564 +5°C ± 3°C A1A 79 €

S0695000 Sodium amidotrizoate 1 125 mg 1 1150 +5°C ± 3°C A1A 79 €

Y0001669 Sodium aminosalicylate dihydrate 1 10 mg 1 1993 +5°C ± 3°C A1A 79 €

Y0000300 Sodium aminosalicylate dihydrate - reference spectrum

1 n/a 1 L 79 €

Y0001816 Sodium Aminosalicylate dihydrate for equipment qualification

1 5000 mg 1 20232,20512,20532

+5°C ± 3°C A1a 79 €

Y0000039 Sodium ascorbate 1 50 mg 1 1791 +5°C ± 3°C A1A 79 €

S0700000 Sodium calcium edetate 1 100 mg 1 0231 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 90For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

S0710000 Sodium cetostearyl sulfate 1 100 mg 1 0847 +5°C ± 3°C A1A 79 €

S0750000 Sodium cromoglicate 2 10 mg 1 0562 +5°C ± 3°C A1A 79 €

Y0001300 Sodium cromoglicate for system suitability 1 20 mg 1 0562 +5°C ± 3°C A1A 79 €

S0760000 Sodium cyclamate 2 100 mg 1 0774 +5°C ± 3°C A1A 79 €

Y0001410 Sodium fusidate 1 10 mg 1 0848 +5°C ± 3°C B1A 79 €

S0780000 Sodium hyaluronate 2 300 mg 1 0912 1472

+5°C ± 3°C A1A 79 €

S0781000 Sodium hyaluronate - reference spectrum 1 n/a 1 1472 L 79 €

Y0001468 Sodium iodohippurate 1 15 mg 1 2352 +5°C ± 3°C A1A 79 €

Y0000620 Sodium laurilsulfate 1 40 mg 1 0802 +5°C ± 3°C A1A 79 €

Y0001772 Sodium lauroylsarcosinate 1 550 mg 1 2542 +5°C ± 3°C A1a 79 €

Y0000808 Sodium phenylbutyrate 1 5 mg 1 2183 +5°C ± 3°C A1A 79 €

Y0000809 Sodium phenylbutyrate impurity C 1 10 mg 1 4-cyclohexylbutanoic acid 2183 +5°C ± 3°C A1A 79 €

S0785000 Sodium picosulfate 2 50 mg 1 1031 +5°C ± 3°C A1a 79 €

Y0000210 Sodium polystyrene sulfonate - reference spectrum

1 n/a 1 1909 L 79 €

Y0000268 Sodium propionate - reference spectrum 1 n/a 1 2041 L 79 €

S0800000 Sodium salicylate 1 100 mg 1 0413 +5°C ± 3°C A1A 79 €

S0808000 Sodium stearyl fumarate 1 50 mg 1 1567 +5°C ± 3°C A1A 79 €

S0808060 Sodium stearyl maleate 2 10 mg 1 1567 +5°C ± 3°C A1A 79 €

S0900000 Sodium taurocholate BRP 2 10000 mg 1 0350 +5°C ± 3°C A1a 79 €

S0930000 Sodium valproate 5 50 mg 1 0678 +5°C ± 3°C A1A 79 €

Y0001743 Solifenacin for system suitability 1 2.52 mg 1 2779 +5°C ± 3°C A1a 79 €

Y0001763 Solifenacin succinate 1 5 mg 1 2779 +5°C ± 3°C B1a 79 €

S0945000 Somatostatin 6 2.09 mg 1 See leaflet 0949 -20°C ± 5°C

C1A 90 €

S0947000 Somatropin 3 55 mg 1 See leaflet 0950, 0951,0952,

2370

-20°C ± 5°C

C1A 150 €

Y0000711 Somatropin/desamidosomatropin resolution mixture

1 33 mg 1 See leaflet 0950,0951,0952

-20°C ± 5°C

C1A 150 €

S0950000 Sorbic acid 2 10 mg 1 0592 +5°C ± 3°C A1A 79 €

New Y0000385 1,4-Sorbitan 3 50 mg 1 See leaflet CÿHŒœO— ; Batch 2 is valid until 30 June 2018 2048 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 91For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

S1000000 Sorbitol 4 1250 mg 1 See leaflet 0435,0436,0437,

1235,1236,1337,

1381,1531,2048

+5°C ± 3°C A1A 79 €

Y0000114 Sotalol hydrochloride 1 25 mg 1 2004 +5°C ± 3°C A1A 79 €

Y0000115 Sotalol impurity B 2 20 mg 1 N-[4-[[(1-methylethyl)amino]acetyl]phenyl]methanesulfonamide 2004 +5°C ± 3°C A1A 79 €

Y0001011 Spanish sage oil for peak identification 2 250 mg 1 1849 +5°C ± 3°C A1A 79 €

Y0000549 Spectinomycin for system suitability 1 20 mg 1 1152, 1658 -20°C ± 5°C

C1a 79 €

Y0000597 Spectinomycin hydrochloride 2 100 mg 1 See leaflet 1152, 1658 -20°C ± 5°C

C1a 79 €

Y0000655 Spectinomycin sulfate tetrahydrate 1 10 mg 1 1658 -20°C ± 5°C

C1A 79 €

Y0001126 Spike lavender oil 1 400 µl 1 2419 +5°C ± 3°C A1A 79 €

S1100000 Spiramycin 6 200 mg 1 See leaflet 0179,0293,1982,20702

-20°C ± 5°C

C1a 79 €

Y0000381 Spirapril hydrochloride monohydrate 1 60 mg 1 See leaflet CœœH–ŒClNœO—Sœ 1766 +5°C ± 3°C A1A 79 €

Y0000332 Spirapril for system suitability 1 15 mg 1 1766 +5°C ± 3°C A1A 79 €

S1200000 Spironolactone 4 160 mg 1 See leaflet; Spironolactone CRS 2 is suitable for monograph 01/2008:0688 only.

0688 +5°C ± 3°C A1A 79 €

Y0001295 Spironolactone for system suitability 2 2.057 mg 1 0688 +5°C ± 3°C A1A 79 €

Y0000185 Squalane 1 250 µl 1 See leaflet C–ÐHÿœ 1630 +5°C ± 3°C A1A 79 €

Y0001050 St. John's wort dry extract 2 500 mg 1 See leaflet 1874 -20°C ± 5°C

C1A 79 €

S1250000 Stanozolol 2 50 mg 1 1568 +5°C ± 3°C A1A 79 €

S1250010 Stanozolol impurity A 1 10 mg 1 17β-hydroxy-17-methyl-5α-androstan-3-one (mestanolone) 1568 +5°C ± 3°C A1A 79 €

Y0001420 Stanozolol impurity B 1 10 mg 1 17β-hydroxy-2-(hydroxymethylene)-17-methyl-5α-androstan-3-one (oxymetholone)

1568 +5°C ± 3°C A1A 79 €

S1300000 Starch BRP 4 50000 mg 1 0350 +5°C ± 3°C A1a 79 €

Y0000408 Stavudine 1 100 mg 1 see leaflet 2130 +5°C ± 3°C A1A 79 €

Y0001683 Stavudine impurity I 1 5 mg 1 1-(5-O-benzoyl-2,3-dideoxy-β-d-glycero-pent-2-enofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione

2130 +5°C ± 3°C A1A 79 €

Y0000421 Stavudine for system suitability 1 10 mg 1 2130 +5°C ± 3°C A1A 79 €

S1340000 Stearic acid 4 100 mg 1 Plastic additive 19 ; Batch 3 is valid until 30 November 2017 0229,0882,1474, 1663, 2058, 30103, 30105, 30106,30107

+5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 92For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

S1350000 Stearyl alcohol 3 250 mg 1 See leaflet CŒ‡H–‡O ; Batch 2 is valid until 28 February 2018 0702,0753,0801,

0802,0847,0969,

1123,1340,1411

+5°C ± 3°C A1A 79 €

Y0000868 Streptokinase for system suitability 1 30 µl 1 0356 -20°C ± 5°C

C1A 79 €

S1400000 Streptomycin sulfate 4 100 mg 1 See leaflet 0032,0033,0053, 0485,20702

-20°C ± 5°C

C1a 79 €

Y0001195 Strychnine 1 40 mg 1 see leaflet 2513,2514 +5°C ± 3°C A1A 79 €

Y0001324 Sucralfate 1 10 mg 1 1796 +5°C ± 3°C A1A 79 €

Y0001344 Sucralose 1 550 mg 1 See leaflet CŒœHŒ„Cl–O‡ 2368 +5°C ± 3°C A1A 79 €

Y0001342 Sucralose impurity B 3 0.5 mg 1 1,6-dichloro-1,6-dideoxy-β-D-fructofuranosyl

6-chloro-6-deoxy-α-D-glucopyranoside (1',6,6'-trichloro- 1',6,6'-trideoxysucrose) ; Batch 2 is valid until 30 April 2017

2368 +5°C ± 3°C A1A 79 €

S1600000 Sucrose 1 100 mg 1 This reference standard batch 1 can only be used for monographs 01/2016:0204, 01/2017:2319, 01/2017:2318 and 01/2017:1570. ; Batch 1 is valid until 31 March 2018

0204,1570,2318, 2319

+5°C ± 3°C A1A 79 €

S1608100 Sufentanil - reference spectrum 1 n/a 1 1569 L 79 €

S1609000 Sufentanil citrate - reference spectrum 1 n/a 1 1269 L 79 €

Y0000528 Sulbactam 2 150 mg 1 See leaflet 2209, 2211, 2212

-20°C ± 5°C

C1a 79 €

Y0000529 Sulbactam sodium 1 10 mg 1 See leaflet 2209 +5°C ± 3°C A1A 79 €

Y0000550 Sulbactam for peak identification 2 20 mg 1 Batch 1 is valid until 31 January 2018 2209 +5°C ± 3°C A1a 79 €

S1700000 Sulfacetamide sodium 1 50 mg 1 0107,0295 +5°C ± 3°C A1A 79 €

S1800000 Sulfadiazine 1 100 mg 1 0294 +5°C ± 3°C A1A 79 €

Y0001480 Sulfadiazine for identification of impurity F 1 15 mg 1 0294 +5°C ± 3°C A1A 79 €

Y0001469 Sulfadiazine impurity A 1 20 mg 1 pyrimidin-2-amine 0294 +5°C ± 3°C A1a 79 €

Y0001677 Sulfadimethoxine 1 60 mg 1 see leaflet 2741, 2745 +5°C ± 3°C A1A 79 €

Y0001679 Sulfadimethoxine for peak identification 1 10 mg 1 2741, 2745 +5°C ± 3°C A1A 79 €

S1900000 Sulfadimidine 1 100 mg 1 0295 +5°C ± 3°C A1A 79 €

Y0001495 Sulfadimidine for peak identification 1 50 mg 1 0295 +5°C ± 3°C A1A 79 €

S1950000 Sulfadoxine 2 50 mg 1 0740 +5°C ± 3°C A1A 79 €

S1975000 Sulfafurazole 1 100 mg 1 0741 +5°C ± 3°C A1A 79 €

S1975600 Sulfaguanidine 2 60 mg 1 0295,1476 +5°C ± 3°C A1A 79 €

S2000000 Sulfamerazine 1 100 mg 1 0358,1571 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 93For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

S2050000 Sulfamethizole 1 100 mg 1 0637 +5°C ± 3°C A1A 79 €

S2100000 Sulfamethoxazole 1 50 mg 1 0108 +5°C ± 3°C A1A 79 €

Y0000412 Sulfamethoxazole impurity A 1 5 mg 1 N-[4-[(5-methylisoxazol-3-yl)sulfamoyl]phenyl]acetamide 0108 +5°C ± 3°C A1A 79 €

Y0000413 Sulfamethoxazole impurity F 3 5 mg 1 4-amino-N-(3-methylisoxazol-5-yl)benzenesulfonamide 0108 +5°C ± 3°C A1A 79 €

S2150000 Sulfamethoxypyridazine 1 50 mg 1 0638 +5°C ± 3°C A1A 79 €

S2151000 Sulfanilamide 2 100 mg 1 1571 +5°C ± 3°C A1A 79 €

S2159100 Sulfapyridine 1 20 mg 1 0863 +5°C ± 3°C A1A 79 €

New S2155000 Sulfasalazine 5 320 mg 2 See leaflet CŒ‡HŒ÷N÷O—S ; Batch 4 is valid until 31 July 2018 0863,1457 +5°C ± 3°C A1A 79 €

S2155010 Sulfasalazine derivative for resolution 2 20 mg 1 2-hydroxy-5-[[4-[[(6-methylpyridin-2-yl)amino]-sulfonyl]phenyl]azo]benzoic acid ; Batch 1 is valid until 28 February 2018

0863 +5°C ± 3°C A1A 79 €

S2158000 Sulfathiazole 2 100 mg 1 0742 +5°C ± 3°C A1A 79 €

S2159000 Sulfinpyrazone 1 30 mg 1 0790 +5°C ± 3°C A1A 79 €

S2159010 Sulfinpyrazone impurity A 3 20 mg 1 1,2-diphenyl-4-[2-(phenylsulfonyl)ethyl]pyrazolidine-3,5-dione 0790 +5°C ± 3°C A1A 79 €

S2159015 Sulfinpyrazone impurity B 3 20 mg 1 1,2-diphenyl-4-[2-(phenylsulfanyl)ethyl]pyrazolidine-3,5-dione 0790 +5°C ± 3°C A1A 79 €

Y0001238 Sulfinpyrazone for system suitability 1 0.5 mg 1 0790 +5°C ± 3°C A1A 79 €

S2180000 Sulindac 3 50 mg 2 See leaflet CœÐHŒŸFO–S; Contains 0.3% m/m of E-isomer 0864 +5°C ± 3°C A1A 79 €

S2190000 Sulpiride 4 100 mg 1 1045,1348 +5°C ± 3°C A1A 79 €

S2191000 Sulpiride impurity A 4 20 mg 1 [(2RS)-1-ethylpyrrolidin-2-yl]methanamine 1045,1490 +5°C ± 3°C A1A 79 €

S2192000 Sulpiride impurity B 3 10 mg 1 methyl 2-methoxy-5-sulfamoylbenzoate 1045 +5°C ± 3°C A1A 79 €

Y0000530 Sultamicillin 1 10 mg 1 2211 +5°C ± 3°C A1A 79 €

Y0000532 Sultamicillin for peak identification 1 10 mg 1 2211 +5°C ± 3°C A1A 79 €

Y0000531 Sultamicillin tosilate 3 200 mg 1 See leaflet 2211,2212 +5°C ± 3°C A1A 79 €

Y0000022 Sumatriptan succinate 1 50 mg 1 See leaflet CŒ‡HœŸN–OÿS 1573 -20°C ± 5°C

C1A 79 €

Y0000026 Sumatriptan impurity mixture 8 3 mg 1 1573 -20°C ± 5°C

C1a 79 €

Y0000027 Sumatriptan for system suitability 6 10 mg 1 Batch 5 is valid until 30 June 2017 1573 -20°C ± 5°C

C1a 79 €

S2200000 Suxamethonium chloride 1 1000 mg 1 0248 +5°C ± 3°C A1A 79 €

Y0001778 Rabeprazole for system suitability 1 15 mg 1 2331,2868 +5°C ± 3°C A1a 79 €

S2400000 Suxibuzone 1 50 mg 1 1574 +5°C ± 3°C A1A 79 €

S2400004 Suxibuzone impurity B 1 10 mg 1 (4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methyl ethyl butanedioate

1574 +5°C ± 3°C A1A 79 €

S2400006 Suxibuzone impurity C 1 10 mg 1 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-1,2-dihydro-4H-pyrazole-3,5-dione

1574 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 94For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

S5000001 Swine erysipelas bacteria, serotyp 1 (for vaccines - vet. use) BRP

1 1 mg 1 See leaflet See leaflet,0064

+5°C ± 3°C B1B UN2814 90 €

S5000002 Swine erysipelas bacteria, serotyp 2 (for vaccines - vet. use) BRP

1 1 mg 1 See leaflet See leaflet,0064

+5°C ± 3°C B1B UN2814 90 €

Y0001854 Tacalcitol monohydrate 1 15 mg 1 see leaflet CœŸH÷÷O–,HœO 2272 -20°C ± 5°C

C1a 300 €

Y0001610 Tacalcitol for system suitability 1 0.025 mg 1 2272 -20°C ± 5°C

C1A 79 €

Y0001824 Tacalcitol impurity A 1 0.001 mg 1 (5E,7E)-(24R)-9,10-secocholesta-5,7,10(19)-triene-1α,3β,24-triol (trans-tacalcitol)

2272 -20°C ± 5°C

C1a 79 €

Y0001926 Tacrolimus monohydrate 1 80 mg 1 See leaflet C÷÷Hÿ„NOŒœ*HœO 2244 +5°C ± 3°C A1a 79 €

Y0001933 Tacrolimus for system suitability 1 10 mg 1 2244 +5°C ± 3°C A1a 79 €

Y0001910 Tacalcitol monohydrate - reference spectrum 1 1 1 2272 L 79 €

Y0001417 Tadalafil 2 200 mg 1 see leaflet 2606 +5°C ± 3°C A1A 79 €

T0010000 Talampicillin hydrochloride 1 50 mg 1 0808,0852 +5°C ± 3°C A1A 79 €

T0014000 Tamoxifen citrate 2 80 mg 1 1046 +5°C ± 3°C A1A 79 €

T0015000 Tamoxifen citrate for performance test 3 10 mg 1 1046 +5°C ± 3°C A1A 79 €

Y0000650 Tamsulosin hydrochloride 1 10 mg 1 2131 +5°C ± 3°C A1A 79 €

Y0000651 Tamsulosin impurity D 2 10 mg 1 2-methoxy-5-[(2R)-2-[[2-(2-methoxyphenoxy)ethyl]amino]propyl]benzenesulfonamide

2131 +5°C ± 3°C A1A 79 €

Y0000652 Tamsulosin impurity H 2 10 mg 1 (2R)-N-[2-(2-ethoxyphenoxy)ethyl]-1-(4-methoxyphenyl)propan-2-amine

2131 +5°C ± 3°C A1A 79 €

Y0000653 Tamsulosin racemate 2 15 mg 1 2131 +5°C ± 3°C A1A 79 €

Y0001560 Tanshinone IIa 1 15 mg 1 See leaflet CŒ„HŒ‡O– 2663 +5°C ± 3°C A1A 79 €

Y0001840 Taxifolin 1 15 mg 1 See leaflet CŒ—HŒœOŸ 2726 -20°C ± 5°C

C1a 79 €

Y0001102 Teicoplanin 2 50 mg 1 see leaflet 2358 -20°C ± 5°C

C1a 79 €

Y0001047 Teicoplanin for identification 1 40 mg 1 2358 -20°C ± 5°C

C1a 79 €

Y0000648 Telmisartan 1 30 mg 1 2154 +5°C ± 3°C A1A 79 €

Y0000649 Telmisartan for peak identification 3 10 mg 1 2154 +5°C ± 3°C A1A 79 €

Y0001003 Telmisartan for system suitability 4 0.26 mg 1 2154 +5°C ± 3°C A1A 79 €

T0040000 Temazepam - * psy 1 50 mg 1 0954 +5°C ± 3°C A2A 79 €

Y0000344 Temazepam impurity C 1 5 mg 1 (3RS)-7-chloro-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl acetate

0954 +5°C ± 3°C A1A 79 €

Y0000345 Temazepam impurity D 1 5 mg 1 (3RS)-7-chloro-3-methoxy-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one

0954 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 95For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000346 Temazepam impurity F 2 10 mg 1 (5RS)-7-chloro-1-methyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione

0954 +5°C ± 3°C A1A 79 €

Y0000347 Temazepam impurity G 1 5 mg 1 (5RS)-7-chloro-1,4-dimethyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione

0954 +5°C ± 3°C A1A 79 €

Y0001827 Temozolomide 1 70 mg 1 See leaflet CÿHÿNÿOœ 2780 +5°C ± 3°C A1a 79 €

Y0001960 Temozolomide for peak identification 1 10 mg 1 2780 +5°C ± 3°C A1a 79 €

T0040800 Tenoxicam 2 100 mg 1 1156 +5°C ± 3°C A1A 79 €

New Y0001114 Tenoxicam impurity mixture 2 0.0042 mg 1 Batch 1 is valid until 31 July 2018 1156 +5°C ± 3°C A1A 79 €

Y0000621 Terazosin hydrochloride dihydrate 1 40 mg 1 2021 +5°C ± 3°C A1A 79 €

Y0000622 Terazosin impurity A 1 10 mg 1 2-chloro-6,7-dimethoxyquinazolin-4-amine 2021 +5°C ± 3°C A1A 79 €

Y0000665 Terazosin impurity E 1 10 mg 1 2,2'-(piperazine-1,4-diyl)bis(6,7-dimethoxyquinazolin-4-amine) 2021 +5°C ± 3°C A1A 79 €

Y0000623 Terazosin impurity L 1 10 mg 1 1-(furan-2-ylcarbonyl)piperazine 2021 +5°C ± 3°C A1A 79 €

Y0000624 Terazosin impurity N 1 10 mg 1 See leaflet C„HŒÿNœOœ; 1-[[(2RS)-tetrahydrofuran-2-yl]carbonyl]piperazine

2021 +5°C ± 3°C A1A 79 €

Y0000666 Terazosin for system suitability 1 0.5 mg 1 2021 +5°C ± 3°C A1a 79 €

Y0000535 Terbinafine hydrochloride 1 10 mg 1 1734 +5°C ± 3°C A1A 79 €

Y0001143 Terbinafine for system suitability 2 10 mg 1 1734 +5°C ± 3°C A1a 79 €

T0050000 Terbutaline sulfate 2 100 mg 1 0690, 2451 +5°C ± 3°C A1A 79 €

T0050015 Terbutaline impurity C 4 15 mg 1 1-(3,5-dihydroxyphenyl)-2-[(1,1-dimethylethyl)amino]ethanone 0690 +5°C ± 3°C A1a 79 €

T0060000 Terconazole 2 250 mg 1 1270 +5°C ± 3°C A1A 79 €

T0071000 Terfenadine 1 100 mg 1 0955 +5°C ± 3°C A1A 79 €

T0080000 Terfenadine impurity A 2 20 mg 1 1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(hydroxydiphenylmethyl) piperidin-1-yl]butan-1-one

0955 +5°C ± 3°C A1A 79 €

Y0001916 Teriparatide 1 1 mg 1 see leaflet ; Batch 1 is valid until 29 January 2018 2829 -20°C ± 5°C

C1a 79 €

Y0001895 Teriparatide for system suitability 1 1.3 mg 1 2829 -20°C ± 5°C

C1a 79 €

Y0001897 Terlipressin 1 1 mg 1 2646 -20°C ± 5°C

C1a 79 €

Y0001898 Terlipressin for NMR identification 1 2.9 mg 1 2646 -20°C ± 5°C

C1a 79 €

Y0001899 Terlipressin impurity mixture 1 0.03 mg 1 2646 -20°C ± 5°C

C1a 79 €

T0100000 Testosterone 3 30 mg 1 1373, 1048 +5°C ± 3°C A1A 79 €

Y0000342 Testosterone for impurity D identification 2 20 mg 1 1373 +5°C ± 3°C A1A 79 €

Y0000343 Testosterone for system suitability 3 20 mg 1 1373 +5°C ± 3°C A1A 79 €

T0210000 Testosterone caproate 1 50 mg 1 1048 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 96For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

T0240000 Testosterone decanoate 3 50 mg 1 See leaflet Cœ„H÷ÿO– ; Batch 2 is valid until 31 December 2017 1048, 1736 -20°C ± 5°C

C1A 79 €

Y0000696 Testosterone decanoate for system suitability 1 0.4 mg 1 1736 -20°C ± 5°C

C1A 79 €

T0250000 Testosterone enantate 2 40 mg 1 1048 -20°C ± 5°C

C1A 79 €

Y0001313 Testosterone enantate impurity H 1 10 mg 1 androst-5-ene-3β,17β-diyl diheptanoate 1048 -20°C ± 5°C

C1A 79 €

Y0001312 Testosterone enantate for peak identification 1 10 mg 1 1048 -20°C ± 5°C

C1A 79 €

Y0001317 Testosterone enantate for system suitability 1 2 mg 1 1048 -20°C ± 5°C

C1A 79 €

T0260000 Testosterone isocaproate 2 50 mg 1 See leaflet Cœ—H–‡O– 1048,1737 +5°C ± 3°C A1A 79 €

Y0000716 Testosterone isocaproate for system suitability 1 5 mg 1 1737 +5°C ± 3°C A1A 79 €

T0300000 Testosterone propionate 2 60 mg 1 See leaflet CœœH–œO– 0297 +5°C ± 3°C A1A 79 €

Y0001409 Testosterone propionate for system suitability 2 10 mg 1 Batch 1 is valid until 30 September 2017 0297 +5°C ± 3°C A1A 79 €

T0400000 Tetanus vaccine (adsorbed) 3 30 mg 1 See leaflet See leaflet,20708

-20°C ± 5°C

C1A 90 €

T0500000 Tetracaine hydrochloride 1 100 mg 1 0057 +5°C ± 3°C A1A 79 €

Y0001002 Tetracaine for system suitability 2 2 mg 1 Batch 1 is valid until 31 January 2018 0057 +5°C ± 3°C A1A 79 €

T0550000 Tetracosactide 3 20.4 mg 2 See leaflet CŒ–ÿHœŒÐN÷ÐO–ŒS 0644 -20°C ± 5°C

C1a 79 €

T0600000 Tetracycline hydrochloride 3 100 mg 1 See leaflet CœœHœ—ClNœO‡ 0173, 0210,0211,165

4

+5°C ± 3°C A1A 79 €

Y0001165 Tetrandrine 1 20 mg 1 See leaflet C–‡H÷œNœOÿ 2478 +5°C ± 3°C A1A 79 €

Y0001087 Tetra-O-acetyl-mannose triflate 2 80 mg 1 See leaflet CŒ—HŒ„F–OŒœS ; Batch 1 is valid until 30 November 2017 2294 -20°C ± 5°C

C1A 79 €

Y0000015 Tetrazepam - reference spectrum 1 n/a 1 1738 L 79 €

Y0000008 Tetrazepam impurity C 1 20 mg 1 7-chloro-5-cyclohexyl-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one

1738 +5°C ± 3°C A1A 79 €

Y0000460 Tetryzoline hydrochloride 1 10 mg 1 2101 +5°C ± 3°C A1A 79 €

Y0000723 Thebaine - * narc 1 15 mg 1 see leaflet 0777,1839,1840,1841

+5°C ± 3°C A2A 79 €

T0700000 Theobromine 2 25 mg 1 0298 +5°C ± 3°C A1A 79 €

T0800000 Theophylline 1 100 mg 1 0300,0301 +5°C ± 3°C A1A 79 €

Y0000294 Theophylline - reference spectrum 1 n/a 1 0299,0302 L 79 €

Y0000336 Thiamazole 1 125 mg 1 0884,1706 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 97For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000372 Thiamazole impurity A 1 15 mg 1 2,2-dimethoxy-N-methylethanamine 1706 +5°C ± 3°C A1A 79 €

Y0000373 Thiamazole impurity C 4 20 mg 1 1-methyl-2-(methylsulfanyl)-1H-imidazole ; Batch 3 is valid until 31 March 2017

1706 +5°C ± 3°C A1a 79 €

Y0000467 Thiamine hydrochloride 2 10 mg 1 0303 +5°C ± 3°C A1A 79 €

Y0001749 Thiamine for system suitability 2 0.5 mg 1 Batch 1 is valid until 31 December 2017 0303,0531 +5°C ± 3°C A1a 79 €

Y0001758 Thiamine nitrate 1 15 mg 1 0531 +5°C ± 3°C A1a 79 €

T1100000 Thiamphenicol 1 125 mg 1 0109 +5°C ± 3°C A1A 79 €

Y0001789 Thiocolchicoside hydrate 1 60 mg 1 See leaflet CœŸH––NOŒÐS 2814,2896 +5°C ± 3°C A1a 79 €

Y0001790 Thiocolchicoside crystallised from ethanol 1 10 mg 1 2896 +5°C ± 3°C A1a 79 €

Y0001791 Thiocolchicoside for system suitability 1 10 mg 1 2814,2896 +5°C ± 3°C A1a 79 €

Y0000546 Thioctic acid 2 110 mg 1 See leaflet 1648 +5°C ± 3°C A1A 79 €

Y0000545 Thioctic acid containing impurity B 2 25 mg 1 1648 +5°C ± 3°C A1A 79 €

Y0000592 Thioctic acid for system suitability 2 15 mg 1 1648 +5°C ± 3°C A1A 79 €

Y0000109 Thiomersal 1 30 mg 1 1625 +5°C ± 3°C A1A 79 €

T1200000 Thiopental 1 500 mg 1 0212 +5°C ± 3°C A1A 79 €

Y0001478 Thiopental for system suitability 2 10 mg 1 Batch 1 is valid until 31 December 2017 0212 +5°C ± 3°C A1A 79 €

Y0000704 Thioridazine 1 10 mg 1 2005 +5°C ± 3°C A1A 79 €

T1300000 Thioridazine hydrochloride 1 100 mg 1 0586 +5°C ± 3°C A1A 79 €

Y0000541 Thioridazine for system suitability 1 0.21 mg 1 0586, 2005 +5°C ± 3°C A1A 79 €

T1305100 Thioxanthene 3 20 mg 1 1347 +5°C ± 3°C A1A 79 €

T1305000 Thioxanthone 2 10 mg 1 1347 +5°C ± 3°C A1A 79 €

T1340000 Threonine 1 50 mg 1 1049 +5°C ± 3°C A1A 79 €

T1350000 Thymol 2 50 mg 1 0791 +5°C ± 3°C A1A 79 €

T1410000 Tiabendazole 1 50 mg 1 0866 +5°C ± 3°C A1A 79 €

Y0000379 Tiamulin - reference spectrum 1 n/a 1 1660 L 79 €

Y0000333 Tiamulin hydrogen fumarate 2 500 mg 1 See leaflet C–œH—ŒNO‡S 1659,1660 +5°C ± 3°C A1A 79 €

Y0000414 Tiamulin for peak identification 2 10 mg 1 1659 +5°C ± 3°C A1A 79 €

Y0000151 Tianeptine sodium - reference spectrum 1 n/a 1 2022 L 79 €

Y0000153 Tianeptine impurity A 1 30 mg 1 ethyl 7-bromoheptanoate 2022 +5°C ± 3°C A1A 79 €

Y0000152 Sodium Tianeptine for system suitability 1 30 mg 1 2022 +5°C ± 3°C A1A 79 €

T1405000 Tiapride hydrochloride 1 60 mg 1 1575 +5°C ± 3°C A1A 79 €

New T1405050 Tiapride N-oxide 2 15 mg 1 Batch 1 is valid until 31 July 2018 1575 +5°C ± 3°C A1A 79 €

T1410900 Tiaprofenic acid 1 50 mg 1 1157 +5°C ± 3°C A1A 79 €

T1410910 Tiaprofenic acid impurity C 1 20 mg 1 (2RS)-2-(5-benzoylthiophen-3-yl)propanoic acid 1157 +5°C ± 3°C A1A 79 €

Y0000748 Tibolone - reference spectrum 1 n/a 1 1739 L 79 €

Y0000668 Tibolone for system suitability 1 10 mg 1 1739 +5°C ± 3°C B1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 98For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000465 Ticarcillin monosodium 3 250 mg 1 see leaflet 0956 -20°C ± 5°C

C1a 79 €

T1420010 Ticarcillin impurity A 2 50 mg 1 See leaflet; (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[[(thiophen-3-yl)acetyl]-amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid (decarboxyticarcillin)

0956 +5°C ± 3°C A1A 79 €

T1423000 Ticlopidine hydrochloride 3 50 mg 1 1050 +5°C ± 3°C A1A 79 €

T1423025 Ticlopidine impurity F 3 15 mg 1 6-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine 1050 +5°C ± 3°C A1A 79 €

New Y0001940 Tigecycline for system suitability 1 10 mg 1 2825 -20°C ± 5°C

C1a 79 €

New Y0001944 Tigecycline impurity B 1 10 mg 1 (4S,4aS,5aR,12aS)-9-amino-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1, 4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide (9-aminominocycline)

2825 -20°C ± 5°C

C1a 79 €

Y0000325 Tilidine hydrochloride hemihydrate - reference spectrum

1 n/a 1 1767 L 79 €

Y0000644 (R)-timolol 3 20 mg 1 Batch 2 is valid until 31 January 2018 0572 +5°C ± 3°C A1A 79 €

T1450000 Timolol maleate 4 100 mg 1 Batch 3 is valid until 28 February 2018 0572 +5°C ± 3°C A1A 79 €

Y0001690 Timolol impurity F 1 10 mg 1 4-(4-chloro-1,2,5-thiadiazol-3-yl)morpholine 0572 +5°C ± 3°C A1A 79 €

Y0001270 Timolol for system suitability 2 5.045 mg 1 0572 +5°C ± 3°C A1A 79 €

T1470000 Tinidazole 1 100 mg 1 1051 +5°C ± 3°C A1A 79 €

Y0000899 Tinidazole impurity A 1 15 mg 1 2-methyl-5-nitro-1H-imidazole 1051 +5°C ± 3°C A1A 79 €

T1471000 Tinidazole impurity B 4 20 mg 1 1-[2-(ethylsulphonyl)ethyl]-2-methyl-4-nitro-1H-imidazole 1051 +5°C ± 3°C A1A 79 €

T1490000 Tinzaparin sodium 1 250 mg 1 1271 +5°C ± 3°C A1a 79 €

Y0000292 Tioconazole - reference spectrum 1 n/a 1 2074 L 79 €

Y0000282 Tioconazole for system suitability 1 50 mg 1 2074 +5°C ± 3°C A1A 79 €

Y0001188 Tiotropium bromide monohydrate 1 10 mg 1 2420 +5°C ± 3°C A1A 79 €

Y0001929 Tiotropium for system suitability 1 1 10 mg 1 2420 +5°C ± 3°C A1a 79 €

Y0001179 Tiotropium impurity mixture 2 0.08 mg 1 2420 +5°C ± 3°C A1a 79 €

Y0001700 Tizanidine hydrochloride 1 100 mg 1 See leaflet C„H„ClœN—S 2578 +5°C ± 3°C A1A 79 €

Y0001698 Tizanidine impurity B 1 10 mg 1 N-(5-chloro-2,1,3-benzothiadiazol-4-yl)thiourea 2578 +5°C ± 3°C A1A 79 €

T1500000 Tobramycin 4 49 mg 1 See leaflet CŒ‡H–ŸN—O„; Suitable for LC assay only 0645 +5°C ± 3°C A1A 79 €

Y0001210 Tobramycin for identification 1 250 mg 1 Suitable for identification tests only 0645 +5°C ± 3°C A1A 79 €

T1550000 alpha-Tocopherol 8 1.5 mL 1 See leaflet Cœ„H—ÐOœ ; Vitamin E 0692,1256 +5°C ± 3°C A1A 79 €

New T1600000 alpha-Tocopheryl acetate 10 500 mg 1 See leaflet C–ŒH—œO– ; Batch 9 is valid until 30 April 2018 0439,0691,1257

+5°C ± 3°C A1A 79 €

Y0000383 All-rac-alpha-tocopherol for peak identification 3 50 mg 1 0692 +5°C ± 3°C A1a 79 €

New Y0000384 All-rac-alpha-tocopheryl acetate for peak identification

3 30 mg 1 Batch 2 is valid until 30 June 2018 0439 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 99For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

T1610000 RRR-alpha-Tocopheryl hydrogen succinate 1 150 mg 1 See leaflet C––H—÷O— 1258,1259 +5°C ± 3°C A1A 79 €

T1700000 Tolbutamide 1 100 mg 1 0304 +5°C ± 3°C A1A 79 €

Y0000154 Tolfenamic acid 1 100 mg 1 2039 +5°C ± 3°C A1A 79 €

T1707000 Tolnaftate 1 60 mg 1 1158 +5°C ± 3°C A1A 79 €

Y0001123 Tolnaftate for system suitability 1 10 mg 1 1158 +5°C ± 3°C A1A 79 €

Y0001696 Tolterodine tartrate 1 5 mg 1 2781 +5°C ± 3°C A1A 79 €

Y0001699 Tolterodine impurity E 1 5 mg 1 4-methyl-2-[(1RS)-3-[(1-methylethyl)amino]-1-phenylpropyl]phenol

2781 +5°C ± 3°C A1A 79 €

Y0001697 Tolterodine for system suitability 1 5 mg 1 2781 +5°C ± 3°C A1A 79 €

Y0000461 Torasemide anhydrous 1 10 mg 1 2132 +5°C ± 3°C A1A 79 €

Y0001366 Torasemide impurity E 2 0.0006 mg 1 ethyl [[4-[(3-methylphenyl)amino]pyridin-3-yl]sulfonyl]carbamate ; Batch 1 is valid until 31 August 2017

2132 +5°C ± 3°C A1A 79 €

Y0000462 Torasemide for system suitability 2 5 mg 1 2132 +5°C ± 3°C A1A 79 €

Y0000155 Tramadol hydrochloride 3 75 mg 1 1681 +5°C ± 3°C A1A 79 €

Y0000156 Tramadol impurity A 4 25 mg 1 (1RS,2SR)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-cyclohexanol

1681 +5°C ± 3°C A1A 79 €

Y0000157 Tramadol impurity E 4 15 mg 1 (2RS)-2-[(dimethylamino)methyl]cyclohexanone 1681 +5°C ± 3°C A1A 79 €

Y0000072 Tramazoline hydrochloride monohydrate 1 20 mg 1 1597 +5°C ± 3°C A1a 79 €

Y0000065 Tramazoline impurity A 2 15 mg 1 N-(naphthalen-1-yl)-4,5-dihydro-1H-imidazol-2-amine 1597 +5°C ± 3°C A1A 79 €

Y0000066 Tramazoline impurity B 2 15 mg 1 See leaflet; Mixture of 1-acetyl-N-(5,6,7,8-tetrahydronaphthalen-1-yl)-4,5-dihydro-1H-imidazol-2-amine and 1-[(EZ)-1-[(5,6,7,8-tetrahydronaphthalen-1-yl)imino]ethyl]imidazolidin-2-one

1597 +5°C ± 3°C A1A 79 €

Y0000501 Trandolapril 1 10 mg 1 2245 +5°C ± 3°C A1A 79 €

Y0000495 Trandolapril impurity C 1 10 mg 1 (2S,3aR,7aS)-1-[(2S)-2-[[(1S)-3-cyclohexyl-1-(ethoxycarbonyl)propyl]amino]propanoyl]octahydro-1H-indole-2-carboxylic acid (hexahydrotrandolapril)

2245 +5°C ± 3°C A1A 79 €

Y0000496 Trandolapril impurity D 1 10 mg 1 ethyl (2S)-2-[(3S,5aS,9aR,10aS)-3-methyl-1,4-dioxodecahydropyrazino[1,2-a]indol-2(1H)-yl]-4-phenylbutanoate (trandolapril diketopiperazine)

2245 +5°C ± 3°C A1A 79 €

T1810000 Tranexamic acid 5 50 mg 1 0875 +5°C ± 3°C A1A 79 €

T1820000 Trapidil 1 50 mg 1 1576 +5°C ± 3°C A1A 79 €

T1820002 Trapidil impurity A 1 20 mg 1 5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-ol 1576 +5°C ± 3°C A1A 79 €

T1820004 Trapidil impurity B 1 20 mg 1 1,2,4-triazol-3-amine 1576 +5°C ± 3°C A1A 79 €

Y0001172 Trehalose dihydrate 1 250 mg 1 See leaflet CŒœHœœOŒŒ,2HœO 2297 +5°C ± 3°C A1A 79 €

T1850000 Tretinoin 2 50 mg 1 0693,1019,1385

+5°C ± 3°C B1A 79 €

G0400010 Triacetin - reference spectrum 1 n/a 1 1106 L 79 €

T1899990 Triamcinolone 2 150 mg 1 1376 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 100For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

T1900000 Triamcinolone acetonide 6 150 mg 1 See leaflet Cœ÷H–ŒFOÿ 0533,0867,1075

+5°C ± 3°C A1A 79 €

Y0001459 Triamcinolone acetonide for system suitability 2 10 mg 1 Batch 1 is valid until 31 December 2017 0533 +5°C ± 3°C A1A 79 €

Y0000050 Triamcinolone impurity C 1 10 mg 1 9-fluoro-11β,16α,17,21-tetrahydroxypregn-4-ene-3,20-dione (pretriamcinolone)

1376 +5°C ± 3°C A1A 79 €

T1950000 Triamcinolone hexacetonide 3 100 mg 1 See leaflet C–ÐH÷ŒFOŸ 0533,0867 +5°C ± 3°C A1A 79 €

Y0001843 Triamcinolone Hexacetonide for system suitability

1 10 mg 1 0867 +5°C ± 3°C A1a 79 €

Y0000837 Triamterene 1 10 mg 1 0058 +5°C ± 3°C A1A 79 €

Y0000870 Triamterene impurity B 1 0.5 mg 1 2,7-diamino-6-phenylpteridin-4-ol 0058 +5°C ± 3°C A1A 79 €

T1975000 Triazolam - * psy 1 10 mg 1 1065 +5°C ± 3°C A2A 79 €

Y0000165 Tribenoside 4 150 mg 1 See leaflet ; Batch 3 is valid until 28 February 2018 1740 -20°C ± 5°C

C1A 79 €

Y0000166 Tribenoside impurity A 4 70 mg 1 See leaflet C–ÐH–÷Oÿ; 3,5,6-tri-O-benzyl-1,2-O-(1-methylethylidene)-

α-d-glucofuranose 1740 -20°C ±

5°CC1A 79 €

Y0001628 Tribenoside impurity D 1 35 mg 1 Benzyl ether 1740 +5°C ± 3°C A1A 79 €

Y0001055 Tributyl acetylcitrate 2 1 mL 1 1770 +5°C ± 3°C A1A 79 €

Y0000799 Tributyl acetylcitrate for peak identification 1 25 mg 1 1770 +5°C ± 3°C A1A 79 €

T1977990 Tricaprin 2 150 mg 1 Batch 1 is valid until 31 May 2017 1410 -20°C ± 5°C

C1A 79 €

T1977995 Tricaproin 1 40 mg 1 1410 -20°C ± 5°C

C1A 79 €

New T1978000 Tricaprylin 2 450 mg 1 Batch 1 is valid until 31 July 2018 1410 -20°C ± 5°C

C1a 79 €

Y0000111 Trichloroacetic acid - reference spectrum 1 n/a 1 1967 L 79 €

T1985000 Trichlorotrifluoroethane 1 2.5 ml 1 0393 +5°C ± 3°C A1A 79 €

Y0001737 Triclabendazole 1 10 mg 1 2609 +5°C ± 3°C A1A 79 €

Y0001723 Triclabendazole for system suitability 1 0.012 mg 1 2609 +5°C ± 3°C A1A 79 €

T1986000 Triethyl citrate - reference spectrum 1 n/a 1 1479 L 79 €

T2000000 Trifluoperazine hydrochloride 1 100 mg 1 0059 +5°C ± 3°C A1A 79 €

T2005000 Triflusal 1 50 mg 1 1377 +5°C ± 3°C A1A 79 €

T2005010 Triflusal impurity B 1 15 mg 1 2-hydroxy-4-(trifluoromethyl)benzoic acid (4-(trifluoromethyl)salicylic acid)

1377 +5°C ± 3°C A1A 79 €

Y0000720 Triglycerol diisostearate 1 200 mg 1 2032 +5°C ± 3°C A1A 79 €

Y0000108 Trihexyphenidyl hydrochloride 1 100 mg 1 1626 +5°C ± 3°C A1A 79 €

New Y0000068 Trihexyphenidyl impurity A 2 20 mg 1 1-phenyl-3-(piperidin-1-yl)propan-1-one ; Batch 1 is valid until 31 May 2018

1626 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 101For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

T2009000 Trilaurin 3 1250 mg 1 1410 -20°C ± 5°C

C1A 79 €

Y0001319 Trimebutine maleate 1 10 mg 1 2182 +5°C ± 3°C A1A 79 €

Y0001260 Trimebutine for system suitability 2 1.02 mg 1 2182 +5°C ± 3°C A1a 79 €

Y0000092 Trimetazidine dihydrochloride - reference spectrum

1 n/a 1 1741 L 79 €

Y0000093 Trimetazidine for system suitability 3 50 mg 1 1741 +5°C ± 3°C A1A 79 €

T2100000 Trimethadione 1 250 mg 1 See leaflet CÿH„NO– 0440 +5°C ± 3°C A1A 79 €

T2200000 Trimethoprim 1 50 mg 1 0060 +5°C ± 3°C A1A 79 €

T2200010 Trimethoprim impurity B 5 15 mg 1 (2,4-diaminopyrimidin-5-yl)(3,4,5-trimethoxyphenyl)methanone 0060 +5°C ± 3°C A1a 79 €

Y0000684 Trimethoprim for system suitability 4 0.00075 mg

1 0060 +5°C ± 3°C A1A 79 €

Y0001497 3-trimethylsilyl-1-propanesulfonic acid sodium salt

2 120 mg 1 See leaflet CÿHŒ—O–SSi,Na 2645, 2165 +5°C ± 3°C A1a 79 €

T2450000 Trimethyltetradecylammonium bromide 2 200 mg 1 0378 +5°C ± 3°C A1A 79 €

T2500000 Trimipramine maleate 1 100 mg 1 0534 +5°C ± 3°C A1A 79 €

Y0000759 Trimipramine for peak identification 1 0.51 mg 1 0534 +5°C ± 3°C A1a 79 €

T2500100 Trimyristin 2 500 mg 1 1410 -20°C ± 5°C

C1A 79 €

Y0000279 Tri-n-butyl phosphate 1 300 µl 1 1682 +5°C ± 3°C A1A 79 €

Y0001113 Triolein 2 30 mg 1 See leaflet C—ŸHŒÐ÷Oÿ ; Batch 1 is valid until 31 December 2017 2454 -20°C ± 5°C

C1A 79 €

T2501200 Tristearin 1 100 mg 1 1410 -20°C ± 5°C

C1A 79 €

T2545000 Trolamine 3 2250 mg 1 1577 +5°C ± 3°C A1A 79 €

Y0001184 Trolamine impurity A 2 250 mg 1 2-aminoethanol (ethanolamine) 1577 +5°C ± 3°C A1A 79 €

Y0001183 Trolamine impurity B 3 1.5 mL 1 2,2′-iminodiethanol (diethanolamine) 1577 +5°C ± 3°C A1A 79 €

T2550000 Trometamol 4 100 mg 1 1053 +5°C ± 3°C A1A 79 €

T2580000 Tropicamide 2 50 mg 1 1159,1197 +5°C ± 3°C A1A 79 €

Y0001247 Tropicamide impurity C 1 10 mg 1 (2RS)-3-hydroxy-2-phenylpropanoic acid (tropic acid) 1159 +5°C ± 3°C A1A 79 €

Y0001248 Tropicamide impurity D (Phenylacetic acid - * Drug Precursor)

1 10 mg 1 Phenylacetic acid 1159 +5°C ± 3°C A3A 79 €

Y0001316 Tropicamide for peak identification 1 10 mg 1 1159 +5°C ± 3°C A1A 79 €

T2580300 Tropine 1 50 mg 1 1308, 2102 +5°C ± 3°C A1A 79 €

Y0000616 Tropisetron hydrochloride 1 40 mg 1 2102 +5°C ± 3°C A1A 79 €

Y0000618 Tropisetron impurity B 1 10 mg 1 1H-indole-3-carboxylic acid 2102 +5°C ± 3°C A1A 79 €

Y0000429 Trospium chloride 1 10 mg 1 1798 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 102For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000432 Trospium impurity A 1 20 mg 1 hydroxydiphenylacetic acid (benzilic acid) 1798 +5°C ± 3°C A1A 79 €

Y0000431 Trospium impurity B 3 20 mg 1 (1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl hydroxydiphenylacetate ; Batch 2 is valid until 30 April 2018

1798 +5°C ± 3°C A1A 79 €

Y0000430 Trospium impurity C 3 5 mg 1 (1R,3R,5S)-3-hydroxyspiro[8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium]

1798 +5°C ± 3°C A1A 79 €

Y0000497 Troxerutin 1 30 mg 1 2133 +5°C ± 3°C A1A 79 €

T2600000 Trypsin BRP 2 100 mg 1 See leaflet 0476,0579,0580, 0694

+5°C ± 3°C A1A 79 €

T2610000 Tryptophan 2 100 mg 1 See leaflet 1272, 2290 +5°C ± 3°C A1A 79 €

T2880000 Tylosin 2 150 mg 1 See leaflet 1273,1274,1661,20702,2802

+5°C ± 3°C A1A 79 €

Y0001927 Tylosin Phosphate 1 10 mg 1 1661, 2802 +5°C ± 3°C A1a 79 €

Y0001914 Tylosin for system suitability 1 10 mg 1 1273, 1274, 1661, 2802

+5°C ± 3°C A1a 79 €

T2880200 Tylosin tartrate - reference spectrum 1 n/a 1 1274 L 79 €

Y0001928 Tylosin tartrate 1 10 mg 1 1274 +5°C ± 3°C A1a 79 €

T2900000 Tyrosine 2 50 mg 1 1161, 1384 +5°C ± 3°C A1A 79 €

T3000000 Tyrothricin 2 20 mg 1 0907,1662 +5°C ± 3°C A1A 79 €

U0020000 Ubidecarenone 3 70 mg 1 See leaflet C—„H„ÐO÷ 1578 +5°C ± 3°C A1A 79 €

U0020008 Ubidecarenone impurity D 2 5 mg 1 5,6-dimethoxy-3-methyl-2-[(all-E)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaenyl]benzene-1,4-dione (ubiquinone-9)

1578 +5°C ± 3°C A1a 79 €

Y0001861 Uncaria stem with hooks dry extract for system suitability

1 10 mg 1 2729 -20°C ± 5°C

C1a 79 €

U0020001 Ubidecarenone for system suitability 3 1 mg 1 1578 +5°C ± 3°C A1A 79 €

U0100000 Uracil arabinoside 2 60 mg 1 0760 +5°C ± 3°C A1A 79 €

U0600000 Urea 2 100 mg 1 0743 +5°C ± 3°C A1A 79 €

U0800000 Ursodeoxycholic acid 3 100 mg 1 Batch 2 is valid until 30 June 2017 1189,1275 +5°C ± 3°C A1A 79 €

Y0001163 Ursodeoxycholic acid for system suitability 3 1.26 mg 1 1275 +5°C ± 3°C A1A 79 €

Y0001523 Ursolic acid 1 25 mg 1 See leaflet C–ÐH÷‡O– 2439 +5°C ± 3°C A1A 79 €

Y0000834 Valaciclovir hydrochloride (anhydrous) 1 100 mg 1 See leaflet CŒ–HœŒNÿO÷Cl 1768,2751 +5°C ± 3°C A1A 79 €

Y0001096 Valaciclovir impurity D 1 10 mg 1 2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-ethyl-l-valinate

1768 +5°C ± 3°C A1A 79 €

Y0001097 Valaciclovir impurity E 1 10 mg 1 2-[(2-amino-6-oxo-1,6 dihydro-9H-purin-9-yl)methoxy]ethyl N-[(benzyloxy)carbonyl]-L-valinate

1768 +5°C ± 3°C A1A 79 €

Y0001098 Valaciclovir impurity F para-toluenesulfonate 1 12 mg 1 2-hydroxyethyl L-valinate 1768 +5°C ± 3°C A1A 79 €

Y0001099 Valaciclovir impurity G 1 10 mg 1 N,N-dimethylpyridin-4-amine 1768,2751 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 103For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0001662 Valaciclovir impurity P 1 5 mg 1 2,2′-[methylenebis[imino(6-oxo-1,6-dihydro-9H-purine-9,2-diyl)methyleneoxy]]diethyl di(l-valinate)

2751 -20°C ± 5°C

C1a 79 €

Y0001655 Valaciclovir impurity S 1 15 mg 1 2751 +5°C ± 3°C A1A 79 €

Y0001225 Valaciclovir for system suitability 1 10 mg 1 1768,2751 +5°C ± 3°C A1A 79 €

Y0000583 Valerian dry extract 3 400 mg 1 See leaflet 0453,1898,1899,2400,2526

-20°C ± 5°C

C1A 79 €

New V0030000 Valine 2 50 mg 1 Batch 1 is valid until 31 July 2018 0796 +5°C ± 3°C A1A 79 €

Y0000584 Valnemulin hydrochloride 1 10 mg 1 2137 +5°C ± 3°C A1A 79 €

Y0000586 Valnemulin impurity E 1 10 mg 1 (3aS,4R,5S,6S,8R,9R,9aR,10R)-6-ethenyl-5-hydroxy-4,6,9,10-tetramethyl-1-oxodecahydro-3a,9-propano-3aH-cyclopenta[8]annulen-8-yl 2-hydroxyacetate (pleuromulin)

2137 +5°C ± 3°C A1A 79 €

Y0000585 Valnemulin for peak identification 1 10.25 mg 1 2137 +5°C ± 3°C A1A 79 €

Y0000533 Valnemulin hydrogen tartrate 1 120 mg 1 See leaflet C–—H—‡NœOŒŒS 2137 +5°C ± 3°C A1A 79 €

V0033000 Valproic acid 3 100 mg 1 1378 +5°C ± 3°C A1A 79 €

Y0001422 Valproic acid for system suitability 3 10 mg 1 0678,1378 +5°C ± 3°C A1A 79 €

Y0001132 Valsartan 1 15 mg 1 2423 +5°C ± 3°C A1A 79 €

Y0001131 Valsartan for peak identification 2 10 mg 1 2423 +5°C ± 3°C A1A 79 €

Y0001145 Valsartan for system suitability 3 0.202 mg 1 Batch 2 is valid until 31 January 2018 2423 +5°C ± 3°C A1A 79 €

V0045000 Vancomycin hydrochloride 3 100 mg 1 See leaflet 1058,20702 -20°C ± 5°C

C1a 79 €

V0050000 Vanillin 2 100 mg 1 0747 +5°C ± 3°C A1A 79 €

Y0001648 Vardenafil for system suitability 1 10 mg 1 2782 +5°C ± 3°C A1A 79 €

Y0001647 Vardenafil hydrochloride 1 120 mg 1 See leaflet 2782 +5°C ± 3°C A1A 79 €

Y0001198 Varicella vaccine ( live) 1 420 mg 1 See leaflet 0648, 2442 -20°C ± 5°C

D1A 90 €

Y0000561 Vecuronium bromide 1 10 mg 1 1769 +5°C ± 3°C A1A 79 €

Y0001862 Vecuronium for system suitability 1 15 mg 1 1769 +5°C ± 3°C A1a 79 €

Y0001093 Vedaprofen 1 5 mg 1 2248 +5°C ± 3°C A1A 79 €

Y0001118 Vedaprofen impurity mixture 1 0.006 mg 1 2248 +5°C ± 3°C A1A 79 €

Y0000587 Venlafaxine hydrochloride 2 50 mg 1 2119 +5°C ± 3°C A1A 79 €

Y0000588 Venlafaxine for system suitability 3 1.002 mg 1 2119 +5°C ± 3°C A1a 79 €

V0100000 Verapamil hydrochloride 1 100 mg 1 0573 +5°C ± 3°C A1A 79 €

V0100018 Verapamil impurity I 3 5 mg 1 (2RS)-2-(3,4-dimethoxyphenyl)-2-[2-[[2-(3,4-dimethoxy-phenyl)ethyl](methyl)amino]ethyl]-3-methylbutanenitrile

0573 +5°C ± 3°C A1A 79 €

V0100026 Verapamil impurity M 2 10 mg 1 5,5'-[[2-(3,4-dimethoxyphenyl)ethyl]imino]bis[2-(3,4-dimethoxyphenyl)-2-(1-methylethyl)pentanenitrile]

0573 +5°C ± 3°C A1A 79 €

Y0000661 Verbenalin 1 11 mg 1 See leaflet CŒŸHœ÷OŒÐ 1854 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 104For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

V0180000 VERO cells 1 1 ml 2 Cell lines (kidney, african green monkey, Cercopithecus aethiops) titration of live measles, mumps and rubella vaccines

0213,0538,1057

Liquid nitrogen

D1A 100 €

Y0001400 Vigabatrin 1 10 mg 1 2305 +5°C ± 3°C A1A 79 €

Y0001401 Vigabatrin impurity A 1 25 mg 1 See leaflet CÿH„NO; (5RS)-5-ethenylpyrrolidin-2-one 2305 -20°C ± 5°C

C1A 79 €

Y0001402 Vigabatrin impurity B 1 20 mg 1 (2E)-2-(2-aminoethyl)but-2-enoic acid 2305 +5°C ± 3°C A1A 79 €

Y0001404 Vigabatrin impurity D 1 50 mg 1 4-aminobutanoic acid 2305 +5°C ± 3°C A1A 79 €

Y0001403 Vigabatrin impurity E 1 10 mg 1 2-[(2RS)-2-aminobut-3-enyl]propanedioic acid 2305 +5°C ± 3°C A1A 79 €

V0300000 Vinblastine sulfate 4 5 mg 1 See leaflet C÷ÿHÿÐN÷OŒ–S 0748,0749 -80°C ± 10°C

D1A 79 €

V0305000 Vinblastine sulfate - reference spectrum 1 n/a 1 0748 L 79 €

V0400000 Vincristine sulfate 5 4.96 mg 1 see leaflet 0748,0749 -80°C ± 10°C

D1A 79 €

V0405000 Vincristine sulfate - reference spectrum 1 n/a 1 0749 L 79 €

V0500000 Vindesine sulfate 3 5 mg 1 See leaflet C÷–H—ŸN—OŒŒS 1276 -80°C ± 10°C

D1A 79 €

V0500010 Vindesine sulfate - reference spectrum 1 n/a 1 1276 L 79 €

Y0000463 Vinorelbine tartrate 3 50 mg 1 2107 -80°C ± 10°C

D1A 79 €

New Y0001938 Vinorelbine for peak identification A 1 10 mg 1 2107 -80°C ± 10°C

D1A 79 €

New Y0001939 Vinorelbine for peak identification B 1 10 mg 1 2107 -80°C ± 10°C

D1A 79 €

Y0000464 Vinorelbine impurity B 4 7 mg 1 methyl (3aR,4R,5S,5aR,10bR,13aR)-3a-ethyl-9-[(6R,8S)-4-ethyl-8-(methoxycarbonyl)1,3,6,7,8,9-hexahydro-2,6-methano-2H-azacyclodecino[4,3-b]indol-8-yl]-4,5-dihydroxy-8-methoxy-6-methyl-3a,4,5,5a,6,11,12,13a-octahydro-1Hindolizino[8,1-cd]carbazole-5-carboxylate This reference standard will be deleted from monograph 01/2008:2107 corrected 7.0 on 2018/04/01. ; Batch 4 is valid until 31 March 2018

2107 -80°C ± 10°C

D1A 79 €

Y0000589 Vinpocetine 1 10 mg 1 2139 +5°C ± 3°C A1A 79 €

Y0000590 Vinpocetine impurity A 3 15 mg 1 ethyl (12S,13aS,13bS)-13a-ethyl-12-hydroxy-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate (ethyl vincaminate) ; Batch 2 is valid until 31 March 2018

2139 +5°C ± 3°C A1A 79 €

Y0000591 Vinpocetine impurity B 2 10 mg 1 methyl (13aS,13bS)-13a-ethyl-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate (apovincamine)

2139 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 105For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Y0000790 Vinpocetine impurity C 2 15 mg 1 ethyl (13aS,13bS)-13a-ethyl-10-methoxy-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate (methoxyvinpocetine)

2139 +5°C ± 3°C A1a 79 €

Y0000760 Vinpocetine impurity D 2 10 mg 1 ethyl (12RS,13aRS,13bRS)-13a-ethyl-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate (dihydrovinpocetine) ; Batch 1 is valid until 28 February 2017

2139 +5°C ± 3°C A1A 79 €

Y0000793 Vinyl acetate 1 200 mg 2 Batch 1 is valid until 31 July 2018 2152,2523 +5°C ± 3°C A1a 79 €

Y0001395 Voriconazole 2 120 mg 1 See leaflet CŒÿHŒ÷F–N—O 2576 +5°C ± 3°C A1A 79 €

Y0001396 Voriconazole impurity B 2 10 mg 1 (2RS,3SR)-2-(2,4-difluorophenyl)-3-pyrimidin-4-yl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

2576 +5°C ± 3°C A1A 79 €

Y0001398 Voriconazole impurity D 2 10 mg 1 (2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol (voriconazole enantiomer)

2576 +5°C ± 3°C A1A 79 €

Y0001397 Voriconazole impurity E 1 50 mg 1 [(1R,4S)-7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-yl]methanesulfonic acid ((+-)-camphorsulfonic acid)

2576 +5°C ± 3°C A1A 79 €

New Y0001975 Zolmitriptan 1 30 mg 1 See leaflet CŒÿHœŒN–Oœ 2737 +5°C ± 3°C A1a 79 €

New Y0001991 Zolmitriptan for system suitability 1 10 mg 1 2737 +5°C ± 3°C A1a 79 €

New Y0001986 Zolmitriptan impurity A n/a 10 mg 1 2737 +5°C ± 3°C A1a 79 €

W0100000

Warfarin sodium 2 10 mg 1 0698 +5°C ± 3°C A1A 79 €

Y0000778 Warfarin sodium clathrate 1 10 mg 1 0699 +5°C ± 3°C A1A 79 €

Y0001599 Wedelolactone 1 15 mg 1 See leaflet 2564 -20°C ± 5°C

C1A 79 €

X0075000 Xylazine hydrochloride 1 125 mg 1 1481 +5°C ± 3°C A1A 79 €

Y0000158 Xylazine impurity C 3 50 mg 1 2,6-dimethylphenyl isothiocyanate ; Batch 2 is valid until 28 February 2017

1481 +5°C ± 3°C A1A 79 €

Y0001224 Xylazine impurity mixture 1 0.02 mg 1 1481 +5°C ± 3°C A1A 79 €

X0080000 Xylitol 2 500 mg 1 See leaflet 1381 +5°C ± 3°C A1A 79 €

X0100000 Xylometazoline hydrochloride 3 100 mg 1 0972,1162 +5°C ± 3°C A1A 79 €

X0101000 Xylometazoline impurity A 3 15 mg 1 N-(2-aminoethyl)-2-[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]acetamide ; Batch 2 is valid until 30 June 2017

1162 +5°C ± 3°C A1A 79 €

X0200000 Xylose 1 100 mg 1 1278 +5°C ± 3°C A1A 79 €

Y0000656 Yohimbine hydrochloride 1 20 mg 1 See leaflet CœŒHœŸClNœO– 2172 +5°C ± 3°C A1A 79 €

Y0001715 Zanamivir hydrate 1 5 mg 1 2611 +5°C ± 3°C A1A 79 €

Y0001703 Zanamivir impurity F 1 10 mg 1 see leaflet C÷HŸClN÷; 1H-pyrazole-1-carboximidamide 2611 +5°C ± 3°C A1A 79 €

Y0001702 Zanamivir for assay 1 50 mg 1 see leaflet CŒœHœÐN÷OŸ 2611 +5°C ± 3°C A1A 79 €

Y0001708 Zanamivir for system suitability 1 10 mg 1 2611 +5°C ± 3°C A1A 79 €

List of European Pharmacopoeia Reference Standards Effective from 2018/2/12

© Council of Europe, all rights reserved 2018 106For extra charges, please see terms and conditions.

DGD : Dangerous Goods Declaration.

Order Code

Reference Standard Batch n°

Quantity per vial

Sale Unit

Information Monograph Storage Shipping group

Shipment with DGD

Price

Z1900000 Zidovudine 3 60 mg 1 see leaflet 1059 +5°C ± 3°C A1A 79 €

Z1904000 Zidovudine impurity B 3 5 mg 1 1-(3-chloro-2,3-dideoxy-β-d-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione

1059 +5°C ± 3°C A1A 79 €

Y0001654 Zidovudine impurity D 1 15 mg 1 Triphenylmethanol 1059 +5°C ± 3°C A1A 79 €

Y0001641 Zidovudine for system suitability 1 10 mg 1 1059 +5°C ± 3°C A1A 79 €

Y0001807 Pregabalin impurity B 1 5 mg 1 (3R)-3-(aminomethyl)-5-methylhexanoic acid (pregabalin enantiomer)

2777 +5°C ± 3°C A1a 79 €

Z2000000 Zinc acexamate 1 50 mg 1 1279 +5°C ± 3°C A1A 79 €

Z2000010 Zinc acexamate impurity A 1 50 mg 1 6-[[6-(acetylamino)hexanoyl]amino]hexanoic acid 1279 +5°C ± 3°C A1A 79 €

Y0001286 Ziprasidone hydrochloride monohydrate 1 100 mg 1 see leaflet CœŒHœœClœN÷OS 2421,2649 +5°C ± 3°C A1A 79 €

Y0001626 Ziprasidone mesilate trihydrate 1 30 mg 1 2649 +5°C ± 3°C A1A 79 €

Y0001272 Ziprasidone for system suitability 1 1 10 mg 1 2421, 2649 +5°C ± 3°C A1A 79 €

Y0001241 Ziprasidone for system suitability 2 1 0.465 mg 1 2421, 2649 +5°C ± 3°C A1A 79 €

Z2500000 Zolpidem tartrate - * psy 3 200 mg 1 1280 +5°C ± 3°C A2A 79 €

Z2500010 Zolpidem impurity A 4 10 mg 1 N,N-dimethyl-2-[7-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide

1280 +5°C ± 3°C A1A 79 €

Z3000000 Zopiclone -* psy 2 40 mg 1 1060 +5°C ± 3°C A2A 79 €

Y0001822 Zopiclone Impurity B 1 10 mg 1 (7RS)-6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one

1060 +5°C ± 3°C A1a 79 €

Z3001000 Zopiclone oxide 3 20 mg 1 1060 +5°C ± 3°C A1a 79 €

Y0000062 Zuclopenthixol decanoate - reference spectrum

1 n/a 1 1707 L 79 €

Y0000083 Zuclopenthixol impurity B 1 10 mg 1 2-chloro-9H-thioxanthen-9-one 1707 +5°C ± 3°C A1A 79 €

Y0000534 Zuclopenthixol for system suitability 1 0.26 mg 1 1707 +5°C ± 3°C A1A 79 €